Sentence,class,file
URL http://www.pubmedcentral.nih.gov/ articlerender.fcgi?artid=3361592&tool=pmcentrez&rendertype=abstract.,OADS,/arxiv_data1/oa_pdf/59/65/IMM-148-227.PMC4913286.pdf
URL http://dx.doi.org/10.1038/nri3045.,OADS,/arxiv_data1/oa_pdf/59/65/IMM-148-227.PMC4913286.pdf
Front Immunol 2013; 4:113.. URL http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3653108&tool=pmcen-trez&rendertype=abstract.,OADS,/arxiv_data1/oa_pdf/59/65/IMM-148-227.PMC4913286.pdf
URL http://dx.doi.org/10.1016/B978-0- 12-381978-9.10092-7.,OADS,/arxiv_data1/oa_pdf/59/65/IMM-148-227.PMC4913286.pdf
URL http://www.mdpi.com/2072-6643/7/9/5383/.,Non-OADS,/arxiv_data1/oa_pdf/59/65/IMM-148-227.PMC4913286.pdf
URL http://www.jimmunol.org/cgi/doi/10.4049/jim- munol.164.5.2405.,OADS,/arxiv_data1/oa_pdf/59/65/IMM-148-227.PMC4913286.pdf
URL http://www.jim- munol.org/cgi/doi/10.4049/jimmunol.178.1.145.,Non-OADS,/arxiv_data1/oa_pdf/59/65/IMM-148-227.PMC4913286.pdf
URL http://www.jimmunol.org/cgi/doi/ 10.4049/jimmunol.170.11.5382.,Non-OADS,/arxiv_data1/oa_pdf/59/65/IMM-148-227.PMC4913286.pdf
URL http://dx.doi.org/10.1038/nri3771.,OADS,/arxiv_data1/oa_pdf/59/65/IMM-148-227.PMC4913286.pdf
URL http://dx.doi.org/10.1016/j.immuni.2013.04.005.,OADS,/arxiv_data1/oa_pdf/59/65/IMM-148-227.PMC4913286.pdf
URL http://www.pubmedcentral.nih.gov/articlerender.fcgi?ar- tid=19387&tool=pmcentrez&rendertype=abstract.,OADS,/arxiv_data1/oa_pdf/59/65/IMM-148-227.PMC4913286.pdf
URL http://linkinghub.el- sevier.com/retrieve/pii/S2211124715000261.,Non-OADS,/arxiv_data1/oa_pdf/59/65/IMM-148-227.PMC4913286.pdf
J Steroid Biochem Mol Biol 2013; 136:160–5.. URL http://www.ncbi.nlm.nih.gov/pubmed/ 23098690.,OADS,/arxiv_data1/oa_pdf/59/65/IMM-148-227.PMC4913286.pdf
URL http://www.annualre- views.org/doi/abs/10.1146/annurev-immunol-032414-112220.,Non-OADS,/arxiv_data1/oa_pdf/59/65/IMM-148-227.PMC4913286.pdf
URL http://www.pubmedcentral.nih.gov/articlerender.fcgi?ar- tid=2778256&tool=pmcentrez&rendertype=abstract.,OADS,/arxiv_data1/oa_pdf/59/65/IMM-148-227.PMC4913286.pdf
URL http://linkinghub.elsevier.com/retrieve/ pii/S1074761315003222.,Non-OADS,/arxiv_data1/oa_pdf/59/65/IMM-148-227.PMC4913286.pdf
URL http://www.ncbi.nlm.nih.gov/pubmed/23812096.,OADS,/arxiv_data1/oa_pdf/59/65/IMM-148-227.PMC4913286.pdf
URL http://www.ncbi.nlm.nih.gov/pubmed/25033907.,OADS,/arxiv_data1/oa_pdf/59/65/IMM-148-227.PMC4913286.pdf
Transcrip- tional programming of dendritic cells for enhanced MHC class II antigen presentation.Nat Immunol 2014; 15:161–7 URL http://www.ncbi.nlm.nih.gov/pubmed/24362890.,Non-OADS,/arxiv_data1/oa_pdf/59/65/IMM-148-227.PMC4913286.pdf
URL http://www.pubmedcentral.nih.gov/articlerender.fcgi?ar- tid=3612556&tool=pmcentrez&rendertype=abstract.,OADS,/arxiv_data1/oa_pdf/59/65/IMM-148-227.PMC4913286.pdf
URL http://www.pubmedcentral.nih.gov/arti- clerender.fcgi?artid=3782040&tool=pmcentrez&rendertype=abstract.,OADS,/arxiv_data1/oa_pdf/59/65/IMM-148-227.PMC4913286.pdf
URL http://dx.doi.org/10.1038/mi.2009.13.,OADS,/arxiv_data1/oa_pdf/59/65/IMM-148-227.PMC4913286.pdf
URL http://www.ncbi.nlm.nih.gov/pubmed/21220692.,OADS,/arxiv_data1/oa_pdf/59/65/IMM-148-227.PMC4913286.pdf
URL http://www.pubmedcen- tral.nih.gov/articlerender.fcgi?artid=3130189&tool=pmcentrez&rendertype=abstract.,OADS,/arxiv_data1/oa_pdf/59/65/IMM-148-227.PMC4913286.pdf
"URL http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2583388& tool=pmcentrez&rendertype=abstract.56 Wu S, Liao AP, Xia Y, Li YC, Li J-D, Sartor RB et al.",OADS,/arxiv_data1/oa_pdf/59/65/IMM-148-227.PMC4913286.pdf
URL http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2913341&tool=pm-centrez&rendertype=abstract.,OADS,/arxiv_data1/oa_pdf/59/65/IMM-148-227.PMC4913286.pdf
URL http://dx.doi.org/10.1016/j.immuni.2013.07.004.,OADS,/arxiv_data1/oa_pdf/59/65/IMM-148-227.PMC4913286.pdf
URL http://www.ncbi.nlm.nih.gov/pubmed/24663679.,OADS,/arxiv_data1/oa_pdf/59/65/IMM-148-227.PMC4913286.pdf
URL http://www.jem.org/cgi/doi/10.1084/jem.20141442.,OADS,/arxiv_data1/oa_pdf/59/65/IMM-148-227.PMC4913286.pdf
URL http://www.pubmedcentral.nih.gov/arti- clerender.fcgi?artid=3684798&tool=pmcentrez&rendertype=abstract.,OADS,/arxiv_data1/oa_pdf/59/65/IMM-148-227.PMC4913286.pdf
URL http://www.ncbi.nlm.nih.gov/pubmed/ 24673331.,OADS,/arxiv_data1/oa_pdf/59/65/IMM-148-227.PMC4913286.pdf
URL http://www.pubmedcentral.nih.gov/articleren- der.fcgi?artid=3020784&tool=pmcentrez&rendertype=abstract.,OADS,/arxiv_data1/oa_pdf/59/65/IMM-148-227.PMC4913286.pdf
URL http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3171274&tool=pmcen-trez&rendertype=abstract.,OADS,/arxiv_data1/oa_pdf/59/65/IMM-148-227.PMC4913286.pdf
URL http://www.ncbi.nlm.nih.gov/pubmed/ 17259988.,OADS,/arxiv_data1/oa_pdf/59/65/IMM-148-227.PMC4913286.pdf
URL http://www.ncbi.nlm.nih.gov/pubmed/24643654.,OADS,/arxiv_data1/oa_pdf/59/65/IMM-148-227.PMC4913286.pdf
URL http://www.pubmedcen- tral.nih.gov/articlerender.fcgi?artid=3504609&tool=pmcentrez&rendertype=abstract.,OADS,/arxiv_data1/oa_pdf/59/65/IMM-148-227.PMC4913286.pdf
URL http://www.ncbi.nlm.nih.gov/pubmed/19299729.,Non-OADS,/arxiv_data1/oa_pdf/59/65/IMM-148-227.PMC4913286.pdf
URL http://www.pubmedcentral.nih.gov/arti- clerender.fcgi?artid=2118682&tool=pmcentrez&rendertype=abstract.,OADS,/arxiv_data1/oa_pdf/59/65/IMM-148-227.PMC4913286.pdf
URL http://linkinghub.elsevier.com/retrieve/pii/S1074761314003 008. ª2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/59/65/IMM-148-227.PMC4913286.pdf
"URL http://www.ncbi.nlm.nih.gov/pubmed/ 23966631.79 Chang S-Y, Cha H-R, Chang J-H, Ko H-J, Yang H, Malissen B et al.",OADS,/arxiv_data1/oa_pdf/59/65/IMM-148-227.PMC4913286.pdf
URL http://www.ncbi.nlm.nih.gov/pubmed/ 19914251.,OADS,/arxiv_data1/oa_pdf/59/65/IMM-148-227.PMC4913286.pdf
URL http://www.nature.com/doiﬁnder/10.1038/ni.3200.,Non-OADS,/arxiv_data1/oa_pdf/59/65/IMM-148-227.PMC4913286.pdf
"1 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/eb/78/iew052.PMC4913451.pdf
http://www.bolsadecereales.com.ar.,Non-OADS,/arxiv_data1/oa_pdf/eb/78/iew052.PMC4913451.pdf
"http://www.revistas.ufg.br/index.php/pat/article/view/23691/ 13928 Drees, B. M., and M. E. Rice.",Non-OADS,/arxiv_data1/oa_pdf/eb/78/iew052.PMC4913451.pdf
http://www.magrama.gob.es/minis terio/pags/Biblioteca/Revistas/pdf_Plagas%2FBSVP_35_01_49_58.pdf.,Non-OADS,/arxiv_data1/oa_pdf/eb/78/iew052.PMC4913451.pdf
http://www.pestalert.org/oprDetail.cfm?oprID ¼600.,Non-OADS,/arxiv_data1/oa_pdf/eb/78/iew052.PMC4913451.pdf
http://www.pestalert.org/oprDetail.cfm?oprID ¼629.,Non-OADS,/arxiv_data1/oa_pdf/eb/78/iew052.PMC4913451.pdf
http://www.eeaoc.org.ar/upload/publicaciones/archivos/286/ 20121122085717000000.pdf.,Non-OADS,/arxiv_data1/oa_pdf/eb/78/iew052.PMC4913451.pdf
"Color ABC, 17 October 2013. http://www.abc.com.py/edicion-impresa/economia/senave- en-alerta-tras-ingreso-de-peligrosa-plaga-agricola-629240.html.",Non-OADS,/arxiv_data1/oa_pdf/eb/78/iew052.PMC4913451.pdf
http://www.sinavimo.gov.ar/plaga/heli coverpa-armigera.,Non-OADS,/arxiv_data1/oa_pdf/eb/78/iew052.PMC4913451.pdf
http://www.pherolist.slu.se.,Non-OADS,/arxiv_data1/oa_pdf/eb/78/iew052.PMC4913451.pdf
"1 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/67/88/iew037.PMC4913452.pdf
"1 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/a6/94/iew042.PMC4913455.pdf
"1 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e1/85/iew033.PMC4913456.pdf
"12 (http://www.biomedcentral.com).Kloos, H., and F. S. McCullough.",OADS,/arxiv_data1/oa_pdf/e1/85/iew033.PMC4913456.pdf
"1 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/7b/e3/iew043.PMC4913457.pdf
URL http://www.infostat.,Non-OADS,/arxiv_data1/oa_pdf/7b/e3/iew043.PMC4913457.pdf
"(http://edis.ifas.uﬂ.edu/pdfﬁles/IN/ IN82700.pdf) (accessed: Feb. 20, 2016).",Non-OADS,/arxiv_data1/oa_pdf/7b/e3/iew043.PMC4913457.pdf
"1 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/2c/4a/iew044.PMC4913458.pdf
"R Foundation for Statistical Computing, Vienna, Austria.Avaiable at: http://www.R-project.org.",Non-OADS,/arxiv_data1/oa_pdf/2c/4a/iew044.PMC4913458.pdf
"1 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/12/cd/iew040.PMC4913460.pdf
"This Open Access article is distributed under the terms of the Creative Commons Attribution Noncommercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits any non-commercial use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited.THYROID Volume 26, Number 6, 2016Mary Ann Liebert, Inc.DOI: 10.1089/thy.2016.0001 785",Non-OADS,/arxiv_data1/oa_pdf/c2/04/thy.2016.0001.PMC4913490.pdf
"This Open Access article is distributed under the terms of the Creative Commons Attribution Noncommercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits any noncommercial use,distribution, and reproduction in any medium, provided the original author(s) and the source are credited.POPULATION HEALTH MANAGEMENT Volume 19, Number 3, 2016Mary Ann Liebert, Inc.DOI: 10.1089/pop.2015.0074 163",Non-OADS,/arxiv_data1/oa_pdf/1b/d1/pop.2015.0074.PMC4913494.pdf
"This Open Access article is distributed under the terms of the Creative Commons Attribution Noncommercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits any noncommercial use,distribution, and reproduction in any medium, provided the original author(s) and the source are credited.POPULATION HEALTH MANAGEMENT Volume 19, Number 3, 2016Mary Ann Liebert, Inc.DOI: 10.1089/pop.2015.0049 156",Non-OADS,/arxiv_data1/oa_pdf/f9/9f/pop.2015.0049.PMC4913497.pdf
"Memberzip codes were used to assign members to a Dartmouth Atlas Hospital Referral Region (HRR) using the 2012 zip code crosswalk (http://www.dartmouthatlas.org/downloads/geography/ZipHsaHrr12.xls), with 2 indicator regions for unmatched zip codes in the United States and postal codes in Canada.",Non-OADS,/arxiv_data1/oa_pdf/f9/9f/pop.2015.0049.PMC4913497.pdf
"This Open Access article is distributed under the terms of the Creative Commons Attribution Noncommercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits any noncommercial use,distribution, and reproduction in any medium, provided the original author(s) and the source are credited.JOURNAL OF ENDOUROLOGY Volume 30, Number 6, June 2016Mary Ann Liebert, Inc.Pp.",Non-OADS,/arxiv_data1/oa_pdf/8a/db/end.2016.0051.PMC4913498.pdf
"This Open Access article is distributed under the terms of the Creative Commons Attribution Noncommercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits any noncommercial use,distribution, and reproduction in any medium, provided the original author(s) and the source are credited.JOURNAL OF ENDOUROLOGY Volume 30, Number 6, June 2016Mary Ann Liebert, Inc.Pp.",Non-OADS,/arxiv_data1/oa_pdf/2e/d0/end.2015.0724.PMC4913499.pdf
"1 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/04/8b/iew051.PMC4913500.pdf
"This Open Access article is distributed under the terms of the Creative Commons Attribution Noncommercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits any non-commercial use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited.TISSUE ENGINEERING: Part A Volume 22, Numbers 11 and 12, 2016 Mary Ann Liebert, Inc.DOI: 10.1089/ten.tea.2016.0008 850",Non-OADS,/arxiv_data1/oa_pdf/e9/3a/ten.tea.2016.0008.PMC4913502.pdf
"This Open Access article is distributed under the terms of the Creative Commons Attribution Noncommercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited.BIOPRESERVATION AND BIOBANKING Volume 14, Number 3, 2016Mary Ann Liebert, Inc.DOI: 10.1089/bio.2015.0115 241",Non-OADS,/arxiv_data1/oa_pdf/44/28/bio.2015.0115.PMC4913503.pdf
Available at: http://en.wikipedia.,Non-OADS,/arxiv_data1/oa_pdf/44/28/bio.2015.0115.PMC4913503.pdf
Available at: http://conventions.coe.,Non-OADS,/arxiv_data1/oa_pdf/44/28/bio.2015.0115.PMC4913503.pdf
"Available at: http://conventions.coe.int/Treaty/ en/Treaties/Html/195.htm Accessed March 31, 2015.",Non-OADS,/arxiv_data1/oa_pdf/44/28/bio.2015.0115.PMC4913503.pdf
Available at: http://bioethics.gov/ sites/default/ﬁles/FINALAnticipateCommunicate_PCSBI_0.,Non-OADS,/arxiv_data1/oa_pdf/44/28/bio.2015.0115.PMC4913503.pdf
"Available at: https://cpmc.coriell.org/ Accessed August 31, 2015.",Non-OADS,/arxiv_data1/oa_pdf/44/28/bio.2015.0115.PMC4913503.pdf
"Available at: http://ec.europa.eu/research/ consultations/science-2.0/background.pdf Accessed August 31, 2015.",Non-OADS,/arxiv_data1/oa_pdf/44/28/bio.2015.0115.PMC4913503.pdf
"Available at: https://research.ndorms.ox .ac.uk/rudy/ Accessed December 18, 2015.",OADS,/arxiv_data1/oa_pdf/44/28/bio.2015.0115.PMC4913503.pdf
"Available at: http://truvenhealth.com/Portals/0/NPR-Truven- Health-Poll/NPRPulseDataPrivacy_Nov2014.pdf Accessed August 31, 2015.",Non-OADS,/arxiv_data1/oa_pdf/44/28/bio.2015.0115.PMC4913503.pdf
"This Open Access article is distributed under the terms of the Creative Commons Attribution Noncommercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited.HIGH ALTITUDE MEDICINE & BIOLOGY Volume 17, Number 2, 2016Mary Ann Liebert, Inc.DOI: 10.1089/ham.2016.0031 61",Non-OADS,/arxiv_data1/oa_pdf/d0/67/ham.2016.0031.PMC4913504.pdf
"This Open Access article is distributed under the terms of the Creative Commons Attribution Noncommercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits any noncommercial use,distribution, and reproduction in any medium, provided the original author(s) and the source are credited.POPULATION HEALTH MANAGEMENT Volume 19, Number 3, 2016Mary Ann Liebert, Inc.DOI: 10.1089/pop.2015.0055 196",Non-OADS,/arxiv_data1/oa_pdf/75/fb/pop.2015.0055.PMC4913508.pdf
2007. http://www.leg.state.vt.us/doc s/legdoc.cfm?URL=/docs/2008/ acts/ACT071.htm.,Non-OADS,/arxiv_data1/oa_pdf/75/fb/pop.2015.0055.PMC4913508.pdf
2014. http://www.ncqa.org/ Programs/Recognition/Practices /PatientCenteredMedicalHome PCMH.aspx.,Non-OADS,/arxiv_data1/oa_pdf/75/fb/pop.2015.0055.PMC4913508.pdf
2010:102. http://www.leg.state .vt.us/docs/2010/Acts/ACT128.pdf.,Non-OADS,/arxiv_data1/oa_pdf/75/fb/pop.2015.0055.PMC4913508.pdf
2015:516. http://innovation.cms.gov/ ﬁles/reports/MAPCP-EvalRpt1.pdf.,OADS,/arxiv_data1/oa_pdf/75/fb/pop.2015.0055.PMC4913508.pdf
2014:8. https://www.healthpartners.com/ucm/groups/ public/@hp/@public/documents/documents/cntrb_039627 .pdf.,Non-OADS,/arxiv_data1/oa_pdf/75/fb/pop.2015.0055.PMC4913508.pdf
http://www.ncqa.org/ReportC ards/HealthPlans/Stateof HealthCareQuality/2014TableofContents/Pharyngitis.aspx.,Non-OADS,/arxiv_data1/oa_pdf/75/fb/pop.2015.0055.PMC4913508.pdf
2013:29. https://www.whitehouse.gov/ sites/default/ﬁles/docs/healthcostreport_ﬁnal_noembargo_ v2.pdf.,Non-OADS,/arxiv_data1/oa_pdf/75/fb/pop.2015.0055.PMC4913508.pdf
2014. https://www.pcpcc.org/resource/medical-homes-impact-cost-quality.,Non-OADS,/arxiv_data1/oa_pdf/75/fb/pop.2015.0055.PMC4913508.pdf
2012;12. http://www.commonwealthfund.org/ */ media/ﬁles/publications/data-brief/2012/1601_rosenthal_ recommended_core_measures_pcmh_v2.pdf.,Non-OADS,/arxiv_data1/oa_pdf/75/fb/pop.2015.0055.PMC4913508.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/11/fa/ott-9-3485.PMC4913532.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 3485–3492OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  3485Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S9994 2 PTEN  gene mutations correlate to poor prognosis  in glioma patients: a meta-analysis Feng han1,* rong hu2,* hua Yang1 Jian liu1 Jianmei sui1 Xin Xiang1 Fan Wang1 liangzhao chu1 shibin song1 1Department of n eurosurgery,   affiliated hospital of guizhou Medical  University, 2Department of histology  and embryology, college of Basic  Medical sciences, guizhou Medical  University, guiyang, guizhou, People’s  republic of china *These authors contributed equally  to this workBackground:  We conducted this meta-analysis based on eligible trials to investigate the  relationship between phosphatase and tensin homolog  (PTEN ) genetic mutation and glioma  patients’ survival.",Non-OADS,/arxiv_data1/oa_pdf/11/fa/ott-9-3485.PMC4913532.pdf
"Keywords:  glioma, PTEN genetic mutation, meta-analysis Introduction Glioma is the most common neoplasm of the central nervous system, accounting  for ~40%–50% of brain tumors.1 In 2008, 237,913 individuals were diagnosed with a  primary malignant brain tumor worldwide.2 The overall survival (OS) rates of high- grade glioma at 1- and 5-year were 40% and 10%, respectively.3 The high mortality  rate of gliomas is attributable to their invasiveness and high recurrence rate.4,5 Despite  advances in diagnostics and treatment, such as modern diagnostic procedures, novel  surgical techniques, and subsequent radiochemotherapy, the prognosis of patients  suffered from high-grade glioma remains dismal.6 As a result of this, great attention  has been recently paid to specific tumor-related molecular markers, as complement  to traditional pathology-based diagnostic and prognostic markers, and as potential  individualized therapeutic targets.7correspondence: hua Yang; Jian liu Department of Neurosurgery, Affiliated  hospital of guizhou Medical University,  no 28, guiyi street, Yunyan District,  guiyang, 550004, guizhou Province,  People’s republic of china Tel +86 851 139 8540 2206;   +86 851 8677 0182 email yhmed@163.co m;   568189388@qq.com  Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2016 Volume: 9 Running head verso: Han et al Running head recto: PTEN  gene mutations correlate to poor glioma prognosis DOI: http://dx.doi.org/10.2147/OTT.S99942",Non-OADS,/arxiv_data1/oa_pdf/11/fa/ott-9-3485.PMC4913532.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/11/fa/ott-9-3485.PMC4913532.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/11/fa/ott-9-3485.PMC4913532.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/56/07/ott-9-3525.PMC4913533.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 3525–3533OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  3525Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S10188 4 Decreased FOXP3 + and garP + Tregs to  neoadjuvant chemotherapy associated with  favorable prognosis in advanced gastric cancer Kai li1 Fuchao chen2 huijuan Xie3 1Department of Pathology,   2Department of clinical Pharmacy,   3Department of hyperbaric Oxygen,   Dongfeng hospital, hubei University  of Medicine, shiyan, People’s republic  of chinaAbstract:  Neoadjuvant chemotherapy (NACT) has been an increasingly used therapeutic  strategy to improve the outcome of advanced gastric cancer (GC) over the past few decades.",Non-OADS,/arxiv_data1/oa_pdf/56/07/ott-9-3525.PMC4913533.pdf
"Some studies indicated that preoperative chemotherapy is  potentially down-staging the tumor stages and improves the survival rates of patients  with advanced GC, while some studies suggested that this treatment protocol was correspondence: huijuan Xie Department of hyperbaric Oxygen,  Dongfeng hospital, hubei University of  Medicine, 16 Daling road, Zhangwan  District, shiyan, hubei Province,   People’s republic of china Tel +86 0719 826 8342 email 2012203030001@whu.edu.c n Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2016 Volume: 9 Running head verso: Li et al Running head recto: FOXP3 + and GARP + Tregs response to neoadjuvant chemotherapy DOI: http://dx.doi.org/10.2147/OTT.S101884",Non-OADS,/arxiv_data1/oa_pdf/56/07/ott-9-3525.PMC4913533.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/56/07/ott-9-3525.PMC4913533.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/56/07/ott-9-3525.PMC4913533.pdf
"The full terms of this license are available at https://www.dovepress.com/ terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/26/b8/prbm-9-139.PMC4913534.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Psychology Research and Behavior Management 2016:9 139–146Psychology Research and Behavior Management Dove press submit your manuscript | www.dovepress.co m Dove press  139ORiginal ReseaRchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/PRBM.S9384 6longitudinal burnout-collaboration patterns in  Japanese medical care workers at special needs  schools: a latent class growth analysis Mieko Kanayama1 Machiko suzuki1 Y oshikazu Yuma2 1Department of human health  sciences, Kyoto University graduate  school of Medicine, Kyoto, Japan;   2Department of human Development  education, graduate school of  education, hyogo University of  T eacher education, Kato, hyogo, Japan correspondence: Mieko Kanayama   Department of human health science,  Kyoto University graduate school of  Medicine, 53 Kawahara-cho, shogoin,  sakyo-ku, Kyoto 606-8507, Japan   T el +81 0568 51 9406   Fax +81 0568 51 4699   email kanayama.mieko.56s@st.kyoto-u.ac.j pAbstract:  The present study aimed to identify and characterize potential burnout types and the  relationship between burnout and collaboration over time.",Non-OADS,/arxiv_data1/oa_pdf/26/b8/prbm-9-139.PMC4913534.pdf
"Available from: http://www.huffingtonpost.com/tera- tuten/reducing-nurse-burnout_b_1916350.htm l. Accessed July 28, 2014.",Non-OADS,/arxiv_data1/oa_pdf/26/b8/prbm-9-139.PMC4913534.pdf
"Psychology Research and Behavior Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/psychology-research-and-behavior-management-journa lPsychology Research and Behavior Management is an international, peer- reviewed, open access journal focusing on the science of psychology and  its application in behavior management to develop improved outcomes  in the clinical, educational, sports and business arenas.",Non-OADS,/arxiv_data1/oa_pdf/26/b8/prbm-9-139.PMC4913534.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/26/b8/prbm-9-139.PMC4913534.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/4b/6c/ppa-10-1071.PMC4913535.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Patient Preference and Adherence 2016:10 1071–1077Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  1071OriginAl reseArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PPA.S10087 3 The association between comorbidities and the  quality of life among colorectal cancer survivors  in the People’s republic of china Ji-Wei Wang1,* li sun1,2,* ning Ding3 Jiang li4 Xiao-huan gong1 Xue-Fen chen1 Dong-hui Yu5 Zheng-n ian luo6 Zheng-Ping Yuan7 Jin-Ming Yu1 1school of Public health and  Key laboratory of Public health  safety, Fudan University, shanghai,   2changzhou center for Disease  control and Prevention, changzhou,   Jiangsu Province, People’s republic  of china; 3centre for research  and Action in Public health, The  University of canberra, canberra,   AcT, Australia; 4Jonathan and Karin  Fielding school of Public health,   University of california, los Angeles,   cA, UsA; 5college of clinical  Medicine, Anhui Medical University,   hefei, Anhui Province, 6shanghai  health education Association,   7shanghai cancer rehabilitation club,   shanghai, People’s republic of china *These authors contributed equally  to this workBackground:  Cancer survivors with certain comorbidities had lower quality of life (QOL).",Non-OADS,/arxiv_data1/oa_pdf/4b/6c/ppa-10-1071.PMC4913535.pdf
"Cancer survivors often have other medical conditions or illnesses, called  comorbidities.9,10 The burden of comorbidity is high, with up to 80% of CCS reporting correspondence: Jin-Ming Yu school of Public health, Key laboratory  of Public health safety, Fudan University,  130 Dong-An road, shanghai 200032,  People’s republic of china Tel +86 21 5423 7868 email jmy@fudan.edu.c n Journal name: Patient Preference and Adherence Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Wang et al Running head recto: Association between comorbidities and quality of life DOI: http://dx.doi.org/10.2147/PPA.S100873",Non-OADS,/arxiv_data1/oa_pdf/4b/6c/ppa-10-1071.PMC4913535.pdf
Available from: http://www.shcrc.,Non-OADS,/arxiv_data1/oa_pdf/4b/6c/ppa-10-1071.PMC4913535.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal that focuses on the growing importance of patient   preference  and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/4b/6c/ppa-10-1071.PMC4913535.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/c1/48/vhrm-12-251.PMC4913536.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/c1/48/vhrm-12-251.PMC4913536.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Vascular Health and Risk Management  2016:12 251–261Vascular Health and Risk Management Dovepress submit your manuscript | www.dovepress.com Dovepress  251 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/VHRM.S108947Men with testosterone deficiency and a history  of cardiovascular diseases benefit from long-term  testosterone therapy: observational, real-life data  from a registry study Ahmad Haider1  Aksam Yassin2–4  Karim Sultan Haider1  Gheorghe Doros5  Farid Saad4,6  Giuseppe MC Rosano7 1Private Urology Practice,   Bremerhaven, 2Institute for Urology  and Andrology, Segeberger Kliniken,   Norderstedt, 3Department of  Preventive Medicine, Men’s Health Program, Dresden International University, Dresden, Germany;   4Department of Urology, Gulf  Medical University, Ajman, United Arab Emirates;  5Department for  Epidemiology and Statistics, Boston University School of Public Health,  Boston, MA, USA;  6Global Medical  Affairs Andrology, Bayer Pharma AG,  Berlin, Germany;  7Department of  Cardiology, Centre for Clinical and Basic Science, San Raffaele-Roma,  Rome, ItalyBackground/objectives: Long-term testosterone therapy (TTh) in men with hypogonad- ism has been shown to improve all components of the metabolic syndrome.",Non-OADS,/arxiv_data1/oa_pdf/c1/48/vhrm-12-251.PMC4913536.pdf
"178, 13353 Berlin, Germany Email farid.saad@bayer.comJournal name: Vascular Health and Risk Management  Article Designation: ORIGINAL RESEARCHY ear: 2016V olume: 12Running head verso: Haider et alRunning head recto: Hypogonadal men with preexisting CVD on long-term testosterone therapyDOI: http://dx.doi.org/10.2147/VHRM.S108947",Non-OADS,/arxiv_data1/oa_pdf/c1/48/vhrm-12-251.PMC4913536.pdf
"Vascular Health and Risk Management  2016:12submit your manuscript | www.dovepress.com Dovepress Dovepress Vascular Health and Risk Management  Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/vascular-health-and-risk-management-journal Vascular Health and Risk Management is an international, peer- reviewed journal of therapeutics and risk management, focusing on concise rapid reporting of clinical studies on the processes involved in the maintenance of vascular health; the monitoring, prevention and treatment of vascular disease and its sequelae; and the involvement of metabolic disorders, particularly diabetes.",Non-OADS,/arxiv_data1/oa_pdf/c1/48/vhrm-12-251.PMC4913536.pdf
Visit http://www.dovepress.com/   testimonials.php to read real quotes from published authors.Dovepress 261 Hypogonadal men with preexisting CVD on long-term testosterone therapy 22.,Non-OADS,/arxiv_data1/oa_pdf/c1/48/vhrm-12-251.PMC4913536.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/2a/a6/tacg-9-067.PMC4913537.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/2a/a6/tacg-9-067.PMC4913537.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).The Application of Clinical Genetics 2016:9 67–74The Application of Clinical Genetics Dovepress submit your manuscript | www.dovepress.com Dovepress 67 REVIEW open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/TACG.S69080 Role of elosulfase alfa in mucopolysaccharidosis  IVA Debra S Regier  Pranoot Tanpaiboon Division of Genetics and Metabolism,   Children’s National Medical Center,  Washington, DC, USAAbstract: Mucopolysaccharidosis type IV A (MPS IV A or Morquio A) is an autosomal recessive  lysosomal storage disease which results in a striking skeletal phenotype, but does not negatively  impact the intellect of the patient.",Non-OADS,/arxiv_data1/oa_pdf/2a/a6/tacg-9-067.PMC4913537.pdf
"Mucopolysaccharidoses are classified into seven types (type I, II, III, IV , VI, VII, and IX) based on the accu-Correspondence: Pranoot Tanpaiboon Division of Genetics and Metabolism, Children’s National Medical Center, 111 Michigan Avenue NW, Washington, DC 20010, USAEmail ptanpai@childrensnational.orgJournal name: The Application of Clinical Genetics Article Designation: REVIEWY ear: 2016V olume: 9Running head verso: Regier and TanpaiboonRunning head recto: Role of elosulfase alfa in MPS IV ADOI: http://dx.doi.org/10.2147/TACG.S69080",Non-OADS,/arxiv_data1/oa_pdf/2a/a6/tacg-9-067.PMC4913537.pdf
Available from: http://www.ncbi.nlm.nih.gov/books/ NBK164500/.,Non-OADS,/arxiv_data1/oa_pdf/2a/a6/tacg-9-067.PMC4913537.pdf
Available from: http://www.fda.gov/downloads/advisorycommittees/committeesmeetingmaterials/drugs/endocrino-logicandmetabolicdrugsadvisorycommittee/ucm375127.pdf.,Non-OADS,/arxiv_data1/oa_pdf/2a/a6/tacg-9-067.PMC4913537.pdf
Available from: http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/125460s000lbl.pdf.,Non-OADS,/arxiv_data1/oa_pdf/2a/a6/tacg-9-067.PMC4913537.pdf
"The Application of Clinical Genetics 2016:9submit your manuscript | www.dovepress.com Dovepress Dovepress The Application of Clinical Genetics Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/the-application-of-clinical-genetics-journalThe Application of Clinical Genetics is an international, peer-reviewed  open access journal that welcomes laboratory and clinical findings in the field of human genetics.",Non-OADS,/arxiv_data1/oa_pdf/2a/a6/tacg-9-067.PMC4913537.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes   from published authors.Dovepress 74 Regier and Tanpaiboon,Non-OADS,/arxiv_data1/oa_pdf/2a/a6/tacg-9-067.PMC4913537.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/57/59/sar-7-081.PMC4913538.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",OADS,/arxiv_data1/oa_pdf/57/59/sar-7-081.PMC4913538.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Opioid-induced constipation: rationale for the  role of norbuprenorphine in buprenorphine- treated individuals Lynn R Webster1 Michael Camilleri2 Andrew Finn3 1PRA Health Sciences, Salt Lake City,   UT, 2Mayo Clinic Rochester, MN,   3BioDelivery Sciences, Inc., Raleigh,   NC, USA Correspondence: Lynn R Webster   PRA Health Sciences, 3838 South 700  East #202, Salt Lake City, UT, 84106, USA   T el +1 801 269 8200   Email LRWebsterMD@gmail.co mAbstract:  Buprenorphine and buprenorphine–naloxone fixed combinations are effective for  managing patients with opioid dependence, but constipation is one of the most common side  effects.",Non-OADS,/arxiv_data1/oa_pdf/57/59/sar-7-081.PMC4913538.pdf
Or use: http://youtu.be/BI738v4el8 c,Non-OADS,/arxiv_data1/oa_pdf/57/59/sar-7-081.PMC4913538.pdf
Available from: http://www.bdsi.com/ siteres.aspx?resid =5a738443-a797-41cd-a39a-a8deb2a4a58 5.,Non-OADS,/arxiv_data1/oa_pdf/57/59/sar-7-081.PMC4913538.pdf
"Available from: http://www.accessdata.fda.gov/drugsatfda_docs/ appletter/2002/20732,20733ltr.pd f.  33.",OADS,/arxiv_data1/oa_pdf/57/59/sar-7-081.PMC4913538.pdf
Available from: https://www.tga.gov.au/ auspar/auspar-buprenorphine-naloxone .,Non-OADS,/arxiv_data1/oa_pdf/57/59/sar-7-081.PMC4913538.pdf
"Substance Abuse and Rehabilitation Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/substance abuse-and-rehabilitation-journa lSubstance Abuse and Rehabilitation is an international, peer-reviewed,  open access journal publishing original research, case reports, editorials,  reviews and commentaries on all areas of addiction and substance abuse  and options for treatment and rehabilitation.",Non-OADS,/arxiv_data1/oa_pdf/57/59/sar-7-081.PMC4913538.pdf
Visit http://www.dovepress.com/testimonials.php   to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/57/59/sar-7-081.PMC4913538.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/7d/2e/ott-9-3511.PMC4913539.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 3511–3523OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  3511Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S9971 3cigarette smoking and risk of adult glioma:  a meta-analysis of 24 observational studies  involving more than 2.3 million individuals hong-xing li1,* Xiao-xiao Peng1,2,* Qiang Zong1 Kai Zhang1 Ming-xin Wang1 Yi-zhe liu1 guang-liang han1 1Department of n eurosurgery,   shengli Oilfield central hospital,   2Department of intensive care Unit,   Dongying, shandong, People’s republic  of china *These authors contributed equally  to this workBackground:  Cigarette smoking has been shown to be a risk factor for adult glioma by  some but not all studies.",Non-OADS,/arxiv_data1/oa_pdf/7d/2e/ott-9-3511.PMC4913539.pdf
"In particular, a recent large population-based case–control study involving 13,000  individuals in the People’s Republic of China supported a positive association between  cigarette smoking and gliomas.25 As a result, a reanalysis is appropriate.correspondence: guang-liang han Department of neurosurgery, shengli  Oilfield Central Hospital, 31 Jinan Road,  Dongying, shandong 257000, People’s  republic of china Tel +86 186 5462 6838 Fax +86 54 6855 2224 email hglneurosurgery@163.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2016 Volume: 9 Running head verso: Li et al Running head recto: Cigarette smoking and risk of adult glioma DOI: http://dx.doi.org/10.2147/OTT.S99713",Non-OADS,/arxiv_data1/oa_pdf/7d/2e/ott-9-3511.PMC4913539.pdf
Available from: http://www.cancer.ca/en/prevention-and-screen - ing/live-well/smoking-and-tobacco/smoking-and-cancer/?region =qc.,Non-OADS,/arxiv_data1/oa_pdf/7d/2e/ott-9-3511.PMC4913539.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/7d/2e/ott-9-3511.PMC4913539.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/7d/2e/ott-9-3511.PMC4913539.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/75/ae/vhrm-12-263.PMC4913541.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/75/ae/vhrm-12-263.PMC4913541.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Vascular Health and Risk Management  2016:12 263–268Vascular Health and Risk Management Dovepress submit your manuscript | www.dovepress.com Dovepress  263 REVIEW open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/VHRM.S81342Impact of selective platelet inhibition in reducing  cardiovascular risk – role of vorapaxar Judy WM Cheng Department of Pharmacy Practice,   MCPHS University, Boston, MA, USAAbstract:  This article reviews the pharmacology, clinical efficacy, and safety of vorapaxar in  reducing cardiovascular risk.",Non-OADS,/arxiv_data1/oa_pdf/75/ae/vhrm-12-263.PMC4913541.pdf
"11 Intravenous glycoprotein IIb/IIIa Correspondence: Judy WM Cheng   Department of Pharmacy Practice,  MCPHS University, 179 Longwood Avenue, Boston, MA 02115-5896, USA   Tel +1 617 732 2868   Fax +1 617 732 2244   Email judy.cheng@mcphs.eduJournal name: Vascular Health and Risk Management  Article Designation: REVIEWY ear: 2016V olume: 12Running head verso: ChengRunning head recto: V orapaxar in reducing cardiovascular riskDOI: http://dx.doi.org/10.2147/VHRM.S81342",Non-OADS,/arxiv_data1/oa_pdf/75/ae/vhrm-12-263.PMC4913541.pdf
Available from: http://circ.ahajournals.org/content/early/2014/09/22/CIR.0000000000000133.,Non-OADS,/arxiv_data1/oa_pdf/75/ae/vhrm-12-263.PMC4913541.pdf
Available from: http://www.merck.com/product/usa/pi_circulars/z/zontivity/zontivity_pi.pdf.,OADS,/arxiv_data1/oa_pdf/75/ae/vhrm-12-263.PMC4913541.pdf
Available from: http://www.fda.gov/downloads/advisorycommittees/committeesmeetingmaterials/drugs/cardiovascularandrenaldrugsadvisorycommittee/ucm381327.pdf.,Non-OADS,/arxiv_data1/oa_pdf/75/ae/vhrm-12-263.PMC4913541.pdf
"Vascular Health and Risk Management  2016:12submit your manuscript | www.dovepress.com Dovepress Dovepress Vascular Health and Risk Management  Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/vascular-health-and-risk-management-journal Vascular Health and Risk Management is an international, peer- reviewed journal of therapeutics and risk management, focusing on concise rapid reporting of clinical studies on the processes involved in the maintenance of vascular health; the monitoring, prevention and treatment of vascular disease and its sequelae; and the involvement of metabolic disorders, particularly diabetes.",Non-OADS,/arxiv_data1/oa_pdf/75/ae/vhrm-12-263.PMC4913541.pdf
Visit http://www.dovepress.com/   testimonials.php to read real quotes from published authors.Dovepress 268 Cheng  25.,Non-OADS,/arxiv_data1/oa_pdf/75/ae/vhrm-12-263.PMC4913541.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/c1/cb/ott-9-3493.PMC4913543.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 3493–3500OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  3493Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S10473 4 Positive association between CD44  gene rs13347  cT polymorphism and risk of cancer in asians:  a systemic review and meta-analysis Jinan shi1 Yin Duan2 lei Pan2 Xiaoxi Zhou3 1Department of Medical Oncology,   Zhejiang hospital, 2Department of  Breast surgery, Zhejiang Provincial  Traditional chinese Medical hospital,   3Department of respiratory Medicine,   Zhejiang hospital, hangzhou, Zhejiang  Province, People’s republic of chinaBackground:  Cluster of differentiation 44 (CD44) is an important surface marker of cancer stem  cells in a variety of tumors.",Non-OADS,/arxiv_data1/oa_pdf/c1/cb/ott-9-3493.PMC4913543.pdf
"Keywords:  cancer, CD44, polymorphism, meta-analysis Background Cancer is currently a serious public health burden in the world, which results from  interactions between accumulations of genetic mutation and environmental risk  factors.1,2 In recent years, a small subgroup of cancer cells, called cancer stem  cells (CSCs), have been proved to be responsible for tumor initiation, progression,  metastasis, recurrence, and drug resistance and cause cancer heterogeneity.3 Thus,  eliminating CSCs is considered to be efficient and critical in cancer therapy.4 Several  cell surface markers have been found to identify CSCs, and overexpression of these  markers, such as cluster of differentiation 44 (CD44), CD24, CD133, CD166, and  ALDH1A1, indicates severe clinical features and poor prognosis in a number of  cancers.5–10 Among these cell surface markers, CD44 is one of the most frequently correspondence: Xiaoxi Zhou Department of respiratory Medicine,  Zhejiang hospital, 12 lingyin road,  hangzhou 310009, Zhejiang Province,  People’s republic of china Tel +86 571 8798 7373 Fax +86 571 8798 2776 email xingeliu@hotmail.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2016 Volume: 9 Running head verso: Shi et al Running head recto: CD44 rs13347 C>T polymorphism and cancer risk DOI: http://dx.doi.org/10.2147/OTT.S104734",Non-OADS,/arxiv_data1/oa_pdf/c1/cb/ott-9-3493.PMC4913543.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/c1/cb/ott-9-3493.PMC4913543.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/c1/cb/ott-9-3493.PMC4913543.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/12/7e/ott-9-3501.PMC4913544.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 3501–3509OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  3501Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S9627 8Knockdown of long noncoding rna h19 sensitizes  human glioma cells to temozolomide therapy Pengfei Jiang1,* Ping Wang2,* Xiaoling sun3 Zhongshun Yuan4 rucai Zhan5 Xiangyu Ma2 Weiguo li2 1Medical Department, Yuhuangding  hospital, Yantai, 2neurosurgery  Department, Qilu hospital, shandong  University, Jinan, 3neurosurgery  Department, Yuhuangding hospital,   Yantai, 4neurosurgery Department,   Yinan People’s hospital, linyi,   5neurosurgery Department, no 3   hospital of Jinan, Jinan, People’s  republic of china *These authors contributed equally   to this workAbstract:  Temozolomide (TMZ) is commonly used in glioma chemotherapy.",Non-OADS,/arxiv_data1/oa_pdf/12/7e/ott-9-3501.PMC4913544.pdf
"An increasing number of lncRNAs have been identi - fied to be involved in some important biological processes, such as imprinting control,  cell differentiation, development, and tumorigenesis.5 Apart from this, lncRNAs have  multifunctional roles acting as mediators in cellular signaling, molecular decoys,  molecular guides at the chromatin sites, and during scaffold modeling.6 Alterations of correspondence: Weiguo li neurosurgery Department, Qilu  hospital, shandong University, 107  Wenhua West road, lixia District,  Jinan 250012, shandong, People’s  republic of china Tel +86 531 8216 6631 email leeweiguo_777@126.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2016 Volume: 9 Running head verso: Jiang et al Running head recto: Suppressing H19 improves temozolomide resistance DOI: http://dx.doi.org/10.2147/OTT.S96278",Non-OADS,/arxiv_data1/oa_pdf/12/7e/ott-9-3501.PMC4913544.pdf
"Results h19 expression correlates with TMZ  resistance in glioma patients Initially, we analyzed the sequence of H19, and we found that  there were three transcript variants of H19 ( http://www.ncbi.",Non-OADS,/arxiv_data1/oa_pdf/12/7e/ott-9-3501.PMC4913544.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/12/7e/ott-9-3501.PMC4913544.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/12/7e/ott-9-3501.PMC4913544.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/e9/93/ott-9-3473.PMC4913546.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 3473–3484OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  3473Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S9301 5 Function of aUrKa protein kinase in the formation  of vasculogenic mimicry in triple-negative breast  cancer stem cells Ying liu1,2,* Baocun sun1–3,* Tieju liu1,2,* Xiulan Zhao1,2 Xudong Wang3 Yanlei li1,2 Jie Meng2 Qiang gu1,2 Fang liu1,2 Xueyi Dong1,2 Peimei liu2 ran sun2 nan Zhao1 1Department of Pathology, general  hospital of Tianjin Medical University,   2Department of Pathology, Tianjin  Medical University, 3Department of  Pathology, cancer hospital of Tianjin  Medical University, Tianjin, People’s  republic of china *These authors contributed equally  to this workAbstract:  Tumor cell vasculogenic mimicry (VM), a newly defined pattern of tumor blood supply,  signifies the functional plasticity of aggressive cancer cells forming vascular networks.",Non-OADS,/arxiv_data1/oa_pdf/e9/93/ott-9-3473.PMC4913546.pdf
"Tumors exhibiting VM exhibit aggressive correspondence: Baocun sun general hospital and Department  of Pathology and cancer hospital of  Tianjin Medical University, anshan  road no 154, Tianjin 300052,  People’s republic of china Tel +86 13 6021 11192 Fax +86 22 8333 6813 email sunbaocun@aliyun.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2016 Volume: 9 Running head verso: Liu et al Running head recto: AURKA and vasculogenic mimicry DOI: http://dx.doi.org/10.2147/OTT.S93015",Non-OADS,/arxiv_data1/oa_pdf/e9/93/ott-9-3473.PMC4913546.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/e9/93/ott-9-3473.PMC4913546.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/e9/93/ott-9-3473.PMC4913546.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/6e/95/ott-9-3451.PMC4913548.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 3451–3463OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  3451Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S10574 5Transcription factor activity of estrogen receptor  α activation upon nonylphenol or bisphenol a  treatment enhances the in vitro proliferation,  invasion, and migration of neuroblastoma cells hongda Ma1 Yao Yao2 changli Wang1 liyu Zhang3 long cheng4 Yiren Wang5 Tao Wang6 erguang liang6 hui Jia1 Qinong Ye4 Mingxiao hou1 Fan Feng1 1Department of Pharmacy, general  hospital of shenyang Military area  command, shenyang, 2Department  of Pharmacy, Women & infants  hospital of Zhengzhou, Zhengzhou,   3shaanxi institute of Pediatric Disease,   Xi’an children’s hospital, Xi’an,   4institute of Biotechnology, chinese  Military Medical science academy,   Beijing, 5school of life science,   shenyang Pharmaceutical University,   shenyang, 6institute of T oxicology  and Pharmacology, chinese Military  Medical science academy, Beijing,   People’s republic of chinaAbstract:  Many kinds of endocrine-disrupting chemicals (EDCs), for example, the environmental  estrogens bisphenol A and nonylphenol, may regulate the activity of estrogen receptor α (ERα)  and therefore induce potential disruption of normal endocrine function.",Non-OADS,/arxiv_data1/oa_pdf/6e/95/ott-9-3451.PMC4913548.pdf
"Recently, ectopic expression of ER α has been  identified in neuroblastoma clinical specimens and it could regulate neuroprotection  and proliferation of neuroblastoma by cross talking with Insulin-like growth factor  1 receptor (IGF-1R).6,7 Neuroblastoma is the most common solid tumor of children  under 5 years of age.8–10 Although therapies, for example, surgery, chemotherapy, or correspondence: Fan Feng;   Mingxiao hou Department of Pharmacy, general  hospital of shenyang Military area  command, no 83 Wenhua road, shenhe  District, shenyang 110016, liaoning,  People’s republic of china Tel/fax +86 24 2885 1750 email fengfanbio@126.co m;  houmingxiao188@126.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2016 Volume: 9 Running head verso: Ma et al Running head recto: Nonylphenol or bisphenol A enhances SH-SAY5Y proliferation DOI: http://dx.doi.org/10.2147/OTT.S105745",Non-OADS,/arxiv_data1/oa_pdf/6e/95/ott-9-3451.PMC4913548.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/6e/95/ott-9-3451.PMC4913548.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/6e/95/ott-9-3451.PMC4913548.pdf
"Developmental  Cognitive  Neuroscience  19  (2016)  211–222 Contents  lists  available  at  ScienceDirect Developmental  Cognitive  Neuroscience j  o  ur  nal  ho  me  pa  ge:  http://www.elsevier.com/locate/dcn Longitudinal  development of frontoparietal  activity  during  feedback learning:  Contributions of age, performance,  working  memory  and cortical  thickness Sabine  Petersa,b,∗,  Anna  C.K.",Non-OADS,/arxiv_data1/oa_pdf/bf/fc/main.PMC4913556.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/bf/fc/main.PMC4913556.pdf
"On  the  other hand,  prior  cross-sectional  studies  provided  preliminary  evidence http://dx.doi.org/10.1016/j.dcn.2016.04.004 1878-9293/© 2016  The  Authors.",Non-OADS,/arxiv_data1/oa_pdf/bf/fc/main.PMC4913556.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.,Non-OADS,/arxiv_data1/oa_pdf/bf/fc/main.PMC4913556.pdf
Structural  brain  analysis Cortical  reconstruction  was  measured  automatically  using FreeSurfer 5.3 (http://surfer.nmr.mgh.harvard.edu ).,OADS,/arxiv_data1/oa_pdf/bf/fc/main.PMC4913556.pdf
"Sci.,  http://dx.doi.",OADS,/arxiv_data1/oa_pdf/bf/fc/main.PMC4913556.pdf
http://CRAN.R-project.org/ package=nlme .,Non-OADS,/arxiv_data1/oa_pdf/bf/fc/main.PMC4913556.pdf
"All positions are based on canine mRNA sequences, as published in the NCBI GenBank database (http://www.ncbi.nlm.nih.gov/).",OADS,/arxiv_data1/oa_pdf/0c/c7/JVIM-30-741.PMC4913559.pdf
"GeNorm software (https://genorm.cmgg.be/) was used to analyze relative expression levels of the reference genes, which justiﬁed their use.",OADS,/arxiv_data1/oa_pdf/0c/c7/JVIM-30-741.PMC4913559.pdf
"According to the BRT Club of America website(http://www.brtca.org/brt-information.html accessed November 16, 2015), the BRT breed was developed by interbreeding Rottweilers with other selected breedsduring the 1930s in a military kennel near Moscow.",Non-OADS,/arxiv_data1/oa_pdf/01/d4/JVIM-30-813.PMC4913561.pdf
J Vet Intern Med 2009; 23: 733 –734 (abstract) ehttp://vetmed.tamu.edu/gilab/service/assays/pli Acknowledgments The study was not supported by a grant or other funding.,Non-OADS,/arxiv_data1/oa_pdf/25/ac/JVIM-30-764.PMC4913568.pdf
"The work presented in this study was funded by and performed at the Pet Nutrition Center, Hill’s Pet Nutrition, Inc, Topeka, KS (http://www.hillspet.com/our-company.html).",Non-OADS,/arxiv_data1/oa_pdf/66/3b/JVIM-30-794.PMC4913574.pdf
(http://www.idexx.com/view/xhtml/en_us/corporate/home.jsf).,Non-OADS,/arxiv_data1/oa_pdf/66/3b/JVIM-30-794.PMC4913574.pdf
"bOsiriX version 6.0.2, http://www.osirix-viewer.com.",Non-OADS,/arxiv_data1/oa_pdf/3d/e5/JVIM-30-771.PMC4913576.pdf
"(http://www.R-project.org), R Founda- tion for Statistical Computing, Vienna, Australia Acknowledgments This study is supported by a grant from the Kennel Club Charitable Trust (KCCT), no.",Non-OADS,/arxiv_data1/oa_pdf/4d/69/JVIM-30-853.PMC4913582.pdf
Available at: http://www.thekennel- club.org.uk/registration/breed-registration-statistics/.,Non-OADS,/arxiv_data1/oa_pdf/4d/69/JVIM-30-853.PMC4913582.pdf
Available from: http://www.ginasthma.org/documents/4.,OADS,/arxiv_data1/oa_pdf/f9/3e/JVIM-30-503.PMC4913592.pdf
"Materials and Methods Study Subjects Neurologically normal dogs were recruited from the staﬀ, stu- dents, and neurology service clientele of the NC State VeterinaryHospital and the public via Dodgerslist (http://www.dodgerslist.",Non-OADS,/arxiv_data1/oa_pdf/11/b7/JVIM-30-627.PMC4913607.pdf
"Available at: https://iom.nationalacademies.org/Activities/Disease/NCPF/2015-JUN-08.aspx Accessed February 15, 2016.",Non-OADS,/arxiv_data1/oa_pdf/b9/f9/JVIM-30-527.PMC4913608.pdf
Available at: http://www.fda.gov/downloads/Drugs/ .../Guid ances/ucm073122.pdf.,Non-OADS,/arxiv_data1/oa_pdf/b9/f9/JVIM-30-527.PMC4913608.pdf
Available at: http://www.cancer.gov/about-nci/organizat ion/ccct/about/ctwg- report.pdf.,Non-OADS,/arxiv_data1/oa_pdf/b9/f9/JVIM-30-527.PMC4913608.pdf
Available at: http://grants.nih.gov/grants/olaw/Guide- for-the-care-and-use-of laboratory-animals; Key Concepts.,Non-OADS,/arxiv_data1/oa_pdf/b9/f9/JVIM-30-527.PMC4913608.pdf
Available at: http://altweb.jhsph.edu/pubs/books/humane_exp/het-toc.,Non-OADS,/arxiv_data1/oa_pdf/b9/f9/JVIM-30-527.PMC4913608.pdf
Available at: https://www.avma.org/KB/Policies/Pages/Establishment-and-Use-of-Veterinary-Clinical-Studies-Commit tees.aspx.,Non-OADS,/arxiv_data1/oa_pdf/b9/f9/JVIM-30-527.PMC4913608.pdf
"Available at: http://www.fda.gov/downloads/RegulatoryInformation/Guidances/UCM405006.pdf Accessed February 15, 2016.",Non-OADS,/arxiv_data1/oa_pdf/b9/f9/JVIM-30-527.PMC4913608.pdf
Available at: http://www.hhs.gov/ohrp/policy/fguid.pdf.,Non-OADS,/arxiv_data1/oa_pdf/b9/f9/JVIM-30-527.PMC4913608.pdf
Available at: https://ori.hhs.gov/sites/default/ﬁles/rcrintro.pdf.,OADS,/arxiv_data1/oa_pdf/b9/f9/JVIM-30-527.PMC4913608.pdf
Available at: http://ctep.cancer.,Non-OADS,/arxiv_data1/oa_pdf/b9/f9/JVIM-30-527.PMC4913608.pdf
Available at: https://clinicaltrials.gov/.,Non-OADS,/arxiv_data1/oa_pdf/b9/f9/JVIM-30-527.PMC4913608.pdf
Available at: http://www.vetcancersociety.org/ members/clinical -trials/.,Non-OADS,/arxiv_data1/oa_pdf/b9/f9/JVIM-30-527.PMC4913608.pdf
"Cases were classiﬁed into CKD stages 1 –4 based on the International Renal Interest Society (IRIS) guidelines (http://www.iris-kidney.com/ guidelines/staging.shtml), realizing that some cases could represent acute or acute on chronic disease and therefore not be insteady state.",Non-OADS,/arxiv_data1/oa_pdf/d6/dc/JVIM-30-591.PMC4913609.pdf
"Assays performed at the AnimalHealth Diagnostic Center, Cornell University College of Veteri-nary Medicine, Ithaca, NY chttp://www.mathgoodies.com/calculators/random_number.html dStata IC/11, StataCorp LP, College Station, TX eGraphPad Prism Version 5.0, La Jolla, CA Acknowledgments The authors acknowledge the University of Georgia Equestrian Team, the University of Georgia College of Veterinary Medicine’s Equine Teaching Facility at Oco-nee Farm, and University of Georgia faculty, staﬀ andstudents for provision of healthy horses for this study; and Dr. Roy Berghaus for assistance with data analysis.",Non-OADS,/arxiv_data1/oa_pdf/17/0e/JVIM-30-653.PMC4913614.pdf
"nlm.nih.gov/PubMed), CAB Abstracts (www.cabdirect.org), and Web of Science (http://wok.mimas.ac.uk), search strategies included reference lists of published papers and proceedings of the aforementioned relevantscientiﬁc conferences.",OADS,/arxiv_data1/oa_pdf/95/ba/JVIM-30-477.PMC4913615.pdf
"Available at: http://www.iris-kidney.com/guidelines/recom- mendations.shtml Accessed July 31, 2015.",Non-OADS,/arxiv_data1/oa_pdf/a1/e3/JVIM-30-010.PMC4913620.pdf
"Footnotes ahttp://vetmed.tamu.edu/gilab/service/assays/pli bNationWide, Specialist Laboratories, Cambridge, UK cLantus, Sanoﬁ Aventis, Meyrin, Switzerland dDM Purina Veterinary Diets; Medical Solution, Steinhausen, Switzerland eBydureon; Amylin Pharmaceuticals, San Diego, CA fBody condition chart (cat); Nestl /C19e Purina, St. Louis, MO gSPSS 18.0; SPSS, Chicago, IL hhttp://www.fda.gov/safety/MedWatch/SafetyInformation/ SafetyAlertsforHumanMedicalProducts/ucm188703.htm Acknowledgments Conﬂict of Interest Declaration.",Non-OADS,/arxiv_data1/oa_pdf/4b/9b/JVIM-30-092.PMC4913624.pdf
Available from: http://iacp.site-ym.com/?page=2 [Accessed 2014 May 5].,Non-OADS,/arxiv_data1/oa_pdf/a6/80/JVIM-30-242.PMC4913625.pdf
Available at: http://www.fda.gov/Drugs/ DrugSafety/DrugShortages/ucm050793.htm.,Non-OADS,/arxiv_data1/oa_pdf/a6/80/JVIM-30-242.PMC4913625.pdf
Available from: http://www.iris-kidney.-com/guidelines/grading.shtml.,Non-OADS,/arxiv_data1/oa_pdf/9e/ca/JVIM-30-192.PMC4913627.pdf
Available at: http://putneyvet.com/im- ages/docs/Enroﬂoxacin_Package_Insert.pdf.,Non-OADS,/arxiv_data1/oa_pdf/96/45/JVIM-30-108.PMC4913628.pdf
Available at: http://bayer.naccvp.com/?e=LSdew7K4HnVeeL2EuzyjnfL5DhrAC qQQ&m=product_basic_view&id=1040012.,Non-OADS,/arxiv_data1/oa_pdf/96/45/JVIM-30-108.PMC4913628.pdf
The CSU-CI laboratory (http://csu-cvmbs.colostate.edu/academics/mip/ci-lab/Pages/default.aspx) receives samples from dogs with suspicion of LPD that aresubmitted by reference laboratories and clinicians.,Non-OADS,/arxiv_data1/oa_pdf/94/2c/JVIM-30-215.PMC4913636.pdf
"Speciﬁc guidelines for disclosure for review arti- cles are more diﬃcult to ﬁnd, although leading journal The Lancet Oncology has a clear policy that “For any Review, Historical Review, Personal View, or Health- care Development, The Lancet Oncology will not pub- lish the manuscript if an author, within the past 3 years, and with a relevant company or competitor, has any stocks or shares, equity, a contract of employment, or a named position on a company board ...” (Information for Authors; http://www.thelancet.com/pb/assets/raw/ Lancet/authors/icmje-coi-form.pdf).",Non-OADS,/arxiv_data1/oa_pdf/ac/ca/JVIM-30-008.PMC4913637.pdf
Recruitment of Respondents The survey was made available online through the web address http://www.surveymonkey.com/s/catquality.,OADS,/arxiv_data1/oa_pdf/3f/70/JVIM-30-183.PMC4913638.pdf
"Laboratory Services Abaxis 510-675-6500 www.abaxis.com/veterinary/products/rapid-tests.htmlSeveral serological assays, including some for point-of-care Animal Blood Resources International (ABRI) 1-800-243-5759www.abrint.net/Blood donor typing PCR assays for some blood-borne agentsLaboratory-based serological assays for some blood-borne agents ANTECH Diagnostics 1-800-745-4725 (West) 1-800-872-1001 (East)www.antechdiagnostics.com/main/TestingServices.aspxPCR assays for some blood-borne agents Laboratory-based serological assays for some blood-borne agents Biogal http://www.biogal.co.il/products/immunocomb/pet-technical- informationEhrlichia canis point-of-care antibody assay Specialized Infectious Diseases Laboratory Colorado State University www.dlab.colostate.eduPCR panel and individual assays for some blood-borne agents Combination feline Bartonella spp.",Non-OADS,/arxiv_data1/oa_pdf/f1/c5/JVIM-30-015.PMC4913655.pdf
"PCR and serology Laboratory-based serological assays for some blood-borne agents Galaxy Diagnostics, Inc. 919-313-9672 http://www.galaxydx.com/web/animal-health/Laboratory-based Bartonella spp.",Non-OADS,/arxiv_data1/oa_pdf/f1/c5/JVIM-30-015.PMC4913655.pdf
"Combination of serology, PCR, and culture for dogs or cats IDEXX Laboratories 1-800-548-6733 https://www.idexx.com/smallanimal/reference-laboratories/ directory-tests-services.htmlPCR assays for some blood-borne agents Laboratory-based serological assays for some blood-borne agents Point-of-care serological assays for some blood-borne agents Michigan State University Diagnostic Center for Population and Animal Health 517-353-1683 http://www.animalhealth.msu.eduBlood typing PCR assays for some blood-borne agents Laboratory-based serological assays for some blood-borne agents National Veterinary Laboratories 201-891-2992 http://www.natvetlab.com/Laboratory-based serological assays for some blood-borne agents New York State Veterinary Diagnostic Laboratory/Animal Health Diagnostic Center 607-253-3900 https://ahdc.vet.cornell.edu/PCR assays for some blood-borne agents Laboratory-based serological assays for some blood-borne agents North Carolina State University Vector Borne Disease Laboratory 919-513-8279http://www.cvm.ncsu.edu/vhc/csds/ticklab.htmlPCR panel and individual assays for some blood-borne agents Combination Bartonella spp.",Non-OADS,/arxiv_data1/oa_pdf/f1/c5/JVIM-30-015.PMC4913655.pdf
"serology and PCR/culture for dogs and catsLaboratory-based serological assays for some blood-borne agents Protatek Reference Laboratory 480-545-8499http://www.protatek.com/ref_services.htmlPCR assays for some blood-borne agents Laboratory-based serological assays for some blood-borne agents Real-time PCR Research and Core Diagnostics Facility, University of California, Davis, CA530-752-7991http://www.vetmed.ucdavis.edu/vme/taqmanservice/PCR assays for some blood-borne agents Laboratory-based serological assays for some blood-borne agents Zoetis 888-963-8471https://www.zoetisus.com/products/index.aspxPoint-of-care serological assays for some blood-borne agents Zoologix 818-717-8880 http://www.zoologix.com/dogcat/index.htmPCR panel and individual assays for some blood-borne agents aThe laboratories selected for inclusion either provide standard operating procedures for critical review, have published peer reviewed articles documenting quality control and assay speciﬁcs, are standard operating procedures monitored state-accredited laboratories, are lab-oratories producing kits licensed by the USDA, or are laboratories that panel members have worked with directly providing evidence of quality assurance.",Non-OADS,/arxiv_data1/oa_pdf/f1/c5/JVIM-30-015.PMC4913655.pdf
2010 Available from: http://www.fda.-gov/biologicsbloodvaccines/guidancecomplianceregulatoryinforma-tion/guidances/blood/ucm235855.htm.,Non-OADS,/arxiv_data1/oa_pdf/f1/c5/JVIM-30-015.PMC4913655.pdf
"The PCR targeting the gp36 locus of E. canis was performed and DNA sequencing of the resulting PCR product was completed after the ﬁrst ampliﬁcation.PCR primers for the gp36 gene, EC36-F1 (5 0- GTATGTTTCTTTTATATCATGGC-30) and EC36-R1 (50-GGTTATATTTCAGTTATCAGAAG-30) were used based on a previous study.3Nucleotide sequences gen- erated for both loci were analyzed by Chromas lite version 4.0 (http://www.technelysium.com.au) andaligned with reference sequences from E. canis from GenBank using Clustal W (http://www.clustalw.",OADS,/arxiv_data1/oa_pdf/0c/11/JVIM-30-255.PMC4913662.pdf
Available at: http://www.agcensus.usda.gov/Publica- tions/1997/Ag_Atlas_Maps/Livestock_and_Animals/map193.gif.,Non-OADS,/arxiv_data1/oa_pdf/d2/05/JVIM-30-326.PMC4913666.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Circadian clocksBmal1Fatty acidsInﬂammation Cytokines AMPKNF-κB AMP-activated protein kinase (AMPK)CardamoninAminoimidazole-4-Carboxamide Riboside(AICAR) Fibroblasts Adipocytes 1.,Non-OADS,/arxiv_data1/oa_pdf/db/ac/main.PMC4913702.pdf
http://dx.doi.org/10.1016/j.ebiom.2016.03.037 2352-3964/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/db/ac/main.PMC4913702.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/db/ac/main.PMC4913702.pdf
"This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Insulin, metabolic syndrome Insulin resistance LRP1Chylomicron remnantDiabetesLipoproteinPDGF 1.",Non-OADS,/arxiv_data1/oa_pdf/4b/22/main.PMC4913705.pdf
http://dx.doi.org/10.1016/j.ebiom.2016.04.002 2352-3964/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/4b/22/main.PMC4913705.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/4b/22/main.PMC4913705.pdf
"© 2016 The Author(s) Published by S. Karger AG, Basel  Published online: May 3, 2016 EXTRA  Julie G. Kosteniuk   Canadian Centre for Health and Safety in Agriculture   University of Saskatchewan, 104 Clinic Place   Saskatoon, SK, S7N 2Z4 (Canada)   E-Mail julie.kosteniuk   @   usask.ca www.karger.com/dee DOI: 10.1159/000444790  This article is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 Interna- tional License (CC BY-NC-ND) (http://www.karger.com/Services/OpenAccessLicense).",Non-OADS,/arxiv_data1/oa_pdf/2a/05/dee-0006-0161.PMC4913763.pdf
" © 2016 The Author(s) Published by S. Karger AG, Basel1664–5464/16/0062–0183$39.50/0   Contributions and Letters  Dement Geriatr Cogn Disord Extra 2016;6:183–184   Evaluation of  NOTCH3   Pro167Ser Variation in a Japanese Family with Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy   Toshiki Mizuno    a     Ikuko Mizuta    a     Hidekazu Tomimoto    b      a    Department of Neurology, Graduate School of Medical Science, Kyoto Prefectural  University of Medicine,  Kyoto , and  b    Department of Neurology, Mie University Graduate  School of Medicine,  Tsu , Japan   ǡ  Ǧ ȋǢ͓ͳʹͷ͵ͳͲȌ Ǧ ǡ NOTCH3ǤʹͲͲ͸ǡǡ ͳǡʹǡ͵ǡ Ǯ ǣǡ ǯǯ ȏͳȐǤͳ͸͹ȋͳ͸͹ȌǡͳͶͳȋͳͶͳȌǡ ͹ͷȋ͹ͷȌ Ǥǡ Ǥǡ Ǥ Ǧ  Ǧ NOTCH3ǡ ȏʹȐǤ Ǧ ǡǡ ǡǦ ȏ͵ȐǤȏͳȐǡ ͳͶͳǦ Ǥ͹ͷǦǡ  ȏͶȐǡ  ȏͷȐǤ ͳ͸͹ͳǤ  ʹǤ  Ǥ ȏͳȐǤ	 ǡ ͵ǡͷԢǦͶǡ͵ԢǦ Ͷǡͷ  ǤͷԢǦͶǡ  ͳ͸͹Ǥǡ  Published online: May 4, 2016 EXTRA  Toshiki Mizuno, MD, PhD   Department of Neurology, Graduate School of Medical Science   Kyoto Prefectural University of Medicine   465 Kajii-cho, Kamigyo-ku, Kyoto 602-8566 (Japan)   E-Mail mizuno   @   koto.kpu-m.ac.jp www.karger.com/dee DOI: 10.1159/000445499  This article is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 Interna- tional License (CC BY-NC-ND) (http://www.karger.com/Services/OpenAccessLicense).",Non-OADS,/arxiv_data1/oa_pdf/85/5f/dee-0006-0183.PMC4913764.pdf
"© 2016 The Author(s) Published by S. Karger AG, Basel  Published online: June 3, 2016 EXTRA  Hee-Jin Kim, MD, PhD   Department of Neurology, College of Medicine   Hanyang University Medical Center    17 Heangdang-dong, Seongdong-gu, Seoul (Republic of Korea)   E-Mail hyumcbrain   @   hanyang.ac.kr www.karger.com/dee DOI: 10.1159/000445828  This article is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 Interna- tional License (CC BY-NC-ND) (http://www.karger.com/Services/OpenAccessLicense).",Non-OADS,/arxiv_data1/oa_pdf/aa/7a/dee-0006-0214.PMC4913765.pdf
"© 2016 The Author(s) Published by S. Karger AG, Basel  Published online: May 18, 2016 EXTRA  Marcos Aparecido Sarria Cabrera   Universidade Estadual de Londrina   Rua montese 65-A   Londrina, PR 86015020 (Brazil)   E-Mail marcoscabrera   @   uol.com.br www.karger.com/dee DOI: 10.1159/000444705  This article is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 Interna- tional License (CC BY-NC-ND) (http://www.karger.com/Services/OpenAccessLicense).",Non-OADS,/arxiv_data1/oa_pdf/af/ce/dee-0006-0185.PMC4913766.pdf
"© 2016 The Author(s) Published by S. Karger AG, Basel  Published online: May 26, 2016 EXTRA  Kiyotaka Nakamagoe   University of Tsukuba   Tennodai 1-1-1   Tsukuba, Ibaraki 305-8575 (Japan)   E-Mail nakamagoek   @   md.tsukuba.ac.jp www.karger.com/dee DOI: 10.1159/000445870  This article is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 Interna- tional License (CC BY-NC-ND) (http://www.karger.com/Services/OpenAccessLicense).",Non-OADS,/arxiv_data1/oa_pdf/ff/f2/dee-0006-0194.PMC4913767.pdf
"© 2016 The Author(s) Published by S. Karger AG, Basel   Introduction     Ǧ Ǥ  Published online: May 4, 2016 EXTRA  Kenichi Meguro, MD   Division of Geriatric Behavioral Neurology, Cyclotron and Radioisotope Center (CYRIC)    Tohoku University, 4-1, Seiryo-machi, Aoba-ku   IDAC, 980-8575 Sendai (Japan)   E-Mail k-meg   @   umin.ac.jp www.karger.com/dee DOI: 10.1159/000445539  This article is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 Interna- tional License (CC BY-NC-ND) (http://www.karger.com/Services/OpenAccessLicense).",Non-OADS,/arxiv_data1/oa_pdf/cb/9b/dee-0006-0176.PMC4913768.pdf
"1) 4,14,15using the BoneJ16plugin of ImageJ software (http://imagej.nih.gov/ij/; provided in the public domain bythe National Institutes of Health, Bethesda, MD, USA).",OADS,/arxiv_data1/oa_pdf/58/2c/i1552-5783-57-7-3088.PMC4913800.pdf
"and Environment for Statistical Computing (version 3.2.0; in the public domain, http://www.R-project.org).19Finally, the relationship between the intercept and gradient for bothbeam thickness and pore diameter, as well as how porediameter gradient versus CRVT was related to beam thickness gradient versus CRVT, were assessed using a linear mixed- effect model with age and percent of visible LC serving ascovariates.",OADS,/arxiv_data1/oa_pdf/58/2c/i1552-5783-57-7-3088.PMC4913800.pdf
"Keywords Viable but non-culturable; Legionella; Standard; PCR; Cytometry; Risk assessment This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ) *Medical University Vienna, Institute for Hygiene and Applied Immunology, Water Hygiene Kinderspitalgasse 16, A-1090 Vienna,  Austria alexander.kirschner@meduniwien.ac.at.",Non-OADS,/arxiv_data1/oa_pdf/80/32/emss-68357.PMC4913838.pdf
URL: http://www.waterandhealth.at .,Non-OADS,/arxiv_data1/oa_pdf/80/32/emss-68357.PMC4913838.pdf
"This is an Open Access arti cle distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/by-nc/4.0/ ), which permits non-commercial re- use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/a0/34/ezv488.PMC4913873.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/by- nc/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/84/54/ezw013.PMC4913875.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ Supplementary Information accompanies this paper on The I SME Journal website (http://www.nature.com/ismej)Ecological isolation and cryptic diversity MW Hahn et al 1655 The ISME Journal",Non-OADS,/arxiv_data1/oa_pdf/dd/b7/ismej2015237a.PMC4913878.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/3a/1a/ceor-8-235.PMC4913883.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/3a/1a/ceor-8-235.PMC4913883.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).ClinicoEconomics and Outcomes Research 2016:8 235–241ClinicoEconomics and Outcomes Research Dovepress submit your manuscript | www.dovepress.com Dovepress  235 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CEOR.S107123Savings associated with high-dose hypoallergenic  house dust mite immunotherapy in rhinitis and/or  asthma patients in Spain José Carlos García Robaina1 Carlos Polanco Sánchez2 Elvira Estella Pérez2 1Allergy Department, University  Hospital Nuestra Señora de  Candelaria, Santa Cruz de T enerife,   2Health Economics & Outcomes  Research, Corporate Affairs, Merck S.L., Madrid, SpainObjectives:  To quantify the cost difference between conventional symptomatic treatment of  mite allergy and specific subcutaneous immunotherapy (SCIT).",Non-OADS,/arxiv_data1/oa_pdf/3a/1a/ceor-8-235.PMC4913883.pdf
"2,3Correspondence: José Carlos García  RobainaAllergy Department, Hospital Universitario Nuestra Señora de Candelaria, Carretera General Del Rosario 145, 38010 Santa Cruz de Tenerife, SpainTel +34 922 602 000Email jgarrob@gobiernodecanarias.orgJournal name: ClinicoEconomics and Outcomes Research Article Designation: ORIGINAL RESEARCHY ear: 2016V olume: 8Running head verso: García Robaina et alRunning head recto: Evaluation of clinical and economic value of house dust mite ITDOI: http://dx.doi.org/10.2147/CEOR.S107123",Non-OADS,/arxiv_data1/oa_pdf/3a/1a/ceor-8-235.PMC4913883.pdf
"ClinicoEconomics and Outcomes Research 2016:8submit your manuscript | www.dovepress.com Dovepress Dovepress ClinicoEconomics and Outcomes Research Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/clinicoeconomics-and-outcomes-research-journalClinicoEconomics and Outcomes Research is an international, peer- reviewed open-access journal focusing on health technology assess-ment, pharmacoeconomics and outcomes research in the areas of   diagnosis, medical devices, and clinical, surgical and pharmacological intervention.",Non-OADS,/arxiv_data1/oa_pdf/3a/1a/ceor-8-235.PMC4913883.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 241 Evaluation of clinical and economic value of house dust mite IT 10.,Non-OADS,/arxiv_data1/oa_pdf/3a/1a/ceor-8-235.PMC4913883.pdf
"Physicians Association; 2016 [updated 2016; cited march, 2016] Available from: https://www.comb.cat/cat/professional/asselliure/nomenclator.html.",Non-OADS,/arxiv_data1/oa_pdf/3a/1a/ceor-8-235.PMC4913883.pdf
Available from: https://botplusweb.portalfarma.com/.,Non-OADS,/arxiv_data1/oa_pdf/3a/1a/ceor-8-235.PMC4913883.pdf
Available from: http://www.gobiernodeca-narias.org/boc/2014/061/001.html.,Non-OADS,/arxiv_data1/oa_pdf/3a/1a/ceor-8-235.PMC4913883.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p  and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/d8/63/ceor-8-275.PMC4913884.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Economic analysis of empiric versus diagnostic- driven strategies for immunocompromised  patients with suspected fungal infections in  the People’s Republic of China Ningying Mao1 Beth Lesher2 Qifa Liu3 Lei Qin2 Yixi Chen4 Xin Gao2 Stephanie R Earnshaw5 Cheryl L McDade5 Claudie Charbonneau6 1School of International  Pharmaceutical Business, China  Pharmaceutical University, Nanjing,   People’s Republic of China; 2Pharmerit  International, Bethesda, MD, USA;   3Hematology Department, Nanfang  Hospital, Southern Medical University,   Guangzhou, 4Pfizer Investment Co.   Ltd., Beijing, People’s Republic of  China; 5RTI Health Solutions, Research  Triangle Park, NC, USA; 6Pfizer  International Operations, Paris, France Correspondence: Xin Gao   Pharmerit International, 4350 East West  Highway, Suite 430, Bethesda, MD 20814,  USA  T el +1 240 821 1266   Fax +1 240 821 1296   Email cgao@pharmerit.co mAbstract:  Invasive fungal infections (IFIs) require rapid diagnosis and treatment.",Non-OADS,/arxiv_data1/oa_pdf/d8/63/ceor-8-275.PMC4913884.pdf
"The abstract for this presentation is available  on http://www.valueinhealthjournal.com/article/S1098- 3015(14)04409-X/pd f. Interim findings for the Beijing,  Chengdu, and Guangzhou analyses were presented at the  2015 ISPOR Annual International Meeting, May 16–20,  2015, in Philadelphia, PA, USA, as a poster presentation.",Non-OADS,/arxiv_data1/oa_pdf/d8/63/ceor-8-275.PMC4913884.pdf
The abstract of this poster is available on https://www.rti.,Non-OADS,/arxiv_data1/oa_pdf/d8/63/ceor-8-275.PMC4913884.pdf
"Available from: http://en.wikipedia.org/wiki/Body_weigh t. Accessed  March 24, 2016.",Non-OADS,/arxiv_data1/oa_pdf/d8/63/ceor-8-275.PMC4913884.pdf
"ClinicoEconomics and Outcomes Research Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinicoeconomics-and-outcomes-research-journa lClinicoEconomics & Outcomes Research is an international, peer- reviewed open-access journal focusing on Health Technology Assess - ment, Pharmacoeconomics and Outcomes Research in the areas of  diagnosis, medical devices, and clinical, surgical and pharmacological  intervention.",Non-OADS,/arxiv_data1/oa_pdf/d8/63/ceor-8-275.PMC4913884.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/d8/63/ceor-8-275.PMC4913884.pdf
Keywords HIV/AIDS; Tropism shift; Coreceptor inhibitor; Drug resistance This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/15/72/nihms793912.PMC4913893.pdf
Single  Nucleotide Polymorphism (SNP) analysis was performed using GATK Haplotype Caller  (https://www.broadinstitute.org/gatk/ ).,OADS,/arxiv_data1/oa_pdf/15/72/nihms793912.PMC4913893.pdf
Phylogenetic and statistical analysis Hierarchical clustering was performed based on Euclidean distance matrices and visualized  using GENE-E ( http://www.broadinstitute.org/cancer/software/GENE-E/ ) or iTOF ( http:// itol.embl.de/ ).,OADS,/arxiv_data1/oa_pdf/15/72/nihms793912.PMC4913893.pdf
V3 loop consensus sequences from two functional clusterings and their  significantly different amino acid positions were computed and visualized using IceLogo  (http://iomics.ugent.be/icelogoserver/index.html ).,OADS,/arxiv_data1/oa_pdf/15/72/nihms793912.PMC4913893.pdf
Deep sequence data sets Raw sequence files from this study will be deposited in the NCBI Short Read Archive at  http://www.ncbi.nlm.nih.gov/sraunder BioProject ID PRJNA317236 ; accession numbers:  SAMN0-4633238-04633241.,Non-OADS,/arxiv_data1/oa_pdf/15/72/nihms793912.PMC4913893.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/3f/68/ndt-12-1411.PMC4913959.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Neuropsychiatric Disease and Treatment 2016:12 1411–1417Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  1411OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S10853 7 Self-perceived cognitive deficits and their  relationship with internalized stigma and quality  of life in patients with schizophrenia Yeon-Jeong shin1,2 Y o-han Joo1 Jong-hoon Kim1–3 1Neuroscience research institute,   2Department of health sciences  and Technology, gachon advanced  institute for health sciences &  T echnology, 3Department of  Psychiatry, gil Medical center,   gachon University school of  Medicine, gachon University, incheon,   republic of KoreaBackground:  We investigated self-perceived cognitive deficits and their relationship with  internalized stigma and quality of life in patients with schizophrenia in order to shed light on  the clinical correlates of subjective cognitive deficits in schizophrenia.",Non-OADS,/arxiv_data1/oa_pdf/3f/68/ndt-12-1411.PMC4913959.pdf
"Keywords:  subjective cognitive deficits, internalized stigma, quality of life, schizophrenia Introduction Self-perceived cognitive deficits are subjective disturbances that primarily affect  memory, attention, and executive function, and have been reported since the earliest  description of dementia praecox.1,2 Unlike objective psychopathology that can be  measured using interviewer-rated scales, subjectively experienced deficits are difficult  to quantify and the reliability of the measurements is often questioned; accordingly,  self-perceived cognitive deficits have been relatively neglected in research.3correspondence: Jong-hoon Kim Neuroscience research institute,  Department of Psychiatry, gil Medical  center, gachon University school of  Medicine, gachon University, 1198  guwol-dong, Namdong-gu, incheon,  405-760, republic of Korea Tel +82 32 460 2696 Fax +82 32 472 8813 email jhnp@chol.co m Journal name: Neuropsychiatric Disease and Treatment Article Designation: Original Research Y ear: 2016 Volume: 12 Running head verso: Shin et al Running head recto: Cognitive deficits, stigma, and quality of life in schizophrenia DOI: http://dx.doi.org/10.2147/NDT.S108537",Non-OADS,/arxiv_data1/oa_pdf/3f/68/ndt-12-1411.PMC4913959.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/3f/68/ndt-12-1411.PMC4913959.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/3f/68/ndt-12-1411.PMC4913959.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/78/90/opth-10-1103.PMC4913960.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Ophthalmology 2016:10 1103–1110Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  1103Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S10076 4Baseline visual acuity strongly predicts visual  acuity gain in patients with diabetic macular  edema following anti-vascular endothelial  growth factor treatment across trials Pravin U Dugel1,2 Jost hillenkamp3 sobha sivaprasad4,5 Jessica Vögeler6 Marie-Catherine Mousseau7 andreas Wenzel8 Philippe Margaron8 ron hashmonay8 Pascale Massin9 1retinal Consultants of arizona  lTD, retinal research institute  llC, Phoenix, aZ, 2UsC eye  institute, Keck school of Medicine,   University of southern California,   los angeles, C a, Usa; 3Department  of Ophthalmology, Julius-Maximilians  University, Würzburg, germany;   4nihr Biomedical research Centre,   Moorfields eye hospital, london,   5King’s College hospital, london, UK;   6novartis Pharma gmbh, nürnberg,   germany; 7novartis ireland limited,   Dublin, ireland; 8novartis Pharma ag,   Basel, switzerland; 9Department of  Ophthalmology, hôpital lariboisière,   assistance Publique des hôpitaux de  Paris, Université Paris Diderot, Paris,   FranceObjective:  This study was designed to evaluate the correlation of baseline visual acuity (VA)  with VA outcome in response to anti-vascular endothelial growth factor (VEGF) in diabetic  macular edema using a retrospective analysis of nine clinical trials.",Non-OADS,/arxiv_data1/oa_pdf/78/90/opth-10-1103.PMC4913960.pdf
"Prospective, randomized clinical trials have addressed the efficacy and safety of dif - ferent types of anti-VEGF in the treatment of DME, including pegaptanib, ranibizumab, Correspondence: Pravin U Dugel retinal Consultants of arizona lTD,  1101 e. Missouri avenue Phoenix, aZ  85014, Usa Tel +1 602 222 2221 email pdugel@gmail.co m Journal name: Clinical Ophthalmology Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Dugel et al Running head recto: Plateau effect with anti-VEGFs in DME DOI: http://dx.doi.org/10.2147/OPTH.S100764",Non-OADS,/arxiv_data1/oa_pdf/78/90/opth-10-1103.PMC4913960.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/78/90/opth-10-1103.PMC4913960.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/78/90/opth-10-1103.PMC4913960.pdf
"Available from: http://www.ema.europa.eu/ docs/en_GB/document_library/EPAR_-_Product_Information/ human/000715/WC500043546.pd f. Accessed February 1, 2016.",OADS,/arxiv_data1/oa_pdf/78/90/opth-10-1103.PMC4913960.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/44/9f/ijn-11-2867.PMC4913961.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2016:11 2867–2872International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  2867PersPectIvesopen access to scientific and medical research Open Access Full text Article http: //dx.doi.org/10.2147/IJN.S10585 2 A brief perspective on the diverging theories of  lymphatic targeting with colloids  Karthik siram1 Gregory Marslin2 chellan vijaya raghavan1 Krishnamoorthy Balakumar1 Habibur rahman1 Gregory Franklin3 1Department of Pharmaceutics, P sG  college of Pharmacy, coimbatore,   India; 2centre for the research and  technology of Agro- environment  and Biological sciences, University of  Minho, Braga, Portugal; 3Department  of Integrative Plant Biology, Institute  of Plant Genetics, Polish Academy of  Sciences, Poznań, PolandAbstract:  For targeted delivery of colloids to the lymphatic system, the colloids should  efficiently reach and remain in the lymphatics for a considerable period of time.",Non-OADS,/arxiv_data1/oa_pdf/44/9f/ijn-11-2867.PMC4913961.pdf
"However, the role of phagocytosis  and polyethylene glycol (PEG) attachment to colloids (PEGylation) on lymphatic correspondence: chellan vijaya  raghavan Department of Pharmaceutics, PsG  college of Pharmacy, Peelamedu,  coimbatore, India 641004  tel +91 9843128373 email drvijayaragha@gmail.co m  Gregory Franklin Department of Integrative Plant Biology,  Institute of Plant Genetics, Polish  Academy of Sciences, Strzeszyńska 34,  60-479 Poznań, Poland  tel +48 61 655 0266 Fax +48 61 655 0301  email fgre@igr.poznan.p l Journal name: International Journal of Nanomedicine Article Designation: Perspectives Y ear: 2016 Volume: 11 Running head verso: Siram et al Running head recto: Contradicting approaches in lymphatic targeting DOI: http://dx.doi.org/10.2147/IJN.S105852",Non-OADS,/arxiv_data1/oa_pdf/44/9f/ijn-11-2867.PMC4913961.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/44/9f/ijn-11-2867.PMC4913961.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/44/9f/ijn-11-2867.PMC4913961.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/7b/89/ppa-10-1091.PMC4913962.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Patient Preference and Adherence 2016:10 1091–1100Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  1091OriginAl reseArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PPA.S9970 2The impact of using musculoskeletal ultrasound  imaging and other influencing factors on  medication adherence in patients with  rheumatoid arthritis: a qualitative study Kanta Kumar1,2 Karim raza3,4 Paramjit gill1 sheila greenfield1 1Primary care clinical sciences,   University of Birmingham, Birmingham,   2Faculty of Medical and human  sciences, University of Manchester,   Manchester, 3institute of inflammation  and Ageing, University of Birmingham,   4sandwell and West Birmingham  hospitals nhs Trust, Birmingham, UKBackground:  Medication can ease symptoms and limit disease progression in rheumatoid  arthritis (RA).",Non-OADS,/arxiv_data1/oa_pdf/7b/89/ppa-10-1091.PMC4913962.pdf
"Keywords:  rheumatoid arthritis, medication adherence, patients’ suggestion to improve  medication, disease-modifying antirheumatic drugs Introduction Rheumatoid arthritis (RA) is a chronic inflammatory disease characterized by  synovitis and associated with joint destruction.1 RA causes progressive decline in  functional ability and limits participation in social and work-related activities.2 RA  is also associated with an increased risk of extra-articular complications including  ischemic heart disease.3 While curative therapies are not currently available, treat - ments with disease-modifying antirheumatic drugs (DMARDs) and biologic agents  improve joint function,1 work productivity,4 and health-related quality of life, reducing correspondence: Kanta Kumar Primary care clinical sciences,  University of Birmingham, Vincent Drive,  Birmingham B15 2TT, UK email k.kumar@bham.ac.u kJournal name: Patient Preference and Adherence Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Kumar et al Running head recto: Medication adherence in RA patients DOI: http://dx.doi.org/10.2147/PPA.S99702",Non-OADS,/arxiv_data1/oa_pdf/7b/89/ppa-10-1091.PMC4913962.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal that focuses on the growing importance of patient   preference  and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/7b/89/ppa-10-1091.PMC4913962.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/6a/26/tcrm-12-975.PMC4913963.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Therapeutics and Clinical Risk Management 2016:12 975–981Therapeutics and Clinical Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  975Case Repo RTopen access to scientific and medical research open access Full T ext article http: //dx.doi.org/10.2147/TCRM.S10701 2 Mesalazine-induced eosinophilic pneumonia  with bone marrow infiltration: a case report  and literature review Yunjian Zhang1 Ling Luo1 Xiaofang Wang1 Xiaoyang Liu1 Xiaoyan Wang1 Yi Ding2 1Division of pulmonary and Critical  Care Medicine, Department of  Medicine, 2Department of pathology,   Jishuitan Hospital, Fourth Medical  College of peking University, Beijing,   people’s Republic of ChinaAbstract:  Mesalazine-induced eosinophilic pneumonia has been rarely reported.",Non-OADS,/arxiv_data1/oa_pdf/6a/26/tcrm-12-975.PMC4913963.pdf
"She started Correspondence: Yunjian Zhang Division of pulmonary and Critical Care  Medicine, Department of Medicine,  Jishuitan Hospital, Fourth Medical  College of peking University, No 31, east  Xinjiekou street, Xicheng District, Beijing  100035, people’s Republic of China Tel +86 136 9320 5037 email zhangyjian@126.co m Journal name: Therapeutics and Clinical Risk Management Article Designation: Case report Y ear: 2016 Volume: 12 Running head verso: Zhang et al Running head recto: Mesalazine-induced eosinophilic pneumonia with bone marrow infiltration DOI: http://dx.doi.org/10.2147/TCRM.S107012",Non-OADS,/arxiv_data1/oa_pdf/6a/26/tcrm-12-975.PMC4913963.pdf
"Therapeutics and Clinical Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/therapeutics-and-clinical-risk-management-journa lTherapeutics and Clinical Risk Management is an international, peer- reviewed journal of clinical therapeutics and risk management, focusing  on concise rapid reporting of clinical studies in all therapeutic areas,  outcomes, safety, and programs for the effective, safe, and sustained  use of medicines.",Non-OADS,/arxiv_data1/oa_pdf/6a/26/tcrm-12-975.PMC4913963.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/6a/26/tcrm-12-975.PMC4913963.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/75/82/tcrm-12-983.PMC4913964.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Therapeutics and Clinical Risk Management 2016:12 983–988Therapeutics and Clinical Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  983ORiginal ReseaRChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/TCRM.S10170 9 Prescription of antibiotics in community-acquired  pneumonia in children: are we following the  recommendations?",Non-OADS,/arxiv_data1/oa_pdf/75/82/tcrm-12-983.PMC4913964.pdf
"Keywords:  antibiotic therapy, pneumonia, children, health services Introduction Community-acquired pneumonia (CAP) is one of the main causes of mortality in chil - dren aged less than 5 years, responsible for ~19% of all deaths worldwide.1 Antibiotic  therapy is often empirically initiated, based on the epidemiological knowledge of the  main bacterial agents, according to the age-group and clinical severity.2 Although there was a decrease in all-cause mortality in children in the decade  2000–2010, including mortality caused by pneumonia, it has been estimated that Correspondence: eduardo Jorge da  Fonseca lima instituto de Medicina integral Professor  Fernando Figueira, Rua dos Coelhos, 300,  Boa Vista Recife, Pe, Brazil Tel +55 81 2122 4166 email eduardojorge@imip.org.b rJournal name: Therapeutics and Clinical Risk Management Article Designation: Original Research Y ear: 2016 Volume: 12 Running head verso: Fonseca Lima et al Running head recto: Prescription of antibiotics in children with community-acquired pneumonia DOI: http://dx.doi.org/10.2147/TCRM.S101709",Non-OADS,/arxiv_data1/oa_pdf/75/82/tcrm-12-983.PMC4913964.pdf
"Therapeutics and Clinical Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/therapeutics-and-clinical-risk-management-journa lTherapeutics and Clinical Risk Management is an international, peer- reviewed journal of clinical therapeutics and risk management, focusing  on concise rapid reporting of clinical studies in all therapeutic areas,  outcomes, safety, and programs for the effective, safe, and sustained  use of medicines.",Non-OADS,/arxiv_data1/oa_pdf/75/82/tcrm-12-983.PMC4913964.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/75/82/tcrm-12-983.PMC4913964.pdf
Available  from: http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1806- 37132007000700002&lng=en.,Non-OADS,/arxiv_data1/oa_pdf/75/82/tcrm-12-983.PMC4913964.pdf
"Available from:  http://apps.who.int/iris/bitstream/10665/ 44774/1/9789241502825_eng.pd f. Acessed January 12, 2016.",OADS,/arxiv_data1/oa_pdf/75/82/tcrm-12-983.PMC4913964.pdf
Available from: http://www.who.int/world-health-day/2011/ policybriefs /en/.,Non-OADS,/arxiv_data1/oa_pdf/75/82/tcrm-12-983.PMC4913964.pdf
Available from: http://apps.who.int/iris/bitstream/10665/ 112642/1/9789241564748_eng.pdf?ua =1.,OADS,/arxiv_data1/oa_pdf/75/82/tcrm-12-983.PMC4913964.pdf
Available from: http://www.e-publicacoes.uerj.br/index.php/demetra/ article/view/5573/5139#.VzNhMtIrLIU.,Non-OADS,/arxiv_data1/oa_pdf/75/82/tcrm-12-983.PMC4913964.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/46/c1/ndt-12-1379.PMC4913966.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Neuropsychiatric Disease and Treatment 2016:12 1379–1384Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  1379OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S10685 0 early diagnosis and early start Denver Model  intervention in autism spectrum disorders  delivered in an italian Public health system service raffaella Devescovi1 lorenzo Monasta2 alice Mancini3 Maura Bin1 Valerio Vellante1 Marco carrozzi1 costanza colombi4 1Division of child Neurology and  Psychiatry, 2clinical epidemiology  and Public health research Unit,   institute for Maternal and child  health – irccs “Burlo garofolo”,   Trieste, 3Department of clinical and  experimental Medicine, University  of Pisa, Pisa, italy; 4Department of  Psychiatry, University of Michigan  health system, ann arbor, M i, UsaBackground:  Early diagnosis combined with an early intervention program, such as the Early  Start Denver Model (ESDM), can positively influence the early natural history of autism spectrum  disorders.",Non-OADS,/arxiv_data1/oa_pdf/46/c1/ndt-12-1379.PMC4913966.pdf
"Keywords:  early diagnosis, early intervention, autism spectrum disorder, Early Start Denver  Model, Public Health System service Introduction Autism spectrum disorders (ASDs) are a group of neurodevelopmental abnormalities  that begin in early childhood and are characterized by impairments in social interaction  and communication, as well as repetitive behaviors and restricted interests ( Diagnostic  and Statistical Manual of Mental Disorders , Fifth Edition [ DSM-V ]).1 Given the high  incidence of ASD and the presence of intellectual disabilities and impaired function - ing in many individuals with ASD, developing effective interventions that decrease  symptoms and improve outcomes is a research and clinical priority.2 The role of early intervention in improving children’s outcomes is well supported  by a consistent body of research.3 However, most of the studies supporting early  intervention for children with ASDs have been conducted in university centers with correspondence: raffaella Devescovi Division of child Neurology and  Psychiatry, institute for Maternal and  child health – irccs “Burlo garofolo”,  Via dell’istria 65/1, 34137 Trieste, italy Tel +39 40 378 5407 Fax +39 40 378 5544 email raffaella.devescovi@burlo.trieste.i t Journal name: Neuropsychiatric Disease and Treatment Article Designation: Original Research Y ear: 2016 Volume: 12 Running head verso: Devescovi et al Running head recto: ESDM intervention in Public Health System DOI: http://dx.doi.org/10.2147/NDT.S106850",Non-OADS,/arxiv_data1/oa_pdf/46/c1/ndt-12-1379.PMC4913966.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/46/c1/ndt-12-1379.PMC4913966.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/46/c1/ndt-12-1379.PMC4913966.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/9e/9d/ndt-12-1385.PMC4913969.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Neuropsychiatric Disease and Treatment 2016:12 1385–1388Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  1385Case repor Topen access to scientific and medical research open access Full T ext article http: //dx.doi.org/10.2147/NDT .S10934 5 recognized homonymous hemianopsia and  delirium during the admission examination  leading to diagnosis and appropriate treatment  of a new stroke Konstantin s Tsymbalov Douglas r Fetkenhour Department of physical Medicine  and rehabilitation, University of  rochester Medical Center, rochester,   NY, UsaAbstract:  This case report describes the detection of homonymous hemianopsia and delirium  during the admission physical examination of a patient with esophageal adenocarcinoma, resulting  in the new diagnosis of subacute hemorrhagic stroke.",Non-OADS,/arxiv_data1/oa_pdf/9e/9d/ndt-12-1385.PMC4913969.pdf
"The  patient was medically stabilized and evaluated for admission to a rehabilitation unit.Correspondence: Konstantin s Tsymbalov Department of physical Medicine and  rehabilitation, University of rochester  Medical Center, 601 elmwood avenue,  Box 664, rochester, NY 15642, Usa email ktsymbalov@yahoo.co m Journal name: Neuropsychiatric Disease and Treatment Article Designation: Case report Y ear: 2016 Volume: 12 Running head verso: Tsymbalov and Fetkenhour Running head recto: Detection of homonymous hemianopsia and delirium DOI: http://dx.doi.org/10.2147/NDT.S109345",Non-OADS,/arxiv_data1/oa_pdf/9e/9d/ndt-12-1385.PMC4913969.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/9e/9d/ndt-12-1385.PMC4913969.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/9e/9d/ndt-12-1385.PMC4913969.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/61/c4/tcrm-12-989.PMC4913970.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",OADS,/arxiv_data1/oa_pdf/61/c4/tcrm-12-989.PMC4913970.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Therapeutics and Clinical Risk Management 2016:12 989–994Therapeutics and Clinical Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  989Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/TCRM.S10494 2 Occupational Hiv risk for health care workers:  risk factor and the risk of infection in the course  of professional activities Przemysław Wyżgowski1 Anna Rosiek2 T omasz Grzela1 Krzysztof Leksowski1,2 1Department of General Surgery,   Military Hospital, 2Public Health  Department, Faculty of Health  Sciences, Nicolas Copernicus  University in T oruń, Bydgoszcz, PolandAbstract:  Virtually created panic among health care workers about pandemic acquired immune  deficiency syndrome prompted us to review the scientific literature to investigate the risk of  human immunodeficiency virus (HIV) transmission in the daily works of health care workers,  especially surgeons and anesthesiologists.",Non-OADS,/arxiv_data1/oa_pdf/61/c4/tcrm-12-989.PMC4913970.pdf
"In 2008, Correspondence: Anna Rosiek Public Health  Department , Faculty of  Health Sciences, Nicolas Copernicus  University in Toruń, Przod Pracy 8/7,  85-843 Bydgoszcz, Poland email ania.rosiek@wp.p l Journal name: Therapeutics and Clinical Risk Management Article Designation: Review Y ear: 2016 Volume: 12 Running head verso: Wyz ˙gowski et al Running head recto: Occupational HIV risk for health care workers DOI: http://dx.doi.org/10.2147/TCRM.S104942 Point your SmartPhone at the code above.",Non-OADS,/arxiv_data1/oa_pdf/61/c4/tcrm-12-989.PMC4913970.pdf
Or use: http://youtu.be/ZfrAZG4xKB 8video abstract,Non-OADS,/arxiv_data1/oa_pdf/61/c4/tcrm-12-989.PMC4913970.pdf
"Available  from: http://www.unaids.or g. Accessed November 1, 2015.",Non-OADS,/arxiv_data1/oa_pdf/61/c4/tcrm-12-989.PMC4913970.pdf
"Available  from: http://www.cdc.gov/mmwr/preview/mmwrhtml/00000039.ht m.  Accessed May 31, 2016.",OADS,/arxiv_data1/oa_pdf/61/c4/tcrm-12-989.PMC4913970.pdf
"Therapeutics and Clinical Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/therapeutics-and-clinical-risk-management-journa lTherapeutics and Clinical Risk Management is an international, peer- reviewed journal of clinical therapeutics and risk management, focusing  on concise rapid reporting of clinical studies in all therapeutic areas,  outcomes, safety, and programs for the effective, safe, and sustained  use of medicines.",Non-OADS,/arxiv_data1/oa_pdf/61/c4/tcrm-12-989.PMC4913970.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/61/c4/tcrm-12-989.PMC4913970.pdf
Available  from: https://stacks.cdc.gov/view/cdc/3539 8.,OADS,/arxiv_data1/oa_pdf/61/c4/tcrm-12-989.PMC4913970.pdf
"Available from: https://aidsinfo.nih.gov/contentfiles/ lvguidelines/adultandadolescentgl.pd f. Accessed September 17, 2012.",Non-OADS,/arxiv_data1/oa_pdf/61/c4/tcrm-12-989.PMC4913970.pdf
"Available from: http://www.cdc.gov/nhsn/ PDFs/NaSH/NaSH-Report-6-2011.pd f. Accessed November 1, 2015.",OADS,/arxiv_data1/oa_pdf/61/c4/tcrm-12-989.PMC4913970.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/5c/c9/ott-9-3595.PMC4913971.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 3595–3602OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  3595Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S10235 6 high expression of substance P and its receptor  neurokinin-1 receptor in colorectal cancer is  associated with tumor progression and prognosis Xiao-Yi chen,1,* guo-Qing  ru,2,* Ying-Yu Ma,1 Jun Xie,3  Wan-Yuan chen,2 hui-Ju  Wang,1 shi-Bing Wang,1 li  li,1 Ke-Tao Jin,4 Xiang- lei  he,2 Xiao-Zhou Mou1 1clinical research institute,   2Department of Pathology, Zhejiang  Provincial People’s hospital,   hangzhou, 3Department of anus- intestines, affiliated hospital of  shaoxing University, 4Department of  gastrointestinal surgery, shaoxing  People’s hospital, shaoxing hospital  of Zhejiang University, shaoxing,   People’s republic of china *These authors contributed equally  to this workBackground:  Epidemiologic evidence suggests that chronic inflammation and/or chronic  infection is associated with cancer development, and the inflammatory process may play a crucial  role in the carcinogenesis and prognosis of colorectal cancer (CRC).",Non-OADS,/arxiv_data1/oa_pdf/5c/c9/ott-9-3595.PMC4913971.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/5c/c9/ott-9-3595.PMC4913971.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/5c/c9/ott-9-3595.PMC4913971.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/75/c3/ott-9-3535.PMC4913972.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 3535–3544OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  3535Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S10635 1 Mir-503 inhibits hepatocellular carcinoma cell  growth via inhibition of insulin-like growth  factor 1 receptor Yao Xiao1  Qinggang Tian2  Jiantai he1  Ming huang1  chao Yang1  liansheng gong1 1Department of hepatobiliary  and Pancreatic surgery, Xiangya  hospital, central south University,   changsha, hunan, 2Department of  general surgery, The Fourth affiliated  hospital of Baotou Medical college,   Baotou, inner Mongolia, People’s  republic of chinaAbstract:  MicroRNAs (miRs) have been demonstrated to play key roles in the development  and progression of hepatocellular carcinoma (HCC).",Non-OADS,/arxiv_data1/oa_pdf/75/c3/ott-9-3535.PMC4913972.pdf
"MicroRNAs (miRs) are a class of noncoding RNAs, 18–25 nucleotides in length,  that have been demonstrated to negatively mediate the expression of their target genes  by inducing mRNA degradation or suppressing protein translation, via  directly binding  to 3′ untranslated regions (3UTRs) of their target mRNAs.3 Moreover, a variety of miRs  have been demonstrated to be involved in the development and progression of HCC by  negatively mediating the expression of their targets.4 Recently, miR-503 was found to  act as a tumor suppressor in several cancer types including HCC.5–7 Zhou et al found correspondence: liansheng gong  Department of hepatobiliary and  Pancreatic surgery, Xiangya hospital,  central south University, Xiangya  road 87, changsha, hunan 410008,  People’s republic of china  Tel +86 731 8975 3060 email gongliansheng8280@163.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2016 Volume: 9 Running head verso: Xiao et al Running head recto: Role of miR-503 in HCC DOI: http://dx.doi.org/10.2147/OTT.S106351",Non-OADS,/arxiv_data1/oa_pdf/75/c3/ott-9-3535.PMC4913972.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/75/c3/ott-9-3535.PMC4913972.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/75/c3/ott-9-3535.PMC4913972.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/78/6a/ndt-12-1397.PMC4913973.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Neuropsychiatric Disease and Treatment 2016:12 1397–1410Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  1397OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S10754 5 anterior cingulate hyperactivations during  negative emotion processing among men with  schizophrenia and a history of violent behavior andràs Tikàsz1,2 stéphane Potvin1,2 Ovidiu lungu2–4 christian c Joyal5,6 sheilagh hodgins2,5 adrianna Mendrek1,7 alexandre Dumais1,2,5 1centre de recherche de l’institut  Universitaire en santé Mentale de  Montréal, 2Department of Psychiatry,   University of Montreal, 3centre de  recherche de l’ institut Universitaire  de gériatrie de Montréal, 4centre for  research in aging, Donald Berman  Maimonides geriatric centre,   5institut Philippe-Pinel de Montréal,   6Department of Psychology, Université  du Québec à Trois-rivières, Trois- rivières, 7Department of Psychology,   Bishop’s University, sherbrooke, Qc ,   canadaBackground:  Evidence suggests a 2.1–4.6 times increase in the risk of violent behavior in  schizophrenia compared to the general population.",Non-OADS,/arxiv_data1/oa_pdf/78/6a/ndt-12-1397.PMC4913973.pdf
"Of particular concern is the evidence showing an increased risk of  aggressive and violent behavior (severe assaults, attempted murder, homicide) among  people with schizophrenia compared to the general population.2–6 Although most people  with schizophrenia are not violent,7,8 individuals suffering from schizophrenia were  found to be 2.1–4.6 times more likely to commit a violent crime or engage in violent  behavior than the general population, even when taking into account socioeconomic  status (SES), comorbid substance use, and personality disorders.2,9,10 In addition to correspondence: alexandre Dumais institut Philippe-Pinel de Montréal,  10905 henri-Bourassa est, Montréal,  Qc h1c 1h1, canada Tel +1 514 648 8461 email alexandre.dumais@umontreal.c aJournal name: Neuropsychiatric Disease and Treatment Article Designation: Original Research Y ear: 2016 Volume: 12 Running head verso: Tikàsz et al Running head recto: Anterior cingulate hyperactivations during negative emotion processing DOI: http://dx.doi.org/10.2147/NDT.S107545",Non-OADS,/arxiv_data1/oa_pdf/78/6a/ndt-12-1397.PMC4913973.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/78/6a/ndt-12-1397.PMC4913973.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/78/6a/ndt-12-1397.PMC4913973.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/24/ff/ott-9-3579.PMC4913974.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 3579–3588OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  3579Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S10547 0 Microrna-92a promotes metastasis of  nasopharyngeal carcinoma by targeting the  PTen/aKT pathway haixiong Zhang1 hui cao1 Dadao Xu1 Kang Zhu2 1Department of Otorhinolaryngology,   head and neck surgery, the  First affiliated hospital of Xi’an  Medical college, 2Department of  Otorhinolaryngology, head and neck  surgery, the second affiliated hospital  of Xi’an Jiaotong University, Xi’an,   People’s republic of chinaAbstract:  MicroRNAs have been confirmed to be a group of important regulators during the  pathogenesis of nasopharyngeal carcinoma (NPC).",Non-OADS,/arxiv_data1/oa_pdf/24/ff/ott-9-3579.PMC4913974.pdf
"MicroRNAs (miRNAs) is a group of short noncoding RNAs, which regulate  gene expression through mRNA cleavage and/or translation inhibition by binding to  the 3′-untranslated region (3 ′-UTR) of the targeted mRNA.6 It can modulate various  cellular processes including proliferation, apoptosis, movement, and differentiation.7–9  And numerous studies have demonstrated that aberrant expression or dysfunction  of miRNAs plays critical roles in the initiation and progression of various human  malignancies.10–12correspondence: Kang Zhu Department of Otorhinolaryngology,  head and neck surgery, the second  Affiliated Hospital of Xi’an Jiaotong  University, no 157 Xiwu road, Xi’an  710004, People’s republic of china Tel +86 29 8767 9325 Fax +86 29 8767 9325 email kzhu_xjtu@163.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2016 Volume: 9 Running head verso: Zhang et al Running head recto: MicroRNA-92a promotes metastasis of NPC DOI: http://dx.doi.org/10.2147/OTT.S105470",Non-OADS,/arxiv_data1/oa_pdf/24/ff/ott-9-3579.PMC4913974.pdf
"These  results demonstrate that miR-92a exerts its oncogenic role  in NPC by potentiating the migratory and invasive ability  of NPC cells.PTen is a downstream target of mir-92a  in nPc cells To further elucidate the underlying molecular mecha - nisms involved in the oncogenic role of miR-92 in NPC  cells, we used two publicly available databases Tar - getScan 7.0 ( http://www.targetscan.org /) and miRanda   (http://www.microrna.org /) to search for the potential down - stream targets of miR-92a.",OADS,/arxiv_data1/oa_pdf/24/ff/ott-9-3579.PMC4913974.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/24/ff/ott-9-3579.PMC4913974.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/24/ff/ott-9-3579.PMC4913974.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/7d/44/prom-7-073.PMC4913975.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",OADS,/arxiv_data1/oa_pdf/7d/44/prom-7-073.PMC4913975.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Patient Related Outcome Measures 2016:7 73–80Patient Related Outcome Measures Dove press submit your manuscript | www.dovepress.co m Dove press  73ORiginal ReseaRchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/PROM.S9682 2Validation of the Oxford Participation and  activities Questionnaire David Morley sarah Dummett laura Kelly Jill Dawson Ray Fitzpatrick crispin Jenkinson health services Research Unit,   nuffield Department of Population  health, University of Oxford, Oxford,   UK correspondence: David Morley   Health Services Research Unit, Nuffield  Department of Population health,  University of Oxford, Old Road campus,  Oxford OX3 7lF , UK   T el +44 0 1865 289 432   email david.morley@dph.ox.ac.u kPurpose:  There is growing interest in the management of long-term conditions and in keeping  people active and participating in the community.",Non-OADS,/arxiv_data1/oa_pdf/7d/44/prom-7-073.PMC4913975.pdf
Further  details regarding the development and validation of the  Ox-PAQ can be found at the University of Oxford Health  Services Research Unit Web site http://www.ndph.ox.ac.uk/ research/health-services-research-unit-hsru/research/oxpaq- initiativ e. Information regarding the use of the Ox-PAQ can  be obtained from the authors DM or CJ.,Non-OADS,/arxiv_data1/oa_pdf/7d/44/prom-7-073.PMC4913975.pdf
"Patient Related Outcome Measures Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-related-outcome-measures-journa lPatient Related Outcome Measures is an international, peer-reviewed,  open access journal focusing on treatment outcomes specifically  relevant to patients.",Non-OADS,/arxiv_data1/oa_pdf/7d/44/prom-7-073.PMC4913975.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/7d/44/prom-7-073.PMC4913975.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p  and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/3f/44/lra-9-035.PMC4913978.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Successful treatment of Raynaud’s syndrome in a  lupus patient with continuous bilateral popliteal  sciatic nerve blocks: a case report Thuan Dao1 David Amaro-Driedger2 Jaideep Mehta1 1Department of Anesthesiology,   2McGovern Medical School, The  University of Texas Health Science  Center at Houston, Houston, TX, USA Correspondence: Jaideep Mehta   Department of Anesthesiology, McGovern  Medical School, The University of T exas  Health Science Center at Houston, 6431  Fannin Street, MSB 5.020, Houston, TX  77030, USA   T el +1 713 500 6200   Email Jaideep.H.Mehta @gmail.comAbstract:  Raynaud’ s syndrome has been treated medically and invasively, sometimes with  regional anesthesia leading up to sympathectomy.",Non-OADS,/arxiv_data1/oa_pdf/3f/44/lra-9-035.PMC4913978.pdf
"Local and Regional Anesthesia Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/local-and-regional-anesthesia-journa lLocal and Regional Anesthesia is an international, peer-reviewed,  open access journal publishing on the development, pharmacology,  delivery and targeting and clinical use of local and regional anesthet - ics and analgesics.",Non-OADS,/arxiv_data1/oa_pdf/3f/44/lra-9-035.PMC4913978.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real  quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/3f/44/lra-9-035.PMC4913978.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/0a/11/ijn-11-2785.PMC4913979.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2016:11 2785–2797International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  2785OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S10125 1amphiphilic core–shell nanoparticles containing  dense polyethyleneimine shells for efficient  delivery of microrNa to Kupffer cells Zuojin liu1,* Dechao Niu2,3,* Junyong Zhang1 Wenfeng Zhang1 Yuan Yao2 Pei li2 Jianping gong1 1Department of hepatobiliary  surgery,  The second affiliated hospital  of chongqing Medical University,   chongqing, 2Department of applied  Biology and chemical T echnology,   The hong Kong Polytechnic  University, hung hom, Kowloon,   hong Kong, 3lab of low-Dimensional  Materials chemistry, school of  Materials science and engineering,   east china University of science  and T echnology, shanghai, People’s  republic of china *These authors contributed equally  to this workAbstract:  Efficient and targeted delivery approach to transfer exogenous genes into  macrophages is still a great challenge.",Non-OADS,/arxiv_data1/oa_pdf/0a/11/ijn-11-2785.PMC4913979.pdf
"KCs account for 80%–90% of total fixed tissue  macrophages in the body.1 Among all tissue-resident macrophages, KCs express a wide  repertoire of receptors for the recognition of pathogens and danger signals such as  Toll-like receptors, members of the inflammasome, and scavenger receptors.2,3 Using  their special receptor repertoire, KCs are involved in liver physiological homeostasis  and response to infection, toxins, transient ischemia, and various other stresses  through the expression and secretion of multiple inflammatory mediators.4 Therefore,  current investigations in KCs mostly focus on the signaling pathways that regulate correspondence: Jianping gong Department of hepatobiliary surgery,  The Second Affiliated Hospital of  chongqing Medical University, No  76,  linjiang road, chongqing 400010,  People’s republic of china Tel/fax +86 23 6369 3532 email gongjianping11@126.co m  Pei li Department of applied Biology and  chemical Technology, The hong Kong  Polytechnic University, 11 Yuk choi  road, hung hom, Kowloon, hong Kong,  People’s republic of china email pei.li@polyu.edu.h k Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Liu et al Running head recto: Amphiphilic core–shell nanoparticles containing dense PEI shells DOI: http://dx.doi.org/10.2147/IJN.S101251",Non-OADS,/arxiv_data1/oa_pdf/0a/11/ijn-11-2785.PMC4913979.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/0a/11/ijn-11-2785.PMC4913979.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/0a/11/ijn-11-2785.PMC4913979.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/c8/66/ndt-12-1365.PMC4913981.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Neuropsychiatric Disease and Treatment 2016:12 1365–1370Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  1365OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S10693 3 The effect of apoe e4 on blood pressure in  patients with and without depression Knut a hestad1–3 Knut engedal4 Jon elling Whist1,5 Per g Farup1,6 1Department of research, innlandet  hospital Trust, Brumunddal, Norway;   2Department of Psychology, Faculty  of social sciences and T echnology  Management, Norwegian University  of science and T echnology, Trondheim,   Norway; 3Department of Public  health, hedmark University college,   elverum, Norway; 4Norwegian  center for aging and health, Vestfold  health Trust, Tønsberg, Norway;   5Department of Medical Biochemistry,   innlandet hospital Trust, lillehammer,   Norway; 6Unit for applied clinical  research, Department of cancer  research and Molecular Medicine,   Faculty of  Medicine, Norwegian  University of science and T echnology,   Trondheim,  NorwayIntroduction:  Depression is considered an independent risk factor for hypertension, particularly  for people with recurrent episodes or a long history of depression.",Non-OADS,/arxiv_data1/oa_pdf/c8/66/ndt-12-1365.PMC4913981.pdf
"The heterozygotic e4 variant, found in approximately 18% of the  Norwegian population,14 has been associated with atherosclerosis, Alzheimer’s   disease, correspondence: Knut a hestad Department of research, innlandet  hospital Trust, Post Box 104, 2381  Brumunddal, Norway Tel +47 4121 0640 email knut.hestad@svt.ntnu.n o Journal name: Neuropsychiatric Disease and Treatment Article Designation: Original Research Y ear: 2016 Volume: 12 Running head verso: Hestad et al Running head recto: ApoE e4 and blood pressure in depression DOI: http://dx.doi.org/10.2147/NDT.S106933",Non-OADS,/arxiv_data1/oa_pdf/c8/66/ndt-12-1365.PMC4913981.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/c8/66/ndt-12-1365.PMC4913981.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/c8/66/ndt-12-1365.PMC4913981.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/ca/23/ott-9-3465.PMC4913982.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 3465–3471OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  3465Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S10131 9 The expression of ERCC1  and BRCA1  predicts  prognosis of platinum-based chemotherapy  in urothelial cancer Wenhui song hongshun Ma Department of Urology, Tianjin First  center hospital, Tianjin, People’s  republic of chinaObjective:  To investigate the expression and clinical significance of ERCC1  and BRCA1  genes  in urothelial cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/ca/23/ott-9-3465.PMC4913982.pdf
"Studies showed that the abnormal expression of the DNA damage repair- related genes, such as excision repair cross-complementation group 1 ( ERCC1 ) and breast  cancer 1, early onset ( BRCA1 ), is closely related to cancer multidrug resistance.2 ERCC1   and BRCA1  are key genes in the nucleotide excision repair (NER) pathway, which are  closely related to platinum resistance.3 The NER system is the main defense mechanism  for repairing DNA damage caused by carcinogens and chemotherapy drugs.4 This study analyzed the protein expression levels of ERCC1 and BRCA1 in 42  cases  of urothelial cancer specimens and investigated their relationships with clinical features, correspondence: hongshun Ma Department of Urology, Tianjin First  center hospital, 24 Fukang road,  nankai District, Tianjin 300192,  People’s republic of china Tel +86 22 186 2205 6378 Fax +86 22 022 2362 6850 email davidwen@126.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2016 Volume: 9 Running head verso: Song and Ma Running head recto: ERCC1 and BRCA1 expression in urothelial cancer DOI: http://dx.doi.org/10.2147/OTT.S101319",Non-OADS,/arxiv_data1/oa_pdf/ca/23/ott-9-3465.PMC4913982.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/ca/23/ott-9-3465.PMC4913982.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/ca/23/ott-9-3465.PMC4913982.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/7a/22/jir-9-123.PMC4913983.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/7a/22/jir-9-123.PMC4913983.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Journal of Inflammation Research 2016:9 123–131Journal of Inflammation Research Dovepress submit your manuscript | www.dovepress.com Dovepress 123 REVIEW open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/JIR.S106206 Vitamin D and the immunomodulation of rotator  cuff injury Kaitlin A Dougherty1 Matthew F Dilisio2 Devendra K Agrawal1 1Department of Clinical &  Translational Science, 2Department  of Orthopedic Surgery, Creighton  University School of Medicine,  Omaha, NE, USAAbstract: Tendon-to-bone healing after rotator cuff repair surgery has a failure rate of 20%–94%.",Non-OADS,/arxiv_data1/oa_pdf/7a/22/jir-9-123.PMC4913983.pdf
"3Correspondence: Devendra K Agrawal Department of Clinical & Translational Science, CRISS II Room 510, 2500 California Plaza, Omaha, NE 68178, USATel +1 402 280 2938Fax +1 402 280 1421Email dkagr@creighton.eduJournal name: Journal of Inflammation Research Article Designation: REVIEWY ear: 2016V olume: 9Running head verso: Dougherty et alRunning head recto: Vitamin D and rotator cuff injuryDOI: http://dx.doi.org/10.2147/JIR.S106206",Non-OADS,/arxiv_data1/oa_pdf/7a/22/jir-9-123.PMC4913983.pdf
Avail-able from: http://www.cdc.gov/nchs/ahcd/ahcd_questionnaires.htm.,OADS,/arxiv_data1/oa_pdf/7a/22/jir-9-123.PMC4913983.pdf
“Bone mass measurement: What the numbers mean.” Avail-able from: http://www.niams.nih.gov/health_info/bone/bone_health/bone_mass_measure.asp.,Non-OADS,/arxiv_data1/oa_pdf/7a/22/jir-9-123.PMC4913983.pdf
"Journal of Inflammation Research 2016:9submit your manuscript | www.dovepress.com Dovepress Dovepress Journal of Inflammation Research Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/journal-of-inflammation-research-journalThe Journal of Inflammation Research is an international, peer-reviewed  open access journal that welcomes laboratory and clinical findings on the molecular basis, cell biology and pharmacology of inflammation including original research, reviews, symposium reports, hypothesis for - mation and commentaries on: acute/chronic inflammation; mediators of inflammation; cellular processes; molecular mechanisms; pharmacology and novel anti-inflammatory drugs; clinical conditions involving inflam-mation.",Non-OADS,/arxiv_data1/oa_pdf/7a/22/jir-9-123.PMC4913983.pdf
Visit http://www.dove   press.com/testimonials.php to read real quotes from published authors.Dovepress 131 Vitamin D and rotator cuff injury,Non-OADS,/arxiv_data1/oa_pdf/7a/22/jir-9-123.PMC4913983.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/f5/42/ndt-12-1389.PMC4913984.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Neuropsychiatric Disease and Treatment 2016:12 1389–1396Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  1389OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S10665 2 levels of serum immunomodulators and alterations  with electroconvulsive therapy in treatment-resistant  major depression serkan Zincir1 Pelin Öztürk2 ali emrah Bilgen3 Filiz i.zci4 cihad Yükselir5 1Department of Psychiatry, gölcük  Military hospital, Kocaeli, 2Psychiatry  clinic, erenkoy Training and  research hospital for Psychiatric  and Neurological Diseases,   istanbul, 3Department of Psychiatry,   etimesgut Military hospital, ankara,   4Department of Psychiatry, istanbul  Bilim University, istanbul, 5Department  of Psychiatry, gulhane Military  Medical Faculty, ankara, T urkeyAbstract:  Studies in recent years have indicated that neuroimmunological events and immune  activation may have a place in the etiology of depression.",Non-OADS,/arxiv_data1/oa_pdf/f5/42/ndt-12-1389.PMC4913984.pdf
"The interactions and relationships of hormones, neurotransmitters, and peptides  included in the immune system and the central nervous system have been examined in  many studies.2–4 There is consensus that stress and depression have adverse effects on  the immune system.5–7 The changes caused by stress on the immune system have been  reported to vary depending on whether the stress is acute or chronic.8,9 Immune media - tors appear to contribute to the pathophysiology of diseases, such as schizophrenia,  depression, and dementia.10 Increased serum concentrations of the proinflammatory  cytokines, interleukin 1 (IL-1) and IL-6, C-reactive protein (CRP), haptoglobin, and correspondence: serkan Zincir Department of Psychiatry, gölcük  Military hospital, Donanma street,  Number 1, Kocaeli/gölcük 41650,  Turkey Tel +90 535 349 8825 email drserkanzincir@yahoo.co m Journal name: Neuropsychiatric Disease and Treatment Article Designation: Original Research Y ear: 2016 Volume: 12 Running head verso: Zincir et al Running head recto: Immunomodulators and ECT in major depression DOI: http://dx.doi.org/10.2147/NDT.S106652",Non-OADS,/arxiv_data1/oa_pdf/f5/42/ndt-12-1389.PMC4913984.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/f5/42/ndt-12-1389.PMC4913984.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/f5/42/ndt-12-1389.PMC4913984.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/75/5a/ijn-11-2883.PMC4913985.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2016:11 2883–2900International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  2883OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S10634 6 comparative toxicity and biodistribution of  copper nanoparticles and cupric ions in rats In-chul lee1 Je-Won Ko1 sung-hyeuk Park1 Je-Oh lim1 In-sik shin1 changjong Moon1 sung-hwan Kim2 Jeong-Doo heo3 Jong-choon Kim1 1college of Veterinary Medicine BK21  Plus Project Team, chonnam National  University, gwangju, 2Jeonbuk  Department of Inhalation research,   Korea Institute of T oxicology,   Jeongeup, 3gyeongnam Department  of environment and Toxicology, Korea  Institute of T oxicology, gyeongnam,   republic of KoreaAbstract:  Despite widespread use and prospective biomedical applications of copper  nanoparticles (Cu NPs), their biosafety issues and kinetics remain unclear.",Non-OADS,/arxiv_data1/oa_pdf/75/5a/ijn-11-2883.PMC4913985.pdf
"Keywords:  copper nanoparticles, cupric ions, comparative toxicity, toxicokinetics Introduction In recent years, scientific research on nanoparticles (NPs) has shown a tremendous  and rapid growth owing to their wide applications in various fields, including elec - tronics, cosmetics, food industry, and medicine.1–3 The use of fabricated NPs has  great potential in a wide range of applications, since their distinct physicochemical  characteristics can be utilized in an application-specific manner by modifying their  size, surface properties, and shape.4 However, their unique physicochemical proper - ties may affect their toxicological behavior in vivo by facilitating cellular uptake and  translocation of the particles in the body.5,6 Furthermore, the physiological milieu  influences the interaction between biological systems and NPs and can determine  the fate and biosafety of NPs.7 Currently, with the widespread use of NPs, health  risks and environmental effects related to NP exposure have become of great con - cern.8 In addition, the applications of NPs have been limited by lack of verification  of biosafety.9–11 Thus, a detailed evaluation of their potential toxicity in vivo must  precede any prospective applications.12correspondence: Jeong-Doo heo gyeongnam Department of  environment and Toxicology, Korea  Institute of Toxicology, 17 Jegok-gil, Jinju,  gyeongnam 660-844, republic of Korea email jdher@kitox.re.k r  Jong-choon Kim college of Veterinary Medicine BK21  Plus Project Team, chonnam National  University, gwangju 500-757, republic  of Korea Tel +82 62 530 2827 email toxkim@jnu.ac.k r Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Lee et al Running head recto: Toxicity and biodistribution of copper nanoparticles DOI: http://dx.doi.org/10.2147/IJN.S106346",Non-OADS,/arxiv_data1/oa_pdf/75/5a/ijn-11-2883.PMC4913985.pdf
"Available from: https://ntp.niehs.nih.gov/ iccvam/suppdocs/feddocs/oecd/oecd_gl423.pd f. Accessed February 5,  2016.",OADS,/arxiv_data1/oa_pdf/75/5a/ijn-11-2883.PMC4913985.pdf
"Available from: https://ntp.niehs.nih.gov/ iccvam/suppdocs/feddocs/oecd/oecd_gl420.pd f. Accessed February 5,  2016.",OADS,/arxiv_data1/oa_pdf/75/5a/ijn-11-2883.PMC4913985.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/75/5a/ijn-11-2883.PMC4913985.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/75/5a/ijn-11-2883.PMC4913985.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/30/a8/ndt-12-1419.PMC4913986.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Neuropsychiatric Disease and Treatment 2016:12 1419–1423Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  1419OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S10293 2 Body integrity identity disorder crosses culture:  case reports in the Japanese and chinese literature rianne M Blom1 Nienke c Vulink1 sija J van der Wal1 Takashi Nakamae1–3 Zhonglin Tan1,4 eske M Derks1 Damiaan Denys1,5 1Department of Psychiatry, academic  Medical center, University of  amsterdam, amsterdam, the  Netherlands; 2Department of  Psychiatry, graduate school of  Medical science, Kyoto Prefectural  University of Medicine, 3Department  of Neural computation for Decision- Making, aTr Brain information  communication research laboratory  group, Kyoto, Japan; 4Department of  Psychiatry, hangzhou Mental health  center, hangzhou, People’s republic  of china; 5Netherlands institute for  Neuroscience, royal Netherlands  academy of arts and sciences,   amsterdam, the NetherlandsAbstract:  Body integrity identity disorder (BIID) is a condition in which people do not perceive  a part of their body as their own, which results in a strong desire for amputation or paralyzation.",Non-OADS,/arxiv_data1/oa_pdf/30/a8/ndt-12-1419.PMC4913986.pdf
"Currently, some neuroscientists prefer to correspondence: rianne M Blom Department of Psychiatry, academic  Medical center, University of  amsterdam, Pa.1-151, Meibergdreef 5,  1105 aZ amsterdam, the Netherlands Tel +31 20 891 3600 Fax +31 20 891 3898 email riannemb@gmail.co m Journal name: Neuropsychiatric Disease and Treatment Article Designation: Original Research Y ear: 2016 Volume: 12 Running head verso: Blom et al Running head recto: BIID in Japan and the People’s Republic of China DOI: http://dx.doi.org/10.2147/NDT.S102932",Non-OADS,/arxiv_data1/oa_pdf/30/a8/ndt-12-1419.PMC4913986.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/30/a8/ndt-12-1419.PMC4913986.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/30/a8/ndt-12-1419.PMC4913986.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/af/af/jpr-9-405.PMC4913987.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",OADS,/arxiv_data1/oa_pdf/af/af/jpr-9-405.PMC4913987.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Journal of Pain Research 2016:9 405–416Journal of Pain Research Dove press submit your manuscript | www.dovepress.co m Dove press  405ORiginal ReseaRchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/JPR.S9777 0Pain relief and functional improvement in patients  with neuropathic pain associated with spinal  cord injury: an exploratory analysis of pregabalin  clinical trials alesia sadosky1 Bruce Parsons1 Birol emir1 edward c nieshoff2 1Pfizer inc., new Y ork, nY,   2Rehabilitation institute of Michigan,   Detroit, M i, Usa correspondence: alesia sadosky   Pfizer Inc., 235 East 42nd Street, New  Y ork, nY 10017, Usa   T el +1 212 733 9491   Fax +1 646 441 4757   email alesia.sadosky@pfizer.co mBackground:  Characterizing relationships between pain relief and function can inform patient  management decisions.",Non-OADS,/arxiv_data1/oa_pdf/af/af/jpr-9-405.PMC4913987.pdf
"Available  from: https://www.nscisc.uab.edu/PublicDocuments/fact_figures_docs/ Facts%202013.pd f. Accessed August 22, 2013.",Non-OADS,/arxiv_data1/oa_pdf/af/af/jpr-9-405.PMC4913987.pdf
Available from: http://www.who.int/classifications/icfbrowser /.,OADS,/arxiv_data1/oa_pdf/af/af/jpr-9-405.PMC4913987.pdf
"Journal of Pain Research Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/journal-of-pain-research-journa lThe Journal of Pain Research is an international, peer-reviewed, open  access, online journal that welcomes laboratory and clinical findings  in the fields of pain research and the prevention and management  of pain.",Non-OADS,/arxiv_data1/oa_pdf/af/af/jpr-9-405.PMC4913987.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/af/af/jpr-9-405.PMC4913987.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/29/74/ott-9-3555.PMC4913988.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 3555–3563OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  3555Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S10573 6 mir-135a acts as a tumor suppressor in gastric  cancer in part by targeting KiFc1 chuanlei Zhang1 Xiaoqi chen1 Xinju chen1 Xinting Wang1 aiying Ji1 lifeng Jiang2 Feng sang3 Fucheng li4 1Department of Digestive Diseases,   The First affiliated hospital of  henan University of Traditional  chinese Medicine, 2Department of  chinese Traditional and Western  Medicine, henan cancer hospital,   affiliated cancer hospital of  Zhengzhou University, 3Department  of acquired immune Deficiency  syndrome Treatment and research  center, Key laboratory of Viral  Diseases Prevention and Treatment  of Traditional chinese Medicine of  henan Province, 4The First affiliated  hospital of henan University of  Traditional chinese Medicine,   Zhengzhou, People’s republic  of chinaAbstract:  miR-135a was downregulated in the majority of human primary gastric cancer (GC)  tissues and GC cell lines.",Non-OADS,/arxiv_data1/oa_pdf/29/74/ott-9-3555.PMC4913988.pdf
"MicroRNAs (miRNAs) are an evolutionarily conserved group of small noncoding  RNAs that posttranscriptionally regulate gene expression and play important roles in a  variety of physiological and pathological processes, such as development, cell prolif - eration, apoptosis, differentiation, and signal transduction.4 To date, more than 1,000  human miRNAs have been identified.5 Increasing evidence has shown that miRNAs  are frequently dysregulated in human malignant tumors and that miRNAs can act as  oncogenes or tumor suppressor genes, which depend on the genes they modulate.6–10  For example, miR-21 downregulates tumor suppressor Pdcd4 and stimulates invasion,  intravasation, and metastasis in colorectal cancer;6 miR-7 suppresses brain metastasis  of breast cancer stem-like cells by regulating KLF4;7 miR-103/107 promotes metastasis correspondence: Xiaoqi chen Department of Digestive Diseases,  The First Affiliated Hospital of Henan  University of Traditional chinese  Medicine, no 19 People’s road,  Zhengzhou 450000, henan,  People’s republic of china Tel +86 371 6623 1632 email akkwedo@126.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2016 Volume: 9 Running head verso: Zhang et al Running head recto: miR-135a as a tumor suppressor DOI: http://dx.doi.org/10.2147/OTT.S105736",Non-OADS,/arxiv_data1/oa_pdf/29/74/ott-9-3555.PMC4913988.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/29/74/ott-9-3555.PMC4913988.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/29/74/ott-9-3555.PMC4913988.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/e7/4f/ppa-10-1079.PMC4913989.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Patient Preference and Adherence 2016:10 1079–1090Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  1079OriginAl reseArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PPA.S10779 0 Openness to and preference for attributes  of biologic therapy prior to initiation among  patients with rheumatoid arthritis: patient and  rheumatologist perspectives and implications  for decision making susan c Bolge1 Amir goren2 Duncan Brown2 seth ginsberg3 isabel Allen4 1health economics & Outcomes  research, Janssen scientific Affairs,   llc, raritan, nJ, 2health Outcomes  Practice, Kantar health, new Y ork,   3global healthy living Foundation,   Upper nyack, nY, 4Department  of Biostatistics & epidemiology,   University of california san Francisco,   san Francisco, cA, UsAPurpose:  Despite American College of Rheumatology recommendations, appropriate and  timely initiation of biologic therapies does not always occur.",Non-OADS,/arxiv_data1/oa_pdf/e7/4f/ppa-10-1079.PMC4913989.pdf
"Keywords:  intravenous infusion, subcutaneous injection, biologics, discussions about treat - ment, patient-provider communication Introduction Rheumatoid arthritis (RA), a chronic progressive autoimmune condition, is estimated  to affect between 0.5% and 1.0% of the adult population globally.1 The prevalence correspondence: Amir goren health Outcomes Practice, Kantar  health, 11 Madison Ave, Floor 12,  new York, nY 10010, UsA Tel +1 212 706 3909 Fax +1 212 647 7659 email amir.goren@kantarhealth.co m Journal name: Patient Preference and Adherence Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Bolge et al Running head recto: Perspectives regarding biologic therapy openness and preference in RA DOI: http://dx.doi.org/10.2147/PPA.S107790",Non-OADS,/arxiv_data1/oa_pdf/e7/4f/ppa-10-1079.PMC4913989.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal that focuses on the growing importance of patient   preference  and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/e7/4f/ppa-10-1079.PMC4913989.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/ff/d4/opth-10-1111.PMC4913990.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Ophthalmology 2016:10 1111–1116Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  1111Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S9645 2survey of intravitreal injection techniques among  retina specialists in israel Ori segal1,2 Yael segal-Trivitz1,3 arie Y nemet1,2 noa geffen1,2 ronit nesher1,2 Michael Mimouni4 1Department of Ophthalmology,   Meir Medical Center, Kfar saba, 2The  sackler school of Medicine, T el aviv  University, T el aviv, 3Department  of Psychiatry, geha Psychiatric  hospital, Petah Tikva, 4Department of  Ophthalmology, rambam health Care  Campus, haifa, israelPurpose:  The purpose of this study was to describe antivascular endothelial growth factor  intravitreal injection techniques of retinal specialists in order to establish a cornerstone for  future practice guidelines.",Non-OADS,/arxiv_data1/oa_pdf/ff/d4/opth-10-1111.PMC4913990.pdf
"In November Correspondence: Michael Mimouni Department of Ophthalmology, rambam  health Care Campus, haaliya hashniya  st 8, haifa 3109601, israel Tel +972 4 523 292 429 email michael@intername.co.i l Journal name: Clinical Ophthalmology Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Segal et al Running head recto: Survey of intravitreal injection techniques DOI: http://dx.doi.org/10.2147/OPTH.S96452",Non-OADS,/arxiv_data1/oa_pdf/ff/d4/opth-10-1111.PMC4913990.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/ff/d4/opth-10-1111.PMC4913990.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/ff/d4/opth-10-1111.PMC4913990.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/02/0a/tcrm-12-995.PMC4913991.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Therapeutics and Clinical Risk Management 2016:12 995–1001Therapeutics and Clinical Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  995ORiginal ReseaRChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/TCRM.S10440 0Value of cyst localization to predict cystobiliary  communication in patients undergoing  conservative surgery with hydatid cyst Bircan alan1 Murat Kapan2 Memik T eke1 Salih Hattapog ˘lu1 Zülfü Arıkanog ˘lu2 1Department of Radiology,   2Department of general surgery,   Faculty of Medicine, Dicle University,   Diyarbakır, T urkeyObjective:  The objectives of this study were to investigate the relationship between the  segmental localization of liver hydatid cyst by computed tomography (CT) and the presence of  cystobiliary communication (CBC) and to identify the risk factors for CBC.",Non-OADS,/arxiv_data1/oa_pdf/02/0a/tcrm-12-995.PMC4913991.pdf
"Correspondence: Bircan alan Department of Radiology, Faculty of  Medicine, Dicle University, seyrantepe  mevkii, 21280 Diyarbakır, Turkey Tel +90 412 2488001/4738 email bircanalan@hotmail.co m Journal name: Therapeutics and Clinical Risk Management Article Designation: Original Research Y ear: 2016 Volume: 12 Running head verso: Alan et al Running head recto: Cystobiliary communication with hydatid cyst DOI: http://dx.doi.org/10.2147/TCRM.S104400",Non-OADS,/arxiv_data1/oa_pdf/02/0a/tcrm-12-995.PMC4913991.pdf
"Therapeutics and Clinical Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/therapeutics-and-clinical-risk-management-journa lTherapeutics and Clinical Risk Management is an international, peer- reviewed journal of clinical therapeutics and risk management, focusing  on concise rapid reporting of clinical studies in all therapeutic areas,  outcomes, safety, and programs for the effective, safe, and sustained  use of medicines.",Non-OADS,/arxiv_data1/oa_pdf/02/0a/tcrm-12-995.PMC4913991.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/02/0a/tcrm-12-995.PMC4913991.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/6d/54/ndt-12-1371.PMC4913992.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Neuropsychiatric Disease and Treatment 2016:12 1371–1378Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  1371OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S10963 3 abnormal spontaneous regional brain activity  in primary insomnia: a resting-state functional  magnetic resonance imaging study chao li1 Xiaofen Ma2 Mengshi Dong2 Yi Yin1 Kelei hua1 Meng li2 changhong li2 Wenfeng Zhan2 cheng li2,3 guihua Jiang2 1Department of Medical imaging,   The affiliated guangdong No  2  Provincial People’s hospital of  southern Medical University,   The Third clinical Medical college  of southern Medical University,   2Department of Medical imaging,   3Department of renal Transplantation,   The affiliated  guangdong  No 2  Provincial People’s hospital of  southern Medical University,   guangzhou, People’s  republic  of chinaObjective:  Investigating functional specialization is crucial for a complete understanding of the  neural mechanisms of primary insomnia (PI).",Non-OADS,/arxiv_data1/oa_pdf/6d/54/ndt-12-1371.PMC4913992.pdf
"Both task-based and resting-state functional magnetic resonance imaging (fMRI)  have emerged as a useful tool to explore the neuromechanism of PI5–12 or sleep depri - vation.13 fMRI is a novel noninvasive imaging technique for measuring spontaneous  brain activity14,15 and more economical to implement than positron emission tomog - raphy and single photon emission computed tomography in clinical studies.16 Using  resting-state fMRI with amplitude of low frequency fluctuations (ALFFs) algorithm,  correspondence: guihua Jiang Department of Medical imaging,  The Affiliated Guangdong No 2 Provincial  People’s hospital of southern Medical  University, guangzhou 510317, People’s  republic of china Tel/fax +86 20 8916 8071 email jiangguihua1970@163.co m  cheng li Department of renal Transplantation,  The Affiliated Guangdong No 2 Provincial  People’s hospital of southern Medical  University, guangzhou 510317, People’s  republic of china Tel/fax +86 20 139 2422 8992 email 182838li@163.co m Journal name: Neuropsychiatric Disease and Treatment Article Designation: Original Research Y ear: 2016 Volume: 12 Running head verso: Li et al Running head recto: Abnormal spontaneous regional brain activity in primary insomnia DOI: http://dx.doi.org/10.2147/NDT.S109633",Non-OADS,/arxiv_data1/oa_pdf/6d/54/ndt-12-1371.PMC4913992.pdf
Data processing and alFF calculations Data Processing Assistant for Resting-State Functional MR  Imaging toolbox ( http://www.restfmri.net/forum/DPARS F)29  was used to postprocess the imaging data.,OADS,/arxiv_data1/oa_pdf/6d/54/ndt-12-1371.PMC4913992.pdf
"Statistical parametric mapping software  (SPM8, http://www.fil.ion.ucl.ac.uk/sp m) was used to ana - lyze fMRI data in a voxel-by-voxel fashion.",OADS,/arxiv_data1/oa_pdf/6d/54/ndt-12-1371.PMC4913992.pdf
"A corrected significance level of individual voxel  P,0.01 and the contiguous cluster volume $540 mm3 were  used to determine the statistical significance (corrected for  multiple comparisons with AlphaSim corrected threshold of  cluster P,0.05, http://afni.nimh.nih.gov/afni /).",OADS,/arxiv_data1/oa_pdf/6d/54/ndt-12-1371.PMC4913992.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/6d/54/ndt-12-1371.PMC4913992.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/6d/54/ndt-12-1371.PMC4913992.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/08/14/ott-9-3589.PMC4913993.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 3589–3593OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  3589Case repO rTopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S10458 3 Bilateral breast adenocarcinomas with EML4– ALK fusion in a patient with multiple metastases  successfully treated with crizotinib: is lung the  primary site?",Non-OADS,/arxiv_data1/oa_pdf/08/14/ott-9-3589.PMC4913993.pdf
"A computed tomography scan of the chest showed bilateral lung masses Correspondence: shikai Wu Department of radiation Oncology,  307 Hospital of people’s Liberation army,  No 8 east road, Fengtai District, Beijing  100071, people’s republic of China Tel/fax +86 10 6694 7196 email skywu4923@sina.co m Journal name: OncoTargets and Therapy Article Designation: Case report Y ear: 2016 Volume: 9 Running head verso: Liu et al Running head recto: Bilateral breast adenocarcinomas with EML4–ALK  fusion DOI: http://dx.doi.org/10.2147/OTT.S104583",Non-OADS,/arxiv_data1/oa_pdf/08/14/ott-9-3589.PMC4913993.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/08/14/ott-9-3589.PMC4913993.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/08/14/ott-9-3589.PMC4913993.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/6b/8c/prbm-9-133.PMC4913994.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",OADS,/arxiv_data1/oa_pdf/6b/8c/prbm-9-133.PMC4913994.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Psychology Research and Behavior Management 2016:9 133–138Psychology Research and Behavior Management Dove press submit your manuscript | www.dovepress.co m Dove press  133ORiginal ReseaRchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/PRBM.S9143 3can theoretical intervention improve hand  hygiene behavior among nurses?",Non-OADS,/arxiv_data1/oa_pdf/6b/8c/prbm-9-133.PMC4913994.pdf
"Psychology Research and Behavior Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/psychology-research-and-behavior-management-journa lPsychology Research and Behavior Management is an international, peer- reviewed, open access journal focusing on the science of psychology and  its application in behavior management to develop improved outcomes  in the clinical, educational, sports and business arenas.",Non-OADS,/arxiv_data1/oa_pdf/6b/8c/prbm-9-133.PMC4913994.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/6b/8c/prbm-9-133.PMC4913994.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/44/ec/ijwh-8-203.PMC4913995.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Women’s Health 2016:8 203–211International Journal of Women’s Health Dove press submit your manuscript | www.dovepress.co m Dove press  203OrIg Inal researcHopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJWH.S10488 7 effects of group sexual counseling on the traditional  perceptions and attitudes of Iranian pregnant  women ali navidian1 shahindokht navabi rigi2 Parvin soltani2 1Department of counseling,   Pregnancy Health research center,   Zahedan University of Medical  sciences, Zahedan, Iran; 2Department  of Midwifery, nursing and Midwifery  school, Zahedan University of Medical  sciences, Zahedan, IranBackground:  Marital relationships may fluctuate due to physical and psychological changes  during pregnancy.",Non-OADS,/arxiv_data1/oa_pdf/44/ec/ijwh-8-203.PMC4913995.pdf
"In other words, during transition from the role of a spouse to that of a parent,  the relationship between a couple changes.5 The quality of their relationship during  pregnancy is largely influenced by their sexual relations and their set of specific beliefs;  this is a global issue.6 Sexual activity during pregnancy is influenced by several factors including  hormonal changes, such as increased levels of estrogen, progesterone, and prolactin,  which may reduce the sexual desire and motivation due to nausea, vomiting, breast  tenderness, weight gain, anxiety, fatigue, etc.7–9correspondence: Parvin soltani Department of Midwifery, nursing and  Midwifery school, Zahedan University  of Medical sciences, Mashahir square,  PO Box 98139-1379, Zahedan, Iran Tel +98 543 344 2482 Fax +98 543 344 2481 email p_soltani.ac88@yahoo.co m Journal name: International Journal of Women’s Health Article Designation: Original Research Y ear: 2016 Volume: 8 Running head verso: Navidian et al Running head recto: Group sexual counseling on the traditional perceptions DOI: http://dx.doi.org/10.2147/IJWH.S104887",Non-OADS,/arxiv_data1/oa_pdf/44/ec/ijwh-8-203.PMC4913995.pdf
"International Journal of Women’s Health Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-womens-health-journa lThe International Journal of Women’s Health is an international, peer- reviewed open-access journal publishing original research, reports,  editorials, reviews and commentaries on all aspects of women’s  healthcare including gynecology, obstetrics, and breast cancer.",Non-OADS,/arxiv_data1/oa_pdf/44/ec/ijwh-8-203.PMC4913995.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/44/ec/ijwh-8-203.PMC4913995.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/28/e4/tcrm-12-1003.PMC4913996.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Therapeutics and Clinical Risk Management 2016:12 1003–1008Therapeutics and Clinical Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  1003Case Repo RTopen access to scientific and medical research open access Full T ext article http: //dx.doi.org/10.2147/TCRM.S10903 3 Direct thrombolysis of multiple thrombi in both  right and left heart atrium in a patient on  extracorporeal membrane oxygenation support  following urgent double-lung transplantation:  a case report Lukas pollert1 Zuzana prikrylova1 Jan Berousek1 Frantisek Mosna1 Robert Lischke2 1Department of anaesthesiology  and Intensive Care, 2nd Faculty of  Medicine, 23rd surgical Department,   1st Faculty of Medicine, Charles  University in prague and Motol  University Hospital, praha, Czech  RepublicBackground:  Lung transplantation is considered an established treatment for patients with  end-stage chronic respiratory failure.",Non-OADS,/arxiv_data1/oa_pdf/28/e4/tcrm-12-1003.PMC4913996.pdf
"Keywords:  thrombolysis, double-lung transplantation, extracorporeal membrane oxygenation,  general anesthesia, lymphangioleiomyomatosis Introduction Lung transplantation is considered an established treatment for patients with end-stage  chronic respiratory failure.1 The disproportionately higher number of candidates in  comparison to available organs explains the long waiting times and high risk of mor - tality while on the waiting list.1 The lack of efficacious and safe means of artificial  respiratory support for patients who develop acute respiratory failure with refrac - tory hypoxemia and hypercapnia contributes to the high mortality rate in patients Correspondence: Lukas pollert Department of anaesthesiology and  Intensive Care, 2nd Faculty of Medicine,  Charles University in prague and Motol  University Hospital, V Úvalu 84, 150 06  prague 5, Czech Republic Tel +420 224 435 400 Fax +420 224 435 420 email lukas.pollert@fnmotol.c z Journal name: Therapeutics and Clinical Risk Management Article Designation: Case report Y ear: 2016 Volume: 12 Running head verso: Pollert et al Running head recto: Direct thrombolysis of multiple thrombi in a patient on ECMO DOI: http://dx.doi.org/10.2147/TCRM.S109033",Non-OADS,/arxiv_data1/oa_pdf/28/e4/tcrm-12-1003.PMC4913996.pdf
"Therapeutics and Clinical Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/therapeutics-and-clinical-risk-management-journa lTherapeutics and Clinical Risk Management is an international, peer- reviewed journal of clinical therapeutics and risk management, focusing  on concise rapid reporting of clinical studies in all therapeutic areas,  outcomes, safety, and programs for the effective, safe, and sustained  use of medicines.",Non-OADS,/arxiv_data1/oa_pdf/28/e4/tcrm-12-1003.PMC4913996.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/28/e4/tcrm-12-1003.PMC4913996.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/c7/a7/ott-9-3565.PMC4913997.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 3565–3569OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  3565Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S10652 7 association between GSTP1  ile105Val  polymorphism and urinary system cancer risk:  evidence from 51 studies Yixiang Zhang1 Yeqing Yuan1 Yufang chen2 Zhao Wang3 Fangfang li3 Qingsong Zhao4 1Department of Urology, The second  affiliated hospital of Jinan University,   shenzhen People’s hospital,   shenzhen, guangdong, 2Department  of Pharmacology, school of Basic  Medicine, T ongji Medical college,   huazhong University of science  and T echnology, Wuhan, hubei,   3Department of Medical Oncology,   state Key laboratory of Oncology in  south china, collaborative innovation  center for cancer Medicine, sun  Yat-sen University cancer center,   guangzhou, guangdong, 4Department  of Urology, The First People’s hospital  of Jining, Jining, shandong, People’s  republic of chinaAbstract:  The GSTP1  gene plays an important role in detoxification of carcinogens.",Non-OADS,/arxiv_data1/oa_pdf/c7/a7/ott-9-3565.PMC4913997.pdf
"In humans, the GSTs super family has been  categorized into eight distinct gene families: α, µ, κ, π, σ, ω, θ, and ζ.10 The  GSTP1  gene, located on chromosome 11q13, belongs to the π gene family.11   The GSTP1  Ile105Val (rs1695 A .G) polymorphism may cause a substitution of correspondence: Qingsong Zhao Department of Urology, The First  People’s hospital of Jining, 6 Jiankang  road, Jining 272011, shandong,  People’s republic of china Tel/fax +86 0537 225 3431 email zhaoqs16@sina.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2016 Volume: 9 Running head verso: Zhang et al Running head recto: GSTP1  Ile105Val polymorphism and urinary system cancer risk DOI: http://dx.doi.org/10.2147/OTT.S106527",Non-OADS,/arxiv_data1/oa_pdf/c7/a7/ott-9-3565.PMC4913997.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/c7/a7/ott-9-3565.PMC4913997.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/c7/a7/ott-9-3565.PMC4913997.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/a8/cf/ott-9-3571.PMC4913998.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 3571–3577OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  3571Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S10878 1 1p/19q codeletion and RET rearrangements  in small-cell lung cancer hongyang lu1,2 haimiao Xu3 Fajun Xie2 Jing Qin2 na han2 Yun Fan1,2 Weimin Mao1 1Zhejiang cancer hospital, Zhejiang  Key laboratory of Diagnosis  &  Treatment Technology on Thoracic  Oncology (lung and esophagus),   2Department of Thoracic Medical  Oncology, 3Department of Pathology,   Zhejiang cancer hospital, hangzhou,   People’s republic of chinaAbstract:  The prognosis of small-cell lung cancer (SCLC) is poor despite reports suggesting  modest improvement in survival.",Non-OADS,/arxiv_data1/oa_pdf/a8/cf/ott-9-3571.PMC4913998.pdf
"While SCLC is sensitive to chemotherapy (70%–80% response rate), it recurs  easily.7,8 The National Comprehensive Cancer Network guidelines recommend temozo - lomide as a second-line treatment for SCLC and the drug has been used to treat relapsed  SCLC, particularly with brain metastases.9,10 The 1p/19q codeletion is an important  predictive and prognostic factor in anaplastic and recurrent oligodendrogliomas correspondence: Weimin Mao; Yun Fan Zhejiang Key laboratory of Diagnosis &  Treatment Technology on Thoracic  Oncology (lung and esophagus), Zhejiang  cancer hospital, hangzhou 310022,  People’s republic of china Tel +86 571 8812 2388;   +86 571 8812 2091 Fax +86 571 8812 2508 email weiminmao@163.co m;   fanyun@zjcc.org.c n Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2016 Volume: 9 Running head verso: Lu et al Running head recto: 1p/19q codeletion and RET rearrangements in SCLC DOI: http://dx.doi.org/10.2147/OTT.S108781",Non-OADS,/arxiv_data1/oa_pdf/a8/cf/ott-9-3571.PMC4913998.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/a8/cf/ott-9-3571.PMC4913998.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/a8/cf/ott-9-3571.PMC4913998.pdf
"© Brittany J Belin, Lauren M Goins, and R Dyche Mullins *Address correspondence to: R Dyche Mullins; Email: dyche@mullinslab.ucsf.eduSubmitted: 03/28/2015; Accepted: 03/31/2015 http://dx.doi.org/10.1080/19490992.2014.1047714 This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License (http://creativecommons.o rg/licenses/ by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/46/fb/kbia-04-06-1047714.PMC4914014.pdf
"3,11,16As we start to understand the mechanisms how forcesrequired to bend the membrane are gener-ated, an overarching theme is emerging:Keywords: actin, curvature, lipid, plasma membrane, signaling *Correspondence to: Maja Matis; Email: matism@uni-muenster.de and Milos Galic; Email: galic@uni-muenster.de Submitted: 12/26/2014Accepted: 01/06/2015http://dx.doi.org/10.1080/19490992.2015.1005524 This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non- Commercial License (http://creativecommons.org/ licenses/by-nc/3.0/), which permits unrestrictednon-commercial use, distribution, and reproductionin any medium, provided the original work is prop- erly cited.",Non-OADS,/arxiv_data1/oa_pdf/40/89/kbia-04-4-5-1005524.PMC4914016.pdf
Cur- rent Opinion in Cell Biology 2011; 23:523-30;PMID:21890337; http://dx.doi.org/10.1016/j.ceb.,OADS,/arxiv_data1/oa_pdf/40/89/kbia-04-4-5-1005524.PMC4914016.pdf
Annual Review of Biophysics and Biomolecular Struc-ture 2006; 35:459-88; PMID:16689645; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/40/89/kbia-04-4-5-1005524.PMC4914016.pdf
"Nature 1994; 368:113-9; PMID:8139653; http://dx.doi.org/10.1038/368113a0 5. le Duc Q, Shi Q, Blonk I, Sonnenberg A, Wang N, Leckband D, de Rooij J. Vinculin potentiates E-cad- herin mechanosensing and is recruited to actin- anchored sites within adherens junctions in a myosinII-dependent manner.",OADS,/arxiv_data1/oa_pdf/40/89/kbia-04-4-5-1005524.PMC4914016.pdf
The Journal of Cell Biology 2010; 189:1107-15; PMID:20584916; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/40/89/kbia-04-4-5-1005524.PMC4914016.pdf
Sci-ence 1993; 260:1124-7; PMID:7684161; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/40/89/kbia-04-4-5-1005524.PMC4914016.pdf
eLife 2014; 3; PMID:25479385; http://dx.doi.org/10.7554/eLife.032828.,OADS,/arxiv_data1/oa_pdf/40/89/kbia-04-4-5-1005524.PMC4914016.pdf
The Journal of Cell Biology 2008; 182:355-66; PMID:18644890;http://dx.doi.org/10.1083/jcb.200801056 10.,Non-OADS,/arxiv_data1/oa_pdf/40/89/kbia-04-4-5-1005524.PMC4914016.pdf
EMBO Reports 2004;5:250-5; PMID:14993925; http://dx.doi.org/10.1038/ sj.embor.7400105 11.,OADS,/arxiv_data1/oa_pdf/40/89/kbia-04-4-5-1005524.PMC4914016.pdf
Biochi-mica et Biophysica Acta 2014; 1838:532-45; PMID:23899502; http://dx.doi.org/10.1016/j.bbamem.,OADS,/arxiv_data1/oa_pdf/40/89/kbia-04-4-5-1005524.PMC4914016.pdf
Current Biology : CB 2006;16:130-9; PMID:16431365; http://dx.doi.org/ 10.1016/j.cub.2005.11.069 15.,OADS,/arxiv_data1/oa_pdf/40/89/kbia-04-4-5-1005524.PMC4914016.pdf
The EMBO Journal 2009; 28:3303-14; PMID:19816406; http://dx.doi.org/10.1038/emboj.,Non-OADS,/arxiv_data1/oa_pdf/40/89/kbia-04-4-5-1005524.PMC4914016.pdf
The Journal of Cell Biology 2007; 176:953-64; PMID:17371834; http://dx.doi.org/10.1083/jcb.200609176 17.,Non-OADS,/arxiv_data1/oa_pdf/40/89/kbia-04-4-5-1005524.PMC4914016.pdf
Current Opinion in Cell Biology 2014; 29:53-60; PMID:24747171; http://dx.doi.org/10.1016/j.ceb.2014.03.006 18.,OADS,/arxiv_data1/oa_pdf/40/89/kbia-04-4-5-1005524.PMC4914016.pdf
Cell2014; 156:1132-8; PMID:24630717; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/40/89/kbia-04-4-5-1005524.PMC4914016.pdf
Developmental Cell2012; 23:886-95; PMID:23153485; http://dx.doi.org/ 10.1016/j.devcel.2012.10.009 20.,OADS,/arxiv_data1/oa_pdf/40/89/kbia-04-4-5-1005524.PMC4914016.pdf
Nature 2005; 438:590-6; PMID:16319878; http://dx.doi.org/10.1038/nature04396 22.,OADS,/arxiv_data1/oa_pdf/40/89/kbia-04-4-5-1005524.PMC4914016.pdf
FEBS Letters 2010; 584:1840-7;PMID:19837069; http://dx.doi.org/10.1016/j.febslet.,OADS,/arxiv_data1/oa_pdf/40/89/kbia-04-4-5-1005524.PMC4914016.pdf
Nature 1986; 319:96-7; PMID:3079886; http://dx.doi.org/10.1038/ 319096b0 25.,Non-OADS,/arxiv_data1/oa_pdf/40/89/kbia-04-4-5-1005524.PMC4914016.pdf
Nature 1994; 371:168-70;PMID:8072546; http://dx.doi.org/10.1038/371168a0 26.,Non-OADS,/arxiv_data1/oa_pdf/40/89/kbia-04-4-5-1005524.PMC4914016.pdf
PLoS Biology 2011; 9:e1000604; PMID:21445324; http://dx.doi.org/ 10.1371/journal.pbio.1000604 28.,Non-OADS,/arxiv_data1/oa_pdf/40/89/kbia-04-4-5-1005524.PMC4914016.pdf
Nat Neurosci 2004; 7:364-72; PMID:15034583; http://dx.doi.org/10.1038/nn1210 29.,Non-OADS,/arxiv_data1/oa_pdf/40/89/kbia-04-4-5-1005524.PMC4914016.pdf
Nature1998; 392:923-6; PMID:9582072; http://dx.doi.org/ 10.1038/31940 30.,Non-OADS,/arxiv_data1/oa_pdf/40/89/kbia-04-4-5-1005524.PMC4914016.pdf
Cell 2012; 149:923-35; PMID:22559944; http://dx.doi.org/10.1016/j.cell.,OADS,/arxiv_data1/oa_pdf/40/89/kbia-04-4-5-1005524.PMC4914016.pdf
Current Biology: CB 2001; 11:1645-55; PMID:11696321;http://dx.doi.org/10.1016/S0960-9822(01)00506-1 35.,Non-OADS,/arxiv_data1/oa_pdf/40/89/kbia-04-4-5-1005524.PMC4914016.pdf
Nature Cell Biology 2012; 14:874-81; PMID:22750946; http://dx.doi.org/ 10.1038/ncb2533 36.,OADS,/arxiv_data1/oa_pdf/40/89/kbia-04-4-5-1005524.PMC4914016.pdf
Methods in Molecular Biology 2014; 1174:275-84; PMID:24947389; http://dx.doi.org/ 10.1007/978-1-4939-0944-5_19 37.,Non-OADS,/arxiv_data1/oa_pdf/40/89/kbia-04-4-5-1005524.PMC4914016.pdf
eLife 2014; 3:e02893; PMID:25124458; http://dx.doi.org/10.7554/eLife.,Non-OADS,/arxiv_data1/oa_pdf/40/89/kbia-04-4-5-1005524.PMC4914016.pdf
"Choles- terol accumulates in cell bodies, but is decreased in dis- tal axons, of Niemann-Pick C1-deﬁcient neurons.Journal of Neurochemistry 2002; 83:1154-63; PMID:12437586; http://dx.doi.org/10.1046/j.1471- 4159.2002.01220.x39.",Non-OADS,/arxiv_data1/oa_pdf/40/89/kbia-04-4-5-1005524.PMC4914016.pdf
Progress in Lipid Research 2012; 51:23-35; PMID:22142854; http://dx.doi.org/10.1016/j.plipres.2011.11.004 40.,Non-OADS,/arxiv_data1/oa_pdf/40/89/kbia-04-4-5-1005524.PMC4914016.pdf
Molecular and Cellular Biology 2012; 32:1396- 407; PMID:22331463; http://dx.doi.org/10.1128/ MCB.06113-11 42.,OADS,/arxiv_data1/oa_pdf/40/89/kbia-04-4-5-1005524.PMC4914016.pdf
Molecular Biology of the Cell 2009; 20:5166-80; PMID:19846664; http://dx.doi.org/10.1091/mbc.E09-01-0083 44.,Non-OADS,/arxiv_data1/oa_pdf/40/89/kbia-04-4-5-1005524.PMC4914016.pdf
Nature Methods 2008; 5:605-7; PMID:18536722; http://dx.doi.org/10.1038/nmeth.1220 45.,Non-OADS,/arxiv_data1/oa_pdf/40/89/kbia-04-4-5-1005524.PMC4914016.pdf
"4P1 ParA and F SopA have very weak intrinsic ATPase activity.7,8 We have shown that the ATP-activated dimers can non-speciﬁ-cally bind and undergo hop diffusion across a DNA-carpeted *Correspondence to: Kiyoshi Mizuuchi; Email: kiyoshimi@helix.nih.gov Submitted: 11/03/2014; Accepted: 11/10/2014 http://dx.doi.org/10.4161/19490992.2014.987581 This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License (http://creativecommons.o rg/licenses/ by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/28/b8/kbia-04-4-5-987581.PMC4914017.pdf
Mol Microbiol 2012; 86:513-23; PMID:22934804 [http://dx.doi.org/ 10.1111/mmi.12017] 4.,Non-OADS,/arxiv_data1/oa_pdf/28/b8/kbia-04-4-5-987581.PMC4914017.pdf
Cell 2010; 141:927-42; PMID:20550930 [http://dx.doi.org/ 10.1016/j.cell.2010.05.033] 5.,OADS,/arxiv_data1/oa_pdf/28/b8/kbia-04-4-5-987581.PMC4914017.pdf
J Mol Biol 1983; 169:353-72;PMID:6312056 [http://dx.doi.org/10.1016/S0022- 2836(83)80055-2] 6.,OADS,/arxiv_data1/oa_pdf/28/b8/kbia-04-4-5-987581.PMC4914017.pdf
Mol Gen Genet 1992; 234:346-52; PMID:1406581 [http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/28/b8/kbia-04-4-5-987581.PMC4914017.pdf
EMBO J 2013; 32:1238-49; PMID:23443047 [http://dx.doi.org/10.1038/emboj.2013.34] 10.,Non-OADS,/arxiv_data1/oa_pdf/28/b8/kbia-04-4-5-987581.PMC4914017.pdf
Mol Microbiol 2007; 64:1198-213; PMID:17542915 [http://dx.doi.org/10.1111/ j.1365-2958.2007.05728.x] 15.,Non-OADS,/arxiv_data1/oa_pdf/28/b8/kbia-04-4-5-987581.PMC4914017.pdf
Proc Natl Acad Sci USA 2009;106:19369-74; PMID:19906997; http://dx.doi.org/ 10.1073/pnas.0908347106 16.,OADS,/arxiv_data1/oa_pdf/28/b8/kbia-04-4-5-987581.PMC4914017.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non- Commercial License (http://creativecommons.org/licenses/by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/dc/d8/kbia-06-01-1131890.PMC4914023.pdf
Cold Spring Harbor Perspect Biol2014; 6:a016832; PMID:24591520; http://dx.doi.org/ 10.1101/cshperspect.a016832 2.,Non-OADS,/arxiv_data1/oa_pdf/dc/d8/kbia-06-01-1131890.PMC4914023.pdf
Cold Spring Har- bor Perspect Biol 2014; 6:a016857; PMID:24851870; http://dx.doi.org/10.1101/cshper-spect.a016857 3.,Non-OADS,/arxiv_data1/oa_pdf/dc/d8/kbia-06-01-1131890.PMC4914023.pdf
Nat RevMol Cell Biol 2007; 8:786-97; PMID:17878918;http://dx.doi.org/10.1038/nrm2258 4.,OADS,/arxiv_data1/oa_pdf/dc/d8/kbia-06-01-1131890.PMC4914023.pdf
Curr Opin Cell Biol 2007; 19:394- 401; PMID:17628466; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/dc/d8/kbia-06-01-1131890.PMC4914023.pdf
Curr Opin Cell Biol 2013; 25:495-505;PMID:23726022; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/dc/d8/kbia-06-01-1131890.PMC4914023.pdf
Cell 2003; 112:519-33; PMID:12600315; http://dx.doi.org/10.1016/S0092-8674(03)00112-07.,OADS,/arxiv_data1/oa_pdf/dc/d8/kbia-06-01-1131890.PMC4914023.pdf
Nat Rev Mol Cell Biol 2006; 7:631- 43; PMID:16912714; http://dx.doi.org/10.1038/ nrm2002 8.,OADS,/arxiv_data1/oa_pdf/dc/d8/kbia-06-01-1131890.PMC4914023.pdf
Biochim Biophys Acta 2005; 1744:120-44; PMID:15893389; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/dc/d8/kbia-06-01-1131890.PMC4914023.pdf
Science 2009; 323:474-7; PMID:19164740; http://dx.doi.org/10.1126/science.1161748 11.,Non-OADS,/arxiv_data1/oa_pdf/dc/d8/kbia-06-01-1131890.PMC4914023.pdf
Disorders of lysosome-relatedorganelle biogenesis: clinical and molecular genetics.Annu Rev Genomics Hum Genet 2008; 9:359-86; PMID:18544035; http://dx.doi.org/10.1146/annurev.,OADS,/arxiv_data1/oa_pdf/dc/d8/kbia-06-01-1131890.PMC4914023.pdf
Physiology 2012; 27:85-99; PMID:22505665; http://dx.doi.org/10.1152/physiol.00043.2011 13.,Non-OADS,/arxiv_data1/oa_pdf/dc/d8/kbia-06-01-1131890.PMC4914023.pdf
Pigment Cell Melanoma Res 2015; 29:43-59; PMID:26527546; http://dx.doi.org/10.1111/pcmr.12434 14.,Non-OADS,/arxiv_data1/oa_pdf/dc/d8/kbia-06-01-1131890.PMC4914023.pdf
Semin Immunol 2005; 17:87-94; PMID:15582491; http://dx.doi.org/10.1016/j.smim.2004.09.007 15.,Non-OADS,/arxiv_data1/oa_pdf/dc/d8/kbia-06-01-1131890.PMC4914023.pdf
J Cell Biol 1993;120:885-96; PMID:8432729; http://dx.doi.org/ 10.1083/jcb.120.4.885 16.,OADS,/arxiv_data1/oa_pdf/dc/d8/kbia-06-01-1131890.PMC4914023.pdf
Blood 2012; 120:4072-81; PMID:22927249; http://dx.doi.org/10.1182/blood-2012-04-420745 18.,Non-OADS,/arxiv_data1/oa_pdf/dc/d8/kbia-06-01-1131890.PMC4914023.pdf
Blood 2012; 120:404-14;PMID:22611153; http://dx.doi.org/10.1182/blood- 2011-11-389551SNAREs IN THE MATURATION AND FUNCTION OF LROs 9,Non-OADS,/arxiv_data1/oa_pdf/dc/d8/kbia-06-01-1131890.PMC4914023.pdf
Semin Cell Dev Biol 2002; 13:263-70;PMID:12243725; http://dx.doi.org/10.1016/ S1084952102000551 20.,OADS,/arxiv_data1/oa_pdf/dc/d8/kbia-06-01-1131890.PMC4914023.pdf
Am J Physiol Lung Cell Mol Physiol 2012; 302:L919-32; PMID:22367786; http://dx.doi.org/ 10.1152/ajplung.00383.2011 22.,Non-OADS,/arxiv_data1/oa_pdf/dc/d8/kbia-06-01-1131890.PMC4914023.pdf
Mol Biol Cell 2007; 18:3463-71; PMID:17596510; http://dx.doi.org/10.1091/mbc.E07-03-0193 23.,Non-OADS,/arxiv_data1/oa_pdf/dc/d8/kbia-06-01-1131890.PMC4914023.pdf
J Cell Sci2012; 125:817-30; PMID:22421360; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/dc/d8/kbia-06-01-1131890.PMC4914023.pdf
Annu Rev Cell Dev Biol 2012; 28:279-308; PMID:23057743; http://dx.doi.org/10.1146/annurev-cellbio-101011-155818 25.,OADS,/arxiv_data1/oa_pdf/dc/d8/kbia-06-01-1131890.PMC4914023.pdf
Trends Cell Biol 2014; 24:35-43; PMID:24119662; http://dx.doi.org/10.1016/j.tcb.2013.09.006 26.,OADS,/arxiv_data1/oa_pdf/dc/d8/kbia-06-01-1131890.PMC4914023.pdf
Nature 2012;490:201-7; PMID:23060190; http://dx.doi.org/ 10.1038/nature11320 27.,Non-OADS,/arxiv_data1/oa_pdf/dc/d8/kbia-06-01-1131890.PMC4914023.pdf
J Biol Chem 2001;276:19820-7; PMID:11278762; http://dx.doi.org/ 10.1074/jbc.M010838200 28.,OADS,/arxiv_data1/oa_pdf/dc/d8/kbia-06-01-1131890.PMC4914023.pdf
J Cell Sci 2015; 128:3263-76; PMID:26208634; http://dx.doi.org/10.1242/jcs.171165 29.,OADS,/arxiv_data1/oa_pdf/dc/d8/kbia-06-01-1131890.PMC4914023.pdf
J Biol Chem2010; 285:7794-804; PMID:20048159; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/dc/d8/kbia-06-01-1131890.PMC4914023.pdf
Curr Biol 2012; 22:2135-9; PMID:23084991;http://dx.doi.org/10.1016/j.cub.2012.09.020 33.,OADS,/arxiv_data1/oa_pdf/dc/d8/kbia-06-01-1131890.PMC4914023.pdf
J Cell Biol 2015; 209:563-77; PMID:26008744; http://dx.doi.org/10.1083/jcb.,OADS,/arxiv_data1/oa_pdf/dc/d8/kbia-06-01-1131890.PMC4914023.pdf
J Cell Biol 2009; 187:247-64; PMID:19841138; http://dx.doi.org/10.1083/jcb.,OADS,/arxiv_data1/oa_pdf/dc/d8/kbia-06-01-1131890.PMC4914023.pdf
Nat Struct Mol Biol2012; 19:1300-9; PMID:23104059; http://dx.doi.org/ 10.1038/nsmb.2414 37.,OADS,/arxiv_data1/oa_pdf/dc/d8/kbia-06-01-1131890.PMC4914023.pdf
J Biol Chem 2001; 276:49183-7; PMID:11598115; http://dx.doi.org/10.1074/jbc.M106646200 38.,OADS,/arxiv_data1/oa_pdf/dc/d8/kbia-06-01-1131890.PMC4914023.pdf
PMID:22279617; http://dx.doi .org/10.4161/cl.1.4.,Non-OADS,/arxiv_data1/oa_pdf/dc/d8/kbia-06-01-1131890.PMC4914023.pdf
Mol BiolCell 2007; 18:768-80; PMID:17182842; http://dx.doi.org/10.1091/mbc.E06-12-1066 41.,Non-OADS,/arxiv_data1/oa_pdf/dc/d8/kbia-06-01-1131890.PMC4914023.pdf
Dev Cell 2012; 22:979-88;PMID:22521722; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/dc/d8/kbia-06-01-1131890.PMC4914023.pdf
Mol Biol Cell 2006; 17:4014-26; PMID:16760431; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/dc/d8/kbia-06-01-1131890.PMC4914023.pdf
Nature 1998; 395:347-53; PMID:9759724; http://dx.doi.org/10.1038/26412 45.,Non-OADS,/arxiv_data1/oa_pdf/dc/d8/kbia-06-01-1131890.PMC4914023.pdf
Biochemistry 2004; 43:3499-506; PMID:15035620; http://dx.doi.org/ 10.1021/bi036338y 46.,Non-OADS,/arxiv_data1/oa_pdf/dc/d8/kbia-06-01-1131890.PMC4914023.pdf
Cell Biol Int 2012; 36:785-91; PMID:22571236; http://dx.doi.org/10.1042/CBI20110146 47.,OADS,/arxiv_data1/oa_pdf/dc/d8/kbia-06-01-1131890.PMC4914023.pdf
Vitam Horm 2009; 80:473-506; PMID:19251047; http://dx.doi.org/10.1016/S0083-6729(08)00616-X 49.,Non-OADS,/arxiv_data1/oa_pdf/dc/d8/kbia-06-01-1131890.PMC4914023.pdf
Proc Natl Acad Sci U S A 2007; 104:14122-7; PMID:17709738; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/dc/d8/kbia-06-01-1131890.PMC4914023.pdf
J Cell Sci 2014; 127:5218-27; PMID:25344253;http://dx.doi.org/10.1242/jcs.153742 51.,OADS,/arxiv_data1/oa_pdf/dc/d8/kbia-06-01-1131890.PMC4914023.pdf
Am J Physiol Lung Cell Mol Physiol 2011; 301:L461-77; PMID:21764986;http://dx.doi.org/10.1152/ajplung.00056.2011 52.,Non-OADS,/arxiv_data1/oa_pdf/dc/d8/kbia-06-01-1131890.PMC4914023.pdf
PLoS One 2014; 9:e84926; PMID:24465451; http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/dc/d8/kbia-06-01-1131890.PMC4914023.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/50/5b/ijn-11-2815.PMC4914027.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2016:11 2815–2827International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  2815OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S10477 4 Phytosome-hyaluronic acid systems for ocular  delivery of l-carnosine hamdy abdelkader1,2 Michael r longman1 raid g alany1,3 Barbara Pierscionek4 1Drug Discovery, Delivery and Patient  care (DDDP c) Theme, school of life  sciences, Pharmacy and chemistry,   Kingston University london,   Kingston Upon Thames, london,   UK; 2Department of Pharmaceutics,   Faculty of Pharmacy, Minia University,   Mina, egypt; 3school of Pharmacy,   The University of auckland, auckland,   New Zealand; 4Vision cognition and  Neuroscience Theme, Faculty of  science, engineering and computing,   Kingston University london, Kingston  Upon Thames, london, UKAbstract:  This study reports on L-carnosine phytosomes as an alternative for the prodrug  N-acetyl-L-carnosine as a novel delivery system to the lens.",Non-OADS,/arxiv_data1/oa_pdf/50/5b/ijn-11-2815.PMC4914027.pdf
"N-acetyl carnosine in turn  is hydrolyzed by esterase in the aqueous humor to release L-carnosine to the lens.2,3 correspondence: raid g alany; hamdy  abdelkader Drug Discovery, Delivery and Patient  care (DDDPc) Theme, school of life  sciences, Pharmacy and chemistry,  Kingston University london, Penrhyn  road, Kingston Upon Thames, surrey  KT1 2ee, UK Tel +44 20 8417 9000; +44 7440 714 585 email r.alany@kingston.ac.u k;  h.abdelkader@kingston.ac.u kJournal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Abdelkader et al Running head recto: Phytosome-hyaluronic acid systems for ocular delivery of L-carnosine DOI: http://dx.doi.org/10.2147/IJN.S104774",Non-OADS,/arxiv_data1/oa_pdf/50/5b/ijn-11-2815.PMC4914027.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/50/5b/ijn-11-2815.PMC4914027.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/50/5b/ijn-11-2815.PMC4914027.pdf
"*Correspondence to: James R Sellers; Email: sellersj@nhlbi.nih.govSubmitted: 04/14/2015; Revised: 05/11/2015; Accepted: 05/14/2015 http://dx.doi.org/10.1080/19490992.2015.1054092 www.tandfonline.com 169 BioArchitectureBioArchitecture 4:6, 169--188; November/December 2014REVIEW",Non-OADS,/arxiv_data1/oa_pdf/8b/b7/kbia-04-06-1054092.PMC4914028.pdf
Biochim Biophys Acta 2000; 1496:3-22; PMID:10722873; http://dx.doi.org/10.1016/S0167-4889(00)00005-7 2.,OADS,/arxiv_data1/oa_pdf/8b/b7/kbia-04-06-1054092.PMC4914028.pdf
Genome Biol 2007; 8:R196; PMID:17877792; http://dx.doi.org/ 10.1186/gb-2007-8-9-r196 3.,OADS,/arxiv_data1/oa_pdf/8b/b7/kbia-04-06-1054092.PMC4914028.pdf
Curr Opin Cell Biol 1992; 4:27-35; PMID:1558751; http://dx.doi.org/10.1016/0955-0674(92)90055-H 4.,OADS,/arxiv_data1/oa_pdf/8b/b7/kbia-04-06-1054092.PMC4914028.pdf
FEBS Lett 2002; 513:107-13;PMID:11911888; http://dx.doi.org/10.1016/S0014- 5793(01)03239-2 5.,OADS,/arxiv_data1/oa_pdf/8b/b7/kbia-04-06-1054092.PMC4914028.pdf
Eur J Biochem 2003; 270:404-14; PMID:12542690; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/8b/b7/kbia-04-06-1054092.PMC4914028.pdf
J Mol Biol 1980; 144:223-45; PMID:6454788; http://dx.doi.org/10.1016/0022- 2836(80)90088-1 8.,OADS,/arxiv_data1/oa_pdf/8b/b7/kbia-04-06-1054092.PMC4914028.pdf
Arch Biochem Biophys 1959; 79:191-9; http://dx.doi.org/10.1016/0003-9861(59)90395-9 9.,Non-OADS,/arxiv_data1/oa_pdf/8b/b7/kbia-04-06-1054092.PMC4914028.pdf
J Cell Sci 2012; 125:1627-32; PMID:22566666; http://dx.doi.org/10.1242/ jcs.094300 10.,OADS,/arxiv_data1/oa_pdf/8b/b7/kbia-04-06-1054092.PMC4914028.pdf
BMC Genomics2006; 7:300; PMID:17134497; http://dx.doi.org/ 10.1186/1471-2164-7-300 11.,OADS,/arxiv_data1/oa_pdf/8b/b7/kbia-04-06-1054092.PMC4914028.pdf
Bio- chemistry 1990; 29:11089-94; PMID:2271696;http://dx.doi.org/10.1021/bi00502a011 12.,Non-OADS,/arxiv_data1/oa_pdf/8b/b7/kbia-04-06-1054092.PMC4914028.pdf
J Cell Biol 1990; 110:1137-47; PMID:2139032; http://dx.doi.org/10.1083/jcb.110.4.1137 13.,OADS,/arxiv_data1/oa_pdf/8b/b7/kbia-04-06-1054092.PMC4914028.pdf
Cell Motil Cytoskeleton 1993; 24:189-99;PMID:8467525; http://dx.doi.org/10.1002/ cm.970240306 14.,Non-OADS,/arxiv_data1/oa_pdf/8b/b7/kbia-04-06-1054092.PMC4914028.pdf
J Cell Biol 1994; 126:375-89; PMID:8034741; http://dx.doi.org/10.1083/jcb.126.2.375 15.,Non-OADS,/arxiv_data1/oa_pdf/8b/b7/kbia-04-06-1054092.PMC4914028.pdf
J Cell Biol 1993; 120:1393-403; PMID:8449985; http://dx.doi.org/10.1083/ jcb.120.6.1393 www.tandfonline.com 183 BioArchitecture,Non-OADS,/arxiv_data1/oa_pdf/8b/b7/kbia-04-06-1054092.PMC4914028.pdf
Cell Motil Cytoskeleton 2000; 47:269-81; PMID:11093248; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/8b/b7/kbia-04-06-1054092.PMC4914028.pdf
"Wang F, Chen L, Arcucci O, Harvey EV, Bowers B, Xu Y, Hammer JA, 3rd, Sellers JR. Effect of ADP and ionic strength on the kinetic and motile properties of recombinant mouse myosin V. J Biol Chem 2000;275:4329-35; PMID:10660602; http://dx.doi.org/ 10.1074/jbc.275.6.4329 18.",Non-OADS,/arxiv_data1/oa_pdf/8b/b7/kbia-04-06-1054092.PMC4914028.pdf
J Cell Biol 1994; 127:425-40; PMID:7929586; http://dx.doi.org/10.1083/jcb.127.2.425 22.,Non-OADS,/arxiv_data1/oa_pdf/8b/b7/kbia-04-06-1054092.PMC4914028.pdf
Biochem J 2001; 354:267-74; PMID:11171103; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/8b/b7/kbia-04-06-1054092.PMC4914028.pdf
Cell 2008; 135:123-36; PMID:18854160; http://dx.doi.org/10.1016/j.cell.2008.09.018 26.,OADS,/arxiv_data1/oa_pdf/8b/b7/kbia-04-06-1054092.PMC4914028.pdf
Embo J 2002; 21:2149-58; PMID:11980712; http://dx.doi.org/10.1093/emboj/21.9.2149 27.,Non-OADS,/arxiv_data1/oa_pdf/8b/b7/kbia-04-06-1054092.PMC4914028.pdf
Proc NatlAcad Sci U S A 2004; 101:4787-92; PMID:15037754; http://dx.doi.org/10.1073/ pnas.0306892101 28.,OADS,/arxiv_data1/oa_pdf/8b/b7/kbia-04-06-1054092.PMC4914028.pdf
J Biol Chem2005; 280:41562-7; PMID:16254000; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/8b/b7/kbia-04-06-1054092.PMC4914028.pdf
Biochemistry 2000; 39:14196-202; PMID:11087368; http://dx.doi.org/10.1021/ bi001701b 30.,Non-OADS,/arxiv_data1/oa_pdf/8b/b7/kbia-04-06-1054092.PMC4914028.pdf
Proc Natl Acad Sci U S A 2009; 106:4189-94; PMID:19255446; http://dx.doi.org/10.1073/ pnas.0808682106 31.,OADS,/arxiv_data1/oa_pdf/8b/b7/kbia-04-06-1054092.PMC4914028.pdf
Febs J 2013; 280:5511-32;PMID:23663249; http://dx.doi.org/10.1111/ febs.12337 32.,OADS,/arxiv_data1/oa_pdf/8b/b7/kbia-04-06-1054092.PMC4914028.pdf
J Mol Biol 1988;204:191-204; PMID:3145979; http://dx.doi.org/ 10.1016/0022-2836(88)90608-0 33.,Non-OADS,/arxiv_data1/oa_pdf/8b/b7/kbia-04-06-1054092.PMC4914028.pdf
J Mol Biol 2006; 359:509-25; PMID:16678204; http://dx.doi.org/10.1016/j.jmb.2006.03.066 34.,OADS,/arxiv_data1/oa_pdf/8b/b7/kbia-04-06-1054092.PMC4914028.pdf
Embo J 2003; 22:362-71; PMID:12554638; http://dx.doi.org/10.1093/emboj/cdg058 36.,OADS,/arxiv_data1/oa_pdf/8b/b7/kbia-04-06-1054092.PMC4914028.pdf
"Terrak M, Rebowski G, Lu RC, Grabarek Z, Domi- nguez R. Structure of the light chain-binding domainof myosin V. Proc Natl Acad Sci U S A 2005; 102:12718-23; PMID:16120677; http://dx.doi.org/ 10.1073/pnas.0503899102 37.",OADS,/arxiv_data1/oa_pdf/8b/b7/kbia-04-06-1054092.PMC4914028.pdf
Dev Cell 2007; 13:391-404; PMID:17765682; http://dx.doi.org/10.1016/j.devcel.2007.07.007 38.,OADS,/arxiv_data1/oa_pdf/8b/b7/kbia-04-06-1054092.PMC4914028.pdf
Trafﬁc2011; 12:287-300; PMID:21143563; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/8b/b7/kbia-04-06-1054092.PMC4914028.pdf
Cell Struct Funct 2001; 26:243-51; PMID:11699641; http://dx.doi.org/10.1247/ csf.26.243 41.,OADS,/arxiv_data1/oa_pdf/8b/b7/kbia-04-06-1054092.PMC4914028.pdf
Aging Cell 2012; 11:203-12; PMID: ...; http://dx.doi.org/ 10.1111/j.1474-9726.2011.00774.x 42.,OADS,/arxiv_data1/oa_pdf/8b/b7/kbia-04-06-1054092.PMC4914028.pdf
Biochem Bio-phys Res Commun 2014; 449:284-8; PMID:24857983; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/8b/b7/kbia-04-06-1054092.PMC4914028.pdf
Eur J Bio- chem 1979; 99:385-94; PMID:159176; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/8b/b7/kbia-04-06-1054092.PMC4914028.pdf
Faseb J 2011; 25:4394-405; PMID:21885653; http://dx.doi.org/10.1096/fj.11-19197346.,Non-OADS,/arxiv_data1/oa_pdf/8b/b7/kbia-04-06-1054092.PMC4914028.pdf
BMC Geno- mics 2009; 10:117; PMID:19298669; http://dx.doi.org/10.1186/1471-2164-10-117 47.,Non-OADS,/arxiv_data1/oa_pdf/8b/b7/kbia-04-06-1054092.PMC4914028.pdf
PLoS One 2014; 9:e90077;PMID:24587213; http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/8b/b7/kbia-04-06-1054092.PMC4914028.pdf
Biophys J 2011; 100:1737-46;PMID:21463587; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/8b/b7/kbia-04-06-1054092.PMC4914028.pdf
Am J Physiol Heart Circ Physiol 2007; 292:H1643-54; PMID:17142342; http://dx.doi.org/ 10.1152/ajpheart.00931.2006 52.,Non-OADS,/arxiv_data1/oa_pdf/8b/b7/kbia-04-06-1054092.PMC4914028.pdf
Proc Natl Acad Sci U S A 2010; 107:17403-8; PMID:20855589; http://dx.doi.org/ 10.1073/pnas.1009619107 53.,OADS,/arxiv_data1/oa_pdf/8b/b7/kbia-04-06-1054092.PMC4914028.pdf
Nat Genet 1996; 13:63-9; PMID:8673105; http://dx.doi.org/10.1038/ng0596-63 55.,Non-OADS,/arxiv_data1/oa_pdf/8b/b7/kbia-04-06-1054092.PMC4914028.pdf
Int J Impot Res 2007; 19:62-8; PMID:16885993; http://dx.doi.org/10.1038/sj.ijir.3901503 56.,OADS,/arxiv_data1/oa_pdf/8b/b7/kbia-04-06-1054092.PMC4914028.pdf
Biochem Biophys Res Commun 2002; 295:112-8; PMID:12083776; http://dx.doi.org/10.1016/S0006- 291X(02)00640-X 57.,OADS,/arxiv_data1/oa_pdf/8b/b7/kbia-04-06-1054092.PMC4914028.pdf
J Cell Biol 1997; 139:1805-19; PMID:9412474; http://dx.doi.org/10.1083/jcb.139.7.1805 59.,Non-OADS,/arxiv_data1/oa_pdf/8b/b7/kbia-04-06-1054092.PMC4914028.pdf
J Cell Biol 2014; 206:435-50; PMID:25092658; http://dx.doi.org/10.1083/jcb.201402004 184 Volume 4 Issue 6 BioArchitecture,Non-OADS,/arxiv_data1/oa_pdf/8b/b7/kbia-04-06-1054092.PMC4914028.pdf
J Biol Chem 2000; 275:37167-72; PMID:10945998; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/8b/b7/kbia-04-06-1054092.PMC4914028.pdf
Nat Struct Biol 2001; 8:226-9; PMID:11224566; http://dx.doi.org/10.1038/84962 64.,OADS,/arxiv_data1/oa_pdf/8b/b7/kbia-04-06-1054092.PMC4914028.pdf
Proc Natl Acad Sci U S A 1994; 91:12403-7; PMID:7809049; http://dx.doi.org/10.1073/ pnas.91.26.12403 65.,OADS,/arxiv_data1/oa_pdf/8b/b7/kbia-04-06-1054092.PMC4914028.pdf
Nature 1993; 365:454-6; PMID:8413589; http://dx.doi.org/10.1038/365454a0 66.,OADS,/arxiv_data1/oa_pdf/8b/b7/kbia-04-06-1054092.PMC4914028.pdf
Cell Molecular Life Sci 2012; 69:299-311; PMID:21687988; http://dx.doi.org/10.1007/s00018- 011-0749-8 67.,OADS,/arxiv_data1/oa_pdf/8b/b7/kbia-04-06-1054092.PMC4914028.pdf
PlantCell Physiol 2007; 48:886-91; PMID:17504816; http://dx.doi.org/10.1093/pcp/pcm054 68.,Non-OADS,/arxiv_data1/oa_pdf/8b/b7/kbia-04-06-1054092.PMC4914028.pdf
Proc Natl Acad Sci U S A 2014; 111:2116-21; PMID:24469830; http://dx.doi.org/ 10.1073/pnas.1321022111 69.,OADS,/arxiv_data1/oa_pdf/8b/b7/kbia-04-06-1054092.PMC4914028.pdf
Structure 1996; 4:21-32;PMID:8805510; http://dx.doi.org/10.1016/S0969- 2126(96)00006-8 70.,OADS,/arxiv_data1/oa_pdf/8b/b7/kbia-04-06-1054092.PMC4914028.pdf
Cell 1998; 94:559-71; PMID:9741621; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/8b/b7/kbia-04-06-1054092.PMC4914028.pdf
Proc Natl Acad Sci U S A 2000; 97:11238-43; PMID:11016966; http://dx.doi.org/10.1073/ pnas.200376897 72.,OADS,/arxiv_data1/oa_pdf/8b/b7/kbia-04-06-1054092.PMC4914028.pdf
Proc Natl Acad Sci U S A 1995; 92:10644-7; PMID:7479857; http://dx.doi.org/ 10.1073/pnas.92.23.10644 73.,OADS,/arxiv_data1/oa_pdf/8b/b7/kbia-04-06-1054092.PMC4914028.pdf
Proc Natl Acad Sci U S A 2011; 108:114-9; PMID:21149681; http://dx.doi.org/10.1073/ pnas.1016288107 74.,OADS,/arxiv_data1/oa_pdf/8b/b7/kbia-04-06-1054092.PMC4914028.pdf
Nature 2003; 425:419-23; PMID:14508494; http://dx.doi.org/10.1038/nature01927 75.,Non-OADS,/arxiv_data1/oa_pdf/8b/b7/kbia-04-06-1054092.PMC4914028.pdf
Nature 2005; 435:779-85; PMID:15944696; http://dx.doi.org/10.1038/ nature03592 76.,OADS,/arxiv_data1/oa_pdf/8b/b7/kbia-04-06-1054092.PMC4914028.pdf
J Mol Biol 2014; 426:2070-81; PMID:24636949; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/8b/b7/kbia-04-06-1054092.PMC4914028.pdf
Proc Natl Acad Sci U S A 2008; 105:5710-5; PMID:18391215; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/8b/b7/kbia-04-06-1054092.PMC4914028.pdf
Biochemistry 2006; 45:11598-604; PMID:16981719; http://dx.doi.org/10.1021/ bi0613877 79.,Non-OADS,/arxiv_data1/oa_pdf/8b/b7/kbia-04-06-1054092.PMC4914028.pdf
Proc NatlAcad Sci U S A 2006; 103:19326-31; PMID:17151196; http://dx.doi.org/10.1073/ pnas.0609436103 80.,OADS,/arxiv_data1/oa_pdf/8b/b7/kbia-04-06-1054092.PMC4914028.pdf
J Biol Chem 2006; 281:31987-94; PMID:16920704; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/8b/b7/kbia-04-06-1054092.PMC4914028.pdf
Biochemistry 2006; 45:11564-77; PMID:16981716; http://dx.doi.org/ 10.1021/bi061142u 83.,Non-OADS,/arxiv_data1/oa_pdf/8b/b7/kbia-04-06-1054092.PMC4914028.pdf
Nature 1999; 401:505-8; PMID:10519557;http://dx.doi.org/10.1038/46835 85.,Non-OADS,/arxiv_data1/oa_pdf/8b/b7/kbia-04-06-1054092.PMC4914028.pdf
Biophys J 2011; 100:2964- 73; PMID:21689530; http://dx.doi.org/10.1016/j.bpj.2011.05.010 86.,OADS,/arxiv_data1/oa_pdf/8b/b7/kbia-04-06-1054092.PMC4914028.pdf
Curr Opin Cell Biol 1999;11:26-33; PMID:10047526; http://dx.doi.org/ 10.1016/S0955-0674(99)80004-0 87.,OADS,/arxiv_data1/oa_pdf/8b/b7/kbia-04-06-1054092.PMC4914028.pdf
Cell Mol Life Sci 2013; 70:1-21; PMID:22565821; http://dx.doi.org/10.1007/s00018-012-1002-9 88.,OADS,/arxiv_data1/oa_pdf/8b/b7/kbia-04-06-1054092.PMC4914028.pdf
Biol Chem 2013; 394:1399-410; PMID:23950574; http://dx.doi.org/10.1515/hsz-2013-018189.,Non-OADS,/arxiv_data1/oa_pdf/8b/b7/kbia-04-06-1054092.PMC4914028.pdf
J Cell Biol 1989; 109:2887-94; PMID:2531749; http://dx.doi.org/ 10.1083/jcb.109.6.2887 90.,OADS,/arxiv_data1/oa_pdf/8b/b7/kbia-04-06-1054092.PMC4914028.pdf
J Cell Biol 1999; 147:1385-90; PMID:10613897; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/8b/b7/kbia-04-06-1054092.PMC4914028.pdf
J Mol Biol 2011; 408:863-78; PMID:21419133; http://dx.doi.org/10.1016/j.jmb.2011.03.019 93.,OADS,/arxiv_data1/oa_pdf/8b/b7/kbia-04-06-1054092.PMC4914028.pdf
Curr Opin Cell Biol 1991; 3:105- 11; http://dx.doi.org/10.1016/0955-0674(91)90172-U 94.,OADS,/arxiv_data1/oa_pdf/8b/b7/kbia-04-06-1054092.PMC4914028.pdf
J Physiol 2015; 593:473-5;PMID:25630266; http://dx.doi.org/10.1113/ jphysiol.2014.285866 95.,Non-OADS,/arxiv_data1/oa_pdf/8b/b7/kbia-04-06-1054092.PMC4914028.pdf
Proc Natl Acad Sci U S A 2010; 107:8207-12; PMID:20404208; http://dx.doi.org/10.1073/ pnas.1001941107 99.,OADS,/arxiv_data1/oa_pdf/8b/b7/kbia-04-06-1054092.PMC4914028.pdf
J Struct Biol 2014; 185:375-82; PMID:24361582; http://dx.doi.org/ 10.1016/j.jsb.2013.12.008 100.,OADS,/arxiv_data1/oa_pdf/8b/b7/kbia-04-06-1054092.PMC4914028.pdf
Proc Natl Acad Sci U S A 1994; 91:1490-4; PMID: ...; http://dx.doi.org/10.1073/ pnas.91.4.1490 102.,OADS,/arxiv_data1/oa_pdf/8b/b7/kbia-04-06-1054092.PMC4914028.pdf
J Biol Chem 2012; 287:22068-79; PMID:22549781; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/8b/b7/kbia-04-06-1054092.PMC4914028.pdf
Biochemistry 1997; 36:2063-7; PMID:9047304; http://dx.doi.org/ 10.1021/bi9624651 106.,Non-OADS,/arxiv_data1/oa_pdf/8b/b7/kbia-04-06-1054092.PMC4914028.pdf
BMC Cell Biol 2011; 12:52; PMID:22136066; http://dx.doi.org/10.1186/1471-2121-12-52 107.,Non-OADS,/arxiv_data1/oa_pdf/8b/b7/kbia-04-06-1054092.PMC4914028.pdf
Dev Cell 2014; 31:747-60; PMID:25482883; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/8b/b7/kbia-04-06-1054092.PMC4914028.pdf
Myosin phosphorylation and force potentia- tion in skeletal muscle: evidence from animal models.J Muscle Res Cell Motil 2013; 34:317-32; PMID:24162313; http://dx.doi.org/10.1007/s10974- 013-9363-8 109.,Non-OADS,/arxiv_data1/oa_pdf/8b/b7/kbia-04-06-1054092.PMC4914028.pdf
Arch Biochem Biophys 2011; 510:120-8; PMID:21284933; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/8b/b7/kbia-04-06-1054092.PMC4914028.pdf
J Cell Physiol 1985; 125:301-5; PMID:4055914; http://dx.doi.org/10.1002/ jcp.1041250219 111.,Non-OADS,/arxiv_data1/oa_pdf/8b/b7/kbia-04-06-1054092.PMC4914028.pdf
Proc Natl Acad Sci U S A1990; 87:414-8; PMID:2136951; http://dx.doi.org/ 10.1073/pnas.87.1.414 113.,OADS,/arxiv_data1/oa_pdf/8b/b7/kbia-04-06-1054092.PMC4914028.pdf
Cardiovasc Res 2008; 79:481-91; PMID:18411228; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/8b/b7/kbia-04-06-1054092.PMC4914028.pdf
Car- diovasc Res 2009; 82:84-92; PMID:19150977;http://dx.doi.org/10.1093/cvr/cvp016 118.,Non-OADS,/arxiv_data1/oa_pdf/8b/b7/kbia-04-06-1054092.PMC4914028.pdf
Eur J Cell Biol 2006; 85:969-79;PMID:16814425; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/8b/b7/kbia-04-06-1054092.PMC4914028.pdf
J Cell Biol 2004; 167:315-25; PMID:15504913; http://dx.doi.org/10.1083/jcb.200404045 121.,OADS,/arxiv_data1/oa_pdf/8b/b7/kbia-04-06-1054092.PMC4914028.pdf
J Biol Chem 1999; 274:17691-5; PMID:10364209; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/8b/b7/kbia-04-06-1054092.PMC4914028.pdf
J Mol Biol 2008; 384:780-97; PMID:18951904;http://dx.doi.org/10.1016/j.jmb.2008.10.013 126.,OADS,/arxiv_data1/oa_pdf/8b/b7/kbia-04-06-1054092.PMC4914028.pdf
J Mol Biol 1970; 54:313-26; PMID:4250215; http://dx.doi.org/ 10.1016/0022-2836(70)90432-8 128.,OADS,/arxiv_data1/oa_pdf/8b/b7/kbia-04-06-1054092.PMC4914028.pdf
J Mol Biol 1976; 104:747-75; PMID:134163; http://dx.doi.org/ 10.1016/0022-2836(76)90180-7 129.,Non-OADS,/arxiv_data1/oa_pdf/8b/b7/kbia-04-06-1054092.PMC4914028.pdf
Nature 1994; 368:306-12; PMID:8127365;http://dx.doi.org/10.1038/368306a0 130.,Non-OADS,/arxiv_data1/oa_pdf/8b/b7/kbia-04-06-1054092.PMC4914028.pdf
J Mol Biol 2009; 394:496-505; PMID:19769984; http://dx.doi.org/10.1016/j.jmb.2009.09.035 132.,OADS,/arxiv_data1/oa_pdf/8b/b7/kbia-04-06-1054092.PMC4914028.pdf
Cold Spring Harb Symp Quant Biol 1982; 46 Pt 2:929-38; PMID:6955111; http://dx.doi.org/10.1101/SQB.1982.046.01.087 133.,OADS,/arxiv_data1/oa_pdf/8b/b7/kbia-04-06-1054092.PMC4914028.pdf
J Mol Biol 1990; 216:85-93; PMID:2146399; http://dx.doi.org/10.1016/S0022-2836(05)80062-2 135.,OADS,/arxiv_data1/oa_pdf/8b/b7/kbia-04-06-1054092.PMC4914028.pdf
J Mol Biol 2012;415:274-87; PMID:22079364; http://dx.doi.org/ 10.1016/j.jmb.2011.10.047 137.,OADS,/arxiv_data1/oa_pdf/8b/b7/kbia-04-06-1054092.PMC4914028.pdf
Mol Biol Cell 2010;21:3952-62; PMID:20861308; http://dx.doi.org/ 10.1091/mbc.E10-04-0293 139.,Non-OADS,/arxiv_data1/oa_pdf/8b/b7/kbia-04-06-1054092.PMC4914028.pdf
Biochem J 2011;434:171-80; PMID:21126233; http://dx.doi.org/ 10.1042/BJ20101473 140.,Non-OADS,/arxiv_data1/oa_pdf/8b/b7/kbia-04-06-1054092.PMC4914028.pdf
Nat Cell Biol 2013; 15:325-34; PMID:23417121; http://dx.doi.org/10.1038/ncb2689 141.,OADS,/arxiv_data1/oa_pdf/8b/b7/kbia-04-06-1054092.PMC4914028.pdf
"Sellers JR, Veigel C. Walking with myosin V. Curr Opin Cell Biol 2006; 18:68-73; PMID:16378722; http://dx.doi.org/10.1016/j.ceb.2005.12.014 142.",OADS,/arxiv_data1/oa_pdf/8b/b7/kbia-04-06-1054092.PMC4914028.pdf
Nature 2006; 442:212-5; PMID:16838021; http://dx.doi.org/10.1038/nature04865 143.,OADS,/arxiv_data1/oa_pdf/8b/b7/kbia-04-06-1054092.PMC4914028.pdf
Regulated conforma- tion of myosin V. J Biol Chem 2004; 279:2333-6;PMID:14634000; http://dx.doi.org/10.1074/jbc.,Non-OADS,/arxiv_data1/oa_pdf/8b/b7/kbia-04-06-1054092.PMC4914028.pdf
Biochem Biophys Res Commun 2004; 315:538-45; PMID:14975734; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/8b/b7/kbia-04-06-1054092.PMC4914028.pdf
J Cell Biol 2004; 164:877-86;PMID:15007063; http://dx.doi.org/10.1083/ jcb.200310065 147.,OADS,/arxiv_data1/oa_pdf/8b/b7/kbia-04-06-1054092.PMC4914028.pdf
Nat Struct Mol Biol 2005; 12:127-32; PMID:15665867;http://dx.doi.org/10.1038/nsmb894 148.,OADS,/arxiv_data1/oa_pdf/8b/b7/kbia-04-06-1054092.PMC4914028.pdf
Rab27a is an essential component of melanosomereceptor for myosin Va. Mol Biol Cell 2002; 13:1735-49; PMID:12006666; http://dx.doi.org/ 10.1091/mbc.01-12-0595 150.,Non-OADS,/arxiv_data1/oa_pdf/8b/b7/kbia-04-06-1054092.PMC4914028.pdf
Biol Chem 2013; 288:29313-22; PMID:23979131; http://dx.doi.org/10.1074/jbc.M113.476929 151.,OADS,/arxiv_data1/oa_pdf/8b/b7/kbia-04-06-1054092.PMC4914028.pdf
J Biol Chem 1999; 274:27448-56; PMID:10488077; http://dx.doi.org/10.1074/ jbc.274.39.27448 152.,OADS,/arxiv_data1/oa_pdf/8b/b7/kbia-04-06-1054092.PMC4914028.pdf
Calmodulin bridging of IQ motifs in myosin-V. FEBS Lett 2004; 567:166-70;PMID:15178316; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/8b/b7/kbia-04-06-1054092.PMC4914028.pdf
Regulatory implications of a novel mode of interaction of calmodulin with a dou- ble IQ-motif target sequence from murine dilute myo- sin V. Protein Sci 2002; 11:2909-23; PMID:12441389; http://dx.doi.org/10.1110/ ps.0210402 154.,Non-OADS,/arxiv_data1/oa_pdf/8b/b7/kbia-04-06-1054092.PMC4914028.pdf
Proc Natl Acad Sci U S A 2010; 107:698-702;PMID:20080738; http://dx.doi.org/10.1073/ pnas.0911426107 155.,OADS,/arxiv_data1/oa_pdf/8b/b7/kbia-04-06-1054092.PMC4914028.pdf
J Biol Chem 2000; 275:21618-23; PMID:10777479; http://dx.doi.org/ 10.1074/jbc.M000363200 156.,OADS,/arxiv_data1/oa_pdf/8b/b7/kbia-04-06-1054092.PMC4914028.pdf
J Biol Chem 2000; 275:21624-30;PMID:10781577; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/8b/b7/kbia-04-06-1054092.PMC4914028.pdf
J Biol Chem 1999; 274:21575-80; PMID:10419463; http://dx.doi.org/10.1074/ jbc.274.31.21575 158.,OADS,/arxiv_data1/oa_pdf/8b/b7/kbia-04-06-1054092.PMC4914028.pdf
Biophys J 2012; 102:2799-807; PMID:22735530; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/8b/b7/kbia-04-06-1054092.PMC4914028.pdf
Science 2008; 321:133-6; PMID:18599791; http://dx.doi.org/10.1126/science.1159419 160.,Non-OADS,/arxiv_data1/oa_pdf/8b/b7/kbia-04-06-1054092.PMC4914028.pdf
Biochemistry 2007; 46:11718-26; PMID:17910470; http://dx.doi.org/10.1021/ bi700894h 163.,Non-OADS,/arxiv_data1/oa_pdf/8b/b7/kbia-04-06-1054092.PMC4914028.pdf
Embo J 2004; 23:1433-40; PMID:15014434; http://dx.doi.org/10.1038/sj.emboj.7600169 164.,OADS,/arxiv_data1/oa_pdf/8b/b7/kbia-04-06-1054092.PMC4914028.pdf
"J Biol Chem 2010; 285:24933-42; PMID:20538589; http://dx.doi.org/10.1074/jbc.M110.101105 165. van Bodegraven AA, Curley CR, Hunt KA, Monsuur AJ, Linskens RK, Onnie CM, Crusius JB, Annese V,Latiano A, Silverberg MS, et al.",OADS,/arxiv_data1/oa_pdf/8b/b7/kbia-04-06-1054092.PMC4914028.pdf
Gas- troenterology 2006; 131:1768-74; PMID:17087940;http://dx.doi.org/10.1053/j.gastro.2006.09.011166.,OADS,/arxiv_data1/oa_pdf/8b/b7/kbia-04-06-1054092.PMC4914028.pdf
Hum Mutat 2004; 24:274-5;PMID:15300860; http://dx.doi.org/10.1002/ humu.9272 167.,OADS,/arxiv_data1/oa_pdf/8b/b7/kbia-04-06-1054092.PMC4914028.pdf
Proc Natl Acad Sci U S A 2014; 111:E227-36; PMID:24379364; http://dx.doi.org/ 10.1073/pnas.1319285110 168.,OADS,/arxiv_data1/oa_pdf/8b/b7/kbia-04-06-1054092.PMC4914028.pdf
Cell Motil Cytoskeleton 2006; 63:604-22; PMID:16917818; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/8b/b7/kbia-04-06-1054092.PMC4914028.pdf
Cytoskeleton (Hoboken) 2013; 70:281-95; PMID:23568824; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/8b/b7/kbia-04-06-1054092.PMC4914028.pdf
J Biol Chem 2014; 289:18535-48; PMID:24825904;http://dx.doi.org/10.1074/jbc.M114.569087 175.,OADS,/arxiv_data1/oa_pdf/8b/b7/kbia-04-06-1054092.PMC4914028.pdf
Biochem Biophys Res Commun 2012; 417:686-91; PMID:22166199; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/8b/b7/kbia-04-06-1054092.PMC4914028.pdf
J Biol Chem 2009; 284:1252-66; PMID:18945678; http://dx.doi.org/ 10.1074/jbc.M801861200 177.,OADS,/arxiv_data1/oa_pdf/8b/b7/kbia-04-06-1054092.PMC4914028.pdf
J Biol Chem 2005; 280:23741-7;PMID:15826951; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/8b/b7/kbia-04-06-1054092.PMC4914028.pdf
Curr Biol 2000; 10:727-30; PMID:10873803; http://dx.doi.org/10.1016/S0960-9822(00)00539-X 181.,OADS,/arxiv_data1/oa_pdf/8b/b7/kbia-04-06-1054092.PMC4914028.pdf
"The Dictyoste- lium class I myosin, MyoD, contains a novel light chain that lacks high-afﬁnity calcium-binding sites.Biochem J 2003; 374:697-705; PMID:12826013; http://dx.doi.org/10.1042/BJ20030656 183.",Non-OADS,/arxiv_data1/oa_pdf/8b/b7/kbia-04-06-1054092.PMC4914028.pdf
J Muscle Res Cell Motil 1997; 18:395-8; PMID:9172081; http://dx.doi.org/10.1023/ A:1018686428955 184.,Non-OADS,/arxiv_data1/oa_pdf/8b/b7/kbia-04-06-1054092.PMC4914028.pdf
J Biol Chem 2014; 289:17030-42;PMID:24790102; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/8b/b7/kbia-04-06-1054092.PMC4914028.pdf
Identiﬁcation of calmodulin and MlcC as light chains for Dictyostelium myosin-I isozymes.Biochemistry 2011; 50:6579-88; PMID:21671662; http://dx.doi.org/10.1021/bi2007178 187.,Non-OADS,/arxiv_data1/oa_pdf/8b/b7/kbia-04-06-1054092.PMC4914028.pdf
J Biol Chem 2006; 281:24728-36; PMID:16790438; http://dx.doi.org/ 10.1074/jbc.M602094200 188.,OADS,/arxiv_data1/oa_pdf/8b/b7/kbia-04-06-1054092.PMC4914028.pdf
Proc Natl Acad Sci U S A2012; 109:13290-5; PMID:22851764; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/8b/b7/kbia-04-06-1054092.PMC4914028.pdf
"Homma K, Saito J, Ikebe R, Ikebe M. Motor function and regulation of myosin X. J Biol Chem 2001; 276:34348-54; PMID:11457842; http://dx.doi.org/ 10.1074/jbc.M104785200 190.",OADS,/arxiv_data1/oa_pdf/8b/b7/kbia-04-06-1054092.PMC4914028.pdf
J Biol Chem 2005; 280:15071-83; PMID:15705568; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/8b/b7/kbia-04-06-1054092.PMC4914028.pdf
The tumor-sensitive calmod- ulin-like protein is a speciﬁc light chain of human unconventional myosin X. J Biol Chem 2001; 276:12182-9; PMID:11278607; http://dx.doi.org/ 10.1074/jbc.M010056200 192.,Non-OADS,/arxiv_data1/oa_pdf/8b/b7/kbia-04-06-1054092.PMC4914028.pdf
Biochemistry 2010; 49:8105-16; PMID:20731332; http://dx.doi.org/10.1021/ bi100644q 193.,Non-OADS,/arxiv_data1/oa_pdf/8b/b7/kbia-04-06-1054092.PMC4914028.pdf
PLoS One 2014; 9:e98056; PMID:24892871; http://dx.doi.org/ 10.1371/journal.pone.0098056 194.,Non-OADS,/arxiv_data1/oa_pdf/8b/b7/kbia-04-06-1054092.PMC4914028.pdf
PLoS Pathog 2010; 6:e1000720; PMID:20084115; http://dx.doi.org/10.1371/journal.ppat.1000720 196.,Non-OADS,/arxiv_data1/oa_pdf/8b/b7/kbia-04-06-1054092.PMC4914028.pdf
Proc Natl Acad Sci U S A 2006; 103:4852-7; PMID:16547135; http://dx.doi.org/10.1073/ pnas.0510907103 197.,OADS,/arxiv_data1/oa_pdf/8b/b7/kbia-04-06-1054092.PMC4914028.pdf
JMuscle Res Cell Motil 2007; 28:285-91; PMID:17994197; http://dx.doi.org/10.1007/s10974- 007-9124-7 200.,OADS,/arxiv_data1/oa_pdf/8b/b7/kbia-04-06-1054092.PMC4914028.pdf
Mol Biol Cell 2005;16:4519-30; PMID:16030255; http://dx.doi.org/ 10.1091/mbc.E05-03-0252 201.,Non-OADS,/arxiv_data1/oa_pdf/8b/b7/kbia-04-06-1054092.PMC4914028.pdf
Nat Chem Biol 2010; 6:457-63; PMID:20436488; http://dx.doi.org/10.1038/ nchembio.363 202.,OADS,/arxiv_data1/oa_pdf/8b/b7/kbia-04-06-1054092.PMC4914028.pdf
Bio- chem Biophys Res Commun 2006; 350:543-8; PMID:17022938; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/8b/b7/kbia-04-06-1054092.PMC4914028.pdf
Bio-chemistry 2011; 50:7809-21; PMID:21819137; http://dx.doi.org/10.1021/bi2008992 206.,Non-OADS,/arxiv_data1/oa_pdf/8b/b7/kbia-04-06-1054092.PMC4914028.pdf
Cardiovasc Res 2008; 79:97-108; PMID:18343897; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/8b/b7/kbia-04-06-1054092.PMC4914028.pdf
J Biol Chem 2000; 275:34512-20; PMID:10944522; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/8b/b7/kbia-04-06-1054092.PMC4914028.pdf
J Muscle Res Cell Motil 2010; 31:163-70; PMID:20711642; http://dx.doi.org/10.1007/s10974- 010-9220-y 210.,Non-OADS,/arxiv_data1/oa_pdf/8b/b7/kbia-04-06-1054092.PMC4914028.pdf
Proc Natl Acad Sci U S A 2013; 110:12607-12; PMID:23798412; http://dx.doi.org/ 10.1073/pnas.1309493110 211.,OADS,/arxiv_data1/oa_pdf/8b/b7/kbia-04-06-1054092.PMC4914028.pdf
JBiol Chem 2014; 289:5158-67; PMID:24344137; http://dx.doi.org/10.1074/jbc.M113.511204 212.,OADS,/arxiv_data1/oa_pdf/8b/b7/kbia-04-06-1054092.PMC4914028.pdf
Bio- chem Biophys Res Commun 2010; 402:537-42; PMID:20971064; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/8b/b7/kbia-04-06-1054092.PMC4914028.pdf
Mol Biol Cell 2004; 15:838-50;PMID:14657248; http://dx.doi.org/10.1091/mbc.,OADS,/arxiv_data1/oa_pdf/8b/b7/kbia-04-06-1054092.PMC4914028.pdf
Mol Biosyst 2014; 10:2693-8; PMID:25091814; http://dx.doi.org/10.1039/ C4MB00364K 215.,OADS,/arxiv_data1/oa_pdf/8b/b7/kbia-04-06-1054092.PMC4914028.pdf
J Biol Chem 2002; 277:21514-21; PMID:11940582; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/8b/b7/kbia-04-06-1054092.PMC4914028.pdf
Proc Natl Acad Sci U S A 2006;103:5746-51; PMID:16585515; http://dx.doi.org/ 10.1073/pnas.0509935103 217.,OADS,/arxiv_data1/oa_pdf/8b/b7/kbia-04-06-1054092.PMC4914028.pdf
Biochem Biophys Res Commun 2007;354:1034-9; PMID:17276406; http://dx.doi.org/ 10.1016/j.bbrc.2007.01.112 219.,OADS,/arxiv_data1/oa_pdf/8b/b7/kbia-04-06-1054092.PMC4914028.pdf
J Biol Chem 2001; 276:5932-42; PMID:11087749; http://dx.doi.org/10.1074/jbc.M008715200 220.,OADS,/arxiv_data1/oa_pdf/8b/b7/kbia-04-06-1054092.PMC4914028.pdf
Mol Microbiol 2004; 53:687-96;PMID:15228544; http://dx.doi.org/10.1111/j.1365- 2958.2004.04157.x 221.,Non-OADS,/arxiv_data1/oa_pdf/8b/b7/kbia-04-06-1054092.PMC4914028.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/eb/cd/jir-9-103.PMC4914030.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",OADS,/arxiv_data1/oa_pdf/eb/cd/jir-9-103.PMC4914030.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Journal of Inflammation Research 2016:9 103–113submit your manuscript | www.dovepress.co m Dove press  103 http: //dx.doi.org/10.2147/JIR.S9988 7TNF-related apoptosis-inducing ligand deficiency  enhances survival in murine colon ascendens  stent peritonitis Katharina Beyer1 Laura Stollhof1 Christian Poetschke2 Wolfram von Bernstorff1 Lars Ivo Partecke1 Stephan Diedrich1 stefan Maier1 Barbara M Bröker2 Claus-Dieter Heidecke1 1Department of General, Visceral,   Thoracic, and Vascular Surgery,   2Institute of Immunology, University of  Greifswald, Greifswald, Germany Correspondence: Katharina Beyer   Klinik für Allgemein-, Viszeral-, Thorax-  und Gefäßchirurgie, Universitätsmedizin  Greifswald, Ferdinand Sauerbruch Straße,  Greifswald 17475, Germany   T el +49 3834 86 6096   Email katharinacziupka@googlemail.co mBackground:  Apart from inducing apoptosis in tumor cells, tumor necrosis factor (TNF)- related apoptosis-inducing ligand (TRAIL) influences inflammatory reactions.",Non-OADS,/arxiv_data1/oa_pdf/eb/cd/jir-9-103.PMC4914030.pdf
"Journal of Inflammation Research Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/journal-of-inflammation-research-journa lThe Journal of Inflammation Research is an international, peer-reviewed  open-access journal that welcomes laboratory and clinical findings on the  molecular basis, cell biology and pharmacology of inflammation including  original research, reviews, symposium reports, hypothesis formation and  commentaries on: acute/chronic inflammation; mediators of inflamma -tion; cellular processes; molecular mechanisms; pharmacology and novel  anti-inflammatory drugs; clinical conditions involving inflammation.",Non-OADS,/arxiv_data1/oa_pdf/eb/cd/jir-9-103.PMC4914030.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/eb/cd/jir-9-103.PMC4914030.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/3d/1e/opth-10-1117.PMC4914034.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Ophthalmology 2016:10 1117–1122Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  1117Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S10673 4 Macular morphology and response to ranibizumab  treatment in patients with wet age-related  macular degeneration nikolaos Dervenis saad Y ounis Western eye hospital, imperial  College healthcare nhs Trust,   london, UKPurpose:  The purpose of this study was to assess whether specific characteristics of spectral  domain optical coherence tomography (SD-OCT) affect structural and functional outcomes and  number of injections needed in ranibizumab (0.05 mL of 10 mg/mL Lucentis solution)-treated  wet age-related macular degeneration (AMD) patients.",Non-OADS,/arxiv_data1/oa_pdf/3d/1e/opth-10-1117.PMC4914034.pdf
"It was proposed .20 years  ago by the Macular Photocoagulation Study Group that defined choroidal neovascular  membrane (CNVM) types based on their location and pattern of hyperfluorescence  (classic, occult, extra-, juxta-, subfoveal).3 This CNVM classification was useful in the Correspondence: nikolaos Dervenis Western eye hospital, imperial College  healthcare nhs Trust, 153-173  Marylebone road, london nW1  5Qh, UK Tel +44 20 3312 6666 email nikosdervenis@gmail.co mJournal name: Clinical Ophthalmology Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Dervenis and Y ounis Running head recto: Macular morphology and response to ranibizumab treatment DOI: http://dx.doi.org/10.2147/OPTH.S106734",Non-OADS,/arxiv_data1/oa_pdf/3d/1e/opth-10-1117.PMC4914034.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/3d/1e/opth-10-1117.PMC4914034.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/3d/1e/opth-10-1117.PMC4914034.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/4f/35/ott-9-3545.PMC4914054.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 3545–3554OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  3545Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S10045 5intensity-modulated radiotherapy for gliomas:  dosimetric effects of changes in gross tumor  volume on organs at risk and healthy brain tissue Zhen Yang1 Zijian Zhang1 Xia Wang1 Y ongmei hu1 Zhiping lyu1 lei huo2 rui Wei1 Jun Fu1 Jidong hong1 1Department of Oncology,   2Department of n eurosurgery,   The institute of skull Base surgery  and neurooncology at hunan,   central south University, Xiangya  hospital, changsha, hunan, People’s  republic of chinaAim:  The aim of this study was to explore the effects of changes in the gross tumor volume  (GTV) on dose distribution in organs at risk (OARs) and healthy brain tissue in patients with  gliomas.",Non-OADS,/arxiv_data1/oa_pdf/4f/35/ott-9-3545.PMC4914054.pdf
"Glioblastoma accounts for the majority of gliomas, while astrocytoma and glioblas - toma combined account for about three-fourths of all gliomas as defined by CBTRUS.1  Radiotherapy (RT) is one of the adjuvant modalities involved in the multimodal treatment  of gliomas.2 Five previous clinical trials have demonstrated a statistically significant survival  benefit from postoperative RT as compared with the supportive care or the administration  of different chemotherapy schedules without RT.3 Postoperative RT and concurrent and  adjuvant chemotherapy with temozolomide remain the standard treatment for patients  with glioblastoma.4 In the treatment of high-grade gliomas, intensity-modulated RT  (IMRT) improves the radiation dose coverage and allows for dose escalation to target  volumes while sparing normal structures.5,6 Previous research has indicated that the gross correspondence: Jidong hong Department of radiation Oncology,  central south University, Xiangya  hospital, no 87, Xiangya road,  changsha, hunan 410008,  People’s republic of china Tel +86 731 8975 3733 Fax +86 731 8975 3336 email hongjidong1966@126.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2016 Volume: 9 Running head verso: Y ang et al Running head recto: Intensity-modulated radiotherapy for gliomas DOI: http://dx.doi.org/10.2147/OTT.S100455",Non-OADS,/arxiv_data1/oa_pdf/4f/35/ott-9-3545.PMC4914054.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/4f/35/ott-9-3545.PMC4914054.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/4f/35/ott-9-3545.PMC4914054.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/06/26/copd-11-1327.PMC4914068.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of COPD 2016:11 1327–1333International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  1327OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/COPD.S10558 3 Factors associated with exacerbation in mild-   to-moderate COPD patients Joo Kyung Kim1 soo haeng lee1 Bho hyeon lee1 Chang Y oul lee2 Do Jin Kim3 Kyung hoon Min4 sung Kyoung Kim5 Kwang ha Y oo6 Ki-suck Jung1 Y ong Il hwang1 1Division of Pulmonary, allergy and  Critical Care Medicine, Department of  Internal Medicine, hallym University  sacred heart hospital, anyang, 2Division  of Pulmonary, allergy and Critical  Care Medicine, Department of Internal  Medicine, Chuncheon sacred heart  hospital, hallym University, 3Division  of Pulmonary, allergy and Critical  Care Medicine, Department of Internal  Medicine, soonchunhyang University  Bucheon hospital, Bucheon, 4Division  of Pulmonary, allergy and Critical  Care Medicine, Department of Internal  Medicine, Korea University guro  hospital, seoul, 5Division of Pulmonary,  allergy and Critical Care Medicine,  Department of Internal Medicine,  st Vincent’s hospital, The Catholic  University of Korea, suwon, 6Division  of Pulmonary, allergy and Critical  Care Medicine, Department of Internal  Medicine, Konkuk University Medical  Center, seoul, republic of KoreaIntroduction:  COPD exacerbation negatively impacts the patient’s quality of life and lung  function, increases mortality, and increases socioeconomic costs.",Non-OADS,/arxiv_data1/oa_pdf/06/26/copd-11-1327.PMC4914068.pdf
"Keywords:  COPD, exacerbation, risk factors Introduction Patients with COPD may experience acute exacerbations, which are defined as events  characterized by a worsening of respiratory symptoms that is beyond normal day-to-day  variations, necessitating a change in medications.1 COPD exacerbation is important  because frequent acute exacerbations have a negative effect on the quality of life of  patients2 and are one of the most common causes of hospitalization and mortality.3  Moreover, the frequency of exacerbations contributes to a long-term decline in lung  function.4 From economic perspectives, acute exacerbation results in an increase in  the economic and social burden.5 Regardless of the degree of airflow limitation, the  known precipitating factors for acute exacerbation include viral or bacterial infection, Correspondence: Yong Il hwang Division of Pulmonary, allergy and  Critical Care Medicine, Department of  Internal Medicine, hallym University  sacred heart hospital, 896 Pyeongan- dong, Dongan-gu, anyang-si, gyeonggi-do  431-070, republic of Korea Tel +82 31 380 3715 Fax +82 31 380 3973 email hyicyk@hallym.or.k r Journal name: International Journal of COPD Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Kim et al Running head recto: Exacerbation in mild-to-moderate COPD DOI: http://dx.doi.org/10.2147/COPD.S105583",Non-OADS,/arxiv_data1/oa_pdf/06/26/copd-11-1327.PMC4914068.pdf
"Available from: http://www.lungkorea.org/ thesis/guide.ph p. Accessed February 5, 2014.",Non-OADS,/arxiv_data1/oa_pdf/06/26/copd-11-1327.PMC4914068.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/06/26/copd-11-1327.PMC4914068.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/06/26/copd-11-1327.PMC4914068.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/66/3f/ijn-11-2829.PMC4914069.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2016:11 2829–2838International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  2829OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S10418 7 Development of self-nanoemulsifying drug  delivery systems for the enhancement of solubility  and oral bioavailability of fenofibrate, a poorly  water-soluble drug Kazi Mohsin1 rayan alamri1 ajaz ahmad2 Mohammad raish3 Fars K alanazi1 Muhammad Delwar  hussain4 1Kayyali chair for Pharmaceutical  Industry, Department of  Pharmaceutics, 2Department of  Clinical Pharmacy, 3Department  of Pharmaceutics, College of  Pharmacy, King Saud University,   Riyadh, Saudi Arabia; 4Department  of Pharmaceutical and Biomedical  Sciences, College of Pharmacy,   California Health Science University,   Clovis, CA, USABackground:  Self-nanoemulsifying drug delivery systems (SNEDDS) have become a popular  formulation option as nanocarriers for poorly water-soluble drugs.",Non-OADS,/arxiv_data1/oa_pdf/66/3f/ijn-11-2829.PMC4914069.pdf
"In recent years, two-thirds of all the new  chemical entities identified in drug discovery programs have been emerging as poorly correspondence: Kazi Mohsin Department of Pharmaceutics, College  of Pharmacy, King Saud University,  PO Box 2457, Riyadh 11451, Saudi Arabia Tel +966 11 467 7372 Fax +966 11 467 6295 email mkazi@ksu.edu.s a  Muhammad Delwar hussain Department of Pharmaceutical and  Biomedical Sciences, College of  Pharmacy, California Health Science  University, Clovis, CA 93612, USA Tel +1 559 369 2715 Fax +1 559 473 1487 email dhussain@chsu.or g Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Mohsin et al Running head recto: Improving bioavailability by self-nanoemulsifying drug delivery systems DOI: http://dx.doi.org/10.2147/IJN.S104187",Non-OADS,/arxiv_data1/oa_pdf/66/3f/ijn-11-2829.PMC4914069.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/66/3f/ijn-11-2829.PMC4914069.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/66/3f/ijn-11-2829.PMC4914069.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/51/ad/ijn-11-2855.PMC4914070.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2016:11 2855–2865International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  2855OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S10835 5 Transformation of eutectic emulsion to  nanosuspension fabricating with solvent  evaporation and ultrasonication technique Thawatchai Phaechamud1 sarun T untarawongsa2 1Department of Pharmaceutical  T echnology, 2Pharmaceutical  Intelligence Unit Prachote  Plengwittaya, Faculty of Pharmacy,   silpakorn University, Nakhon  Pathom, ThailandAbstract:  Eutectic solvent can solubilize high amount of some therapeutic compounds.",Non-OADS,/arxiv_data1/oa_pdf/51/ad/ijn-11-2855.PMC4914070.pdf
"For example, celecoxib dissolved in ethyl  acetate or ibuprofen dissolved in ethanol as the internal phase was transformed into  nanosuspensions with emulsion diffusion method with particle sizes of 140–700 nm  and 18.7–161 nm, respectively.6,7correspondence: Thawatchai Phaechamud Department of Pharmaceutical T echnology,   Faculty of Pharmacy, silpakorn  University, rachamakka Nai rd, Nakhon  Pathom 73000, Thailand Tel +66 90 987 7225 Fax +66 34 255 801 email thawatchaienator@gmail.co m Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Phaechamud and Tuntarawongsa Running head recto: Transformation of eutectic emulsion to nanosuspension DOI: http://dx.doi.org/10.2147/IJN.S108355",Non-OADS,/arxiv_data1/oa_pdf/51/ad/ijn-11-2855.PMC4914070.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/51/ad/ijn-11-2855.PMC4914070.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/51/ad/ijn-11-2855.PMC4914070.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/3b/aa/copd-11-1317.PMC4914071.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of COPD 2016:11 1317–1326International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  1317OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/COPD.S10520 6Prevalence of and risk factors for postoperative  pulmonary complications after lung cancer  surgery in patients with early-stage COPD eun sun Kim1 Y oung Tae Kim2 Chang hyun Kang2 In Kyu Park2 Won Bae1 sun Mi Choi1 Jinwoo lee1 Y oung sik Park1 Chang-hoon lee1 sang-Min lee1 Jae-Joon Yim1 Y oung Whan Kim1 sung Koo han1 Chul-gyu Y oo1 1Division of Pulmonary and Critical  Care Medicine, Department of  Internal Medicine, 2Department of  Thoracic and Cardiovascular surgery,   seoul national University College of  Medicine, seoul, republic of KoreaPurpose:  This study aimed to investigate whether the prevalence of postoperative pulmonary  complications (PPCs) in patients with non-small-cell lung cancer (NSCLC) is even higher in  the early stages of COPD than in such patients with normal lung function and to verify the  usefulness of symptom- or quality of life (QoL)-based scores in predicting risk for PPCs.",Non-OADS,/arxiv_data1/oa_pdf/3b/aa/copd-11-1317.PMC4914071.pdf
"Other major significant clinical and economic impacts of  PPCs include a prolonged hospital stay and the need for admission to the intensive  care unit.7–9 Many previous studies8,10–22 have suggested that the patient’s health status,  age, sex, body mass index (BMI), history of smoking, chronic pulmonary disease, and Correspondence: Chul-gyu Yoo Division of Pulmonary and Critical  Care Medicine, Department of Internal  Medicine, seoul national University  College of Medicine, 101, Daehak-ro,  Jongno-gu, seoul 03080, republic  of Korea Tel +82 2 2072 3760 Fax +82 2 2072 0630 email cgyoo@snu.ac.k r Journal name: International Journal of COPD Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Kim et al Running head recto: Postop pulmonary complications in patients with early-stage COPD DOI: http://dx.doi.org/10.2147/COPD.S105206",Non-OADS,/arxiv_data1/oa_pdf/3b/aa/copd-11-1317.PMC4914071.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/3b/aa/copd-11-1317.PMC4914071.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/3b/aa/copd-11-1317.PMC4914071.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/6b/dd/copd-11-1307.PMC4914072.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of COPD 2016:11 1307–1316International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  1307OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/COPD.S10687 5 Changes in respiratory function impairment  following the treatment of severe pulmonary  tuberculosis – limitations for the underlying  COPD detection Milan radovic1,2 lidija ristic1,2 Zorica Ciric1,2 Violeta Dinic-radovic3 Ivana stankovic1,2 Tatjana Pejcic1,2 Milan rancic1,2 Dragan Bogdanovic4 1Department of Internal Medicine,   Faculty of Medicine, University of nis,   2Clinic for lung Diseases, 3Clinic for  gastroenterology and hepatology,   Clinical Centre of nis, 4Public health  Institute nis, nis, republic of serbiaBackground:  During the treatment phase of active pulmonary tuberculosis (PTB), respiratory  function impairment is usually restrictive.",Non-OADS,/arxiv_data1/oa_pdf/6b/dd/copd-11-1307.PMC4914072.pdf
"Keywords:  tuberculosis, pulmonary, respiratory function tests, lung diseases, obstructive Introduction Severe (extensive) forms of active pulmonary tuberculosis (PTB), with its long-term  evolution in cases of bronchogenic forms of the disease, contribute to serious destruc - tion of lung parenchyma, including permanent scarring, bronchiectasis, and fibrosis,   leading to significant respiratory function impairment.1,2 It is estimated that COPD Correspondence: Milan radovic Department of Internal Medicine, Faculty  of Medicine, University of nis, Boulevard  Dr Zorana Djindjica 81, 18000 nis,  republic of serbia Tel/fax +381 1865 2035 email milanradovic@ptt.r s Journal name: International Journal of COPD Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Radovic et al Running head recto: Limitations for underlying COPD detection in pulmonary tuberculosis DOI: http://dx.doi.org/10.2147/COPD.S106875",Non-OADS,/arxiv_data1/oa_pdf/6b/dd/copd-11-1307.PMC4914072.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/6b/dd/copd-11-1307.PMC4914072.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/6b/dd/copd-11-1307.PMC4914072.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/df/2a/dddt-10-1973.PMC4914073.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Drug Design, Development and Therapy 2016:10 1973–1986Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1973Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S10399 3 Prophylactic effects of Clausena excavata  Burum.",Non-OADS,/arxiv_data1/oa_pdf/df/2a/dddt-10-1973.PMC4914073.pdf
"Hence, there is a great need to develop more efficacious drugs for the treatment of  the disease.3correspondence: rasedee abdullah Department of Veterinary laboratory  Diagnosis, Faculty of Veterinary Medicine,  Universiti Putra Malaysia, Persiaran Mardi,  43400 serdang, selangor, Malaysia email rasedee@gmail.co m  noorlidah abdullah Faculty of science, institute of Biological  sciences, Faculty of science, University  of Malaya, 50603, WP Kuala lumpur,  Malaysia email noorlidah@um.edu.m y Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Albaayit et al Running head recto: C. excavata  leaf extract in ethanol-induced gastric ulcer DOI: http://dx.doi.org/10.2147/DDDT.S103993",Non-OADS,/arxiv_data1/oa_pdf/df/2a/dddt-10-1973.PMC4914073.pdf
"evaluation of immunopositive gastric tissue sections Brown-colored cells, signifying positive staining, were selected  and estimated as a proportion of the total focal slide area using  the ImageJ software (National Institutes of Health, Bethesda,  MD, USA) ( http://imagej.nih.gov/ij /).",OADS,/arxiv_data1/oa_pdf/df/2a/dddt-10-1973.PMC4914073.pdf
"Briefly, tissue homogenate was centrifuged at 3,000 × g  for 10 minutes and the supernatant was used for the detec - tion of cytokine levels using commercial enzyme-linked  immunosorbent assay kits for TNF- α (http://www.cusabio.",Non-OADS,/arxiv_data1/oa_pdf/df/2a/dddt-10-1973.PMC4914073.pdf
"html), IL-6 ( http://www.cusabio.com/ELISA-Kit/Rat- Interleukin-6IL-6- ELISA -KIT-84597.htm l), and IL-10  (http://www.cusabio.com/ELISA-Kit/Rat-Interleukin- 10IL-10-ELISA-KIT-84236.htm l) (Cusabio Biotech Co.  Ltd, Cusabio Biotech Co Ltd, Hubei, People’s Republic  of China).",Non-OADS,/arxiv_data1/oa_pdf/df/2a/dddt-10-1973.PMC4914073.pdf
"Available from: http://www.grants.nih.gov/grants/olaw/ guide-for-the-care-and-use-of-laboratory-animals.pd f. Accessed on  January 24, 2016.",Non-OADS,/arxiv_data1/oa_pdf/df/2a/dddt-10-1973.PMC4914073.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/df/2a/dddt-10-1973.PMC4914073.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/df/2a/dddt-10-1973.PMC4914073.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/3d/53/copd-11-1297.PMC4914074.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of COPD 2016:11 1297–1306International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  1297RevIewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/COPD.S10730 7 The asthma–COPD overlap syndrome: do we  really need another syndrome in the already  complex matrix of airway disease?",Non-OADS,/arxiv_data1/oa_pdf/3d/53/copd-11-1297.PMC4914074.pdf
DOI: http://dx.doi.org/10.2147/COPD.S107307,Non-OADS,/arxiv_data1/oa_pdf/3d/53/copd-11-1297.PMC4914074.pdf
Available from: http://goldcopd.org/asthma-copd-asthma-copd- overlap-syndrome/.,Non-OADS,/arxiv_data1/oa_pdf/3d/53/copd-11-1297.PMC4914074.pdf
Available from: http://ginasthma.org/2016-gina-report-global-strategy- for-asthma-management-and-prevention/.,Non-OADS,/arxiv_data1/oa_pdf/3d/53/copd-11-1297.PMC4914074.pdf
Available from: http://goldcopd.org/global-strategy- diagnosis-management-prevention-copd-2016/.,Non-OADS,/arxiv_data1/oa_pdf/3d/53/copd-11-1297.PMC4914074.pdf
Available from: http://www.nhlbi.nih.gov/guidelines/asthma/asthgdln  htm.,Non-OADS,/arxiv_data1/oa_pdf/3d/53/copd-11-1297.PMC4914074.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/3d/53/copd-11-1297.PMC4914074.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/3d/53/copd-11-1297.PMC4914074.pdf
Available from:  http://www.nationalasthma.org.au/handbook.,Non-OADS,/arxiv_data1/oa_pdf/3d/53/copd-11-1297.PMC4914074.pdf
Available from: http://www.jrs.or.jp/uploads/ uploads/files/photos/765.pdf201 0 54.,Non-OADS,/arxiv_data1/oa_pdf/3d/53/copd-11-1297.PMC4914074.pdf
"Cac1C consisted of four helices, two antiparallel strands and a long wing loop (w1), arranged in the or-derof /H92511-/H92512-/H92513-/H92521-w1- /H92522-/H92514(Figur e 1A).Wedetermined t h r o u g hD a l is e a r c h( http://ekhidna.biocenter.helsinki.fi/ dali server)thatCac1Csharedhighlystructuralsimilarities withsomeWHD-containingproteins,suchashumanATP- dependentDNAhelicaseRECQ1( 41)(Figur e 1B),human transcriptionalactivatorregulatoryfactorRFX1( 42)(Fig- ure1C), E2F transcription factor 4 (E2F4) ( 43) (Supple- mentaryFigureS1A)andhumanRecQhelicaseWRN( 44) (SupplementaryFigureS1B).However,somestructuraldif-ferences were detected between Cac1C and typical WHDs.",OADS,/arxiv_data1/oa_pdf/75/70/gkw106.PMC4914081.pdf
Using HHpred ( http://toolkit.tuebingen.,Non-OADS,/arxiv_data1/oa_pdf/75/70/gkw106.PMC4914081.pdf
"Data mining To remove low quality reads and adaptor sequences (AGATCGGAAGAGCACACGTCTGAACTCCAGT- CAC), the FASTX tool kit ( http://hannonlab.cshl.edu/ fastx toolkit/index.html ) was used as follows: Remove low quality reads (phred score <20); remove 3/prime-end multiplex adapter tag sequence; remove the reads shorter than20 nt; remove low quality reads again.",Non-OADS,/arxiv_data1/oa_pdf/7f/d4/gkw113.PMC4914083.pdf
"In this analysis, randomly selected lncRNA and mRNA pairs were generated using the publicly avail- able program ( https://cell-innovation.nig.ac.jp/wiki/tiki- download wikiattachment.php?attId=5&download=y ).",OADS,/arxiv_data1/oa_pdf/7f/d4/gkw113.PMC4914083.pdf
no GSM530185) ( 32) was converted to the cor- respondingdatasetintheratRn5genomeusingtheUCSC LiftOver tool ( http://hgdownload.cse.ucsc.edu/admin/exe ).,OADS,/arxiv_data1/oa_pdf/7f/d4/gkw113.PMC4914083.pdf
http://www.chemaxon.com .,Non-OADS,/arxiv_data1/oa_pdf/d6/06/gkw114.PMC4914084.pdf
IMR90 methylome data were from http://neomorph.salk.,OADS,/arxiv_data1/oa_pdf/e7/c3/gkw124.PMC4914085.pdf
Peaks were identified (MACS1.4)andanalyzedwithcustomRscripts( 28)avail- ableathttps://github.com/micahgearhart/dux4 .DNase-Seq dataforLHCN-M2cellswasobtainedfromtheENCODE project accession ENCFF001BVR.,OADS,/arxiv_data1/oa_pdf/ba/98/gkw141.PMC4914088.pdf
Paired-end reads were mapped to GRCh37 genome (Star 2.4) and uniquely mapped reads were assigned to genesusingtheEnsemblversion75annotation.DifferentialexpressionwasdeterminedwithDESeq2( 29)usingcustom R scripts available at https://github.com/micahgearhart/ dux4.,OADS,/arxiv_data1/oa_pdf/ba/98/gkw141.PMC4914088.pdf
"The ChIP-seq data are availableatDDBJ( http://www.ddbj.nig.ac.jp )underacces- sion numbers DRA004142 (Atf1 replicate 1), DRA004446 (Atf1replicate2), and DRA003541 (H3and H3K9ac).",OADS,/arxiv_data1/oa_pdf/49/af/gkw142.PMC4914089.pdf
"Band analysis was performed by ImageJsoftware(availableat http://imagej.nih.gov/ij/ ).The percentage of incorporated dNMP was plotted as a func- tionoftheaddeddNTPs.DatawerefittedbyKaleidagraph software(Kaleidagraph,SynergyCorp.,USA).Kineticspa-rameters were evaluated according to ref.",OADS,/arxiv_data1/oa_pdf/b1/eb/gkw170.PMC4914090.pdf
These comparative gene annotations are available as a re-source ( http://bds.mpi-cbg.de/hillerlab/CESAR/ ).,OADS,/arxiv_data1/oa_pdf/ee/02/gkw210.PMC4914097.pdf
CE- SAR ( https://github.com/hillerlab/CESAR/ ) can read- ily be applied to other alignments to accurately an-notate coding genes in many other vertebrate and invertebrate genomes.,Non-OADS,/arxiv_data1/oa_pdf/ee/02/gkw210.PMC4914097.pdf
These comparative gene annotations in99non-humanvertebratesareanimportantresourcethatis available at http://bds.mpi-cbg.de/hillerlab/CESAR/ .,OADS,/arxiv_data1/oa_pdf/ee/02/gkw210.PMC4914097.pdf
"Since the simu- lated data sets from ( 49) lack alignments with splice site shifts and real frameshifts, we created simulated data setsusing Evolver ( http://www.drive5.com/evolver/ ), a method previously used to compare genome alignment methods (50).",OADS,/arxiv_data1/oa_pdf/ee/02/gkw210.PMC4914097.pdf
"All data sets, including the cDNA, thesurroundinggenomicsequenceandthetruealignments are available at http://bds.mpi-cbg.de/hillerlab/CESAR/ .",OADS,/arxiv_data1/oa_pdf/ee/02/gkw210.PMC4914097.pdf
"The coordinates of the intact exons and anno-tated genes (genePred format) for the 99 species and the 100-way realignment (maf format, 7.9 GB) are available at http://bds.mpi-cbg.de/hillerlab/CESAR/ for download and visualization as atrack hub in theUCSC genome browser.",OADS,/arxiv_data1/oa_pdf/ee/02/gkw210.PMC4914097.pdf
AVAILABILITY CESAR’s source code is available at https://github.com/ hillerlab/CESAR/ .,Non-OADS,/arxiv_data1/oa_pdf/ee/02/gkw210.PMC4914097.pdf
aRNhAck is freely available at http://csb.cs.mcgill.ca/arnhack .,Non-OADS,/arxiv_data1/oa_pdf/9c/1d/gkw217.PMC4914100.pdf
The TAD were downloaded fromHi-C project database ( http://yuelab.org/hi-c/ ).,OADS,/arxiv_data1/oa_pdf/c9/ef/gkw225.PMC4914103.pdf
"AVAILABILITY The CITD software, the predicted chromatin interactions, topological domains and their states on 100 cell types withdifferent resolutions can be freely downloaded from lab website (https://cb.utdallas.edu/CITD/index.htm ).",OADS,/arxiv_data1/oa_pdf/c9/ef/gkw225.PMC4914103.pdf
We have made the source code available at the github reposi- tory http://github.com/uci-cbcl/DanQ .,Non-OADS,/arxiv_data1/oa_pdf/91/21/gkw226.PMC4914104.pdf
"The first model we trained contains 320 convolution kernels with random ini- tial weights, referred to as DanQ, took 60 epochs to fullytrain and each epoch of training takes ∼6 h. The second model we trained, which we designated as DanQ-JASPAR because half of the kernels are initialized with motifs fromthe JASPAR database ( 20), contains 1024 convolution ker- nels,took30epochstofullytrain,andeachepochoftrain- ingtakes ∼12 h. Our implementation utilizes the Keras 0.2.0 library (https://github.com/fchollet/keras ) with the Theano 0.7.1 (21,22) backend.",Non-OADS,/arxiv_data1/oa_pdf/91/21/gkw226.PMC4914104.pdf
"We trained two boosted ensemble classifier models, one for the GRASP set and one for the GWAS set, using the XGBoost implementation ( https://github.com/tqchen/ xgboost).Foradetailedspecificationsofthehyperparame- ters, see Supplementary Note.",Non-OADS,/arxiv_data1/oa_pdf/91/21/gkw226.PMC4914104.pdf
AVAILABILITY VarDict is implemented in Perl and is publicly available in GitHub ( https://github.com/AstraZeneca-NGS/VarDict ).,OADS,/arxiv_data1/oa_pdf/4b/5a/gkw227.PMC4914105.pdf
"A Java re-implementation of VarDict with improvedperformance is also publicly available in GitHub (https://github.com/AstraZeneca-NGS/VarDictJava ), butcurrentlywithouttheSVcalling capability.",OADS,/arxiv_data1/oa_pdf/4b/5a/gkw227.PMC4914105.pdf
Pathway analysis was performed using the DAVID Bioinformatics Resource (https://david.ncifcrf.gov ) as previouslydescribed ( 31).,OADS,/arxiv_data1/oa_pdf/00/70/gkw350.PMC4914116.pdf
The data collected inthisstudyispubliclyaccessiblevia http://www.bioinf.uni- leipzig.de/publications/supplements/15-065 .,OADS,/arxiv_data1/oa_pdf/30/23/gkw386.PMC4914119.pdf
We retrieved the BAM files containing the genomic loci of the reads from 114 sRNA-seq data sets (read length of 101 nt) from theUCSCENCODEanalysishub( http://genome.ucsc.edu/ ENCODE ).,OADS,/arxiv_data1/oa_pdf/30/23/gkw386.PMC4914119.pdf
"ListofpredictedinteractionsbetweennucleotideswhosemodificationhasbeenconfirmedexperimentallyandthecorrespondingguidesnoRNAs Modified nucleotideCurrentlyassigned guideSupport by HTP NewlypredictedguideLocationof ASE ICIConservationlevelofthe snoRNA 18S-683 SNORD19 - SNORD136 D’ 1.22 Eutherians18S-1326 SNORD33 + snoID 0337 D’ 1.84 Primates 18S-1410 NA + snoID 0340 D 1.33 Primates 18S-1606 NA + SNORD73A /B D’ 1.17 TetrapodesandTeleostes 18S-681 unknown + SNORA14A /B5/primestem 0.84 Amniotes 18S-681 unknown + SNORA55 3/primestem 1.2 Tetrapodes 28S-4266 unknown - SNORA78 5/primestem 0.92 TetrapodesandTeleostes 18S-1046 NA + SNORA57 3/primestem 0.9 Deuterostomes 18S-1232 NA + SNORA70A /B/E/11/14 5/primestem 1.18 Vertebrates 28S-2619 NA + SNORA38A /B5/prime-stem 0.84 Therians The modification data originated either from snoRNAbase ( https://www-snorna.biotoul.fr/ ), in which case guide snoRNAs were sometimes already as- signed, or from the high-throughput (HTP) approaches, in which case the guiding snoRNAs were not known so far.",Non-OADS,/arxiv_data1/oa_pdf/30/23/gkw386.PMC4914119.pdf
"snoRNA- LBME-db( https://www-snorna.biotoul.fr/ )isanoutstand- ing resource in this domain ( 41), providing detailed infor- mation to more than 361 snoRNA genes and their tar- get RNAs.",OADS,/arxiv_data1/oa_pdf/30/23/gkw386.PMC4914119.pdf
The collision en- ergy for each targeted peptide was predicted by Skyline software ( https://brendanx-uw1.gs.washington.edu/labkey/ project/home/software/Skyline/begin.view )(37).,OADS,/arxiv_data1/oa_pdf/49/99/gkw391.PMC4914120.pdf
Logo maps were generated us-ingtheweb-basedBerkeleyWebLogoapplication( http://weblogo.berkeley.,OADS,/arxiv_data1/oa_pdf/49/99/gkw391.PMC4914120.pdf
"SATIVA is freely available at https://github.com/amkozlov/sativa .INTRODUCTION Taxonomy is the science of classifying and naming groups of organisms, usually based on shared characteristics and/or presumed natural relatedness.",OADS,/arxiv_data1/oa_pdf/d9/04/gkw396.PMC4914121.pdf
"MATERIALS AND METHODS SATIV A pipeline for taxonomy curation We implemented our taxonomic curation method in a pipeline called SATIVA ( Semi-Automatic Taxonomy Improvementand Validation Algorithm,seeFigure 1).Itis open-source and freely available under https://github.com/ amkozlov/sativa .",OADS,/arxiv_data1/oa_pdf/d9/04/gkw396.PMC4914121.pdf
FurtherdetailsonsimulationareavailableintheSupple- mentaryMaterial.Scriptsanddatafilescanbedownloadedfromhttps://github.com/amkozlov/mislabels16-data .,Non-OADS,/arxiv_data1/oa_pdf/d9/04/gkw396.PMC4914121.pdf
"The following primary an- tibodies were used according to the manufacturer’s rec-ommendations: anti-DGCR8 (1:300, 10 996-1-AP; Pro- teinTech Group, Chicago IL, USA - http://www.ptglab.",Non-OADS,/arxiv_data1/oa_pdf/88/04/gkw400.PMC4914122.pdf
This PCR product was then Gibson As-sembled into SacII cut pRS416gT (with a specific guide se- quence cloned into the gRNA locus as above) adjacent to the GPM1 terminator and transformed into DH5 /H9251.T h e plasmiddesignforthe20ntcomplementarity unc-22Aplas- midisavailableat https://benchling.com/s/O5VobNjd oras Supplementary Figure S1a.,Non-OADS,/arxiv_data1/oa_pdf/1d/ab/gkw417.PMC4914125.pdf
"Pathway-Express (16), SPIA ( 8),Pathway-Guide (Advaita Bioinformatics, http://www.advaitabio.com ),TopoGSA (17)a n dBayesian Pathway Analysis (BPA) (18) are some of topology-based pathway analysis approaches.",OADS,/arxiv_data1/oa_pdf/62/68/gkw429.PMC4914126.pdf
All the pro-grams described here are available through our website (http://cmgm.stanford.edu/biology/long/files/ichida2016/ LDSS-P dist.zip).,Non-OADS,/arxiv_data1/oa_pdf/b1/44/gkw435.PMC4914127.pdf
"The data were stored in stan- dard tab-delimited GFF3 format, and are freely available from our website ( http://cmgm.stanford.edu/biology/long/ files/ichida2016/ ).",OADS,/arxiv_data1/oa_pdf/b1/44/gkw435.PMC4914127.pdf
"Of these, we tested Sailfish 0.7.6 ( 17), Salmon 0.5.0 (unpub- lished; manuscript: Patro, Duggal, and Kingsford, bioRxiv 2015, doi:10.1101 /021592), and Kallisto 0.42.3 (unpub- lished but available at http://pachterlab.github.io/kallisto ).",Non-OADS,/arxiv_data1/oa_pdf/2c/df/gkw448.PMC4914128.pdf
"Fourthandlastaremethodsperformingdifferentialexpres- sionanalysisonthebasisofpreviouslyestablishedquantifi-cations.WetestedDESeq21.10( 30,31),limma /voom3.22.7 (32,33), edgeR 3.8.6 ( 34), sleuth 0.28.0 (unpublished but availableat http://pachterlab.github.io/sleuth/ )andCuffdiff 2.2.1(22).ThesoftwaredetailsarelistedinSupplementary Table S1, while the different pipelines and parameters used arelistedalongwiththeresultsinSupplementaryTableS2.",OADS,/arxiv_data1/oa_pdf/2c/df/gkw448.PMC4914128.pdf
http://creativecommons.org/ licenses/by-nc-nd/3.0.,Non-OADS,/arxiv_data1/oa_pdf/ea/74/txd-1-e44.PMC4914138.pdf
"Next, we identified 117 differentially expressedmicroRNAs between ACR versus control lung transplantpatients after adjustment for multiple comparisons using a false discovery rate less than 0.05 (Figure 1B; Table S1, SDC, http://links.lww.com/TXD/A16).",Non-OADS,/arxiv_data1/oa_pdf/ea/74/txd-1-e44.PMC4914138.pdf
"This subset of 40 ACR-associated microRNAs influenced the expression of 253 genes based on previously published experimental results (Figure 2; Table S2, SDC, http://links.lww.com/TXD/A16).",OADS,/arxiv_data1/oa_pdf/ea/74/txd-1-e44.PMC4914138.pdf
"We identified a large number of overrepresented processes and pathways, many of which mapped to cellular proliferation, differentiation, migration as well as apoptosis, cancer, and developmental programs (Figure 3B; comprehensive list in Table S3, SDC, http://links.lww.com/TXD/A16).",OADS,/arxiv_data1/oa_pdf/ea/74/txd-1-e44.PMC4914138.pdf
"E-mail: joungkim@postech.ac.kr http://dx.doi.org/10.5483/BMBRep.2016.49.1.258Received 14 December 2015Keywords: Amygdala, D4R, Fear conditioning, LTD, PTSD Abbreviations:  ITC, intercalated cell mass; D4R, dopamine receptor  subtype 4; DA, dopamine; LTD, long-term depression; PTSD, post- traumatic stress disorder; STDP , spike-timing dependent plasticity Perspective to:  Kwon et al.",Non-OADS,/arxiv_data1/oa_pdf/0d/20/BMB-49-1.PMC4914206.pdf
Dopamine-dependent synaptic plasticity in an amygdala inhibitory circuit controls fear memory expression Joo Han Lee and Joung-Hun Kim 2BMB Reports http://bmbreports.org Fig.,Non-OADS,/arxiv_data1/oa_pdf/0d/20/BMB-49-1.PMC4914206.pdf
"http://dx.doi.org/10.5483/BMBRep.2016.49.1.242Received 25 October 2015Keywords: IEL, Lineage commitment, ThPOK, Runx3, T-bet ISSN: 1976-670X (electronic edition) Copyright ⓒ 2016 by the The Korean Society for Biochemistry and Molecular Biology This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://c reativecommons.org/li- censes/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the ori ginal work is properly cited.Lineage re-commitment of CD4CD8  intraepithelial  lymphocytes in the gut Yunji Park1,#,*, Sook-Jin Moon1,# & Seung-Woo Lee1,2,* 1Division of Integrative Biosciences and Biotechnology, 2Department of Life Sciences, Pohang University of Science and Technology,  Pohang 37673, Korea The gastrointestinal tract forms the largest surface in our body  with constantly being exposed to various antigens, which provides unique microenvironment for the immune system in  the intestine.",Non-OADS,/arxiv_data1/oa_pdf/d0/7a/BMB-49-11.PMC4914207.pdf
12 BMB Reports http://bmbreports.org Fig.,Non-OADS,/arxiv_data1/oa_pdf/d0/7a/BMB-49-11.PMC4914207.pdf
"13 http://bmbreports.org BMB Reportspression (3), they are not self-destructive, and instead they  have been shown to mediate immune regulation by expressing several regulatory molecules including interleukin-10 (IL-10),  TGF- and lymphocyte activation gene 3 (LAG 3) (28, 29).",Non-OADS,/arxiv_data1/oa_pdf/d0/7a/BMB-49-11.PMC4914207.pdf
14 BMB Reports http://bmbreports.org Fig.,Non-OADS,/arxiv_data1/oa_pdf/d0/7a/BMB-49-11.PMC4914207.pdf
"15 http://bmbreports.org BMB Reportsdicates that DP IELs are “activated yet resting” like other IEL  subsets, which is confirmed by increased uptake of thymidine analog BrdU and week signals of cell-cycle marker Ki67 (5).",OADS,/arxiv_data1/oa_pdf/d0/7a/BMB-49-11.PMC4914207.pdf
16 BMB Reports http://bmbreports.org14.,Non-OADS,/arxiv_data1/oa_pdf/d0/7a/BMB-49-11.PMC4914207.pdf
17 http://bmbreports.org BMB Reports49.,Non-OADS,/arxiv_data1/oa_pdf/d0/7a/BMB-49-11.PMC4914207.pdf
"Jiwon Shim, Tel: +82-2-2220-2615; Fax:  +82-2-2298-0319; E-mail: jshim@hanyang.ac.kr, Jin-Wu Nam,  Tel: +82-2-2220-2428; Fax: +82-2-2298-0319; E-mail: jwnam@  hanyang.ac.kr http://dx.doi.org/10.5483/BMBRep.2016.49.1.217Received 19 October 2015Keywords: Adult stem cell, Differentiation, Embryonic stem cell,  microRNA, Proliferation, Self-renewal ISSN: 1976-670X (electronic edition) Copyright ⓒ 2016 by the The Korean Society for Biochemistry and Molecular Biology This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://c reativecommons.org/li- censes/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the ori ginal work is properly cited.The expression and functional roles of microRNAs in stem cell  differentiation Jiwon Shim1,* & Jin-Wu Nam1,2,* 1Department of Life Science, College of Natural Sciences, 2Research Institute of Natural Sciences, Hanyang University, Seoul 04763, Korea microRNAs (miRNAs) are key regulators of cell state transition  and retention during stem cell proliferation and differentiation by post-transcriptionally downregulating hundreds of con- served target genes via seed-pairing in their 3’ untranslated  region.",Non-OADS,/arxiv_data1/oa_pdf/00/ea/BMB-49-3.PMC4914210.pdf
microRNAs in stem cell differentiation Jiwon Shim and Jin-Wu Nam 4BMB Reports http://bmbreports.org Fig.,OADS,/arxiv_data1/oa_pdf/00/ea/BMB-49-3.PMC4914210.pdf
 microRNAs in stem cell differentiation Jiwon Shim and Jin-Wu Nam 5 http://bmbreports.org BMB Reports Fig.,OADS,/arxiv_data1/oa_pdf/00/ea/BMB-49-3.PMC4914210.pdf
"microRNAs in stem cell differentiation Jiwon Shim and Jin-Wu Nam 6BMB Reports http://bmbreports.orgTuT7, which bind to lin28 via a zinc finger domain, redundan- tly uridylate pre-let-7, leading to downregulation of let-7 (41-43).",OADS,/arxiv_data1/oa_pdf/00/ea/BMB-49-3.PMC4914210.pdf
 microRNAs in stem cell differentiation Jiwon Shim and Jin-Wu Nam 7 http://bmbreports.org BMB Reports Fig.,OADS,/arxiv_data1/oa_pdf/00/ea/BMB-49-3.PMC4914210.pdf
"microRNAs in stem cell differentiation Jiwon Shim and Jin-Wu Nam 8BMB Reports http://bmbreports.orglator of myogenesis, transforming growth factor  (TGF), sup- presses miR-24 expression, which inhibits the expression of markers of myogenic differentiation (74).",OADS,/arxiv_data1/oa_pdf/00/ea/BMB-49-3.PMC4914210.pdf
 microRNAs in stem cell differentiation Jiwon Shim and Jin-Wu Nam 9 http://bmbreports.org BMB Reportsinducible mir-302 expression.,OADS,/arxiv_data1/oa_pdf/00/ea/BMB-49-3.PMC4914210.pdf
microRNAs in stem cell differentiation Jiwon Shim and Jin-Wu Nam 10 BMB Reports http://bmbreports.org355-362 57.,OADS,/arxiv_data1/oa_pdf/00/ea/BMB-49-3.PMC4914210.pdf
"Tel: +86-29-88491840; Fax: +86-29-  88491840; E-mail: qianair@nwpu.edu.cn http://dx.doi.org/10.5483/BMBRep.2016.49.1.185Received 8 September 2015, Revised 12 October 2015,  Accepted 27 October 2015 Keywords: Function, Isoform, MACF1, Structure, Spectraplakin ISSN: 1976-670X (electronic edition) Copyright ⓒ 2016 by the The Korean Society for Biochemistry and Molecular Biology This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://c reativecommons.org/li- censes/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the ori ginal work is properly cited.Isoforms, structures, and functi ons of versatile spectraplakin  MACF1 Lifang Hu1, Peihong Su1, Runzhi Li1, Chong Yin1, Yan Zhang1, Peng Shang1, Tuanmin Yang2 & Airong Qian1,* 1Key Laboratory for Space Bioscience and Biotechnology, Institute of Special Environmental Biophysics, School of Life Sciences,  Northwestern Polytechnical University, Xi’an, Shaanxi 710072, 2Honghui Hospital, Xi’an Jiaotong University College of Medicine, Xi’an,  Shaanxi 710054, P. R. China Spectraplakins are crucially important communicators, linking  cytoskeletal components to each other and cellular junctions.",Non-OADS,/arxiv_data1/oa_pdf/6e/9a/BMB-49-37.PMC4914211.pdf
38 BMB Reports http://bmbreports.org Fig.,Non-OADS,/arxiv_data1/oa_pdf/6e/9a/BMB-49-37.PMC4914211.pdf
"39 http://bmbreports.org BMB ReportsIsoform Tissue distribution Domains References ACF7-1/MACF1a1 Broadly expressed with predominance in  skin, kidney, and stomachABD (CH1, CH2), Plakin, Spectrin repeats, EF hand,  and GAR.",Non-OADS,/arxiv_data1/oa_pdf/6e/9a/BMB-49-37.PMC4914211.pdf
40 BMB Reports http://bmbreports.orgthe structural stability of tandem CH domains (28).,OADS,/arxiv_data1/oa_pdf/6e/9a/BMB-49-37.PMC4914211.pdf
41 http://bmbreports.org BMB ReportsGolgi network to peripheral phagophores in the early step of  autophagy (43).,Non-OADS,/arxiv_data1/oa_pdf/6e/9a/BMB-49-37.PMC4914211.pdf
42 BMB Reports http://bmbreports.orgwith mainly manifestation of generalized hypotonia and pain.,Non-OADS,/arxiv_data1/oa_pdf/6e/9a/BMB-49-37.PMC4914211.pdf
43 http://bmbreports.org BMB Reportsbinding proteins.,Non-OADS,/arxiv_data1/oa_pdf/6e/9a/BMB-49-37.PMC4914211.pdf
44 BMB Reports http://bmbreports.orgmice.,Non-OADS,/arxiv_data1/oa_pdf/6e/9a/BMB-49-37.PMC4914211.pdf
"Tel: +82-43-229-8562; Fax: +82-43-232-  8799; E-mail: jhkang@cju.ac.kr http://dx.doi.org/10.5483/BMBRep.2016.49.1.103Received 27 May 2015, Revised 4 June 2015, Accepted 12 June 2015Keywords: Ceruloplasmin, Copper, Reactive oxygen species, Salsolinol ISSN: 1976-670X (electronic edition) Copyright ⓒ 2016 by the The Korean Society for Biochemistry and Molecular Biology This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://c reativecommons.org/li- censes/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the ori ginal work is properly cited.Oxidative modification of human ceruloplasmin induced by a  catechol neurotoxin, salsolinol  Seung-Sub Kim1, Jae Yoon Kang2 & Jung Hoon Kang1,* 1Department of Biomedical Science, Cheongju University, Cheongju 28160, 2School of Interdisciplinary St udies, Korea University, Seoul  02841, Korea Salsolinol (SAL), a compound derived from dopamine meta- bolism, is the most probable neurotoxin involved in the pathogenesis of Parkinson’s disease (PD).",Non-OADS,/arxiv_data1/oa_pdf/2f/78/BMB-49-45.PMC4914212.pdf
46 BMB Reports http://bmbreports.org Fig.,Non-OADS,/arxiv_data1/oa_pdf/2f/78/BMB-49-45.PMC4914212.pdf
47 http://bmbreports.org BMB Reports Fig.,Non-OADS,/arxiv_data1/oa_pdf/2f/78/BMB-49-45.PMC4914212.pdf
48 BMB Reports http://bmbreports.org Fig.,Non-OADS,/arxiv_data1/oa_pdf/2f/78/BMB-49-45.PMC4914212.pdf
"49 http://bmbreports.org BMB Reportsamine, for 1 h at 37oC followed by washing in 50% ethanol.",Non-OADS,/arxiv_data1/oa_pdf/2f/78/BMB-49-45.PMC4914212.pdf
50 BMB Reports http://bmbreports.org22.,Non-OADS,/arxiv_data1/oa_pdf/2f/78/BMB-49-45.PMC4914212.pdf
"http://dx.doi.org/10.5483/BMBRep.2016.49.1.102Received 22 May 2015, Revised 16 June 2015,  Accepted 5 August 2015 Keywords: B-cell lymphoma 2, Breast cancer, Cell death, Glycogen  synthase kinase-3 , Paclitaxel ISSN: 1976-670X (electronic edition) Copyright ⓒ 2016 by the The Korean Society for Biochemistry and Molecular Biology This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://c reativecommons.org/li- censes/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the ori ginal work is properly cited.Enhancement of paclitaxel-induced breast cancer cell death via  the glycogen synthase kinase-3 -mediated B-cell lymphoma 2  regulation Kyung Tae Noh1,#,*, Gil Sun Cha2,#, Tae Heung Kang2,#, Joon Cho3,#, In Duk Jung2, Kwang-Youn Kim4, Soon-Cheol Ahn5,  Ji Chang You6,* & Yeong-Min Park2,* 1Department of Infectious Diseases, Armed Forces Medical Research Institute, Daejeon 34059, 2Department of Immunology, KU Open  Innovation Center, College of Medici ne, Konkuk University, Chungju 27478, 3Department of Neurosurgery, Konkuk University Hospital,  Seoul 05030, 4School of Life Sciences, Ulsan National Institute of Science and Technology, Ulsan 44919, 5Department of Microbiology and  Immunology, Pusan National University School of Medicine, Yangsan 50612, 6National Research Laboratory of Molecular Virology,  Department of Pathology, School of Medicine, Th e Catholic University of Korea, Seoul 03083, Korea Glycogen synthase kinase-3  (GSK-3) is a serine/threonine  protein kinase that is known to mediate cancer cell death.",Non-OADS,/arxiv_data1/oa_pdf/22/e6/BMB-49-51.PMC4914213.pdf
52 BMB Reports http://bmbreports.org Fig.,Non-OADS,/arxiv_data1/oa_pdf/22/e6/BMB-49-51.PMC4914213.pdf
53 http://bmbreports.org BMB Reports Fig.,Non-OADS,/arxiv_data1/oa_pdf/22/e6/BMB-49-51.PMC4914213.pdf
54 BMB Reports http://bmbreports.org Fig.,Non-OADS,/arxiv_data1/oa_pdf/22/e6/BMB-49-51.PMC4914213.pdf
55 http://bmbreports.org BMB Reportsinformation for therapeutic benefit to treat breast and other can- cers using nano-particle and GSK-3  siRNA.,Non-OADS,/arxiv_data1/oa_pdf/22/e6/BMB-49-51.PMC4914213.pdf
"56 BMB Reports http://bmbreports.org(NRF) funded by the Ministry of Education, Science and  Technology (2012R1A1A2042924, 2012R1A2A1A03008433, and 2013R1A2A2A01068353) REFERENCES 1.",Non-OADS,/arxiv_data1/oa_pdf/22/e6/BMB-49-51.PMC4914213.pdf
"Tel: +82-33-248-2116; Fax: +82-33-256-  3420; E-mail: jinpark@hallym.ac.kr http://dx.doi.org/10.5483/BMBRep.2016.49.1.141Received 6 July 2015, Revised 21 July 2015, Accepted 12 August 2015Keywords: Adhesion, HO-1, Keratinocyte, NF- B, TNF- ISSN: 1976-670X (electronic edition) Copyright ⓒ 2016 by the The Korean Society for Biochemistry and Molecular Biology This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://c reativecommons.org/li- censes/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the ori ginal work is properly cited.2,3-Dimethoxy-2 ′-hydroxychalcone ameliorates TNF- -induced  ICAM-1 expression and subsequent monocyte adhesiveness via NF-kappaB inhibition and HO-1 induction in HaCaT cells Hyejin Kim1, Gi Soo Youn1, Soo Yeon An1, Hyeok Yil Kwon2, Soo Young Choi1 & Jinseu Park1,* 1Department of Biomedical Science and Research Institute for Bioscience & Biotechnology, Hallym University, Chuncheon 24252,  2Department of Physiology, College of Medicine, Hallym University, Chuncheon 24252, Korea Up-regulation of adhesion molecules plays an important role  in the infiltration of leukocytes into the skin during the devel-opment of various inflammatory skin diseases, such as atopic  dermatitis.",Non-OADS,/arxiv_data1/oa_pdf/bc/a2/BMB-49-57.PMC4914214.pdf
58 BMB Reports http://bmbreports.org Fig.,Non-OADS,/arxiv_data1/oa_pdf/bc/a2/BMB-49-57.PMC4914214.pdf
59 http://bmbreports.org BMB Reports Fig.,Non-OADS,/arxiv_data1/oa_pdf/bc/a2/BMB-49-57.PMC4914214.pdf
60 BMB Reports http://bmbreports.org Fig.,Non-OADS,/arxiv_data1/oa_pdf/bc/a2/BMB-49-57.PMC4914214.pdf
"61 http://bmbreports.org BMB Reportsflammatory response (20, 21).",Non-OADS,/arxiv_data1/oa_pdf/bc/a2/BMB-49-57.PMC4914214.pdf
62 BMB Reports http://bmbreports.org4.,Non-OADS,/arxiv_data1/oa_pdf/bc/a2/BMB-49-57.PMC4914214.pdf
"Tel: +82-33-248-2113; Fax: +82-33-256-  3420; E-mail: keunwook@hallym.ac.kr http://dx.doi.org/10.5483/BMBRep.2016.49.1.201Received 7 October 2015, Revised 19 October 2015,  Accepted 22 October 2015 Keywords: mTOR, torin, rapamycin, leukemic cell, T-ALL ISSN: 1976-670X (electronic edition) Copyright ⓒ 2016 by the The Korean Society for Biochemistry and Molecular Biology This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://c reativecommons.org/li- censes/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the ori ginal work is properly cited.Rapamycin-resistant and torin-sensitive mTOR signaling  promotes the survival and proliferation of leukemic cells Seohyun Park, Hyunsub Sim & Keunwook Lee * Department of Biomedical Science, College of Natural Science, Hallym University, Chuncheon 24252, Korea The serine/threonine kinase mTOR is essential for the phos- phoinositide 3-kinases (PI3K) signaling pathway, and regulates the development and function of immune cells.",Non-OADS,/arxiv_data1/oa_pdf/4a/ec/BMB-49-63.PMC4914215.pdf
64 BMB Reports http://bmbreports.org Fig.,Non-OADS,/arxiv_data1/oa_pdf/4a/ec/BMB-49-63.PMC4914215.pdf
65 http://bmbreports.org BMB Reports Fig.,Non-OADS,/arxiv_data1/oa_pdf/4a/ec/BMB-49-63.PMC4914215.pdf
66 BMB Reports http://bmbreports.org Fig.,Non-OADS,/arxiv_data1/oa_pdf/4a/ec/BMB-49-63.PMC4914215.pdf
67 http://bmbreports.org BMB Reportswith apoptosis and cell cycle arrest via modulating FoxOs and  NF-B.,Non-OADS,/arxiv_data1/oa_pdf/4a/ec/BMB-49-63.PMC4914215.pdf
"68 BMB Reports http://bmbreports.orgACKNOWLEDGEMENTS This research was supported by a grant (NRF-2014R1A1A4- A01008734) of Basic Science Research Program funded by the  Ministry of Education through the National Research Founda-tion, a Korean Mouse Phenotyping Project (NRF-2014M3A9- D5A01073841) funded by the Ministry of Science, ICT, and  Future Planning through the National Research Foundation, and Hallym University Research Fund 2014 (H20140034).",Non-OADS,/arxiv_data1/oa_pdf/4a/ec/BMB-49-63.PMC4914215.pdf
e-mail: hiraga@equinst.go.jp ©2016 Japanese Society of Equine Science This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.J.,Non-OADS,/arxiv_data1/oa_pdf/67/89/jes-27-37.PMC4914396.pdf
e-mail: nrm@aber.ac.uk ©2016 Japanese Society of Equine Science This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.J.,Non-OADS,/arxiv_data1/oa_pdf/af/10/jes-27-49.PMC4914397.pdf
e-mail: kaz_msm@vet.kagoshima-u.ac.jp ©2016 Japanese Society of Equine Science This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.J.,Non-OADS,/arxiv_data1/oa_pdf/b5/34/jes-27-57.PMC4914398.pdf
e-mail: active1982415@yahoo.co.jp ©2016 Japanese Society of Equine Science This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.J.,Non-OADS,/arxiv_data1/oa_pdf/e1/4b/jes-27-67.PMC4914399.pdf
e-mail: torisu@cc.miyazaki-u.ac.jp ©2016 Japanese Society of Equine Science This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.J.,Non-OADS,/arxiv_data1/oa_pdf/c2/db/jes-27-77.PMC4914400.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which per-mits any noncommercial use, distribution, and reproduction in anymedium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/92/0e/40801_2016_Article_67.PMC4914530.pdf
http://www.ncbi.nlm.nih.gov/ pubmed .Accessed 5 Jan 2016.,Non-OADS,/arxiv_data1/oa_pdf/92/0e/40801_2016_Article_67.PMC4914530.pdf
http://www.ecfr.gov/cgi-bin/text-idx?SID= 7921869728d8c21c6846aafab37668c9&mc=true&node=pt21.5.,OADS,/arxiv_data1/oa_pdf/92/0e/40801_2016_Article_67.PMC4914530.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 InternationalLicense (http://creativecommons.org/licenses/by-nc/4.0/), which per-mits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commonslicense, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/f5/68/40801_2016_Article_73.PMC4914533.pdf
"Ontario Drug Policy Research Network, Antipsychotic use in the elderly 2015. http://odprn.ca/antipsychotics-in-the-elderly/ .",Non-OADS,/arxiv_data1/oa_pdf/f5/68/40801_2016_Article_73.PMC4914533.pdf
Available from: http://www.healthycanadians.gc.ca/recall-alert- rappel-avis/hc-sc/2005/14307a-eng.php .,OADS,/arxiv_data1/oa_pdf/f5/68/40801_2016_Article_73.PMC4914533.pdf
Available from: http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm110212.htm .,Non-OADS,/arxiv_data1/oa_pdf/f5/68/40801_2016_Article_73.PMC4914533.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which per-mits any noncommercial use, distribution, and reproduction in anymedium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/36/0a/40801_2016_Article_77.PMC4914536.pdf
http://apps.who.int/medicinedocs/pdf/s6164e/s6164e.pdf .,Non-OADS,/arxiv_data1/oa_pdf/36/0a/40801_2016_Article_77.PMC4914536.pdf
"Summary of Product Characteristics: Topamax, Janssen-Cilag GmbH; 2014. http://www.fachinfo.de .",Non-OADS,/arxiv_data1/oa_pdf/36/0a/40801_2016_Article_77.PMC4914536.pdf
"Summary of Product Characteristics: Keppra, UCB Pharma GmbH; 2014. http://www.fachinfo.de .",Non-OADS,/arxiv_data1/oa_pdf/36/0a/40801_2016_Article_77.PMC4914536.pdf
"Summary of Product Characteristics: Lyrica, Pﬁzer Ltd; 2014. http://www.fachinfo.de .",Non-OADS,/arxiv_data1/oa_pdf/36/0a/40801_2016_Article_77.PMC4914536.pdf
"Summary of Product Characteristics: Zonegran, Esai GmbH; 2013. http://www.fachinfo.de .",Non-OADS,/arxiv_data1/oa_pdf/36/0a/40801_2016_Article_77.PMC4914536.pdf
"Summary of Product Characteristics: Apydan extend, Desitin Arzneimittel GmbH; 2014. http://www.fachinfo.de .",Non-OADS,/arxiv_data1/oa_pdf/36/0a/40801_2016_Article_77.PMC4914536.pdf
"Summary of Product Characteristics: Vimpat, UCB Pharma GmbH; 2014. http://www.fachinfo.de .",Non-OADS,/arxiv_data1/oa_pdf/36/0a/40801_2016_Article_77.PMC4914536.pdf
2013. https://www.dgfe.info/ cweb2/cgi-bin-noauth/cache/VAL_BLOB/5038/5038/1355/Therapieempfehlungen%20Fokale%20Epilepsien%20DGfE%202505 13-2.pdf .,Non-OADS,/arxiv_data1/oa_pdf/36/0a/40801_2016_Article_77.PMC4914536.pdf
2012. http://www.dgn.org/ leitlinien/11-leitlinien-der-dgn/2302-ll-1-2012-erster- epileptischer-anfall-und-epilepsien-im-erwachsenenalter .,Non-OADS,/arxiv_data1/oa_pdf/36/0a/40801_2016_Article_77.PMC4914536.pdf
"Summary of Product Characteristics: Zebinix, Bial-Portela & Ca, SA; 2010. http://www.fachinfo.de .",Non-OADS,/arxiv_data1/oa_pdf/36/0a/40801_2016_Article_77.PMC4914536.pdf
"Summary of Product Characteristics: Topamax, Janssen-Cilag GmbH; 2011. http://www.fachinfo.de .",Non-OADS,/arxiv_data1/oa_pdf/36/0a/40801_2016_Article_77.PMC4914536.pdf
"Summary of Product Characteristics: Keppra, UCB Pharma GmbH; 2011. http://www.fachinfo.de , Accessed 14 Nov 2011.",Non-OADS,/arxiv_data1/oa_pdf/36/0a/40801_2016_Article_77.PMC4914536.pdf
"Summary of Product Characteristics: Lyrica, Pﬁzer Ltd; 2011. http://www.fachinfo.de , Accessed 14 Nov 2011.",Non-OADS,/arxiv_data1/oa_pdf/36/0a/40801_2016_Article_77.PMC4914536.pdf
"Summary of Product Characteristics: Zonegran, Esai GmbH; 2011. http://www.fachinfo.de .",Non-OADS,/arxiv_data1/oa_pdf/36/0a/40801_2016_Article_77.PMC4914536.pdf
"Summary of Product Characteristics: Apydan extend, Desitin Arzneimittel GmbH; 2010. http://www.fachinfo.de .",Non-OADS,/arxiv_data1/oa_pdf/36/0a/40801_2016_Article_77.PMC4914536.pdf
"Summary of Product Characteristics: Vimpat, UCB Pharma GmbH; 2011. http://www.fachinfo.de .",Non-OADS,/arxiv_data1/oa_pdf/36/0a/40801_2016_Article_77.PMC4914536.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 InternationalLicense (http://creativecommons.org/licenses/by-nc/4.0/), which per- mits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the originalauthor(s) and the source, provide a link to the Creative Commonslicense, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/c4/8a/40801_2016_Article_72.PMC4914537.pdf
Retrieved http://us.milliman.,Non-OADS,/arxiv_data1/oa_pdf/c4/8a/40801_2016_Article_72.PMC4914537.pdf
Retrieved https://www.census.gov/prod/cen2010/ briefs/c2010br-01.pdf .,OADS,/arxiv_data1/oa_pdf/c4/8a/40801_2016_Article_72.PMC4914537.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which per-mits any noncommercial use, distribution, and reproduction in anymedium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/ea/5e/40801_2016_Article_76.PMC4914538.pdf
"Carla Nikkel is currently employed and a shareholder of Valeritas, Inc. Scott Abbott is cur-rently employed and a shareholder of Valeritas, Inc. Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which per- mits any noncommercial use, distribution, and reproduction in anymedium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/3a/d8/40801_2016_Article_75.PMC4914539.pdf
ART-037 Rev: H 09/ 2011. http://www.go-vgo.com/sites/defa ult/ﬁles/upload/instructions- for-patient-use.pdf .,Non-OADS,/arxiv_data1/oa_pdf/3a/d8/40801_2016_Article_75.PMC4914539.pdf
"Tampa: Elsevier, Gold Standard, Inc.; 2014. https://prospectorx.com/Home.aspx .",Non-OADS,/arxiv_data1/oa_pdf/3a/d8/40801_2016_Article_75.PMC4914539.pdf
[Erratum appears in Prev Chronic Dis 2013;10. http://www.cdc.gov/pcd/ issues/2013/12_0065e.htm ].,Non-OADS,/arxiv_data1/oa_pdf/3a/d8/40801_2016_Article_75.PMC4914539.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which per-mits any noncommercial use, distribution, and reproduction in anymedium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/c8/5f/40801_2016_Article_71.PMC4914540.pdf
2013. http://laws-lois.justice.gc.ca/eng/ AnnualStatutes/2014_24/page-1.html .,Non-OADS,/arxiv_data1/oa_pdf/c8/5f/40801_2016_Article_71.PMC4914540.pdf
2010. http://evs.nci.nih.gov/ftp1/CTCAE/ CTCAE_4.03_2010-06-14_QuickReference_5x7.pdf .,OADS,/arxiv_data1/oa_pdf/c8/5f/40801_2016_Article_71.PMC4914540.pdf
2012. http://www.merckman uals.com/profession al/clinical-pharma cology/adverse-drugreactions/adverse-drug-reactions .,Non-OADS,/arxiv_data1/oa_pdf/c8/5f/40801_2016_Article_71.PMC4914540.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which per- mits any noncommercial use, distribution, and reproduction in anymedium, provided you give appropriate credit to the originalauthor(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/10/35/40801_2016_Article_70.PMC4914541.pdf
Monitoring report 2014. http://www.hiv-monitoring.nl/ﬁles/8914/1527/1076/ SHM_Monitoring_report_2014.pdf2014 .,Non-OADS,/arxiv_data1/oa_pdf/10/35/40801_2016_Article_70.PMC4914541.pdf
http://www.scp.,Non-OADS,/arxiv_data1/oa_pdf/10/35/40801_2016_Article_70.PMC4914541.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which per- mits any noncommercial use, distribution, and reproduction in anymedium, provided you give appropriate credit to the originalauthor(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/1e/ca/40801_2016_Article_68.PMC4914542.pdf
20 Jan 2011. http://www.ema.europa.eu/docs/en_GB/document_ library/Summary_of_opinion_-_I nitial_authorisation/human/ 001245/WC500101046.pdf .,Non-OADS,/arxiv_data1/oa_pdf/1e/ca/40801_2016_Article_68.PMC4914542.pdf
"Medicines and Healthcare Products Regulatory Agency, 10 Jul 2013. https://www.gov.uk/drug-safety-update/retigabine- trobalt-indication-restricted-to-last-line-use-and-new-monitoring-requirements .",Non-OADS,/arxiv_data1/oa_pdf/1e/ca/40801_2016_Article_68.PMC4914542.pdf
http://www.fda.gov/Drugs/DrugSafety/ucm372774.,Non-OADS,/arxiv_data1/oa_pdf/1e/ca/40801_2016_Article_68.PMC4914542.pdf
http://www.fda.gov/Drugs/DrugSafety/ucm334024.htm .,Non-OADS,/arxiv_data1/oa_pdf/1e/ca/40801_2016_Article_68.PMC4914542.pdf
"Compliance with Ethical Standards Funding This study was part of the EUROmediCAT research project (http://www.euromedicat.eu ), which is supported by the European Commission under the 7th Framework Programme Grant Agreement No 260598.Newer Antiepileptic Drugs and Congenital Anomalies 141",Non-OADS,/arxiv_data1/oa_pdf/43/e6/40801_2016_Article_78.PMC4914544.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 InternationalLicense (http://creativecommons.org/licenses/by-nc/4.0/), which per- mits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the originalauthor(s) and the source, provide a link to the Creative Commonslicense, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/43/e6/40801_2016_Article_78.PMC4914544.pdf
2012; Available at: http://www.nice.,Non-OADS,/arxiv_data1/oa_pdf/43/e6/40801_2016_Article_78.PMC4914544.pdf
2014; Available at: http://www.ema.europa.eu/ema/index.jsp?curl= pages/medicines/human/referrals/Valproate_and_related_substances/human_referral_prac_000032.jsp&mid=WC0b01ac05805c516f .,Non-OADS,/arxiv_data1/oa_pdf/43/e6/40801_2016_Article_78.PMC4914544.pdf
"EUROCAT Guide 1.3 and reference documents, instructions for the registration and surveillance of congenitalanomalies, September 2005, Available at: http://www.eurocat.",Non-OADS,/arxiv_data1/oa_pdf/43/e6/40801_2016_Article_78.PMC4914544.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which per-mits any noncommercial use, distribution, and reproduction in anymedium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/81/92/40801_2016_Article_74.PMC4914546.pdf
Available online at: http://www5.imperial.,Non-OADS,/arxiv_data1/oa_pdf/81/92/40801_2016_Article_74.PMC4914546.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ REFERENCES 1 Hollmann TJ, Hornick JL.",Non-OADS,/arxiv_data1/oa_pdf/e3/41/jclinpath-2016-203650.PMC4914571.pdf
Available from: http://www.ahpa.com.au/ Home/DeﬁnitionofAlliedHealth.aspx (accessed 9 November 2015).,Non-OADS,/arxiv_data1/oa_pdf/ab/c4/JMRS-63-075.PMC4914811.pdf
Available from: http://www.globocan.iarc.fr/ Pages/fact_sheets_cancer.aspx.,Non-OADS,/arxiv_data1/oa_pdf/10/88/JMRS-63-081.PMC4914812.pdf
Available from: http://www.aihw.gov.au/ publication-detail/?id=6442468382 (accessed October 2014).,Non-OADS,/arxiv_data1/oa_pdf/10/88/JMRS-63-081.PMC4914812.pdf
Available from: http://www.aihw.gov.au/publication-detail/?,Non-OADS,/arxiv_data1/oa_pdf/10/88/JMRS-63-081.PMC4914812.pdf
Available from: http://canceraustralia.gov.au/affected-cancer/cancer- types/breast-cancer/breast-cancer-statistics.,Non-OADS,/arxiv_data1/oa_pdf/10/88/JMRS-63-081.PMC4914812.pdf
Available from: http://www.healthinfonet.ecu.edu.,Non-OADS,/arxiv_data1/oa_pdf/10/88/JMRS-63-081.PMC4914812.pdf
Available from: http://www.aihw.gov.au/WorkArea/DownloadAsset.aspx?,Non-OADS,/arxiv_data1/oa_pdf/10/88/JMRS-63-081.PMC4914812.pdf
Available from: http://www.aihw.gov.au/WorkArea/DownloadAsset.,OADS,/arxiv_data1/oa_pdf/10/88/JMRS-63-081.PMC4914812.pdf
Available from: http://www.aihw.gov.au/publication-detail/?,Non-OADS,/arxiv_data1/oa_pdf/10/88/JMRS-63-081.PMC4914812.pdf
Available from: http://www.cancer.org/ acs/groups/cid/documents/webcontent/003165-pdf.pdf (accessed October 2014).32.,Non-OADS,/arxiv_data1/oa_pdf/10/88/JMRS-63-081.PMC4914812.pdf
Available from: http://www.ranzcr.edu.au/ documents/detail.cfm?ophileEntry=823&ophileLibrary=29&ophileReturnpage=list.cfm&llLetter=All.,OADS,/arxiv_data1/oa_pdf/cc/25/JMRS-63-104.PMC4914814.pdf
Available from: http://www.ranzcr.edu.au/ documents/detail.cfm?ophileEntry=466&ophileLibrary= 29&ophileReturnpage=list.cfm&llLetter=All.,OADS,/arxiv_data1/oa_pdf/cc/25/JMRS-63-104.PMC4914814.pdf
Available from: http://www.ndt-ed.,Non-OADS,/arxiv_data1/oa_pdf/a7/7e/JMRS-63-133.PMC4914815.pdf
Available from: http://www.mrtboard.org.nz/assets_mrtb/ Uploads/Code-of-Ethics-for-Medical-Radiation-Techno logists2.pdf.28.,Non-OADS,/arxiv_data1/oa_pdf/a7/7e/JMRS-63-133.PMC4914815.pdf
Available from: https://www.mcnz.org.nz/assets/News-and- Publications/Statements/Information-choice-of-treatment- and-informed-consent.pdf (accessed January 2016).,Non-OADS,/arxiv_data1/oa_pdf/a7/7e/JMRS-63-133.PMC4914815.pdf
Available from: http://www.nzno.org.nz/ Portals/0/publications/Code%20of%20Ethics%202010.pdf.,Non-OADS,/arxiv_data1/oa_pdf/a7/7e/JMRS-63-133.PMC4914815.pdf
Available from: http://www.dcnz.org.nz/assets/Uploads/Practice-standards/ Standards-Framework-for-Oral-Health-Practitioners.pdf.,Non-OADS,/arxiv_data1/oa_pdf/a7/7e/JMRS-63-133.PMC4914815.pdf
Available from: http://www.physioboard.org.nz/sites/ default/ﬁles/NZ_Physiotherapy_ Code_of_Ethics_with_ commentary_FINAL_0.pdf (accessed January 2016).,Non-OADS,/arxiv_data1/oa_pdf/a7/7e/JMRS-63-133.PMC4914815.pdf
Available from: http://www.otboard.org.nz/wp- content/uploads/2015/04/CodeofEthics_April2015-1.pdf.,Non-OADS,/arxiv_data1/oa_pdf/a7/7e/JMRS-63-133.PMC4914815.pdf
Available from: http://usir.salford.ac.uk/38008/1/Ebook%20Hanze% 202015.pdf.,Non-OADS,/arxiv_data1/oa_pdf/fa/09/JMRS-63-073.PMC4914816.pdf
Available from: http://home.cern/about (accessed 4 April 2016).,Non-OADS,/arxiv_data1/oa_pdf/fa/09/JMRS-63-073.PMC4914816.pdf
Available from: http://www.efrs.eu/research (accessed 4 April 2016).,Non-OADS,/arxiv_data1/oa_pdf/fa/09/JMRS-63-073.PMC4914816.pdf
Available from: http://www.isrrt.org/isrrt/ (accessed 4 April 2016).,Non-OADS,/arxiv_data1/oa_pdf/fa/09/JMRS-63-073.PMC4914816.pdf
Available from: https://www.epsrc.ac.uk/funding/ howtoapply/routes/network/ideas/whatisasandpit/ (accessed 4 April 2016).,Non-OADS,/arxiv_data1/oa_pdf/fa/09/JMRS-63-073.PMC4914816.pdf
Available from http://journals.lww.com/.10.,Non-OADS,/arxiv_data1/oa_pdf/ed/56/JMRS-63-089.PMC4914818.pdf
Available from: http://www.biomedcentral.com/content/pdf/1472- 6963-12-421.pdf.,Non-OADS,/arxiv_data1/oa_pdf/ed/56/JMRS-63-089.PMC4914818.pdf
Available from: http://www.search.informit.com.,Non-OADS,/arxiv_data1/oa_pdf/ed/56/JMRS-63-089.PMC4914818.pdf
Available from: http://www.ncbi.nlm.nih.gov/pubmed/ 18700089.,Non-OADS,/arxiv_data1/oa_pdf/ed/56/JMRS-63-089.PMC4914818.pdf
Available from: http://go.galegroup.com/ps/i.do?id=GALE%7CA120039091&v=2.1&u=per_unit& it=r&p=AONE&sw=w&asid=b752d11fdd9dd0dabebc6a2ce b06fdbf.,OADS,/arxiv_data1/oa_pdf/ed/56/JMRS-63-089.PMC4914818.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/c0/ef/ijem-14-01-34726.PMC4914821.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ Supplementary Information accompanies this paper on the Oncogene website (http://www.nature.com/onc)ASCT2 controls glutamine-mediated breast cancer growth M van Geldermalsen et al 3208 Oncogene (2016) 3201 –3208 © 2016 Macmillan Publishers Limited",Non-OADS,/arxiv_data1/oa_pdf/53/e6/onc2015381a.PMC4914826.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribu - tion-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncom - mercial usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/73/85/jjm-09-04-30046.PMC4914860.pdf
"This is an open-access article distributed under the terms of the Creative  Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the mate - rial just in noncommercial usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/82/b9/ijem-14-01-22827.PMC4914861.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/70/61/rjw046.PMC4915075.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/31/33/rjw081.PMC4915105.pdf
"http://dx.doi.org/10.5483/BMBRep.2016.49.2.173Received 17 August 2015, Revised 27 August 2015,  Accepted 2 September 2015 Keywords: Anti-inflammatory, Bile acid, Lipogenesis, Peroxisome  proliferator-activated receptor- , Ursodeoxycholic acid ISSN: 1976-670X (electronic edition) Copyright ⓒ 2016 by the The Korean Society for Biochemistry and Molecular Biology This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://c reativecommons.org/li- censes/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the ori ginal work is properly cited.Ursodeoxycholic acid decreases age-related adiposity and  inflammation in mice Ah-Reum Oh1,#, Jin-Sik Bae1,#, Junghoon Lee1, Eunji Shin1, Byung-Chul Oh1, Sang-Chul Park1 & Ji-Young Cha1,2,* 1Department of Molecular Medicine, Lee Gil Ya Cancer and Diabetes Institute, Gachon University, Incheon 21999, 2Gachon Medical  Research Institute, Gil Hospital, Incheon 21565, Korea Ursodeoxycholic acid (UDCA), a natural, hydrophilic nontoxic  bile acid, is clinically effective for treating cholestatic and chronic liver diseases.",Non-OADS,/arxiv_data1/oa_pdf/d4/9d/BMB-49-105.PMC4915113.pdf
106 BMB Reports http://bmbreports.org Fig.,Non-OADS,/arxiv_data1/oa_pdf/d4/9d/BMB-49-105.PMC4915113.pdf
107 http://bmbreports.org BMB Reports Fig.,Non-OADS,/arxiv_data1/oa_pdf/d4/9d/BMB-49-105.PMC4915113.pdf
108 BMB Reports http://bmbreports.org Fig.,Non-OADS,/arxiv_data1/oa_pdf/d4/9d/BMB-49-105.PMC4915113.pdf
109 http://bmbreports.org BMB Reportsways: ChREBP-medicated lipogenesis and PPARG-mediated  lipid uptake/secretion.,Non-OADS,/arxiv_data1/oa_pdf/d4/9d/BMB-49-105.PMC4915113.pdf
110 BMB Reports http://bmbreports.orgREFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/d4/9d/BMB-49-105.PMC4915113.pdf
"Tel: +82-2-2228-0837; Fax: +82-2-312-5041;  E-mail: japol13@yuhs.ac http://dx.doi.org/10.5483/BMBRep.2016.49.2.128Received 26 June 2015, Revised 27 July 2015,  Accepted 9 September 2015 Keywords: Adipogenesis, AKT , Caffeine, Glycogen synthase kinase,  Mitotic clonal expansion ISSN: 1976-670X (electronic edition) Copyright ⓒ 2016 by the The Korean Society for Biochemistry and Molecular Biology This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://c reativecommons.org/li- censes/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the ori ginal work is properly cited.Caffeine inhibits adipogenesis through modulation of mitotic  clonal expansion and the AKT/GSK3 pathway in 3T3-L1 adipocytes Hyo Jung Kim1, Bo Kyung Yoon2, Hyounkyoung Park1, Jo Woon Seok1,3, Hyeonjin Choi1, Jung Hwan Yu1,3, Yoonjeong Choi1,3,  Su Jin Song1,3, Ara Kim1,3 & Jae-woo Kim1,3,4,* 1Department of Biochemistry and Molecular Biology, Integrated Ge nomic Research Center for Metabolic Regulation, Institute of Gen etic  Science, Yonsei University College of Medicine, 2Yonsei University College of Medicine, 3Brain Korea 21 PLUS Project for Medical Science,  Yonsei University, 4Severance Biomedical Science Institute, Yonsei University College of Medicine, Seoul 03722, Korea Caffeine has been proposed to have several beneficial effects  on obesity and its related metabolic diseases; however, how  caffeine affects adipocyte differentiation has not been eluci-dated.",Non-OADS,/arxiv_data1/oa_pdf/b8/24/BMB-49-111.PMC4915114.pdf
112 BMB Reports http://bmbreports.org Fig.,Non-OADS,/arxiv_data1/oa_pdf/b8/24/BMB-49-111.PMC4915114.pdf
113 http://bmbreports.org BMB Reports Fig.,Non-OADS,/arxiv_data1/oa_pdf/b8/24/BMB-49-111.PMC4915114.pdf
"114 BMB Reports http://bmbreports.orgFor example, caffeine intake decreased diet-induced insulin re- sistance (20), inhibited lipid accumulation, and stimulated breakdown of accumulated triglyceride in adipocytes (21).",Non-OADS,/arxiv_data1/oa_pdf/b8/24/BMB-49-111.PMC4915114.pdf
115 http://bmbreports.org BMB Reports6.,Non-OADS,/arxiv_data1/oa_pdf/b8/24/BMB-49-111.PMC4915114.pdf
"Young-Gyu Ko, Tel: +82-2-3290-3453; Fax: +82-2-3290-4144; E-mail: ygko@korea.ac.kr, Bong-Woo Kim,  Tel: +82-2-3290-3453; Fax: +82-2-3290-4144; E-mail: kbw@  seowon.ac.kr http://dx.doi.org/10.5483/BMBRep.2016.49.2.232Received 10 November 2015, Revised 30 November 2015,  Accepted 8 December 2015 Keywords: Cytochrome c, Extracellular NADH-dependent respira- tion, Oxidative phosphorylation complexes, Sarcolemma, Skeletal muscle ISSN: 1976-670X (electronic edition) Copyright ⓒ 2016 by the The Korean Society for Biochemistry and Molecular Biology This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://c reativecommons.org/li- censes/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the ori ginal work is properly cited.Mitochondrial oxidative phosphorylation complexes exist in  the sarcolemma of skeletal muscle Hyun Lee1, Seung-Hyeob Kim1, Jae-Seon Lee2, Yun-Hee Yang3, Jwa-Min Nam3, Bong-Woo Kim1,* & Young-Gyu Ko1,* 1Division of Life Sciences, Korea University, Seoul 02841, 2Department of Biomedical Sciences, College of Medicine, Inha University,  Incheon 22212, 3Department of Chemistry, Seoul National University, Seoul 08826, Korea Although proteomic analyses have revealed the presence of mi- tochondrial oxidative phosphorylation (OXPHOS) proteins in the plasma membrane, there have been no in-depth evalua- tions of the presence or function of OXPHOS I-V in the plasma  membrane.",Non-OADS,/arxiv_data1/oa_pdf/f0/6d/BMB-49-116.PMC4915115.pdf
117 http://bmbreports.org BMB Reports Fig.,Non-OADS,/arxiv_data1/oa_pdf/f0/6d/BMB-49-116.PMC4915115.pdf
118 BMB Reports http://bmbreports.org Fig.,Non-OADS,/arxiv_data1/oa_pdf/f0/6d/BMB-49-116.PMC4915115.pdf
119 http://bmbreports.org BMB Reports Fig.,Non-OADS,/arxiv_data1/oa_pdf/f0/6d/BMB-49-116.PMC4915115.pdf
120 BMB Reports http://bmbreports.orgMATERIALS AND METHODS Animals and cell line C57/BL6 male mice were housed in plastic cages on a 12:12 h  light-dark photoperiod with free access to water and food.,Non-OADS,/arxiv_data1/oa_pdf/f0/6d/BMB-49-116.PMC4915115.pdf
121 http://bmbreports.org BMB Reportssignalling.,Non-OADS,/arxiv_data1/oa_pdf/f0/6d/BMB-49-116.PMC4915115.pdf
"Tel: +86-13608367586; Fax: +86-23-  63693609; E-mail: Dengzhongliang7586@126.com http://dx.doi.org/10.5483/BMBRep.2016.49.2.228Received 4 November 2015, Revised 19 November 2015, Accepted 8  December 2015 Keywords: BMP9, BMPs/Smads, IGF1, MSCs, Osteogenic differ- entiation ISSN: 1976-670X (electronic edition) Copyright ⓒ 2016 by the The Korean Society for Biochemistry and Molecular Biology This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://c reativecommons.org/li- censes/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the ori ginal work is properly cited.IGF1 potentiates BMP9-induced osteogenic differentiation in  mesenchymal stem cells through the enhancement of BMP/Smad signaling Liang Chen, Xiang Zou, Ran-Xi Zhang, Chang-Jun Pi, Nian Wu, Liang-Jun Yin & Zhong-Liang Deng * Department of Orthopaedics, The Second Affiliated Hospital, Chongqing Medical University, Chongqing 400010, China Engineered bone tissue is thought to be the ideal alternative for  bone grafts in the treatment of related bone diseases.",Non-OADS,/arxiv_data1/oa_pdf/5d/3e/BMB-49-122.PMC4915116.pdf
123 http://bmbreports.org BMB Reports Fig.,Non-OADS,/arxiv_data1/oa_pdf/5d/3e/BMB-49-122.PMC4915116.pdf
124 BMB Reports http://bmbreports.org Fig.,Non-OADS,/arxiv_data1/oa_pdf/5d/3e/BMB-49-122.PMC4915116.pdf
125 http://bmbreports.org BMB Reportsand IGFBPs degrading enzymes.,Non-OADS,/arxiv_data1/oa_pdf/5d/3e/BMB-49-122.PMC4915116.pdf
126 BMB Reports http://bmbreports.orgpeated in at least three independent experiments.,OADS,/arxiv_data1/oa_pdf/5d/3e/BMB-49-122.PMC4915116.pdf
127 http://bmbreports.org BMB Reportsform an important regulatory loop in BMP9-induced os- teogenic differentiation of mesenchymal stem cells.,Non-OADS,/arxiv_data1/oa_pdf/5d/3e/BMB-49-122.PMC4915116.pdf
"Tel: +82-53-420-4803; Fax: +82-53-427-  1468; E-mail: irislkm@knu.ac.kr http://dx.doi.org/10.5483/BMBRep.2016.49.2.202Received 7 October 2015, Revised 2 November 2015,  Accepted 9 December 2015 Keywords: Astrocytogenesis, Calcium ion, Exchange protein di- rectly activated by cAMP2 (Epac2), Neural precursor cells (NPCs), Pituitary adenylate cyclase-activating peptide (PACAP) ISSN: 1976-670X (electronic edition) Copyright ⓒ 2016 by the The Korean Society for Biochemistry and Molecular Biology This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://c reativecommons.org/li- censes/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the ori ginal work is properly cited.Epac2 contributes to PACAP-induced astrocytic differentiation  through calcium ion influx in neural precursor cells Hyunhyo Seo & Kyungmin Lee * Department of Anatomy, Brain Science & Engineering Institute, Kyungpook National University Graduate School of Medicine, Daegu  41944, Korea Astrocytes play a critical role in normal brain functions and  maintaining the brain microenvironment, and defects in as-trocytogenesis during neurodevelopment could give rise to se- vere mental illness and psychiatric disorders.",Non-OADS,/arxiv_data1/oa_pdf/da/ed/BMB-49-128.PMC4915117.pdf
 PACAP-Epac2-Ca2＋ signaling during astrocytogenesis Hyunhyo Seo and Kyungmin Lee 129 http://bmbreports.org BMB Reports Fig.,OADS,/arxiv_data1/oa_pdf/da/ed/BMB-49-128.PMC4915117.pdf
 PACAP-Epac2-Ca2＋ signaling during astrocytogenesis Hyunhyo Seo and Kyungmin Lee 130 BMB Reports http://bmbreports.org Fig.,OADS,/arxiv_data1/oa_pdf/da/ed/BMB-49-128.PMC4915117.pdf
 PACAP-Epac2-Ca2＋ signaling during astrocytogenesis Hyunhyo Seo and Kyungmin Lee 131 http://bmbreports.org BMB Reports Fig.,OADS,/arxiv_data1/oa_pdf/da/ed/BMB-49-128.PMC4915117.pdf
 PACAP-Epac2-Ca2＋ signaling during astrocytogenesis Hyunhyo Seo and Kyungmin Lee 132 BMB Reports http://bmbreports.orgpathway controls calcium influx for GFAP expression.,OADS,/arxiv_data1/oa_pdf/da/ed/BMB-49-128.PMC4915117.pdf
GFAP intensity was measured by using Image J 1.47v  (http://imagej.nih.gov/ij).,OADS,/arxiv_data1/oa_pdf/da/ed/BMB-49-128.PMC4915117.pdf
 PACAP-Epac2-Ca2＋ signaling during astrocytogenesis Hyunhyo Seo and Kyungmin Lee 133 http://bmbreports.org BMB Reportsimagej.nih.gov/ij).,OADS,/arxiv_data1/oa_pdf/da/ed/BMB-49-128.PMC4915117.pdf
"Data were normalized  to GAPDH, using Image J 1.47v (http://imagej.nih.gov/ij).",OADS,/arxiv_data1/oa_pdf/da/ed/BMB-49-128.PMC4915117.pdf
"E-mail: jinwookim@kaist.ac.kr http://dx.doi.org/10.5483/BMBRep.2016.49.2.006Received 11 January 2016Keywords: Glutamate excitotoxicity, Intercellular protein transfer,  Mitochondria, Otx2, Retina Abbreviations:  Otx2, orthodentricle homeobox 2; RGC, retinal gan- glion cell Perspective to:  Hyoung-Tai Kim et al., Mitochondrial Protection by  Exogenous Otx2 in Mouse Retinal Neurons.",Non-OADS,/arxiv_data1/oa_pdf/7d/69/BMB-49-69.PMC4915118.pdf
70 BMB Reports http://bmbreports.org Fig.,Non-OADS,/arxiv_data1/oa_pdf/7d/69/BMB-49-69.PMC4915118.pdf
"E-mail: jhlee4246@kaist.ac.kr http://dx.doi.org/10.5483/BMBRep.2016.49.2.010Received 15 January 2016Keywords: Focal cortical dysplasia, Mechanistic target of rapamycin,  Mouse model, Somatic mutation Abbreviations:  EEG, electroencephalogram; FCD, focal cortical dys- plasia; FCDII, focal cortical dysplasia type II; HME, hemimegalen-cephaly; ILAE, International League Against Epilepsy; MCD, mal-formation of cortical development; MTOR, mechanistic target of ra-pamycin; S6K, s6 kinase; SNVs, single nucleotide variants; WES, whole exome sequencing Perspective to:  Lim et al (2015), Brain somatic mutations in MTOR cause focal cortical dysplasia type II leading to intractable epilepsy, Nature Medicine, 21 (4) 395-400.",Non-OADS,/arxiv_data1/oa_pdf/c6/56/BMB-49-71.PMC4915119.pdf
Brain somatic mutations in MTOR leading to focal cortical dysplasia Jae Seok Lim and Jeong Ho Lee 72 BMB Reports http://bmbreports.org Fig.,Non-OADS,/arxiv_data1/oa_pdf/c6/56/BMB-49-71.PMC4915119.pdf
"Tel: +82-2-3290-3457; Fax: +82-2-3290-  3628; E-mail: hksong@korea.ac.kr http://dx.doi.org/10.5483/BMBRep.2016.49.2.265Received 18 December 2015Keywords: Autophagy, LIR motif, Receptor, Selective autophagy,  Ubiquitin binding domain ISSN: 1976-670X (electronic edition) Copyright ⓒ 2016 by the The Korean Society for Biochemistry and Molecular Biology This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://c reativecommons.org/li- censes/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the ori ginal work is properly cited.Structure biology of selective autophagy receptors Byeong-Won Kim, Do Hoon Kwon & Hyun Kyu Song * Department of Life Sciences, Korea University, Seoul 02841, Korea Autophagy is a process tightly regulated by various autoph- agy-related proteins.",Non-OADS,/arxiv_data1/oa_pdf/37/a8/BMB-49-73.PMC4915120.pdf
74 BMB Reports http://bmbreports.org Fig.,Non-OADS,/arxiv_data1/oa_pdf/37/a8/BMB-49-73.PMC4915120.pdf
75 http://bmbreports.org BMB Reports Fig.,Non-OADS,/arxiv_data1/oa_pdf/37/a8/BMB-49-73.PMC4915120.pdf
76 BMB Reports http://bmbreports.org Fig.,Non-OADS,/arxiv_data1/oa_pdf/37/a8/BMB-49-73.PMC4915120.pdf
77 http://bmbreports.org BMB Reports Fig.,Non-OADS,/arxiv_data1/oa_pdf/37/a8/BMB-49-73.PMC4915120.pdf
78 BMB Reports http://bmbreports.orgthe molecular mechanism of each autophagy receptors.,OADS,/arxiv_data1/oa_pdf/37/a8/BMB-49-73.PMC4915120.pdf
79 http://bmbreports.org BMB Reportsmain-containing protein 1 (Stbd1) and glycogen metabo- lism: Identification of the Atg8 family interacting motif (AIM) in Stbd1 required for interaction with GABARAPL1.,Non-OADS,/arxiv_data1/oa_pdf/37/a8/BMB-49-73.PMC4915120.pdf
80 BMB Reports http://bmbreports.orgare both essential yet act differently in autophagosome  biogenesis.,Non-OADS,/arxiv_data1/oa_pdf/37/a8/BMB-49-73.PMC4915120.pdf
"http://dx.doi.org/10.5483/BMBRep.2016.49.2.261Received 18 December 2015Keywords: Aging, C. elegans , D. melanogaster , Insulin/IGF-1 signal- ing, Longevity ISSN: 1976-670X (electronic edition) Copyright ⓒ 2016 by the The Korean Society for Biochemistry and Molecular Biology This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://c reativecommons.org/li- censes/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the ori ginal work is properly cited.The role of insulin/IGF-1 signaling in the longevity of model  invertebrates, C. elegans and D. melanogaster Ozlem Altintas1,#, Sangsoon Park2,# & Seung-Jae V. Lee1,2,3,* 1School of Interdisciplinary Bioscience and Bioengineering, 2Department of Life Sciences, and 3Information Technology Convergence  Engineering, Pohang University of Science and Technology, Pohang 37673, Korea Insulin/insulin-like growth factor (IGF)-1 signaling (IIS) pathway  regulates aging in many organisms, ranging from simple in-vertebrates to mammals, including humans.",Non-OADS,/arxiv_data1/oa_pdf/6f/1f/BMB-49-81.PMC4915121.pdf
82 BMB Reports http://bmbreports.org Fig.,Non-OADS,/arxiv_data1/oa_pdf/6f/1f/BMB-49-81.PMC4915121.pdf
"83 http://bmbreports.org BMB Reportsdeacetylase (42, 44).",OADS,/arxiv_data1/oa_pdf/6f/1f/BMB-49-81.PMC4915121.pdf
84 BMB Reports http://bmbreports.org Fig.,Non-OADS,/arxiv_data1/oa_pdf/6f/1f/BMB-49-81.PMC4915121.pdf
85 http://bmbreports.org BMB ReportsINSULIN/IGF-1 SIGNALING PATHWAY AND  Drosophila melanogaster  AGING Insulin/IGF-1 signaling components implicated in the  longevity of D. melanogaster   The IIS pathway of Drosophila melanogaster  consists of many  components (Fig.,Non-OADS,/arxiv_data1/oa_pdf/6f/1f/BMB-49-81.PMC4915121.pdf
86 BMB Reports http://bmbreports.orgregarding the regulatory mechanisms of aging and longevity at  the molecular level.,OADS,/arxiv_data1/oa_pdf/6f/1f/BMB-49-81.PMC4915121.pdf
"87 http://bmbreports.org BMB Reports11, 1975-1980 26.",Non-OADS,/arxiv_data1/oa_pdf/6f/1f/BMB-49-81.PMC4915121.pdf
88 BMB Reports http://bmbreports.org58.,Non-OADS,/arxiv_data1/oa_pdf/6f/1f/BMB-49-81.PMC4915121.pdf
89 http://bmbreports.org BMB Reports91.,Non-OADS,/arxiv_data1/oa_pdf/6f/1f/BMB-49-81.PMC4915121.pdf
90 BMB Reports http://bmbreports.orgelegans .,Non-OADS,/arxiv_data1/oa_pdf/6f/1f/BMB-49-81.PMC4915121.pdf
91 http://bmbreports.org BMB Reportswith familial amyotrophic lateral sclerosis.,Non-OADS,/arxiv_data1/oa_pdf/6f/1f/BMB-49-81.PMC4915121.pdf
92 BMB Reports http://bmbreports.org688-699 184.,Non-OADS,/arxiv_data1/oa_pdf/6f/1f/BMB-49-81.PMC4915121.pdf
"Tel: +1(252)744-3134; Fax: +1(252)744-  3418; E-mail: leemy@ecu.edu http://dx.doi.org/10.5483/BMBRep.2016.49.2.135Received 30 June 2015, Revised 17 August 2015,  Accepted 18 August 2015 Keywords: Germline stem cells, Cell fate specification, Caenorhabditis  elegans , mRNA selection, Translational control ISSN: 1976-670X (electronic edition) Copyright ⓒ 2016 by the The Korean Society for Biochemistry and Molecular Biology This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://c reativecommons.org/li- censes/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the ori ginal work is properly cited.A systematic mRNA control mechanism for germline stem cell  homeostasis and cell fate specification Myon-Hee Lee1,4,*, Srivalli Swathi Mamillapalli1, Brett D. Keiper2 & Dong Seok Cha3 1Department of Medicine, Hematology/Oncology Division, 2Department of Biochemistry and Molecula r Biology, Brody School of Medicine,  East Carolina University, Greenville, NC 27834, USA, 3Department of Oriental Pharmacy, College of Pharmacy, Woosuk University, Jeonju  55338, Korea, 4Lineberger Comprehensive Cancer Center, University of  North Carolina-Chapel Hill, Chapel Hill, NC 27599, USA Germline stem cells (GSCs) are the best understood adult stem  cell types in the nematode Caenorhabditis elegans , and have  provided an important model system for studying stem cells  and their cell fate in vivo , in mammals.",Non-OADS,/arxiv_data1/oa_pdf/83/b3/BMB-49-93.PMC4915122.pdf
94 BMB Reports http://bmbreports.org Fig.,Non-OADS,/arxiv_data1/oa_pdf/83/b3/BMB-49-93.PMC4915122.pdf
95 http://bmbreports.org BMB Reports Fig.,Non-OADS,/arxiv_data1/oa_pdf/83/b3/BMB-49-93.PMC4915122.pdf
96 BMB Reports http://bmbreports.orgtential target of Ras-ERK MAPK signaling is FOG-3 (a homolog  of TOB/BTG anti-proliferative proteins) (26).,Non-OADS,/arxiv_data1/oa_pdf/83/b3/BMB-49-93.PMC4915122.pdf
"97 http://bmbreports.org BMB ReportsCONCLUSIONS  In this review, we describe a new mechanism for C. elegans   GSC homeostasis and their cell fate specification through sev- eral mRNA selection processes.",Non-OADS,/arxiv_data1/oa_pdf/83/b3/BMB-49-93.PMC4915122.pdf
98 BMB Reports http://bmbreports.org20.,Non-OADS,/arxiv_data1/oa_pdf/83/b3/BMB-49-93.PMC4915122.pdf
"Tel: +3592-9792668; Fax: +3592-8723507; E-mail: eva@bio21.bas.bg http://dx.doi.org/10.5483/BMBRep.2016.49.2.238Received 30 October 2013, Revised 20 November 2013,  Accepted 11 November 2013 Keywords: Acetylation, Cisplatin, HMGB1, NER, Tail-less HMGB1  protein ISSN: 1976-670X (electronic edition) Copyright ⓒ 2016 by the The Korean Society for Biochemistry and Molecular Biology This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://c reativecommons.org/li- censes/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the ori ginal work is properly cited.Non-histone protein HMGB1 inhibits the repair of damaged  DNA by cisplatin in NIH-3T3 murine fibroblasts Shazie Yusein-Myashkova, Iva Ugrinova & Evdokia Pasheva * Institute of Molecular Biology, Roumen Tsanev, Bulgarian Academy of Sciences, Sofia 1113, Bulgaria  The nuclear non-histone protein high mobility group box  (HMGB) 1 is known to having an inhibitory effect on the repair of DNA damaged by the antitumor drug cisplatin in vitro .",Non-OADS,/arxiv_data1/oa_pdf/01/b9/BMB-49-99.PMC4915123.pdf
100 BMB Reports http://bmbreports.org Fig.,Non-OADS,/arxiv_data1/oa_pdf/01/b9/BMB-49-99.PMC4915123.pdf
101 http://bmbreports.org BMB Reports Fig.,Non-OADS,/arxiv_data1/oa_pdf/01/b9/BMB-49-99.PMC4915123.pdf
"102 BMB Reports http://bmbreports.orgDISCUSSION  HMGB1 protein specifically recognizes and binds to UV le- sions (3) and DNA damaged by the anticancer drug cisplatin  (4-6, 21), and the affinity of HMGB1 to the lesions is modu-lated by acetylation (21) and the acidic C-tail (6).",Non-OADS,/arxiv_data1/oa_pdf/01/b9/BMB-49-99.PMC4915123.pdf
"103 http://bmbreports.org BMB Reports57oC/40 s, 72oC/60 s); 72oC/5 min.",OADS,/arxiv_data1/oa_pdf/01/b9/BMB-49-99.PMC4915123.pdf
"104 BMB Reports http://bmbreports.orgS A 105 (30), 10320-10325 15.",Non-OADS,/arxiv_data1/oa_pdf/01/b9/BMB-49-99.PMC4915123.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/eb/bf/rjw045.PMC4915124.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/82/4c/rjw083.PMC4915161.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-Non - Commercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial  usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/28/73/nms-05-01-27763.PMC4915204.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-Non - Commercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial  usages, provided the original work is properly cited.Dear Editor, In the clinical setting of nursing, nurses play a specific  role.",Non-OADS,/arxiv_data1/oa_pdf/54/87/nms-05-01-32371.PMC4915205.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-Non - Commercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial  usages, provided the original work is properly cited.Today , all over the world, university nursing programs  are based on professional academic training (1).",Non-OADS,/arxiv_data1/oa_pdf/4f/61/nms-05-01-34273.PMC4915206.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-Non - Commercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial  usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/b1/80/nms-05-01-31292.PMC4915207.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-Non - Commercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial  usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/19/57/nms-05-01-30360.PMC4915208.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-Non - Commercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial  usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/09/94/nms-05-01-28937.PMC4915209.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-Non - Commercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial  usages, provided the original work is properly cited.Dear Editor, Increasing population has remained a concern for  human societies and is thus frequently discussed by ex - perts and politicians (1).",Non-OADS,/arxiv_data1/oa_pdf/6b/fc/nms-05-01-33325.PMC4915210.pdf
Available from: http://marefatefarhangi.nashriyat.ir/node/95.,Non-OADS,/arxiv_data1/oa_pdf/6b/fc/nms-05-01-33325.PMC4915210.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-Non - Commercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial  usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/f0/12/nms-05-01-29913.PMC4915211.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-Non - Commercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial  usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/1f/7d/nms-05-01-28550.PMC4915212.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-Non - Commercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial  usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/74/3c/nms-05-01-32990.PMC4915214.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/4a/db/rjw047.PMC4915215.pdf
"E-mail: chi13@korea.ac.kr http://dx.doi.org/10.5483/BMBRep.2016.49.3.019Received 1 February 2016Keywords: Abasic pivot substitution, Ago, miRNA, Off-target ef- fect, siRNA, Spacer Abbreviations:  2’-OMe, 2’- O-methyl; Ago, Argonaute; HITS-CLIP ,  high throughput sequencing of RNA isolated by crosslinking and immunoprecipitation; IC 50, half maximal inhibitory concentration;  miRNA, microRNA; mRNA, messenger RNA; PCSK9, proprotein convertase subtilisin/kexin type 9; RISC, RNA induced silencing complex; RNAi, RNA interference; siRNA, small interfering RNA; UNA, unlocked nucleic acid Perspective to:  Lee et al.",Non-OADS,/arxiv_data1/oa_pdf/88/e9/BMB-49-135.PMC4915226.pdf
136 BMB Reports http://bmbreports.org Fig.,Non-OADS,/arxiv_data1/oa_pdf/88/e9/BMB-49-135.PMC4915226.pdf
"Soohong Min, E-mail: msh2001560011@ empas.com, Jongkyeong Chung, E-mail: jkc@snu.ac.kr http://dx.doi.org/10.5483/BMBRep.2016.49.3.046Received 4 March 2016Keywords: Anorexigenic pathway, BW , Food intake, MIP , Satiety Abbreviations:  BW , body weight; MIP , myoinhibitory peptide; PER,  proboscis extension reflex; SPR, sex peptide receptor Perspective to:  Soohong Min et al.",OADS,/arxiv_data1/oa_pdf/50/88/BMB-49-137.PMC4915227.pdf
"(2016), Identification of a pepti- dergic pathway critical to satiety responses in Drosophila, Current Biology, 26, 1 –7, March 21, http://dx.doi.org/10.1016/j.cub.2016.",OADS,/arxiv_data1/oa_pdf/50/88/BMB-49-137.PMC4915227.pdf
"Identification of a neural pathway governing satiety in Drosophila Soohong Min and Jongkyeong Chung 138 BMB Reports http://bmbreports.orgnormal elevation of food intake, accompanied by a marked  BW increase.",Non-OADS,/arxiv_data1/oa_pdf/50/88/BMB-49-137.PMC4915227.pdf
"Tel: +82-32-899-6241; Fax: +82-32-899-  6039; E-mail: hylee@ gachon.ac.kr http://dx.doi.org/10.5483/BMBRep.2016.49.3.268Received 25 December 2015Keywords:  Cardiovascular disease, Diabetic dyslipidemia, Lipid me- tabolites, Insulin resistance, Type 2 diabetes ISSN: 1976-670X (electronic edition) Copyright ⓒ 2016 by the The Korean Society for Biochemistry and Molecular Biology This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://c reativecommons.org/li- censes/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the ori ginal work is properly cited.The role of lipids in the pathogenesis and treatment of type 2  diabetes and associated co-morbidities  Derek M. Erion1, Hyun-Jun Park2 & Hui-Young Lee2,3,* 1Takeda Pharmaceuticals 350 Massachusetts Ave. Cambridge, MA, 02139, USA, 2Department of Molecular Medicine, 3Korea Mouse  Metabolic Phenotyping Center, Lee Gil Ya Cancer and Diabetes Institute, School of Medicine, Gachon University, Incheon 21999, K orea  In the past decade, the incidence of type 2 diabetes (T2D) has  rapidly increased, along with the associated cardiovascular complications.",Non-OADS,/arxiv_data1/oa_pdf/36/23/BMB-49-139.PMC4915228.pdf
"140 BMB Reports http://bmbreports.orgtermined, in part by plasma insulin concentrations (12).",OADS,/arxiv_data1/oa_pdf/36/23/BMB-49-139.PMC4915228.pdf
"141 http://bmbreports.org BMB Reportsminimal benefits on LDL cholesterol and triglycerides, when  correcting for glucose control in diabetic patients (37).",Non-OADS,/arxiv_data1/oa_pdf/36/23/BMB-49-139.PMC4915228.pdf
142 BMB Reports http://bmbreports.orgdiabetics including the high triglyceride:ApoB ratio (53).,Non-OADS,/arxiv_data1/oa_pdf/36/23/BMB-49-139.PMC4915228.pdf
"143 http://bmbreports.org BMB Reportsusing this compound made by Pfizer, predicted minimal changes  in hepatic steatosis based on data from diabetic rats despite the elevated circulated triglycerides (74).",Non-OADS,/arxiv_data1/oa_pdf/36/23/BMB-49-139.PMC4915228.pdf
144 BMB Reports http://bmbreports.org Fig.,Non-OADS,/arxiv_data1/oa_pdf/36/23/BMB-49-139.PMC4915228.pdf
"Novartis has tested the potential of using DGAT1 inhibitors in NASH and has observed reductions in  hepatic fat content (AASLD poster #2147, http://www.aasld.",Non-OADS,/arxiv_data1/oa_pdf/36/23/BMB-49-139.PMC4915228.pdf
145 http://bmbreports.org BMB Reportssteatosis (110-112).,Non-OADS,/arxiv_data1/oa_pdf/36/23/BMB-49-139.PMC4915228.pdf
146 BMB Reports http://bmbreports.orgresistance in conditional X-box-binding protein-1 (XBP1)  knock-out mice.,OADS,/arxiv_data1/oa_pdf/36/23/BMB-49-139.PMC4915228.pdf
147 http://bmbreports.org BMB ReportsNIDDM on very-low-density lipoprotein triglyceride and  apolipoprotein B metabolism.,Non-OADS,/arxiv_data1/oa_pdf/36/23/BMB-49-139.PMC4915228.pdf
148 BMB Reports http://bmbreports.orgPravastatin improved glucose metabolism associated  with increasing plasma adiponectin in patients with im-paired glucose tolerance and coronary artery disease.,Non-OADS,/arxiv_data1/oa_pdf/36/23/BMB-49-139.PMC4915228.pdf
"Tel: +44-131-650-5332; Fax: +44-131-650-  5392; E-mail: gloake@staffmail.ed.ac.uk http://dx.doi.org/10.5483/BMBRep.2016.49.3.264Received 22 December 2015Keywords: Cambial meristematic cells, Hairy root culture, Natural  products, Plant bioreactors, Plant cell culture ISSN: 1976-670X (electronic edition) Copyright ⓒ 2016 by the The Korean Society for Biochemistry and Molecular Biology This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://c reativecommons.org/li- censes/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the ori ginal work is properly cited.Plant cell culture strategies for the production of natural  products Marisol Ochoa-Villarreal1, Susan Howat1, SunMi Hong2, Mi Ok Jang2, Young-Woo Jin2, Eun-Kyong Lee 2 & Gary J. Loake1,* 1Institute of Molecular Plant Sciences, School of Biological Sciences, University of Edinburgh, Edinburgh EH9 3BF, UK, 2Unhwa Corp.,  Jeonju 55017, Korea Plants have evolved a vast chemical cornucopia to support  their sessile lifestyles.",Non-OADS,/arxiv_data1/oa_pdf/5f/0a/BMB-49-149.PMC4915229.pdf
"150 BMB Reports http://bmbreports.orgIndustry Products Species Manufacturer Use/Notes Plant Natural Products Food Anthocyanins Euphorbio milii Aralia cordataNippon Paint Co. Ltd,  Osaka JapanTextile dye Coloring agents  Arbtin Catharanthus roseus Mitsui Chemicals Inc.,  Tokio JapanPigments Betacyanin Beta vulgaris Nippon Shinyaku Co., Ltd Pigments Carthamin Carthamus trinctorius Kibun Foods Inc.,  Tokio JapanPigments Geraniol Geraminea spp.",Non-OADS,/arxiv_data1/oa_pdf/5f/0a/BMB-49-149.PMC4915229.pdf
"151 http://bmbreports.org BMB ReportsIndustry Products Species Manufacturer Use/Notes Heterologous proteins Human Glucocerebrosidase  (GCD) enzymeCarrot suspension  culturesProtalix BioTherapeutics  Karmiel, IsraelELELYSOⓇ Plant cell-expressed form  of the glucocerebrosidase enzyme  for treatment of Gaucher disease Vaccine against Newcastle  disease virus (NDV)Tobacco suspension  culturesDow Agrosciences, LLC,  Indianapolis, USAFirst tobacco cell-based vaccine  approved by the FDA against Newcastle disease virus in poultry Human proteins Physcomitrella patens  suspension culturesGreenovation Biotech  BMBH Freiburg,  Germany -galactosidase for Fabry disease  and -glucocerebrosidase  for Gaucher disease.",Non-OADS,/arxiv_data1/oa_pdf/5f/0a/BMB-49-149.PMC4915229.pdf
152 BMB Reports http://bmbreports.orgreactor production platforms.,OADS,/arxiv_data1/oa_pdf/5f/0a/BMB-49-149.PMC4915229.pdf
"For example, ROOTec has developed a mist-  based bioreactor for the production of a number of high-value NPs from a variety of plant species (http://www.rootec.com/)  Table 1.",Non-OADS,/arxiv_data1/oa_pdf/5f/0a/BMB-49-149.PMC4915229.pdf
"Thus, Root Lines Technology Inc.  (http://www.rootlines-tech.com/) (Table 1) have exploited these properties for the industrial-scale production of recombinant  glycosylated proteins.",Non-OADS,/arxiv_data1/oa_pdf/5f/0a/BMB-49-149.PMC4915229.pdf
"153 http://bmbreports.org BMB Reports(Häkkinen et al., 2014) and in the production of a human anti- body in a BY-2 tobacco cell suspension culture (37).",OADS,/arxiv_data1/oa_pdf/5f/0a/BMB-49-149.PMC4915229.pdf
154 BMB Reports http://bmbreports.orgActivated charcoal has been used to increase the production of  vanilla and coniferyl aldehyde.,Non-OADS,/arxiv_data1/oa_pdf/5f/0a/BMB-49-149.PMC4915229.pdf
155 http://bmbreports.org BMB Reportswill rapidly increase in future years due to the established  manifold advantages of these cells over that of DDCs.,Non-OADS,/arxiv_data1/oa_pdf/5f/0a/BMB-49-149.PMC4915229.pdf
156 BMB Reports http://bmbreports.org Fig.,Non-OADS,/arxiv_data1/oa_pdf/5f/0a/BMB-49-149.PMC4915229.pdf
"157 http://bmbreports.org BMB Reportschem Rev 1, 13-25 20.",Non-OADS,/arxiv_data1/oa_pdf/5f/0a/BMB-49-149.PMC4915229.pdf
158 BMB Reports http://bmbreports.org53.,Non-OADS,/arxiv_data1/oa_pdf/5f/0a/BMB-49-149.PMC4915229.pdf
"http://dx.doi.org/10.5483/BMBRep.2016.49.3.205Received 8 October 2015, Revised 4 November 2015,  Accepted 24 November 2015 Keywords: Apoptosis, DD, DED, TNF ISSN: 1976-670X (electronic edition) Copyright ⓒ 2016 by the The Korean Society for Biochemistry and Molecular Biology This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://c reativecommons.org/li- censes/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the ori ginal work is properly cited.Structural insights of homotypic interaction domains in  the ligand-receptor signal transduction of tumor necrosis factor (TNF) Young-Hoon Park1,#, Mi Suk Jeong1,# & Se Bok Jang1,2,* 1Department of Molecular Biology, College of Natural Sciences, Pusan National University, 2Genetic Engineering Institute, Pusan National  University, Busan 46241, Korea Several members of tumor necrosis factor receptor (TNFR) su- perfamily that these members activate caspase-8 from death-in-ducing signaling complex (DISC) in TNF ligand-receptor signal  transduction have been identified.",Non-OADS,/arxiv_data1/oa_pdf/aa/94/BMB-49-159.PMC4915230.pdf
160 BMB Reports http://bmbreports.org Fig.,Non-OADS,/arxiv_data1/oa_pdf/aa/94/BMB-49-159.PMC4915230.pdf
161 http://bmbreports.org BMB Reports A.,Non-OADS,/arxiv_data1/oa_pdf/aa/94/BMB-49-159.PMC4915230.pdf
"162 BMB Reports http://bmbreports.orghelices 5 and 6 (26, 32, 33).",Non-OADS,/arxiv_data1/oa_pdf/aa/94/BMB-49-159.PMC4915230.pdf
163 http://bmbreports.org BMB Reports A.B.,Non-OADS,/arxiv_data1/oa_pdf/aa/94/BMB-49-159.PMC4915230.pdf
"164 BMB Reports http://bmbreports.orggenerating TRADD-dependent complex (complex IIA) and  RIPK1-dependent complex (complex IIB) (63, 70-72).",OADS,/arxiv_data1/oa_pdf/aa/94/BMB-49-159.PMC4915230.pdf
165 http://bmbreports.org BMB ReportsCAD inhibitor in CAD activation and DNA degradation  during apoptosis.,Non-OADS,/arxiv_data1/oa_pdf/aa/94/BMB-49-159.PMC4915230.pdf
166 BMB Reports http://bmbreports.orgMolecular architecture of the DED chains at the DISC:  regulation of procaspase-8 activation by short DED pro-teins c-FLIP and procaspase-8 prodomain.,OADS,/arxiv_data1/oa_pdf/aa/94/BMB-49-159.PMC4915230.pdf
"Tel: +(011)86 731 88602865; Fax: +(011)  86 731 84591661; E-mail: hufanghf@yeah.net http://dx.doi.org/10.5483/BMBRep.2016.49.3.151Received 16 July 2015, Revised 13 August 2015,  Accepted 1 October 2015 Keywords: Breast cancer, Epigenetics, Glucocorticoid receptor, Kaiso ISSN: 1976-670X (electronic edition) Copyright ⓒ 2016 by the The Korean Society for Biochemistry and Molecular Biology This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://c reativecommons.org/li- censes/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the ori ginal work is properly cited.Kaiso represses the expression of  glucocorticoid receptor via a  methylation-dependent mechanism and attenuates the anti-apoptotic activity of glucocorticoids in breast cancer cells Lin Zhou1,2, Yan Zhong3, Fang-hui Yang1, Zi-bo Li1, Jiang Zhou1, Xie-hong Liu1, Min Li1 & Fang Hu4,* 1Department of Clinical Biochemist ry, Clinical Medicine Laboratory, 2Department of Anatomy Histology and Embryology, Institute of  Neuroscience, Changsha Medical University, Changsha, Hunan 410219, 3Department of Gynaecology and Obstetrics, 4Metabolic Syndrome  Research Center, The Second Xiangya Hospital of Central South University, Changsha, Hunan 410011, China Kaiso is a Pox Virus and Zinc Finger (POZ-ZF) transcription  factor with bi-modal DNA-binding specificity.",Non-OADS,/arxiv_data1/oa_pdf/c5/a9/BMB-49-167.PMC4915231.pdf
"168 BMB Reports http://bmbreports.orgMATERIAL AND METHODS Reagents  Antibodies to Kaiso (6F/6F8), Glucocorticoid Receptor (BuGR2),  phosphor-p65 (ab86299), p65 (ab16502), and Sgk-1 (ab59337) were purchased from Abcam (Cambridge, MA, USA).",Non-OADS,/arxiv_data1/oa_pdf/c5/a9/BMB-49-167.PMC4915231.pdf
169 http://bmbreports.org BMB Reports Fig.,Non-OADS,/arxiv_data1/oa_pdf/c5/a9/BMB-49-167.PMC4915231.pdf
170 BMB Reports http://bmbreports.org Fig.,Non-OADS,/arxiv_data1/oa_pdf/c5/a9/BMB-49-167.PMC4915231.pdf
171 http://bmbreports.org BMB Reports Fig.,Non-OADS,/arxiv_data1/oa_pdf/c5/a9/BMB-49-167.PMC4915231.pdf
172 BMB Reports http://bmbreports.orgfrom cytotoxic side effects of the chemotherapy (11).,Non-OADS,/arxiv_data1/oa_pdf/c5/a9/BMB-49-167.PMC4915231.pdf
"Tel: +82-2-6490-5624; Fax: +82-2-6490-  2662; E-mail: hspark@uos.ac.kr http://dx.doi.org/10.5483/BMBRep.2016.49.3.188Received 16 September 2015, Revised 7 October 2015,  Accepted 27 October 2015 Keywords: CDCA, CYP7A1, HIF-1 , Hypoxia, SHP ISSN: 1976-670X (electronic edition) Copyright ⓒ 2016 by the The Korean Society for Biochemistry and Molecular Biology This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://c reativecommons.org/li- censes/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the ori ginal work is properly cited.Hypoxic repression of CYP7A1  through a HIF-1 - and  SHP-independent mechanism Yunwon Moon, Bongju Park &  Hyunsung Park * Department of Life Science, University of Seoul, Seoul 02504, Korea Liver cells experience hypoxic stress when drug-metabolizing  enzymes excessively consume O 2 for hydroxylation.",Non-OADS,/arxiv_data1/oa_pdf/2b/ef/BMB-49-173.PMC4915232.pdf
174 BMB Reports http://bmbreports.org Fig.,Non-OADS,/arxiv_data1/oa_pdf/2b/ef/BMB-49-173.PMC4915232.pdf
175 http://bmbreports.org BMB Reports Fig.,Non-OADS,/arxiv_data1/oa_pdf/2b/ef/BMB-49-173.PMC4915232.pdf
"176 BMB Reports http://bmbreports.orgConsistent with this idea, we observed that CDCA treatment  recovered SHP expression even under severe hypoxia (Fig.",Non-OADS,/arxiv_data1/oa_pdf/2b/ef/BMB-49-173.PMC4915232.pdf
177 http://bmbreports.org BMB ReportsMeasurement of CDCA levels by performing  high-performance liquid chromatography HepG2 cells were seeded in a 60-mm tissue culture plate and  were grown to 70% confluency for 20 hours.,Non-OADS,/arxiv_data1/oa_pdf/2b/ef/BMB-49-173.PMC4915232.pdf
"178 BMB Reports http://bmbreports.orgBiol Chem 283, 31745-31753 21.",OADS,/arxiv_data1/oa_pdf/2b/ef/BMB-49-173.PMC4915232.pdf
"Tel: +86-13628326226; Fax: +86-238901 1217; E-mail: spinecenter_hu@126.com http://dx.doi.org/10.5483/BMBRep.2016.49.3.206Received 11 October 2015, Revised 10 November 2015, Accepted 15  December 2015 Keywords: Bone morphogenetic protein 9, Dickkopf-1, Mesenchy- mal stem cells, Osteoblast differentiation, Wnt/ -catenin signaling ISSN: 1976-670X (electronic edition) Copyright ⓒ 2016 by the The Korean Society for Biochemistry and Molecular Biology This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://c reativecommons.org/li- censes/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the ori ginal work is properly cited.Dickkopf-1 is involved in BMP9-induced osteoblast  differentiation of C3H10T1/2 mesenchymal stem cells Liangbo Lin, Quanhe Qiu, Nian Zhou, Wen Dong, Jieliang Shen, Wei Jiang, Ji Fang, Jie Hao & Zhenming Hu * Department of Orthopaedic Surgery, the First Affiliated Ho spital of Chongqing Medical University, Chongqing 400016, China Bone morphogenetic protein 9 (BMP9) is a potent inducer of  osteogenic differentiation of mesenchymal stem cells.",Non-OADS,/arxiv_data1/oa_pdf/b7/fd/BMB-49-179.PMC4915233.pdf
180 BMB Reports http://bmbreports.org Fig.,Non-OADS,/arxiv_data1/oa_pdf/b7/fd/BMB-49-179.PMC4915233.pdf
181 http://bmbreports.org BMB Reports Fig.,Non-OADS,/arxiv_data1/oa_pdf/b7/fd/BMB-49-179.PMC4915233.pdf
"182 BMB Reports http://bmbreports.orgDISCUSSION Mesenchymal stem cells (MSCs) are adherent marrow stromal  cells, which can self-renew and have the potential to differ- entiate into osteoblasts, chondrocytes, myoblasts or adipocytes (26).",Non-OADS,/arxiv_data1/oa_pdf/b7/fd/BMB-49-179.PMC4915233.pdf
"183 http://bmbreports.org BMB Reportsmycin, maintained at 37oC in a humidified atmosphere of 5%  CO 2.",Non-OADS,/arxiv_data1/oa_pdf/b7/fd/BMB-49-179.PMC4915233.pdf
184 BMB Reports http://bmbreports.org4.,Non-OADS,/arxiv_data1/oa_pdf/b7/fd/BMB-49-179.PMC4915233.pdf
"Tel: +82-2-3010-4292; Fax: +82-2-3010-  8148; E-mail: hchoe@ulsan.ac.kr http://dx.doi.org/10.5483/BMBRep.2016.49.3.271Received 29 December 2015, Revised 15 January 2016,  Accepted 20 January 2016 Keywords: Crotamine, Macrophage, Nitric oxide, p38, TNF-  ISSN: 1976-670X (electronic edition) Copyright ⓒ 2016 by the The Korean Society for Biochemistry and Molecular Biology This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://c reativecommons.org/li- censes/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the ori ginal work is properly cited.Crotamine stimulates phagocytic activity by inducing nitric  oxide and TNF-  via p38 and NF -B signaling in RAW 264.7  macrophages Kyung Jin Lee1, Yun Kyu Kim1, Martin Krupa2, Anh Ngoc Nguyen2, Bich Hang Do2, Boram Chung2, Thi Thu Trang Vu2,  Song Cheol Kim3 & Han Choe2,* 1Department of Convergence Medicine, Asan Institute for Life Sciences, 2Department of Physiology and Bio-Medical Institute of  Technology, 3Department of Surgery, Division of Hepatobilopancreatic Surgery, University of Ulsan College of Medicine, Asan Medical  Center, Seoul 05505, Korea Crotamine is a peptide toxin found in the venom of the  rattlesnake Crotalus durissus  terrificus and has antiproliferative,  antimicrobial, and antifungal activities.",Non-OADS,/arxiv_data1/oa_pdf/35/bd/BMB-49-185.PMC4915234.pdf
186 BMB Reports http://bmbreports.org Fig.,Non-OADS,/arxiv_data1/oa_pdf/35/bd/BMB-49-185.PMC4915234.pdf
187 http://bmbreports.org BMB Reports Fig.,Non-OADS,/arxiv_data1/oa_pdf/35/bd/BMB-49-185.PMC4915234.pdf
188 BMB Reports http://bmbreports.org Fig.,Non-OADS,/arxiv_data1/oa_pdf/35/bd/BMB-49-185.PMC4915234.pdf
189 http://bmbreports.org BMB ReportsNF-B subunit p65 into the nucleus and the subsequent degra- dation of I B-.,Non-OADS,/arxiv_data1/oa_pdf/35/bd/BMB-49-185.PMC4915234.pdf
190 BMB Reports http://bmbreports.orgStatistical analysis Statistical methods can be found in Supplementary section S4.,Non-OADS,/arxiv_data1/oa_pdf/35/bd/BMB-49-185.PMC4915234.pdf
"http://dx.doi.org/10.5483/BMBRep.2016.49.3.219Received 23 October 2015, Revised 25 November 2015, Accepted 21  January 2016 Keywords: Angiogenesis, Aorta ring, Endothelial cells, Phospholi- pase D, T ube formation, VEGF ISSN: 1976-670X (electronic edition) Copyright ⓒ 2016 by the The Korean Society for Biochemistry and Molecular Biology This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://c reativecommons.org/li- censes/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the ori ginal work is properly cited.Loss of phospholipase D2 impa irs VEGF-induced angiogenesis Chang Sup Lee1,#, Jaewang Ghim1,#, Parkyong Song1, Pann-Ghill Suh2 & Sung Ho Ryu1,* 1Department of Life Sciences, Pohang University of Science and Technology (POSTECH), Pohang 37673, 2School of Life Sciences, Ulsan  National Institute of Science and Technology (UNIST), Ulsan 44919, Korea Vascular endothelial growth factor (VEGF) is a key mediator of  angiogenesis and critical for normal embryonic development and repair of pathophysiological conditions in adults.",Non-OADS,/arxiv_data1/oa_pdf/95/fd/BMB-49-191.PMC4915235.pdf
192 BMB Reports http://bmbreports.org Fig.,Non-OADS,/arxiv_data1/oa_pdf/95/fd/BMB-49-191.PMC4915235.pdf
193 http://bmbreports.org BMB Reports Fig.,Non-OADS,/arxiv_data1/oa_pdf/95/fd/BMB-49-191.PMC4915235.pdf
"194 BMB Reports http://bmbreports.orgin VEGF-mediated angiogenesis, although the cell-type specific  roles of PLD2 in the aortic ring, which comprises multiple cell types, are unclear.",Non-OADS,/arxiv_data1/oa_pdf/95/fd/BMB-49-191.PMC4915235.pdf
"195 http://bmbreports.org BMB ReportsQuantitative PCR (qPCR) Total RNA from iHUVECs was isolated using TRIzol reagent,  and cDNAs were generated from 1 g of total RNA.",OADS,/arxiv_data1/oa_pdf/95/fd/BMB-49-191.PMC4915235.pdf
196 BMB Reports http://bmbreports.orgis required for angiogenesis of intersegmental blood ves- sels in zebrafish.,Non-OADS,/arxiv_data1/oa_pdf/95/fd/BMB-49-191.PMC4915235.pdf
"E-mail: drleedr@cha.ac.kr http://dx.doi.org/10.5483/BMBRep.2016.49.4.055Received 14 March 2016Keywords: ESC derivation, HLA-matched, Pluripotent stem cells,  Somatic cell nuclear transfer, Stem cell bank, Therapeutic cloning Abbreviations:  H3K9me3, histone H3 lysine 9 trimethylation; HLA,  human leukocyte antigen; iPS, induced pluripotent stem cell; SCNT , somatic cell nuclear transfer Perspective to:  Young Gie Chung et al (2015), Histone Demethy- lase Expression Enhances Human Somatic Cell Nuclear Transfer Efficiency and Promotes Derivation of Pluripotent Stem Cells, Cell Stem Cell, 17(6):758-66. doi: 10.1016/j.stem.2015.10.001 ISSN: 1976-670X (electronic edition) Copyright ⓒ 2016 by the The Korean Society for Biochemistry and Molecular Biology This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://c reativecommons.org/li- censes/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the ori ginal work is properly cited.An efficient SCNT technology for the establishment of  personalized and public human pluripotent stem cell banks Jeoung Eun Lee1, Young Gie Chung2, Jin Hee Eum1, Yumie Lee2 & Dong Ryul Lee1,2,3,* 1CHA Stem Cell Institute, CHA University, Seongnam 13488, Korea, 2Research Institute for Stem Cell Research, CHA Health Systems, Los  Angeles, CA 90036, USA, 3Department of Biomedical Science, CHA University, Seongnam 13488, Korea Although three different research groups have reported  successful derivations of human somatic cell nuclear transfer-derived embryonic stem cell (SCNT-ESC) lines using  fetal, neonatal and adult fibroblasts, the extremely poor  development of cloned embryos has hindered its potential applications in regenerative medicine.",Non-OADS,/arxiv_data1/oa_pdf/3c/dc/BMB-49-197.PMC4915236.pdf
"198 BMB Reports http://bmbreports.orgeliminates the reliance on finding specific donors, resulting in  a bigger egg donor pool.",Non-OADS,/arxiv_data1/oa_pdf/3c/dc/BMB-49-197.PMC4915236.pdf
"E-mail: kaang@snu.ac.kr http://dx.doi.org/10.5483/BMBRep.2016.49.4.044Received 3 March 2016Keywords: Contextual fear conditioning, Memory, Nrsn1, Ribo- some profiling Abbreviations:  DEG, differentially expressed genes; ESR1, estrogen  receptor 1; Nrsn1, Neurensin 1; RPF , ribosome-protected fragment Perspective to:  Cho et al (2015), Multiple repressive mechanisms in  the hippocampus during memory formation, Science, 350(6256): 82-7, doi: 10.1126/science.aac7368 ISSN: 1976-670X (electronic edition) Copyright ⓒ 2016 by the The Korean Society for Biochemistry and Molecular Biology This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://c reativecommons.org/li- censes/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the ori ginal work is properly cited.Gene repressive mechanisms in the mouse brain involved in  memory formation Nam-Kyung Yu & Bong-Kiun Kaang * Department of Biological Sciences, College of Natural Sciences, Seoul National University, Seoul 08826, Korea Gene regulation in the brain is essential for long-term plasticity  and memory formation.",Non-OADS,/arxiv_data1/oa_pdf/4a/3c/BMB-49-199.PMC4915237.pdf
"Gene repressive mechanisms in the mouse brain involved in memory formation Nam-Kyung Yu and Bong-Kiun Kaang 200 BMB Reports http://bmbreports.orgfound many DEGs at 5 and 10 min that showed alterations in  RPF rather than in RNA levels, indicating that they were translationally regulated.",Non-OADS,/arxiv_data1/oa_pdf/4a/3c/BMB-49-199.PMC4915237.pdf
"Tel: +82-2-2220-2618; Fax: +82-2-2298-  0319; E-mail: sangsubae@hanyang.ac.kr http://dx.doi.org/10.5483/BMBRep.2016.49.4.042Received 29 February 2016Keywords: CRISPR-Cas system, Crystal structure, Single molecule,  Type I CRISPR, T ype II CRISPR ISSN: 1976-670X (electronic edition) Copyright ⓒ 2016 by the The Korean Society for Biochemistry and Molecular Biology This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://c reativecommons.org/li- censes/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the ori ginal work is properly cited.Structural and dynamic views of the CRISPR-Cas system at the  single-molecule level Seung Hwan Lee1 & Sangsu Bae2,3,* 1Center for Genome Engineering, Institute for Basic Science, Seoul 08826, 2Department of Chemistry, 3Institute for Materials Design,  Hanyang University, Seoul 04763, Korea The CRISPR-Cas system has emerged as a fascinating and im- portant genome editing tool.",Non-OADS,/arxiv_data1/oa_pdf/66/80/BMB-49-201.PMC4915238.pdf
Structural and dynamic views of the CRISPR-Cas system at the single-molecule level Seung Hwan Lee and Sangsu Bae 202 BMB Reports http://bmbreports.org Fig.,OADS,/arxiv_data1/oa_pdf/66/80/BMB-49-201.PMC4915238.pdf
Structural and dynamic views of the CRISPR-Cas system at the single-molecule level Seung Hwan Lee and Sangsu Bae 203 http://bmbreports.org BMB Reports Fig.,OADS,/arxiv_data1/oa_pdf/66/80/BMB-49-201.PMC4915238.pdf
Structural and dynamic views of the CRISPR-Cas system at the single-molecule level Seung Hwan Lee and Sangsu Bae 204 BMB Reports http://bmbreports.orgmovement of single Cas9 proteins (with C-terminal Q-dot la- beling) was tracked using a tethered long DNA curtain assay (Fig.,OADS,/arxiv_data1/oa_pdf/66/80/BMB-49-201.PMC4915238.pdf
Structural and dynamic views of the CRISPR-Cas system at the single-molecule level Seung Hwan Lee and Sangsu Bae 205 http://bmbreports.org BMB Reports Fig.,OADS,/arxiv_data1/oa_pdf/66/80/BMB-49-201.PMC4915238.pdf
Structural and dynamic views of the CRISPR-Cas system at the single-molecule level Seung Hwan Lee and Sangsu Bae 206 BMB Reports http://bmbreports.orgRNA-programmed genome editing in human cells.,OADS,/arxiv_data1/oa_pdf/66/80/BMB-49-201.PMC4915238.pdf
Structural and dynamic views of the CRISPR-Cas system at the single-molecule level Seung Hwan Lee and Sangsu Bae 207 http://bmbreports.org BMB Reportsmolecular biology.,OADS,/arxiv_data1/oa_pdf/66/80/BMB-49-201.PMC4915238.pdf
"Tel: +82-62-715-2485; Fax: +82-62-715-  3411; E-mail: dhkim@gist.ac.kr http://dx.doi.org/10.5483/BMBRep.2016.49.4.193Received 24 September 2015, Revised 20 October 2015,  Accepted 25 October 2015 Keywords: Cariporide, Caspase-3, CHOP , microRNA, Unfolded pro- tein response ISSN: 1976-670X (electronic edition) Copyright ⓒ 2016 by the The Korean Society for Biochemistry and Molecular Biology This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://c reativecommons.org/li- censes/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the ori ginal work is properly cited.miR-185 inhibits endoplasmic reticulum stress-induced  apoptosis by targeting Na+/H+ exchanger-1 in the heart Jin Ock Kim, Eun Jeong Kwon, Dong Woo Song, Jong Sub Lee & Do Han Kim * School of Life Sciences and Systems Biology Research Center, Gwangju Institute of Science and Technology (GIST), Gwangju 61005,  Korea Prolonged ER stress (ERS) can be associated with the induction  of apoptotic cell death in various heart diseases.",Non-OADS,/arxiv_data1/oa_pdf/cc/f9/BMB-49-208.PMC4915239.pdf
209 http://bmbreports.org BMB Reports Fig.,Non-OADS,/arxiv_data1/oa_pdf/cc/f9/BMB-49-208.PMC4915239.pdf
210 BMB Reports http://bmbreports.org Fig.,Non-OADS,/arxiv_data1/oa_pdf/cc/f9/BMB-49-208.PMC4915239.pdf
211 http://bmbreports.org BMB Reports Fig.,Non-OADS,/arxiv_data1/oa_pdf/cc/f9/BMB-49-208.PMC4915239.pdf
212 BMB Reports http://bmbreports.orgexpression prevents ERS-induced apoptosis as shown by  TUNEL assay.,Non-OADS,/arxiv_data1/oa_pdf/cc/f9/BMB-49-208.PMC4915239.pdf
"213 http://bmbreports.org BMB Reportsand Gross GJ (1998) A new sodium/hydrogen exchange  inhibitor, EMD 85131, limits infarct size in dogs when ad-ministered before or after coronary artery occlusion.",Non-OADS,/arxiv_data1/oa_pdf/cc/f9/BMB-49-208.PMC4915239.pdf
"http://dx.doi.org/10.5483/BMBRep.2016.49.4.220Received 24 October 2015, Revised 6 November 2015,  Accepted 16 November 2015 Keywords: Barrier integrity, Dabrafenib, HMGB1, Sepsis ISSN: 1976-670X (electronic edition) Copyright ⓒ 2016 by the The Korean Society for Biochemistry and Molecular Biology This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://c reativecommons.org/li- censes/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the ori ginal work is properly cited.Anti-septic effects of dabrafenib on HMGB1-mediated  inflammatory responses Byeongjin Jung1,#, Hyejin Kang1,#, Wonhwa Lee1,2, Hyun Jin Noh3, You-Sun Kim3, Min-Su Han4, Moon-Chang Baek5,*,  Jaehong Kim6,* & Jong-Sup Bae1,* 1College of Pharmacy, CMRI, Research Institute of Pharmace utical Sciences, Kyungpook Na tional University, Daegu 41566, 2Department  of Biochemistry and Cell Biology, BK21 Plus KNU Biomedical Conv ergence Program, School of Medicine, Kyungpook National Universi ty,  Daegu 41944, 3Department of Biochemistry and Department of Biomedical Sciences, Ajou University School of Medicine, Suwon 16499,  4Laboratory for Arthritis and Bone Biology, Fatima Research Institute, Fatima Hospital, Daegu 41199, 5Department of Molecular Medicine,  CMRI, School of Medicine, Kyungpook National University, Daegu 41944, 6Department of Biochemistry, School of Medicine, Gachon  University, Incheon 21999, Korea A nucleosomal protein, high mobility group box 1 (HMGB1) is  known to be a late mediator of sepsis.",Non-OADS,/arxiv_data1/oa_pdf/31/9e/BMB-49-214.PMC4915240.pdf
215 http://bmbreports.org BMB Reports Fig.,Non-OADS,/arxiv_data1/oa_pdf/31/9e/BMB-49-214.PMC4915240.pdf
216 BMB Reports http://bmbreports.org Fig.,Non-OADS,/arxiv_data1/oa_pdf/31/9e/BMB-49-214.PMC4915240.pdf
217 http://bmbreports.org BMB Reports Fig.,Non-OADS,/arxiv_data1/oa_pdf/31/9e/BMB-49-214.PMC4915240.pdf
218 BMB Reports http://bmbreports.org Fig.,Non-OADS,/arxiv_data1/oa_pdf/31/9e/BMB-49-214.PMC4915240.pdf
"219 http://bmbreports.org BMB ReportsACKNOWLEDGEMENTS This study was supported by the Gachon University research  fund of 2014 (GCU 2014-5099), the National Research Foun- dation of Korea (NRF) funded by the Korea government [MSIP] (Grant No.",Non-OADS,/arxiv_data1/oa_pdf/31/9e/BMB-49-214.PMC4915240.pdf
"Tel: +82-2-880-4802; Fax: +82-2-886-  4805; E-mail: cyun@snu.ac.kr http://dx.doi.org/10.5483/BMBRep.2016.49.4.004Received 9 January 2016, Revised 1 February 2016,  Accepted 11 February 2016 Keywords: Biphasic activation, Cancer cell survival, ERK pathway,  pERK translocation, SW480 cells ISSN: 1976-670X (electronic edition) Copyright ⓒ 2016 by the The Korean Society for Biochemistry and Molecular Biology This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://c reativecommons.org/li- censes/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the ori ginal work is properly cited.Biphasic activation of extracellular signal-regulated kinase  (ERK) 1/2 in epidermal growth factor (EGF)-stimulated SW480 colorectal cancer cells Donghyun Joo1, Jong Soo Woo1, Kwang-Hyun Cho2, Seung Hyun Han3, Tae Sun Min4,  Deok-Chun Yang5 & Cheol-Heui Yun1,* 1Department of Agricultural Biotechnology and Center for Agricultural Biomaterials; Research Institute for Agriculture and Life Sciences,  Seoul National University, Seoul 08826, 2Department of Bio and Brain Engineering, Korea Advanced Institute of Science and Technology  (KAIST), Daejeon 34141, 3Department of Oral Microbiology and Immunology, Dental Research Institute, and BK21 Program, School of  Dentistry, Seoul National University, Seoul 08826, 4National Research Foundation of Korea, Daejeon 34113, 5Korean Ginseng Center and  Ginseng Genetic Resource Bank, Kyung Hee University, Yongin 17104, Korea Cancer cells have different characteristics due to the genetic  differences where these unique features may strongly influence the effectiveness of therapeutic interventions.",Non-OADS,/arxiv_data1/oa_pdf/d1/43/BMB-49-220.PMC4915241.pdf
221 http://bmbreports.org BMB Reports Fig.,Non-OADS,/arxiv_data1/oa_pdf/d1/43/BMB-49-220.PMC4915241.pdf
222 BMB Reports http://bmbreports.org Fig.,Non-OADS,/arxiv_data1/oa_pdf/d1/43/BMB-49-220.PMC4915241.pdf
223 http://bmbreports.org BMB Reports Fig.,Non-OADS,/arxiv_data1/oa_pdf/d1/43/BMB-49-220.PMC4915241.pdf
224 BMB Reports http://bmbreports.orgresponsible for sustained ERK activation.,OADS,/arxiv_data1/oa_pdf/d1/43/BMB-49-220.PMC4915241.pdf
225 http://bmbreports.org BMB Reportsnm).,Non-OADS,/arxiv_data1/oa_pdf/d1/43/BMB-49-220.PMC4915241.pdf
"http://dx.doi.org/10.5483/BMBRep.2016.49.4.260Received 18 December 2015, Revised 11 January 2016, Accepted 15 February 2016 Keywords: Cell death, EBNA1, Epstein-Barr Virus, Knockout, TALEN ISSN: 1976-670X (electronic edition) Copyright ⓒ 2016 by the The Korean Society for Biochemistry and Molecular Biology This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://c reativecommons.org/li- censes/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the ori ginal work is properly cited.Targeted disruption of EBNA1 in EBV-infected cells attenuated  cell growth Ka-Won Noh1,#, Jihyun Park1,# & Myung-Soo Kang1,2,3,* 1Department of Health Sciences and Technology, Samsung Advanced Institute for Health Sciences and Technology (SAIHST),  Sungkyunkwan University, 2Samsung Biomedical Research Institute (SBRI), Samsung Medical Center, Seoul 06351, 3BioMembrane  Plasticity Research Center (MPRC), Seoul National  University College of Medicine, Seoul 03080, Korea  Epstein Barr virus (EBV)-encoded nuclear antigen-1 (EBNA1)  plays a pivotal in an EBV episome replication and persistence.",Non-OADS,/arxiv_data1/oa_pdf/c1/d4/BMB-49-226.PMC4915242.pdf
227 http://bmbreports.org BMB Reports Fig.,Non-OADS,/arxiv_data1/oa_pdf/c1/d4/BMB-49-226.PMC4915242.pdf
228 BMB Reports http://bmbreports.org Fig.,Non-OADS,/arxiv_data1/oa_pdf/c1/d4/BMB-49-226.PMC4915242.pdf
229 http://bmbreports.org BMB Reports Fig.,Non-OADS,/arxiv_data1/oa_pdf/c1/d4/BMB-49-226.PMC4915242.pdf
230 BMB Reports http://bmbreports.orgOne representative clone (BJAB:RAJI E1TN-selected-1 [BJRJST-1])  was presumed to be BJAB from the STR.,Non-OADS,/arxiv_data1/oa_pdf/c1/d4/BMB-49-226.PMC4915242.pdf
"231 http://bmbreports.org BMB ReportsCell culture, transfection, sorting and selection of targeted  cells, verification of gene disruption and rate of EBV genome loss upon E1TN introduction  EBNA1 gene disruption was verified by T7E1 assay as de- scribed (17, 18, 20) (detail in SI).",OADS,/arxiv_data1/oa_pdf/c1/d4/BMB-49-226.PMC4915242.pdf
"Tel: +82-2-3290-3452; Fax: +82-2-3290-  3938; E-mail: jhongkim@korea.ac.kr http://dx.doi.org/10.5483/BMBRep.2016.49.4.002Received 6 January 2016, Revised 13 January 2016, Accepted 16 February 2016 Keywords: BLT2, IL-6, Ramulus mori , Raw264.7 cells, ROS ISSN: 1976-670X (electronic edition) Copyright ⓒ 2016 by the The Korean Society for Biochemistry and Molecular Biology This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://c reativecommons.org/li- censes/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the ori ginal work is properly cited.Anti-inflammatory action of ethanolic extract of Ramulus mori  on the BLT2-linked cascade Geun-Soo Park1, Jeong-Keun Kim2 & Jae-Hong Kim1,* 1Department of Biotechnology, College of Life Scie nces and Biotechnology, Korea University, Seoul 02841, 2Department of Chemical  Engineering and Biotechnology, Korea Polytechnic University, Shihung 15073, Korea Mulberry tree twigs ( Ramulus mori ) contain large amounts of  oxyresveratrols and have traditionally been used as herbal medicines because of their anti-inflammatory properties.",Non-OADS,/arxiv_data1/oa_pdf/55/a2/BMB-49-232.PMC4915243.pdf
233 http://bmbreports.org BMB Reports Fig.,Non-OADS,/arxiv_data1/oa_pdf/55/a2/BMB-49-232.PMC4915243.pdf
234 BMB Reports http://bmbreports.org Fig.,Non-OADS,/arxiv_data1/oa_pdf/55/a2/BMB-49-232.PMC4915243.pdf
235 http://bmbreports.org BMB Reports Fig.,Non-OADS,/arxiv_data1/oa_pdf/55/a2/BMB-49-232.PMC4915243.pdf
"236 BMB Reports http://bmbreports.orgAdditionally, we also observed that RME suppressed the BLT2  expression levels (both the mRNA and protein levels) (Figs.",OADS,/arxiv_data1/oa_pdf/55/a2/BMB-49-232.PMC4915243.pdf
237 http://bmbreports.org BMB Reportsand activator of transcription-3-linked cascade.,OADS,/arxiv_data1/oa_pdf/55/a2/BMB-49-232.PMC4915243.pdf
"Tel: +82-33-250-8532; Fax: +82-33-259-  5665; E-mail: kckim@kangwon.ac.kr http://dx.doi.org/10.5483/BMBRep.2016.49.4.031Received 15 February 2016, Revised 22 February 2016,  Accepted 1 March 2016 Keywords: Anticancer drugs, Doxorubicin, Drug resistance, FosB,  SETDB1 ISSN: 1976-670X (electronic edition) Copyright ⓒ 2016 by the The Korean Society for Biochemistry and Molecular Biology This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://c reativecommons.org/li- censes/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the ori ginal work is properly cited.SETDB1 mediated FosB expression increases the cell  proliferation rate during anticancer drug therapy Han-Heom Na1, Hee-Jung Noh1, Hyang-Min Cheong2, Yoonsung Kang3 & Keun-Cheol Kim1,* 1Department of Biological Sciences, College of Natural Sciences, Kangwon National University, Chuncheon 24341, 2Division of Respiratory  Viruses, Center for Disease Control and Prev ention, Korea National Institute of Health, 3Institute for Diagnostic Markers, Eudipia Inc,  Osong 28160, Korea The efficacy of anticancer drugs depends on a variety of signal- ing pathways, which can be positively or negatively regulated.",Non-OADS,/arxiv_data1/oa_pdf/e1/e2/BMB-49-238.PMC4915244.pdf
239 http://bmbreports.org BMB Reports Fig.,Non-OADS,/arxiv_data1/oa_pdf/e1/e2/BMB-49-238.PMC4915244.pdf
240 BMB Reports http://bmbreports.org Fig.,Non-OADS,/arxiv_data1/oa_pdf/e1/e2/BMB-49-238.PMC4915244.pdf
241 http://bmbreports.org BMB Reports Fig.,Non-OADS,/arxiv_data1/oa_pdf/e1/e2/BMB-49-238.PMC4915244.pdf
242 BMB Reports http://bmbreports.orgwith the appropriate secondary antibodies for 1 hr.,Non-OADS,/arxiv_data1/oa_pdf/e1/e2/BMB-49-238.PMC4915244.pdf
243 http://bmbreports.org BMB Reportscells.,Non-OADS,/arxiv_data1/oa_pdf/e1/e2/BMB-49-238.PMC4915244.pdf
"To view a copy of this license,visit http://creativecommons.org/licenses/by-nc-sa/4.0/ Supplementary Information accompanies the paper on the Neuropsychopharmacology website (http://www.nature.com/npp)Glial dysfunction and pathologic repetitive behaviors T Aida et al 1579 Neuropsychopharmacology",Non-OADS,/arxiv_data1/oa_pdf/8f/39/npp201526a.PMC4915262.pdf
Available from:  https://www.nhmrc.gov.au/_files_nhmrc/publications/attachments/e78.,Non-OADS,/arxiv_data1/oa_pdf/e0/a5/JHRS-9-82.PMC4915290.pdf
Available from: http://www.legislation.gov.uk/ukpga/2003/24/ section/1.,Non-OADS,/arxiv_data1/oa_pdf/e0/a5/JHRS-9-82.PMC4915290.pdf
Available from: http://www.mmc.gov.my/ v1/docs/Assisted%20Reproduction.pdf.,Non-OADS,/arxiv_data1/oa_pdf/e0/a5/JHRS-9-82.PMC4915290.pdf
Available from: http://www.icmr.,Non-OADS,/arxiv_data1/oa_pdf/e0/a5/JHRS-9-82.PMC4915290.pdf
Available from: http://www.prsindia.org/uploads/media/vikas_ doc/docs/1241500084~~DraftARTBill.pdf.,Non-OADS,/arxiv_data1/oa_pdf/e0/a5/JHRS-9-82.PMC4915290.pdf
Available from:  https://www.cornellurology.com/resources/guidelines/.,Non-OADS,/arxiv_data1/oa_pdf/e0/a5/JHRS-9-82.PMC4915290.pdf
Available from: http://www.undesadspd.org/LinkClick.,OADS,/arxiv_data1/oa_pdf/e0/a5/JHRS-9-82.PMC4915290.pdf
Available from: https://www.health.gov.,Non-OADS,/arxiv_data1/oa_pdf/e0/a5/JHRS-9-82.PMC4915290.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/6b/ee/cia-11-797.PMC4915295.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Interventions in Aging 2016:11 797–799Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  797Letteropen access to scientific and medical research Open Access Full text Article http: //dx.doi.org/10.2147/CIA.S11120 2 the association between gastric acid inhibitors  and delirium in geriatric inpatients: implications  for clinical practice and research Ling-ling Zhu1 Quan Zhou2 1VIP Care Ward, Division of Nursing,   the Second Affiliated Hospital,   School of Medicine, Zhejiang  University, Hangzhou, Zhejiang  Province, People’s  republic of China;   2Department of Pharmacy, the  Second Affiliated Hospital, School  of Medicine, Zhejiang  University,   Hangzhou, Zhejiang Province, People’s  republic of ChinaDear editor We read with great interest the prospective observational study by Otremba et al,1  which shows that use of proton-pump inhibitors (PPIs) is one of independent factors  associated with development of delirium in geriatric inpatients (odds ratio [OR] =1.67;  confidence interval [CI] =1.11–2.53; P=0.014).",Non-OADS,/arxiv_data1/oa_pdf/6b/ee/cia-11-797.PMC4915295.pdf
"The effect of co-medicated PPIs on the serum concentration of selec - tive serotonin reuptake inhibitors is more pronounced for omeprazole and esomeprazole  than for lansoprazole and pantoprazole, whereas escitalopram, rather than citalopram  and sertraline, is more susceptible to omeprazole and esomeprazole.6 Therefore,  inappropriate drug combinations of PPI-benzodiazepine or PPI-antidepressants is an  element worthy of consideration when evaluating specific factors for development of  delirium in elderly patients.Correspondence: Quan Zhou Department of Pharmacy, the Second  Affiliated Hospital, School of Medicine,  Zhejiang University, Jiefang road No 88,  Shangcheng District, Hangzhou 310009,  Zhejiang Province, People’s  republic of China tel +86 571 8778 4615  Fax +86 571 8702 2776 email zhouquan142602@zju.edu.c n Journal name: Clinical Interventions in Aging Article Designation: Letter Y ear: 2016 Volume: 11 Running head verso: Zhu and Zhou Running head recto: Delirium and gastric acid inhibitors DOI: http://dx.doi.org/10.2147/CIA.S111202",Non-OADS,/arxiv_data1/oa_pdf/6b/ee/cia-11-797.PMC4915295.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lClinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treatments  intended to prevent or delay the onset of maladaptive correlates of aging  in human beings.",Non-OADS,/arxiv_data1/oa_pdf/6b/ee/cia-11-797.PMC4915295.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/6b/ee/cia-11-797.PMC4915295.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/66/15/cia-11-787.PMC4915296.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Interventions in Aging 2016:11 787–795Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  787OrIg InAl reseArChopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CIA.S10710 2 The development and standardization of self- assessment for hearing screening of the elderly gibbeum Kim1 Wondo na1 gungu Kim1 Woojae han2 Jinsook Kim2 1Department of speech Pathology  and Audiology, hallym University  graduate school, Chuncheon,   republic of Korea; 2Division of  speech Pathology and Audiology,   research Institute of Audiology  and speech Pathology, College of  natural sciences, hallym Universtiy,   Chuncheon, republic of KoreaPurpose:  The present study aimed to develop and standardize a screening tool for elderly  people who wish to check for themselves their level of hearing loss.",Non-OADS,/arxiv_data1/oa_pdf/66/15/cia-11-787.PMC4915296.pdf
"Researchers have argued that hearing loss may result from age-related changes  in auditory processing (peripheral system)4,5 or reflect age-related deterioration in  the cognitive processing of speech (central system)6,7 or both.8,9 Nevertheless, com - mon audiometric results of presbycusis are interpreted as bilateral, symmetrical, and Correspondence: Woojae han Division of speech Pathology and  Audiology, College of natural sciences,  hallym University, hallymdaehakgil 1,  Chuncheon, gangwon-do 24252,  republic of Korea Tel +82 33 248 2216 Fax +82 33 256 3420 email woojaehan@hallym.ac.k rJournal name: Clinical Interventions in Aging Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Kim et al Running head recto: Self-assessment for Hearing Screening of the Elderly DOI: http://dx.doi.org/10.2147/CIA.S107102",Non-OADS,/arxiv_data1/oa_pdf/66/15/cia-11-787.PMC4915296.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lClinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treatments  intended to prevent or delay the onset of maladaptive correlates of aging  in human beings.",Non-OADS,/arxiv_data1/oa_pdf/66/15/cia-11-787.PMC4915296.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/66/15/cia-11-787.PMC4915296.pdf
See: http://creativecommons.org/licenses/by-nc/2.0/ http://creativecommons.org/licenses/by-nc/2.0/legalcode REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/bb/c6/bmjqir-u211050-w4430.PMC4915305.pdf
See: http://creativecommons.org/licenses/by-nc/2.0/ http://creativecommons.org/licenses/by-nc/2.0/legalcode REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/26/0a/bmjqir-u210655-w4292.PMC4915306.pdf
See: http://creativecommons.org/licenses/by-nc/2.0/ http://creativecommons.org/licenses/by-nc/2.0/legalcode REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/e4/f7/bmjqir-u211254-w4531.PMC4915307.pdf
See: http://creativecommons.org/licenses/by-nc/2.0/ http://creativecommons.org/licenses/by-nc/2.0/legalcode REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/f5/d3/bmjqir-u206492-w3442.PMC4915308.pdf
Available from: http://www.rcseng.ac.uk/publications/docs/publication.2007-05-14.3777986999/ 2.,Non-OADS,/arxiv_data1/oa_pdf/f5/d3/bmjqir-u206492-w3442.PMC4915308.pdf
Available from: http://www.rcpsych.ac.uk/pdf/REVAL2013%203%20Good%20Psychiatric%20Practice.pdf 3.,Non-OADS,/arxiv_data1/oa_pdf/f5/d3/bmjqir-u206492-w3442.PMC4915308.pdf
Available from: http://www.who.int/patientsafety/solutions/patientsafety/PS-Solution3.pdf 10.,Non-OADS,/arxiv_data1/oa_pdf/f5/d3/bmjqir-u206492-w3442.PMC4915308.pdf
Available from: https://www.rcoa.ac.uk/sites/default/files/ FPM-clinicians-guide2.pdf 12.,Non-OADS,/arxiv_data1/oa_pdf/f5/d3/bmjqir-u206492-w3442.PMC4915308.pdf
See: http://creativecommons.org/licenses/by-nc/2.0/ http://creativecommons.org/licenses/by-nc/2.0/legalcode REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/7d/3f/bmjqir-u209539-w3933.PMC4915309.pdf
Available from:http://www.scribd.com/doc/51180647/Maudsley-Prescribing-Guidelines- 10th-edition.,Non-OADS,/arxiv_data1/oa_pdf/7d/3f/bmjqir-u209539-w3933.PMC4915309.pdf
Available from: https://www.mencap.org.uk/sites/default/files/documents/2008-03/DBIreport.pdf.,Non-OADS,/arxiv_data1/oa_pdf/7d/3f/bmjqir-u209539-w3933.PMC4915309.pdf
Available from: http://webarchive.nationalarchives.gov.uk/20130107105354/http:/www.dh.gov.uk/prod_consum_dh/groups/dh_digitalassets/@dh/@en/documents/digitalasset/dh_106126.pdf.,OADS,/arxiv_data1/oa_pdf/7d/3f/bmjqir-u209539-w3933.PMC4915309.pdf
Available from: http://www.nice.org.uk/guidance/gid-cgwave0654/documents/challenging-behaviour-and-learning-disability-final-scope3.,Non-OADS,/arxiv_data1/oa_pdf/7d/3f/bmjqir-u209539-w3933.PMC4915309.pdf
Available from: http://www.nice.org.uk/guidance/NG11.,Non-OADS,/arxiv_data1/oa_pdf/7d/3f/bmjqir-u209539-w3933.PMC4915309.pdf
Available from: Available at: http://hosted.southglos.gov.uk/wv/summary.pdf.,Non-OADS,/arxiv_data1/oa_pdf/7d/3f/bmjqir-u209539-w3933.PMC4915309.pdf
Available from: http://www.england.nhs.uk/ wp-content/uploads/2014/11/transforming-commissioning-services.,Non-OADS,/arxiv_data1/oa_pdf/7d/3f/bmjqir-u209539-w3933.PMC4915309.pdf
Available from: http://www.england.nhs.uk/wp-content/uploads/2015/07/med-advice-ld-letter.pdf.,Non-OADS,/arxiv_data1/oa_pdf/7d/3f/bmjqir-u209539-w3933.PMC4915309.pdf
Available from: http://www.improvinghealthandlives.org.uk/securefiles/150730_0854//Psychotropic%20medication%20and%20people%20with%20learning%20disabilities%20or%20autism.pdf.,Non-OADS,/arxiv_data1/oa_pdf/7d/3f/bmjqir-u209539-w3933.PMC4915309.pdf
Available from: http://www.rcpsych.ac.uk/pdf/QIF%20poster.pdf.,Non-OADS,/arxiv_data1/oa_pdf/7d/3f/bmjqir-u209539-w3933.PMC4915309.pdf
Available from: http://www.nhsiq.nhs.uk/media/2641823/wandsworth_camhs_final_report_2015.pdf.,Non-OADS,/arxiv_data1/oa_pdf/7d/3f/bmjqir-u209539-w3933.PMC4915309.pdf
Available from: http://www.nhsiq.nhs.uk/media/2641818/sussex_partnership_nhs_ft_final_report_2015.pdf.,Non-OADS,/arxiv_data1/oa_pdf/7d/3f/bmjqir-u209539-w3933.PMC4915309.pdf
See: http://creativecommons.org/licenses/by-nc/2.0/ http://creativecommons.org/licenses/by-nc/2.0/legalcode REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/02/cc/bmjqir-u206760-w2754.PMC4915310.pdf
Available from: http://hcai.dh.gov.uk/files/2011/03/Document_Blood_culture_FINAL_100826.pdf.,Non-OADS,/arxiv_data1/oa_pdf/02/cc/bmjqir-u206760-w2754.PMC4915310.pdf
Available from: https://www.gov.uk/guidance/ amrhai-reference-unit-reference-and-diagnostic-services.,Non-OADS,/arxiv_data1/oa_pdf/02/cc/bmjqir-u206760-w2754.PMC4915310.pdf
"3, 207–212 http://dx.doi.org/10.3109/13625187.2015.1137280 NEW DEVELOPMENTS Midwives as drivers of reproductive health commodity security in Kaduna State, Nigeria Audu Alayandea, Fatima Mamman-Dauraa, Olanike Adedejiaand Ado Zakari Muhammadb aUnited Nations Population Fund, Abuja, Nigeria;bKaduna State Ministry of Health, Kaduna, Nigeria ABSTRACT Objectives : The significant improvement in the contraceptive prevalence rate in Kaduna State, Nigeria, from 8.4% in 2008 to 18.5% in 2013 is a notable achievement.",Non-OADS,/arxiv_data1/oa_pdf/e2/3c/iejc-21-207.PMC4915338.pdf
Available from: http://www.dktinternational.org/publications- resources/newsletters/.,Non-OADS,/arxiv_data1/oa_pdf/e2/3c/iejc-21-207.PMC4915338.pdf
"This is an Open Access article distribut ed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/4.0/), which permits non-commercial re- use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/13/d2/msw044.PMC4915351.pdf
thaliana were obtained from the Arabidopsis interac- tome database (ftp://ftp.arabidopsis.org/home/tair/Proteins/ Protein_interaction_data/Interactome2.0/).,OADS,/arxiv_data1/oa_pdf/13/d2/msw044.PMC4915351.pdf
"This is an Open Access article distribut ed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/4.0/), which permits non-commercial re- use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/a5/03/msw049.PMC4915354.pdf
Genotype Frequency of rs66698963 in 1000GP VCF files of genetic variations data from the 1000GP (phase 3) were downloaded from the official FTP site (ftp://ftp.1000genomes.ebi.ac.uk/vol1/ftp/release/20130502/).,OADS,/arxiv_data1/oa_pdf/a5/03/msw049.PMC4915354.pdf
"This is an Open Access article distribut ed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/4.0/), which permits non-commercial re- use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/17/d3/msw050.PMC4915355.pdf
Supplementary Material Supplementary tables S1–S4 and figure S1 a r ea v a i l a b l ea t Molecular Biology and Evolution online (http://www.mbe.ox fordjournals.org/).,Non-OADS,/arxiv_data1/oa_pdf/17/d3/msw050.PMC4915355.pdf
"This is an Open Access article distribut ed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/4.0/), which permits non-commercial re- use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/52/8f/msw051.PMC4915356.pdf
"2006 )w i t hd e - fault parameters implemented in bwa-0.7.10 using the BWA- MEM algorithm (Li H, unpublished data, http://arxiv.org/abs/ 1303.3997, last accessed May 26, 2013).",OADS,/arxiv_data1/oa_pdf/52/8f/msw051.PMC4915356.pdf
"In order to account for the occurrence of PCR duplicates introduced du ring library construction, we used MarkDuplicates in Picard (http://picard.sourceforge.net) to remove reads with identical external coordinates and insertlengths.",Non-OADS,/arxiv_data1/oa_pdf/52/8f/msw051.PMC4915356.pdf
"GO Enrichment To determine whether any functional classes of genes wereoverrepresented among regions that were candidates for be- ing under selection, we performed functional enrichment analysis of GO using Fisher’s exact test by agriGO’s TermEnrichment tool (http://bioinfo.cau.edu.cn/agriGO/index.",OADS,/arxiv_data1/oa_pdf/52/8f/msw051.PMC4915356.pdf
"This is an Open Access article distribut ed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/4.0/), which permits non-commercial re- use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/7f/37/msw063.PMC4915360.pdf
Supplementary Material Supplementary files S1 and S2are available at Molecular Biology and Evolution online (http://www.mbe.oxfordjour nals.org/).,Non-OADS,/arxiv_data1/oa_pdf/7f/37/msw063.PMC4915360.pdf
"Here, the recent progresses in analyses ofKeywords: Hsp70, nuclear import, SSA2 , starvation, transport carrier, tRNA, yeast © Tohru Yoshihisa *Correspondence to: Tohru Yoshihisa; Email:tyoshihi@sci.u-hyogo.ac.jp Submitted: 07/20/2015 Revised: 08/04/2015Accepted: 08/10/2015http://dx.doi.org/10.1080/19491034.2015.1082696 This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non- Commercial License (http://creativecommons.org/ licenses/by-nc/3.0/), which permits unrestrictednon-commercial use, distribution, and reproduction in any medium, provided the original work is prop- erly cited.",Non-OADS,/arxiv_data1/oa_pdf/55/6d/kncl-06-05-1082696.PMC4915482.pdf
"eLife 2015; 4:e04659;PMID:25853343; http://dx.doi.org/10.7554/ eLife.04659 www.tandfonline.com 339 NucleusNucleus 6:5, 339--343; September/October 2015; Published with license by Taylor and Francis Group, LLCEXTRA VIEW",Non-OADS,/arxiv_data1/oa_pdf/55/6d/kncl-06-05-1082696.PMC4915482.pdf
Mol Biol Cell 2003; 14:3266-79; PMID:12925762; http://dx.doi.org/10.1091/mbc.,Non-OADS,/arxiv_data1/oa_pdf/55/6d/kncl-06-05-1082696.PMC4915482.pdf
Genes Cells 2007; 12:285-97; PMID:17352735; http://dx.doi.org/10.1111/j.1365-2443.2007.01056.x 3.,OADS,/arxiv_data1/oa_pdf/55/6d/kncl-06-05-1082696.PMC4915482.pdf
Science 2005; 309:140-2; PMID:15905365; http://dx.doi.org/ 10.1126/science.1113346 4.,OADS,/arxiv_data1/oa_pdf/55/6d/kncl-06-05-1082696.PMC4915482.pdf
Proc Natl Acad Sci U S A 2005; 102:11290-5; PMID:16040803; http://dx.doi.org/ 10.1073/pnas.0503836102 5.,OADS,/arxiv_data1/oa_pdf/55/6d/kncl-06-05-1082696.PMC4915482.pdf
Genetics 2013; 194:43-67;PMID:23633143; http://dx.doi.org/10.1534/ genetics.112.147470 6.,Non-OADS,/arxiv_data1/oa_pdf/55/6d/kncl-06-05-1082696.PMC4915482.pdf
Mol Cell 1998; 1:359-69; PMID:9660920; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/55/6d/kncl-06-05-1082696.PMC4915482.pdf
EMBO J 1998; 17:7430-41; PMID:9857198; http://dx.doi.org/10.1093/emboj/17.24.7430 10.,Non-OADS,/arxiv_data1/oa_pdf/55/6d/kncl-06-05-1082696.PMC4915482.pdf
EMBO J 2002; 21:6205-15; PMID:12426392; http://dx.doi.org/10.1093/emboj/cdf613 11.,OADS,/arxiv_data1/oa_pdf/55/6d/kncl-06-05-1082696.PMC4915482.pdf
EMBO J 2002; 21:6216- 24; PMID:12426393; http://dx.doi.org/10.1093/emboj/cdf620 12.,Non-OADS,/arxiv_data1/oa_pdf/55/6d/kncl-06-05-1082696.PMC4915482.pdf
eLife 2015; 4:e04659; PMID:25853343; http://dx.doi.org/10.7554/eLife.04659 13.,Non-OADS,/arxiv_data1/oa_pdf/55/6d/kncl-06-05-1082696.PMC4915482.pdf
Mol Biol Cell 2007; 18:2678-86; PMID:17475781; http://dx.doi.org/10.1091/mbc.E07-01-0006 15.,Non-OADS,/arxiv_data1/oa_pdf/55/6d/kncl-06-05-1082696.PMC4915482.pdf
2015; 29:772-83; PMID:25838545; http://dx.doi.org/10.1101/ gad.258293.115 18.,Non-OADS,/arxiv_data1/oa_pdf/55/6d/kncl-06-05-1082696.PMC4915482.pdf
Mol Cell Biol 1987: 7:2568-77; PMID:3302682; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/55/6d/kncl-06-05-1082696.PMC4915482.pdf
Nat Rev Mol Cell Biol 2004; 5:781-91; PMID:15459659; http://dx.doi.org/10.1038/nrm1492 20.,OADS,/arxiv_data1/oa_pdf/55/6d/kncl-06-05-1082696.PMC4915482.pdf
Nat Rev Mol Cell Biol 2010; 11:579-92;PMID:20651708; http://dx.doi.org/10.1038/nrm2941 21.,OADS,/arxiv_data1/oa_pdf/55/6d/kncl-06-05-1082696.PMC4915482.pdf
The translation machinery and 70kd heat shock protein cooperate in protein synthesis.Cell 1992; 71:97-105; PMID:1394434; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/55/6d/kncl-06-05-1082696.PMC4915482.pdf
J Biol Chem 2010; 285: 21282-91; PMID:20439464; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/55/6d/kncl-06-05-1082696.PMC4915482.pdf
Cell 2013; 152:1218-21; PMID:23498931; http://dx.doi.org/10.1016/j.cell.2013.02.042 24.,OADS,/arxiv_data1/oa_pdf/55/6d/kncl-06-05-1082696.PMC4915482.pdf
Genetics 2007; 176:841-52; PMID:17409072; http://dx.doi.org/10.1534/ genetics.106.069732 25.,Non-OADS,/arxiv_data1/oa_pdf/55/6d/kncl-06-05-1082696.PMC4915482.pdf
Mol Biol Cell 2011;22:1091-103; PMID:21289100; http://dx.doi.org/ 10.1091/mbc.E09-07-0594 26.,Non-OADS,/arxiv_data1/oa_pdf/55/6d/kncl-06-05-1082696.PMC4915482.pdf
Mol Biol Cell 2014;25:2840-52; PMID:25057022; http://dx.doi.org/ 10.1091/mbc.E14-04-0948 27.,Non-OADS,/arxiv_data1/oa_pdf/55/6d/kncl-06-05-1082696.PMC4915482.pdf
PLoS One 2012; 7:e42501; PMID:22880006; http://dx.doi.org/ 10.1371/journal.pone.0042501 28.,Non-OADS,/arxiv_data1/oa_pdf/55/6d/kncl-06-05-1082696.PMC4915482.pdf
Nature 2003; 425:737-41; PMID:14562106; http://dx.doi.org/10.1038/nature02046 29.,Non-OADS,/arxiv_data1/oa_pdf/55/6d/kncl-06-05-1082696.PMC4915482.pdf
EMBO J 2006; 25:2142-54; PMID:16642040; http://dx.doi.org/10.1038/sj.emboj.,OADS,/arxiv_data1/oa_pdf/55/6d/kncl-06-05-1082696.PMC4915482.pdf
Cell Mol Life Sci 2006; 63:1813-8; PMID:16794784; http://dx.doi.org/10.1007/s00018- 006-6092-9 32.,OADS,/arxiv_data1/oa_pdf/55/6d/kncl-06-05-1082696.PMC4915482.pdf
Science 2011; 334:817-21; PMID:22076379; http://dx.doi.org/10.1126/science.1213671 34.,Non-OADS,/arxiv_data1/oa_pdf/55/6d/kncl-06-05-1082696.PMC4915482.pdf
Mol Cell Biol 2013; 33:4241-54; PMID:23979602; http://dx.doi.org/ 10.1128/MCB.00785-13 35.,Non-OADS,/arxiv_data1/oa_pdf/55/6d/kncl-06-05-1082696.PMC4915482.pdf
PLoS Biol 2006; 4:e332; PMID:17020411; http://dx.doi.org/10.1371/journal.pbio.0040332 36.,Non-OADS,/arxiv_data1/oa_pdf/55/6d/kncl-06-05-1082696.PMC4915482.pdf
PLoS Pathog 2011; 7:e1002194; PMID:21901095; http://dx.doi.org/10.1371/journal.ppat.1002194 www.tandfonline.com 343 Nucleus,Non-OADS,/arxiv_data1/oa_pdf/55/6d/kncl-06-05-1082696.PMC4915482.pdf
"Therefore, it isnot surprising that aberrant gene expression patterns often corre-late with development and progression to pathological situations.Mechanistically, different elements such as enhancers, promoters,and their target genes have to be brought together in close spatial © Deepak Babu and Melissa J Fullwood *Correspondence to: Melissa J Fullwood; Email: melissa.fullwood@nus.edu.sg Submitted: 06/10/2015; Revised: 09/28/2015; Accepted: 10/06/2015http://dx.doi.org/10.1080/19491034.2015.1106676 This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/), which permits unrestricted non-commercial use,distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/1f/88/kncl-06-05-1106676.PMC4915485.pdf
Cold Spring Harb Perspect Biol 2010; 2(3):a003889; PMID:20300217; http://dx.doi.org/10.1101/cshperspect.a003889 2.,Non-OADS,/arxiv_data1/oa_pdf/1f/88/kncl-06-05-1106676.PMC4915485.pdf
Nat Genet 2009; 41(8):882-4; PMID:19561607; http://dx.doi.org/ 10.1038/ng.403 3.,Non-OADS,/arxiv_data1/oa_pdf/1f/88/kncl-06-05-1106676.PMC4915485.pdf
PLoS Genet 2010; 6(9):e1001126;PMID:20862326; http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/1f/88/kncl-06-05-1106676.PMC4915485.pdf
PLoS Genet 2011; 7(7): e1002165; PMID:21814516; http://dx.doi.org/ 10.1371/journal.pgen.1002165 5.,Non-OADS,/arxiv_data1/oa_pdf/1f/88/kncl-06-05-1106676.PMC4915485.pdf
Science 1993; 261(5118):203-6; PMID:8327891; http://dx.doi.org/10.1126/science.8327891 7.,OADS,/arxiv_data1/oa_pdf/1f/88/kncl-06-05-1106676.PMC4915485.pdf
Nat Biotechnol 2012; 30(1):90-8; PMID:22198700; http://dx.doi.org/10.1038/nbt.2057 9.,Non-OADS,/arxiv_data1/oa_pdf/1f/88/kncl-06-05-1106676.PMC4915485.pdf
Nat Genet 2006; 38(11):1348-54; PMID:17033623; http://dx.doi.org/10.1038/ng1896 10.,Non-OADS,/arxiv_data1/oa_pdf/1f/88/kncl-06-05-1106676.PMC4915485.pdf
Nat Genet 2006; 38(11):1341-7; PMID:17033624; http://dx.doi.org/10.1038/ng1891 11.,OADS,/arxiv_data1/oa_pdf/1f/88/kncl-06-05-1106676.PMC4915485.pdf
Genome Res 2006; 16(10):1299-309;PMID:16954542; http://dx.doi.org/10.1101/ gr.5571506 12.,OADS,/arxiv_data1/oa_pdf/1f/88/kncl-06-05-1106676.PMC4915485.pdf
Nature 2009; 462(7269):58- 64; PMID:19890323; http://dx.doi.org/10.1038/ nature08497 13.,Non-OADS,/arxiv_data1/oa_pdf/1f/88/kncl-06-05-1106676.PMC4915485.pdf
Science 2009; 326 (5950):289-93; PMID:19815776; http://dx.doi.org/10.1126/science.1181369 14.,Non-OADS,/arxiv_data1/oa_pdf/1f/88/kncl-06-05-1106676.PMC4915485.pdf
Science 2002; 295(5558):1306-11; PMID:11847345; http://dx.doi.org/ 10.1126/science.1067799 15.,OADS,/arxiv_data1/oa_pdf/1f/88/kncl-06-05-1106676.PMC4915485.pdf
Nature 2010; 465(7296):363-7; PMID:20436457; http://dx.doi.org/10.1038/nature08973 18.,Non-OADS,/arxiv_data1/oa_pdf/1f/88/kncl-06-05-1106676.PMC4915485.pdf
Cell 2014; 159(7):1665-80; PMID:25497547; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/1f/88/kncl-06-05-1106676.PMC4915485.pdf
PLoS Biol 2006; 4(5):e138; PMID:16623600; http://dx.doi.org/ 10.1371/journal.pbio.0040138 20.,Non-OADS,/arxiv_data1/oa_pdf/1f/88/kncl-06-05-1106676.PMC4915485.pdf
Nat Rev Genet 2001; 2(4):292-301; PMID:11283701; http://dx.doi.org/10.1038/ 35066075 21.,Non-OADS,/arxiv_data1/oa_pdf/1f/88/kncl-06-05-1106676.PMC4915485.pdf
Nat Genet 2004; 36(10):1065-71; PMID:15361872; http://dx.doi.org/10.1038/ng1423 22.,Non-OADS,/arxiv_data1/oa_pdf/1f/88/kncl-06-05-1106676.PMC4915485.pdf
Nature 2013; 502(7469):59-64; PMID:24067610; http://dx.doi.org/10.1038/nature12593 23.,Non-OADS,/arxiv_data1/oa_pdf/1f/88/kncl-06-05-1106676.PMC4915485.pdf
Cell 2012; 148(1-2):84-98; PMID:22265404; http://dx.doi.org/10.1016/j.cell.2011.12.014 24.,OADS,/arxiv_data1/oa_pdf/1f/88/kncl-06-05-1106676.PMC4915485.pdf
Nature 2000; 405(6785):482-5; PMID:10839546; http://dx.doi.org/10.1038/35013100 25.,Non-OADS,/arxiv_data1/oa_pdf/1f/88/kncl-06-05-1106676.PMC4915485.pdf
J Exp Med 2008;205(4):785-98; PMID:18347100; http://dx.doi.org/ 10.1084/jem.20071843 26.,Non-OADS,/arxiv_data1/oa_pdf/1f/88/kncl-06-05-1106676.PMC4915485.pdf
Nat Genet 2011; 43(7):630-8; PMID:21685913; http://dx.doi.org/10.1038/ng.85728.,OADS,/arxiv_data1/oa_pdf/1f/88/kncl-06-05-1106676.PMC4915485.pdf
Proc Natl Acad Sci U S A 2008; 105(51):20398-403; PMID:19074263; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/1f/88/kncl-06-05-1106676.PMC4915485.pdf
Nature 2009; 461 (7261):199-205; PMID:19741700; http://dx.doi.org/ 10.1038/nature08451 31.,Non-OADS,/arxiv_data1/oa_pdf/1f/88/kncl-06-05-1106676.PMC4915485.pdf
Genome Res 2014; 24(12):1905-17; PMID:25228660; http://dx.doi.org/10.1101/ gr.176586.114 32.,OADS,/arxiv_data1/oa_pdf/1f/88/kncl-06-05-1106676.PMC4915485.pdf
Annu Rev Genet 2009; 43:525-58;PMID:19886810; http://dx.doi.org/10.1146/ annurev-genet-102108-134233 33.,Non-OADS,/arxiv_data1/oa_pdf/1f/88/kncl-06-05-1106676.PMC4915485.pdf
Cell 2003; 112(6):765-77; PMID:12654244; http://dx.doi.org/10.1016/S0092- 8674(03)00162-4 3 4 .,OADS,/arxiv_data1/oa_pdf/1f/88/kncl-06-05-1106676.PMC4915485.pdf
Nature 2008; 454(7202):297-301; PMID:18596691; http://dx.doi.org/10.1038/nature07098 35.,Non-OADS,/arxiv_data1/oa_pdf/1f/88/kncl-06-05-1106676.PMC4915485.pdf
Annu Rev Biochem 2005; 74:595-648; PMID:15952899; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/1f/88/kncl-06-05-1106676.PMC4915485.pdf
Trends Genet 2006; 22 (4):218-24; PMID:16497408; http://dx.doi.org/ 10.1016/j.tig.2006.02.007 38.,OADS,/arxiv_data1/oa_pdf/1f/88/kncl-06-05-1106676.PMC4915485.pdf
Proc Natl Acad Sci U S A 2008; 105(9):3443-8; PMID:18299561; http://dx.doi.org/ 10.1073/pnas.0712384105 39.,OADS,/arxiv_data1/oa_pdf/1f/88/kncl-06-05-1106676.PMC4915485.pdf
Genome Res 2013; 23(8):1224-34; PMID:23704192; http://dx.doi.org/10.1101/gr.156570.113 41.,OADS,/arxiv_data1/oa_pdf/1f/88/kncl-06-05-1106676.PMC4915485.pdf
Trends Bio- chem Sci 2010; 35(6):315-22; PMID:20299225; http://dx.doi.org/10.1016/j.tibs.2010.02.004 42.,OADS,/arxiv_data1/oa_pdf/1f/88/kncl-06-05-1106676.PMC4915485.pdf
Semin Cell Dev Biol 2011; 22 (7):776-87; PMID:21840410; http://dx.doi.org/10.1016/j.semcdb.2011.07.024 43.,OADS,/arxiv_data1/oa_pdf/1f/88/kncl-06-05-1106676.PMC4915485.pdf
Nature 2010; 467(7314):430-5; PMID:20720539; http://dx.doi.org/10.1038/ nature09380 44.,Non-OADS,/arxiv_data1/oa_pdf/1f/88/kncl-06-05-1106676.PMC4915485.pdf
Genome Biol 2015; 16:145; PMID:26235388; http://dx.doi.org/ 10.1186/s13059-015-0719-9 46.,OADS,/arxiv_data1/oa_pdf/1f/88/kncl-06-05-1106676.PMC4915485.pdf
Cell Rep 2015; 12(2):272-85; PMID:26146084; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/1f/88/kncl-06-05-1106676.PMC4915485.pdf
Nat Genet 2002; 32(4):623-6; PMID:12426570; http://dx.doi.org/10.1038/ng1051 49.,Non-OADS,/arxiv_data1/oa_pdf/1f/88/kncl-06-05-1106676.PMC4915485.pdf
Devel- opment 2005; 132(4):797-803; PMID:15677727;http://dx.doi.org/10.1242/dev.01613 50.,Non-OADS,/arxiv_data1/oa_pdf/1f/88/kncl-06-05-1106676.PMC4915485.pdf
Hum Mol Genet 2003; 12(14):1725-35; PMID:12837695; http://dx.doi.org/10.1093/hmg/ ddg180 51.,OADS,/arxiv_data1/oa_pdf/1f/88/kncl-06-05-1106676.PMC4915485.pdf
Proc Natl Acad Sci U S A 2002; 99(11):7548-53; PMID:12032320; http://dx.doi.org/ 10.1073/pnas.112212199 52.,OADS,/arxiv_data1/oa_pdf/1f/88/kncl-06-05-1106676.PMC4915485.pdf
Nature 2013;504(7479):306-10; PMID:24213634; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/1f/88/kncl-06-05-1106676.PMC4915485.pdf
Cell Rep 2012; 2 (5):1207-19; PMID:23103170; http://dx.doi.org/ 10.1016/j.celrep.2012.09.022 54.,OADS,/arxiv_data1/oa_pdf/1f/88/kncl-06-05-1106676.PMC4915485.pdf
Cell Res 2012; 22(3):490-503; PMID:22270183;http://dx.doi.org/10.1038/cr.2012.15 55.,OADS,/arxiv_data1/oa_pdf/1f/88/kncl-06-05-1106676.PMC4915485.pdf
Cell 2013; 155 (3):606-20; PMID:24243018; http://dx.doi.org/ 10.1016/j.cell.2013.09.051 56.,OADS,/arxiv_data1/oa_pdf/1f/88/kncl-06-05-1106676.PMC4915485.pdf
Genes Dev 2008; 22(1):20-5; PMID:18172162; http://dx.doi.org/10.1101/gad.45400858.,OADS,/arxiv_data1/oa_pdf/1f/88/kncl-06-05-1106676.PMC4915485.pdf
PLoS One 2008; 3(2):e1661;PMID:18286208; http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/1f/88/kncl-06-05-1106676.PMC4915485.pdf
Cell 2005; 123(7):1227-40; PMID:16377564; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/1f/88/kncl-06-05-1106676.PMC4915485.pdf
Nat Genet 2004; 36(9):1014-8; PMID:15314641; http://dx.doi.org/ 10.1038/ng1411 62.,Non-OADS,/arxiv_data1/oa_pdf/1f/88/kncl-06-05-1106676.PMC4915485.pdf
Cell 2002; 108 (4):501-12; PMID:11909521; http://dx.doi.org/ 10.1016/S0092-8674(02)00617-7 63.,OADS,/arxiv_data1/oa_pdf/1f/88/kncl-06-05-1106676.PMC4915485.pdf
Genes Dev 2005; 19(24):2969-78; PMID:16319194; http://dx.doi.org/10.1101/gad.1362305 64.,OADS,/arxiv_data1/oa_pdf/1f/88/kncl-06-05-1106676.PMC4915485.pdf
Nature 2008; 456(7221):470-6;PMID:18978772; http://dx.doi.org/10.1038/ nature07509 65.,Non-OADS,/arxiv_data1/oa_pdf/1f/88/kncl-06-05-1106676.PMC4915485.pdf
Cancer Discov 2013; 3 (11):1228-37; PMID:24145039; http://dx.doi.org/10.1158/2159-8290.CD-13-0253 67.,Non-OADS,/arxiv_data1/oa_pdf/1f/88/kncl-06-05-1106676.PMC4915485.pdf
Nature 2011; 469(7330):343-9; PMID:21248841; http://dx.doi.org/ 10.1038/nature09784 68.,Non-OADS,/arxiv_data1/oa_pdf/1f/88/kncl-06-05-1106676.PMC4915485.pdf
Nat Rev Cancer 2010; 10(10):669-82; PMID:20865010; http://dx.doi.org/10.1038/nrc2931 69.,Non-OADS,/arxiv_data1/oa_pdf/1f/88/kncl-06-05-1106676.PMC4915485.pdf
Nat Genet 2010; 42(2):181-5; PMID:20081860; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/1f/88/kncl-06-05-1106676.PMC4915485.pdf
Nat Cell Biol 2007; 9 (10):1167-74; PMID:17828248; http://dx.doi.org/10.1038/ncb1637 72.,OADS,/arxiv_data1/oa_pdf/1f/88/kncl-06-05-1106676.PMC4915485.pdf
Trends Genet 2011; 27(11):454-64; PMID:21794944; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/1f/88/kncl-06-05-1106676.PMC4915485.pdf
Genome Res 2010; 20(6):733-44; PMID:20442245; http://dx.doi.org/10.1101/gr.101923.109 75.,OADS,/arxiv_data1/oa_pdf/1f/88/kncl-06-05-1106676.PMC4915485.pdf
Nat Genet 2003; 34 (3):287-91; PMID:12808455; http://dx.doi.org/ 10.1038/ng1177 76.,OADS,/arxiv_data1/oa_pdf/1f/88/kncl-06-05-1106676.PMC4915485.pdf
Science 2013; 341(6146):660-4; PMID:23929981; http://dx.doi.org/10.1126/ science.1237150 79.,Non-OADS,/arxiv_data1/oa_pdf/1f/88/kncl-06-05-1106676.PMC4915485.pdf
Chromosoma 2005; 114(3):146-54; PMID:15988581; http://dx.doi.org/10.1007/s00412-005-0011-y 80.,Non-OADS,/arxiv_data1/oa_pdf/1f/88/kncl-06-05-1106676.PMC4915485.pdf
Cell 2012; 148(5):908-21; PMID:22341456; http://dx.doi.org/ 10.1016/j.cell.2012.02.002 81.,OADS,/arxiv_data1/oa_pdf/1f/88/kncl-06-05-1106676.PMC4915485.pdf
Science 2009; 326(5957):1230;PMID:19933109; http://dx.doi.org/10.1126/ science.1178124 82.,Non-OADS,/arxiv_data1/oa_pdf/1f/88/kncl-06-05-1106676.PMC4915485.pdf
PLoS Genet 2014; 10 (4):e1004250; PMID:24721906; http://dx.doi.org/10.1371/journal.pgen.1004250 84.,Non-OADS,/arxiv_data1/oa_pdf/1f/88/kncl-06-05-1106676.PMC4915485.pdf
Science 2013; 342(6161):948- 53; PMID:24200812; http://dx.doi.org/10.1126/ science.1236083 85.,Non-OADS,/arxiv_data1/oa_pdf/1f/88/kncl-06-05-1106676.PMC4915485.pdf
(6):761-70; PMID:20430782; http://dx.doi.org/ 10.1101/gr.099655.109 87.,Non-OADS,/arxiv_data1/oa_pdf/1f/88/kncl-06-05-1106676.PMC4915485.pdf
Proc Natl Acad Sci U S A 2010; 107(1):139-44; PMID:19966280; http://dx.doi.org/ 10.1073/pnas.0912402107 89.,OADS,/arxiv_data1/oa_pdf/1f/88/kncl-06-05-1106676.PMC4915485.pdf
Nat Biotechnol 2011; 29 (12):1103-8; PMID:22101487; http://dx.doi.org/ 10.1038/nbt.2030 90.,Non-OADS,/arxiv_data1/oa_pdf/1f/88/kncl-06-05-1106676.PMC4915485.pdf
Am J Hum Genet 2013; 93(5):779-97; PMID:24210251; http://dx.doi.org/ 10.1016/j.ajhg.2013.10.012 91.,OADS,/arxiv_data1/oa_pdf/1f/88/kncl-06-05-1106676.PMC4915485.pdf
Nat Genet 2011; 43(8):753-60; PMID:21706003; http://dx.doi.org/10.1038/ng.866 92.,OADS,/arxiv_data1/oa_pdf/1f/88/kncl-06-05-1106676.PMC4915485.pdf
Sci-ence 2012; 337(6099):1190-5; PMID:22955828; http://dx.doi.org/10.1126/science.1222794 93.,OADS,/arxiv_data1/oa_pdf/1f/88/kncl-06-05-1106676.PMC4915485.pdf
BMC Biol 2015; 13:26; PMID:25888893; http://dx.doi.org/10.1186/s12915-015-0138-0 94.,Non-OADS,/arxiv_data1/oa_pdf/1f/88/kncl-06-05-1106676.PMC4915485.pdf
Hum Mol Genet 2015; 24(9):2649-61; PMID:25631878; http://dx.doi.org/10.1093/hmg/ddv029 95.,OADS,/arxiv_data1/oa_pdf/1f/88/kncl-06-05-1106676.PMC4915485.pdf
Am J Hum Genet 2015; 97(1):22-34; PMID:26073781; http://dx.doi.org/ 10.1016/j.ajhg.2015.05.002 97.,OADS,/arxiv_data1/oa_pdf/1f/88/kncl-06-05-1106676.PMC4915485.pdf
Am J Hum Genet 2013; 93 (6):1046-60; PMID:24290378; http://dx.doi.org/ 10.1016/j.ajhg.2013.10.026 98.,OADS,/arxiv_data1/oa_pdf/1f/88/kncl-06-05-1106676.PMC4915485.pdf
Nat Commun 2015; 6:6178; PMID:25695508; http://dx.doi.org/10.1038/ncomms7178 100.,OADS,/arxiv_data1/oa_pdf/1f/88/kncl-06-05-1106676.PMC4915485.pdf
Nat Methods 2014; 11(3):294-6; PMID:24487584; http://dx.doi.org/10.1038/nmeth.2832 101.,OADS,/arxiv_data1/oa_pdf/1f/88/kncl-06-05-1106676.PMC4915485.pdf
Nucleic Acids Res 2013; 41(Web Server issue):W150- 8; PMID:23723249; http://dx.doi.org/10.1093/nar/gkt456 102.,OADS,/arxiv_data1/oa_pdf/1f/88/kncl-06-05-1106676.PMC4915485.pdf
Biomark Med 2010; 4(4):611-29; PMID:20701449; http://dx.doi.org/10.2217/bmm.10.68 103.,Non-OADS,/arxiv_data1/oa_pdf/1f/88/kncl-06-05-1106676.PMC4915485.pdf
Biochim Biophys Acta 2008; 1783(11):2052-60; PMID:18721832; http://dx.doi.org/10.1016/j.bbamcr.2008.07.020 104.,OADS,/arxiv_data1/oa_pdf/1f/88/kncl-06-05-1106676.PMC4915485.pdf
Pigment Cell Melanoma Res 2014; 27 (5):788-800; PMID:24807349; http://dx.doi.org/ 10.1111/pcmr.12258 107.,Non-OADS,/arxiv_data1/oa_pdf/1f/88/kncl-06-05-1106676.PMC4915485.pdf
Int Immunopharmacol 2014; 18(1):7-11; PMID:24211766; http://dx.doi.org/10.1016/j.intimp.2013.10.024 108.,OADS,/arxiv_data1/oa_pdf/1f/88/kncl-06-05-1106676.PMC4915485.pdf
Sci-ence 2012; 338(6112):1360-3; PMID:23118011; http://dx.doi.org/10.1126/science.1228606 109.,OADS,/arxiv_data1/oa_pdf/1f/88/kncl-06-05-1106676.PMC4915485.pdf
Blood 2007; 110(9):3136-42;PMID:17671233; http://dx.doi.org/10.1182/blood- 2007-03-080291 110.,Non-OADS,/arxiv_data1/oa_pdf/1f/88/kncl-06-05-1106676.PMC4915485.pdf
Oncogene 1999; 18(19):2988-96;PMID:10378694; http://dx.doi.org/10.1038/sj.,Non-OADS,/arxiv_data1/oa_pdf/1f/88/kncl-06-05-1106676.PMC4915485.pdf
Nature 2008;452(7184):187-93; PMID:18337816; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/1f/88/kncl-06-05-1106676.PMC4915485.pdf
Nat Biotechnol 2012; 30(11):1095-106; PMID:23138309; http://dx.doi.org/10.1038/ nbt.2422 113.,OADS,/arxiv_data1/oa_pdf/1f/88/kncl-06-05-1106676.PMC4915485.pdf
Nat Rev Drug Discov 2010; 9(1):29-42; PMID:20043027; http://dx.doi.org/10.1038/nrd2897 114.,Non-OADS,/arxiv_data1/oa_pdf/1f/88/kncl-06-05-1106676.PMC4915485.pdf
Cancer Cell 2012; 22 (1):9-20; PMID:22789535; http://dx.doi.org/10.1016/j.ccr.2012.06.008 115.,Non-OADS,/arxiv_data1/oa_pdf/1f/88/kncl-06-05-1106676.PMC4915485.pdf
Cell 2015; 162 (4):911-23; PMID:26276637; http://dx.doi.org/10.1016/j.cell.2015.07.035 116.,OADS,/arxiv_data1/oa_pdf/1f/88/kncl-06-05-1106676.PMC4915485.pdf
EMBO J 2012;31(7):1621-3; PMID:22415369; http://dx.doi.org/ 10.1038/emboj.2012.66 117.,Non-OADS,/arxiv_data1/oa_pdf/1f/88/kncl-06-05-1106676.PMC4915485.pdf
Nat Rev Mol Cell Biol 2013; 14(1):49-55; PMID:23169466;http://dx.doi.org/10.1038/nrm3486 118.,OADS,/arxiv_data1/oa_pdf/1f/88/kncl-06-05-1106676.PMC4915485.pdf
Nat Rev Genet 2010; 11(9):636-46; PMID:20717154; http://dx.doi.org/10.1038/ nrg2842 119.,Non-OADS,/arxiv_data1/oa_pdf/1f/88/kncl-06-05-1106676.PMC4915485.pdf
Nat Methods 2013; 10(10):957-63; PMID:24076990; http://dx.doi.org/ 10.1038/nmeth.2649 120.,OADS,/arxiv_data1/oa_pdf/1f/88/kncl-06-05-1106676.PMC4915485.pdf
Cell 2013; 155(7):1507-20; PMID:24360274; http://dx.doi.org/10.1016/j.cell.2013.11.039 121.,OADS,/arxiv_data1/oa_pdf/1f/88/kncl-06-05-1106676.PMC4915485.pdf
Locus-speciﬁc edit- ing of histone modiﬁcations at endogenous enhancers.Nat Biotechnol 2013; 31(12):1133-6; PMID:24013198; http://dx.doi.org/10.1038/ nbt.2701 122.,OADS,/arxiv_data1/oa_pdf/1f/88/kncl-06-05-1106676.PMC4915485.pdf
Cell 2012; 149(6):1233-44; PMID:22682246; http://dx.doi.org/10.1016/j.cell.2012.03.051 123.,OADS,/arxiv_data1/oa_pdf/1f/88/kncl-06-05-1106676.PMC4915485.pdf
Cell 2013; 155(7):1479-91; PMID:24360272; http://dx.doi.org/10.1016/j.cell.2013.12.001 www.tandfonline.com 393 Nucleus,OADS,/arxiv_data1/oa_pdf/1f/88/kncl-06-05-1106676.PMC4915485.pdf
"An interaction (direct orKeywords: actin, JMY, nuclear architec- ture, nuclear organization, transcription,Wiskott-Aldrich Syndrome, WASH,WASP/N-WASP, WAVE/SCAR,WHAMM © Jeffrey M Verboon, Bina Sugumar, and Susan M Parkhurst*Correspondence to: Susan M Parkhurst; Email:susanp@fredhutch.org Submitted: 07/01/2015 Revised: 08/16/2015Accepted: 08/18/2015http://dx.doi.org/10.1080/19491034.2015.1086051 This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non- Commercial License (http://creativecommons.org/licenses/by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is prop-erly cited.",Non-OADS,/arxiv_data1/oa_pdf/5b/a4/kncl-06-05-1086051.PMC4915506.pdf
Nat Rev Mol Cell Biol 2007; 8:37-48; PMID: 17183359; http://dx.doi.org/10.1038/nrm2069 4.,OADS,/arxiv_data1/oa_pdf/5b/a4/kncl-06-05-1086051.PMC4915506.pdf
Trends Cell Biol 2010; 20:650-61; PMID:20888769; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/5b/a4/kncl-06-05-1086051.PMC4915506.pdf
BMC ResNotes 2012; 5:88; PMID:22316129; http://dx.doi.org/ 10.1186/1756-0500-5-88 7.,Non-OADS,/arxiv_data1/oa_pdf/5b/a4/kncl-06-05-1086051.PMC4915506.pdf
Nature 2000; 404:151-8; PMID:10724160; http://dx.doi.org/ 10.1038/35004513 8.,Non-OADS,/arxiv_data1/oa_pdf/5b/a4/kncl-06-05-1086051.PMC4915506.pdf
Biochemistry 2007;46:3494-502; PMID:17302440; http://dx.doi.org/ 10.1021/bi062152y 9.,Non-OADS,/arxiv_data1/oa_pdf/5b/a4/kncl-06-05-1086051.PMC4915506.pdf
Nature2002; 418:790-3; PMID:12181570; http://dx.doi.org/ 10.1038/nature00859 10.,Non-OADS,/arxiv_data1/oa_pdf/5b/a4/kncl-06-05-1086051.PMC4915506.pdf
Nature 2010; 468: 533-8; PMID:21107423; http://dx.doi.org/10.1038/ nature09623 11.,Non-OADS,/arxiv_data1/oa_pdf/5b/a4/kncl-06-05-1086051.PMC4915506.pdf
Dev Cell 2009; 17:712-23; PMID:19922875;http://dx.doi.org/10.1016/j.devcel.2009.09.010 13.,OADS,/arxiv_data1/oa_pdf/5b/a4/kncl-06-05-1086051.PMC4915506.pdf
J Cell Sci2011; 124:3753-9; PMID:22114305; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/5b/a4/kncl-06-05-1086051.PMC4915506.pdf
Nat Rev Mol Cell Biol 2013; 14:7-12; PMID:23212475; http://dx.doi.org/10.1038/nrm3492 16.,OADS,/arxiv_data1/oa_pdf/5b/a4/kncl-06-05-1086051.PMC4915506.pdf
Mol Biol Cell 2015; 26:1665-74; PMID:25739458; http://dx.doi.org/10.1091/mbc.,OADS,/arxiv_data1/oa_pdf/5b/a4/kncl-06-05-1086051.PMC4915506.pdf
Development 2009; 136:2849-60; PMID:19633175; http://dx.doi.org/10.1242/dev.035246 18.,Non-OADS,/arxiv_data1/oa_pdf/5b/a4/kncl-06-05-1086051.PMC4915506.pdf
Annu Rev Immunol 1999; 17:905-29; PMID:10358777; http://dx.doi.org/10.1146/annurev.,Non-OADS,/arxiv_data1/oa_pdf/5b/a4/kncl-06-05-1086051.PMC4915506.pdf
Nat Rev Immunol 2002; 2:635-46; PMID:12209132; http://dx.doi.org/10.1038/nri884 21.,Non-OADS,/arxiv_data1/oa_pdf/5b/a4/kncl-06-05-1086051.PMC4915506.pdf
Nat Genet 1995; 9:414- 7; PMID:7795648; http://dx.doi.org/10.1038/ng0495-414 22.,Non-OADS,/arxiv_data1/oa_pdf/5b/a4/kncl-06-05-1086051.PMC4915506.pdf
J Cell Sci 2012; 125:3977-88; PMID:22623727; http://dx.doi.org/ 10.1242/jcs.097667 23.,OADS,/arxiv_data1/oa_pdf/5b/a4/kncl-06-05-1086051.PMC4915506.pdf
Cytos keleton (Hoboken) 2013; 70:623-34; PMID:23749625; http://dx.doi.org/ 10.1002/cm.21116 25.,Non-OADS,/arxiv_data1/oa_pdf/5b/a4/kncl-06-05-1086051.PMC4915506.pdf
Transcription 2012; 3:226-30; PMID:22771994; http://dx.doi.org/10.4161/trns.21062 26.,Non-OADS,/arxiv_data1/oa_pdf/5b/a4/kncl-06-05-1086051.PMC4915506.pdf
Small GTPases 2014; 5:e27539; PMID:24603113; http://dx.doi.org/ 10.4161/sgtp.27539 27.,Non-OADS,/arxiv_data1/oa_pdf/5b/a4/kncl-06-05-1086051.PMC4915506.pdf
Cold Spring Harb Perspect Biol 2010; 2:a000620;PMID:20452941; http://dx.doi.org/10.1101/ cshperspect.a000620 28.,Non-OADS,/arxiv_data1/oa_pdf/5b/a4/kncl-06-05-1086051.PMC4915506.pdf
"Cell 1977; 12:883-91; PMID:563771; http://dx.doi.org/10.1016/0092-8674 (77)90152-0 29. de Lanerolle P, Serebryannyy L. Nuclear actin and myosins: life without ﬁlaments.",OADS,/arxiv_data1/oa_pdf/5b/a4/kncl-06-05-1086051.PMC4915506.pdf
Nat Cell Biol 2011;13:1282-8; PMID:22048410; http://dx.doi.org/ 10.1038/ncb2364 30. de Lanerolle P. Nuclear actin and myosins at a glance.,OADS,/arxiv_data1/oa_pdf/5b/a4/kncl-06-05-1086051.PMC4915506.pdf
Mol Immunol 2011; 48:788-92; PMID: 21185603; http://dx.doi.org/10.1016/j.molimm.2010.11.013 32.,Non-OADS,/arxiv_data1/oa_pdf/5b/a4/kncl-06-05-1086051.PMC4915506.pdf
Blood2004; 103:456-64; PMID:12969986; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/5b/a4/kncl-06-05-1086051.PMC4915506.pdf
Blood 2004; 104:4010-9; PMID:15284122; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/5b/a4/kncl-06-05-1086051.PMC4915506.pdf
Blood 2014; 124:3409-19; PMID:25253772; http://dx.doi.org/10.1182/blood- 2014-07-587642 35.,Non-OADS,/arxiv_data1/oa_pdf/5b/a4/kncl-06-05-1086051.PMC4915506.pdf
J Immunol 2014; 193:150-60; PMID:24872192; http://dx.doi.org/ 10.4049/jimmunol.1302923 37.,Non-OADS,/arxiv_data1/oa_pdf/5b/a4/kncl-06-05-1086051.PMC4915506.pdf
J Biol Chem 2003;278:42515-23; PMID:12871950; http://dx.doi.org/ 10.1074/jbc.M302177200 38.,OADS,/arxiv_data1/oa_pdf/5b/a4/kncl-06-05-1086051.PMC4915506.pdf
J Biol Chem 2004;279:9565-76; PMID:14676198; http://dx.doi.org/ 10.1074/jbc.M310739200 39.,OADS,/arxiv_data1/oa_pdf/5b/a4/kncl-06-05-1086051.PMC4915506.pdf
Biochem Biophys Res Commun 2004; 313:468-74; PMID:14697212; http://dx.doi.org/10.1016/j.bbrc.2003.11.139 40.,OADS,/arxiv_data1/oa_pdf/5b/a4/kncl-06-05-1086051.PMC4915506.pdf
Nat Cell Biol 2006; 8:756-63; PMID:16767080;http://dx.doi.org/10.1038/ncb1433 41.,OADS,/arxiv_data1/oa_pdf/5b/a4/kncl-06-05-1086051.PMC4915506.pdf
FEBS Lett 2002;531:109-14; PMID:12417296; http://dx.doi.org/ 10.1016/S0014-5793(02)03447-6 42.,OADS,/arxiv_data1/oa_pdf/5b/a4/kncl-06-05-1086051.PMC4915506.pdf
J Biol Chem 2007;282:7616-23; PMID:17220302; http://dx.doi.org/ 10.1074/jbc.M607596200 43.,OADS,/arxiv_data1/oa_pdf/5b/a4/kncl-06-05-1086051.PMC4915506.pdf
J Cell Sci 2010; 123:128-40; PMID:20016073; http://dx.doi.org/10.1242/jcs.053835 44.,OADS,/arxiv_data1/oa_pdf/5b/a4/kncl-06-05-1086051.PMC4915506.pdf
Genes Dev 2011;25:946-58; PMID:21536734; http://dx.doi.org/ 10.1101/gad.615211 45.,Non-OADS,/arxiv_data1/oa_pdf/5b/a4/kncl-06-05-1086051.PMC4915506.pdf
Science 2013; 341:1002-5; PMID:23990560; http://dx.doi.org/10.1126/science.1240376 46.,OADS,/arxiv_data1/oa_pdf/5b/a4/kncl-06-05-1086051.PMC4915506.pdf
Mol Cell 1999; 4:365-76; PMID:10518217; http://dx.doi.org/ 10.1016/S1097-2765(00)80338-X 358 Volume 6 Issue 5 Nucleus,OADS,/arxiv_data1/oa_pdf/5b/a4/kncl-06-05-1086051.PMC4915506.pdf
Mol Biol Cell 2012; 23:853-63; PMID:22262458; http://dx.doi.org/10.1091/mbc.E11-12-0992 48.,Non-OADS,/arxiv_data1/oa_pdf/5b/a4/kncl-06-05-1086051.PMC4915506.pdf
EMBO Rep 2007; 8:84-90;PMID:17170761; http://dx.doi.org/10.1038/sj.,Non-OADS,/arxiv_data1/oa_pdf/5b/a4/kncl-06-05-1086051.PMC4915506.pdf
J Cell Biol 2007; 178:23-30; PMID:17606864; http://dx.doi.org/10.1083/jcb.200701120 52.,OADS,/arxiv_data1/oa_pdf/5b/a4/kncl-06-05-1086051.PMC4915506.pdf
J Exp Med 2014; 211:2119-34; PMID:25225459; http://dx.doi.org/10.1084/jem.20140169 54.,Non-OADS,/arxiv_data1/oa_pdf/5b/a4/kncl-06-05-1086051.PMC4915506.pdf
Curr Biol 2015; 25:804-10; PMID: 25754639; http://dx.doi.org/10.1016/j.cub.,OADS,/arxiv_data1/oa_pdf/5b/a4/kncl-06-05-1086051.PMC4915506.pdf
PLoS Genet 2007; 3:e237; PMID:18159949;http://dx.doi.org/10.1371/journal.pgen.0030237 57.,Non-OADS,/arxiv_data1/oa_pdf/5b/a4/kncl-06-05-1086051.PMC4915506.pdf
J Cell Sci 2015; 128:373-84; PMID:25431135; http://dx.doi.org/10.1242/jcs.161513 58.,OADS,/arxiv_data1/oa_pdf/5b/a4/kncl-06-05-1086051.PMC4915506.pdf
Nature 2002; 420:439-45; PMID:12459787; http://dx.doi.org/ 10.1038/nature01167 59.,Non-OADS,/arxiv_data1/oa_pdf/5b/a4/kncl-06-05-1086051.PMC4915506.pdf
J Struct Biol 2002; 140:3-9;PMID:12490148; http://dx.doi.org/10.1016/S1047- 8477(02)00528-2 60.,OADS,/arxiv_data1/oa_pdf/5b/a4/kncl-06-05-1086051.PMC4915506.pdf
J Cell Biol 2006;172:541-52; PMID:16476775; http://dx.doi.org/ 10.1083/jcb.200507101 61.,Non-OADS,/arxiv_data1/oa_pdf/5b/a4/kncl-06-05-1086051.PMC4915506.pdf
Mol Biol Cell 2013; 24:982-94;PMID:23447706; http://dx.doi.org/10.1091/mbc.,OADS,/arxiv_data1/oa_pdf/5b/a4/kncl-06-05-1086051.PMC4915506.pdf
Science 2013; 340:864-7; PMID:23558171; http://dx.doi.org/10.1126/science.1235038 63.,OADS,/arxiv_data1/oa_pdf/5b/a4/kncl-06-05-1086051.PMC4915506.pdf
Genes Dev 2004;18:3010-5; PMID:15574586; http://dx.doi.org/ 10.1101/gad.1250804 64.,OADS,/arxiv_data1/oa_pdf/5b/a4/kncl-06-05-1086051.PMC4915506.pdf
Nucleus 2011; 2:72-9; PMID: 21647301; http://dx.doi.org/10.4161/nucl.14508 65.,OADS,/arxiv_data1/oa_pdf/5b/a4/kncl-06-05-1086051.PMC4915506.pdf
Nat Cell Biol 2004; 6:1165-72; PMID:15558034; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/5b/a4/kncl-06-05-1086051.PMC4915506.pdf
J Biol Chem 2011; 286:15171-81; PMID:21378166; http://dx.doi.org/10.1074/jbc.M110.184374 67.,OADS,/arxiv_data1/oa_pdf/5b/a4/kncl-06-05-1086051.PMC4915506.pdf
Proc Natl Acad Sci U S A 2003; 100:6475-80; PMID:12743363; http://dx.doi.org/ 10.1073/pnas.1131933100 68.,OADS,/arxiv_data1/oa_pdf/5b/a4/kncl-06-05-1086051.PMC4915506.pdf
Cell Mol Life Sci 2013; 70:3289-302; PMID:23275942; http://dx.doi.org/10.1007/s00018-012-1235-7 69.,OADS,/arxiv_data1/oa_pdf/5b/a4/kncl-06-05-1086051.PMC4915506.pdf
Trends Cell Biol2014; 24:238-46; PMID:24246764; http://dx.doi.org/ 10.1016/j.tcb.2013.10.007 70.,OADS,/arxiv_data1/oa_pdf/5b/a4/kncl-06-05-1086051.PMC4915506.pdf
Nat Struct Mol Biol 2013;20:426-32; PMID:23524535; http://dx.doi.org/ 10.1038/nsmb.2529 71.,OADS,/arxiv_data1/oa_pdf/5b/a4/kncl-06-05-1086051.PMC4915506.pdf
Curr Biol 2006; 16:825-31; PMID:16631592; http://dx.doi.org/ 10.1016/j.cub.2006.03.059 72.,OADS,/arxiv_data1/oa_pdf/5b/a4/kncl-06-05-1086051.PMC4915506.pdf
J Cell Biol 2007; 179:1095-103; PMID:18070915;http://dx.doi.org/10.1083/jcb.200710058 www.tandfonline.com 359 Nucleus,Non-OADS,/arxiv_data1/oa_pdf/5b/a4/kncl-06-05-1086051.PMC4915506.pdf
"It comprises an N terminal actin-binding domain (ABD) composed of 2 Calponin homology © Pranav Kelkar, Anna Walter, Symeon Papadopoulos, Carmen Mroß, Martina Munck, Vivek S Peche, and Angelika A Noegel *Correspondence to: Angelika A. Noegel; Email: noegel@uni-koeln.deSubmitted: 07/29/2015; Revised: 11/24/2015; Accepted: 11/30/2015 http://dx.doi.org/10.1080/19491034.2015.1128608 This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License (http://creativecommons.o rg/licenses/ by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/cb/5d/kncl-06-06-1128608.PMC4915507.pdf
J Biol Chem 2009;284(19):12593-97; PMID:19126540; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/cb/5d/kncl-06-06-1128608.PMC4915507.pdf
FEBS Lett 2012; 586(10):1533-39; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/cb/5d/kncl-06-06-1128608.PMC4915507.pdf
Mol Cell Biol 2003; 23(4):1418-27; PMID:12556500; http://dx.doi.org/10.1128/ MCB.23.4.1418-1427.2003 5.,Non-OADS,/arxiv_data1/oa_pdf/cb/5d/kncl-06-06-1128608.PMC4915507.pdf
PLoS one 2012; 7(1):e30529; PMID:22295092; http://dx.doi.org/10.1371/ journal.pone.0030529 6.,Non-OADS,/arxiv_data1/oa_pdf/cb/5d/kncl-06-06-1128608.PMC4915507.pdf
J Biol Chem 2003; 278(36):33839- 47; PMID:12810722; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/cb/5d/kncl-06-06-1128608.PMC4915507.pdf
Biochem J2010; 430(1):39-48; PMID:20528776; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/cb/5d/kncl-06-06-1128608.PMC4915507.pdf
J Biol Chem 2013; 288(6):4148-57; PMID:23235156; http://dx.doi.org/10.1074/jbc.M112.436741 9.,OADS,/arxiv_data1/oa_pdf/cb/5d/kncl-06-06-1128608.PMC4915507.pdf
Trends Endocrinol Metab 2008; TEM 19(6):213-22; PMID:18585925; http://dx.doi.org/ 10.1016/j.tem.2008.04.002 10.,OADS,/arxiv_data1/oa_pdf/cb/5d/kncl-06-06-1128608.PMC4915507.pdf
Calcium signal- ing-induced Smad3 nuclear accumulation induces ace- tylcholinesterase transcription in apoptotic HeLa cells.Cell Mol Life Sci 2009; 66(13):2181-93; PMID:19468687; http://dx.doi.org/10.1007/s00018- 009-0037-z 11.,Non-OADS,/arxiv_data1/oa_pdf/cb/5d/kncl-06-06-1128608.PMC4915507.pdf
Cell Signal 2008; 20(5):958-68; PMID:18296025; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/cb/5d/kncl-06-06-1128608.PMC4915507.pdf
J CellBiol 2004; 166(5):661-72; http://dx.doi.org/10.1083/ jcb.200402136 13.,OADS,/arxiv_data1/oa_pdf/cb/5d/kncl-06-06-1128608.PMC4915507.pdf
Science 1995; 270 (5243):1835-8; PMID:8525380; http://dx.doi.org/ 10.1126/science.270.5243.1835 1 4 .,Non-OADS,/arxiv_data1/oa_pdf/cb/5d/kncl-06-06-1128608.PMC4915507.pdf
Mol Cell Biol 2007; 27(2):497-509; PMID:17074802; http://dx.doi.org/ 10.1128/MCB.01772-06 17.,Non-OADS,/arxiv_data1/oa_pdf/cb/5d/kncl-06-06-1128608.PMC4915507.pdf
J Biol Chem 2013; 288(12):8074-84; PMID:23364788; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/cb/5d/kncl-06-06-1128608.PMC4915507.pdf
Proc Natl Acad Sci U S A 1996; 93(25):14574-9; PMID:8962094; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/cb/5d/kncl-06-06-1128608.PMC4915507.pdf
Expert Rev Mol Med 2013; 15: e5; PMID:23830188; http://dx.doi.org/10.1017/ erm.2013.6 20.,Non-OADS,/arxiv_data1/oa_pdf/cb/5d/kncl-06-06-1128608.PMC4915507.pdf
J Cell Sci 2008; 121 (Pt 11):1887-98; PMID:18477613; http://dx.doi.org/10.1242/jcs.019075 21.,OADS,/arxiv_data1/oa_pdf/cb/5d/kncl-06-06-1128608.PMC4915507.pdf
Biochem Soc Trans 2011; 39(6):1693-7; PMID:22103509; http://dx.doi.org/ 10.1042/BST20110658 22.,OADS,/arxiv_data1/oa_pdf/cb/5d/kncl-06-06-1128608.PMC4915507.pdf
J Biol Chem 2011; 286(30):26743-53; PMID:21652697; http://dx.doi.org/10.1074/jbc.M111.233700 23.,OADS,/arxiv_data1/oa_pdf/cb/5d/kncl-06-06-1128608.PMC4915507.pdf
Nucleus 2012; 3(2):172- 86; PMID:22198684; http://dx.doi.org/10.4161/ nucl.19090 2 4 .,OADS,/arxiv_data1/oa_pdf/cb/5d/kncl-06-06-1128608.PMC4915507.pdf
Hum Mol Gen 2007; 16 (23):2816-33; PMID:17761684; http://dx.doi.org/ 10.1093/hmg/ddm238 25.,OADS,/arxiv_data1/oa_pdf/cb/5d/kncl-06-06-1128608.PMC4915507.pdf
Nucleus 2014; 5(2):173-91; PMID: 24781983; http://dx.doi.org/10.4161/nucl.29023 26.,OADS,/arxiv_data1/oa_pdf/cb/5d/kncl-06-06-1128608.PMC4915507.pdf
Mol Biol Cell 2005; 16(7):3411-24; PMID:15843432; http://dx.doi.org/10.1091/mbc.E04-11-1009 27.,Non-OADS,/arxiv_data1/oa_pdf/cb/5d/kncl-06-06-1128608.PMC4915507.pdf
Methods Mol Biol 2012; 920:613-26; PMID:22941631; http://dx.doi.org/ 10.1007/978-1-61779-998-3_40 29.,Non-OADS,/arxiv_data1/oa_pdf/cb/5d/kncl-06-06-1128608.PMC4915507.pdf
"Classical nuclear localization signals:deﬁnition, function, and interaction with importin a.J Biol Chem 2007; 282(8):5101-5; PMID:17170104; http://dx.doi.org/10.1074/jbc.R600026200 30.",OADS,/arxiv_data1/oa_pdf/cb/5d/kncl-06-06-1128608.PMC4915507.pdf
Cell 2014; 159 (6):1447-1460; PMID:25433700; http://dx.doi.org/10.1016/j.cell.2014.10.056 32.,OADS,/arxiv_data1/oa_pdf/cb/5d/kncl-06-06-1128608.PMC4915507.pdf
"J Biol Chem 2010;285(45):34932-8; PMID:20801886; http://dx.doi.org/ 10.1074/jbc.M110.119651 33. van Westering TL, Betts CA, Wood MJ.",OADS,/arxiv_data1/oa_pdf/cb/5d/kncl-06-06-1128608.PMC4915507.pdf
Molecules 2015; 20(5):8823-55; PMID:25988613; http://dx.doi.org/10.3390/molecules20058823 34.,OADS,/arxiv_data1/oa_pdf/cb/5d/kncl-06-06-1128608.PMC4915507.pdf
Biotechniques 2007; 42(1):71-5; PMID:17076895; http://dx.doi.org/10.2144/000112257 38.,Non-OADS,/arxiv_data1/oa_pdf/cb/5d/kncl-06-06-1128608.PMC4915507.pdf
Science 1999; 286(5442):1162-6; PMID:10550055; http://dx.doi.org/ 10.1126/science.286.5442.1162 39.,Non-OADS,/arxiv_data1/oa_pdf/cb/5d/kncl-06-06-1128608.PMC4915507.pdf
Science 1993; 262 (5134):740-4; PMID:8235594; http://dx.doi.org/10.1126/science.8235594 www.tandfonline.com 489 Nucleus,OADS,/arxiv_data1/oa_pdf/cb/5d/kncl-06-06-1128608.PMC4915507.pdf
"4,5 © Hanif Rassoolzadeh, Christos Coucoravas, and Marianne Farnebo *Correspondence to: Marianne Farnebo; Email: marianne.farnebo@ki.seSubmitted: 06/11/2015; Revised: 10/04/2015; Accepted: 10/06/2015 http://dx.doi.org/10.1080/19491034.2015.1106675 This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License (http://creativecommons.o rg/licenses/ by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/3a/4c/kncl-06-05-1106675.PMC4915514.pdf
Nature 2012; 481:287-94; PMID:22258607; http://dx.doi.org/10.1038/ nature107602.,OADS,/arxiv_data1/oa_pdf/3a/4c/kncl-06-05-1106675.PMC4915514.pdf
Nature 2005; 434:605-11; PMID:15758953;http://dx.doi.,OADS,/arxiv_data1/oa_pdf/3a/4c/kncl-06-05-1106675.PMC4915514.pdf
26; PMID:16377563; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/3a/4c/kncl-06-05-1106675.PMC4915514.pdf
Cell 2007; 131:901-14; PMID:18001825; http://dx.doi.org/10.1016/j.cell.2007.09.041 5.,OADS,/arxiv_data1/oa_pdf/3a/4c/kncl-06-05-1106675.PMC4915514.pdf
Protein Cell 2011; 2:202-14; PMID:21468892; http://dx.doi.org/10.1007/s13238- 011-1018-1 8.,Non-OADS,/arxiv_data1/oa_pdf/3a/4c/kncl-06-05-1106675.PMC4915514.pdf
Mol Cell 2009; 33:462-71; PMID:19250907; http://dx.doi.org/10.1016/j.molcel.2009.01.028 9.,OADS,/arxiv_data1/oa_pdf/3a/4c/kncl-06-05-1106675.PMC4915514.pdf
PLoS Biol 2010; 8:e1000521; PMID:21072240; http://dx.doi.org/10.1371/journal.pbio.1000521 10.,Non-OADS,/arxiv_data1/oa_pdf/3a/4c/kncl-06-05-1106675.PMC4915514.pdf
Mol Cell 2009; 34:47-57;PMID:19285445; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/3a/4c/kncl-06-05-1106675.PMC4915514.pdf
Science 2009; 323:644-8; PMID:19179534; http://dx.doi.org/ 10.1126/science.1165357 12.,Non-OADS,/arxiv_data1/oa_pdf/3a/4c/kncl-06-05-1106675.PMC4915514.pdf
Genes Dev 2014; 28:2726-38; PMID:25512560; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/3a/4c/kncl-06-05-1106675.PMC4915514.pdf
Genes Dev 2011; 25:11-6; PMID:21205863; http://dx.doi.org/10.1101/gad.2006411 14.,OADS,/arxiv_data1/oa_pdf/3a/4c/kncl-06-05-1106675.PMC4915514.pdf
Int J Cancer 2007; 121:2532-8; PMID:17683073; http://dx.doi.org/ 10.1002/ijc.22985 16.,Non-OADS,/arxiv_data1/oa_pdf/3a/4c/kncl-06-05-1106675.PMC4915514.pdf
Cancer Res 2009; 69:2349-57; PMID:19276375; http://dx.doi.org/10.1158/0008-5472.CAN-08-2902 17.,Non-OADS,/arxiv_data1/oa_pdf/3a/4c/kncl-06-05-1106675.PMC4915514.pdf
Mol Biol Rep 2013; 40:2145-7; PMID:23192612; http://dx.doi.org/10.1007/s11033- 012-2273-9 18.,Non-OADS,/arxiv_data1/oa_pdf/3a/4c/kncl-06-05-1106675.PMC4915514.pdf
Genes Dev 2011; 25:409-33; PMID:21363960; http://dx.doi.org/10.1101/ gad.2021311 19.,Non-OADS,/arxiv_data1/oa_pdf/3a/4c/kncl-06-05-1106675.PMC4915514.pdf
Nat Methods 2006; 3:995-1000; PMID:17072308; http://dx.doi.org/10.1038/nmeth947 20.,OADS,/arxiv_data1/oa_pdf/3a/4c/kncl-06-05-1106675.PMC4915514.pdf
Cell 2014; 159:1389-403; PMID:25467444;http://dx.doi.org/10.1016/j.cell.2014.10.059 21.,OADS,/arxiv_data1/oa_pdf/3a/4c/kncl-06-05-1106675.PMC4915514.pdf
Science 2007; 318:1637-40; PMID:18006705; http://dx.doi.org/10.1126/ science.1150034 424 Volume 6 Issue 5 Nucleus,Non-OADS,/arxiv_data1/oa_pdf/3a/4c/kncl-06-05-1106675.PMC4915514.pdf
Available at http://www.bil-ibs.be/sites/default/ files/publicaties/200611_95a05_soudage_a_haut_rende - ment_innolas.pdf .,Non-OADS,/arxiv_data1/oa_pdf/c5/64/mew016.PMC4915519.pdf
Available at http://www.dtic.mil/cgi-bin/GetTRDo c?Location=U2&doc=GetTRDoc.pdf&AD=ADA452250 .,OADS,/arxiv_data1/oa_pdf/c5/64/mew016.PMC4915519.pdf
"Published by Oxford University Press on behalf of the British Occupational Hygiene Society.•  651 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/f8/1e/mew021.PMC4915520.pdf
"Published by Oxford University Press on behalf of the British Occupational Hygiene Society.•  684 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ac/ef/mew023.PMC4915521.pdf
Available at http://epa.gov/fedrgstr/EPA-AIR/2006/ January/Day-17/a179.pdf .,OADS,/arxiv_data1/oa_pdf/ac/ef/mew023.PMC4915521.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/f0/17/rrv088.PMC4915533.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/c1/b4/rrv089.PMC4915534.pdf
The number of apoptotic signals within each whole embryo was counted using ImageJ software (freely obtainablefrom the website http://rsb.info.nih.gov/ij/ ).,OADS,/arxiv_data1/oa_pdf/c1/b4/rrv089.PMC4915534.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/8b/f8/rrv090.PMC4915535.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the originalwork is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/fd/0e/rrv091.PMC4915536.pdf
4.03 (http://www.jcog.jp/doctor/tool/ctcaev4.html ).,OADS,/arxiv_data1/oa_pdf/f8/51/rrv092.PMC4915537.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/f8/51/rrv092.PMC4915537.pdf
The full text of the Radiation Dermatitis Grading Atlas for Clinical Trials can be found in the online version (http://www.ncc.go.jp/jp/ncce/clinic/pdf/radiation_oncology_01.pdf).,Non-OADS,/arxiv_data1/oa_pdf/f8/51/rrv092.PMC4915537.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b7/17/rrv101.PMC4915538.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/44/e3/rrw001.PMC4915540.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e3/d7/rrw002.PMC4915541.pdf
"The GeneCards Suite: United States of America, Israel and Hong Kong .http://www.genecards.org/cgi-bin/carddisp.",Non-OADS,/arxiv_data1/oa_pdf/e3/d7/rrw002.PMC4915541.pdf
"The GeneCards Suite: United States of America, Israel and Hong Kong .http://www.genecards.org/cgi-bin/carddisp.",Non-OADS,/arxiv_data1/oa_pdf/e3/d7/rrw002.PMC4915541.pdf
"The GeneCards Suite: United States of America, Israel and Hong Kong .http://www.genecards.org/cgi-bin/carddisp.",Non-OADS,/arxiv_data1/oa_pdf/e3/d7/rrw002.PMC4915541.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/be/40/rrw003.PMC4915542.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the originalwork is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/fa/a9/rrw004.PMC4915543.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/30/e4/rrw008.PMC4915544.pdf
"2, 2015. http://www.nccn.org/professionals/physician_gls/ pdf/hepatobiliary.pdf (24 June 2015, date last accessed).",Non-OADS,/arxiv_data1/oa_pdf/30/e4/rrw008.PMC4915544.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the originalwork is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/bb/4e/rrw014.PMC4915545.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/cd/e3/rrw023.PMC4915546.pdf
"http://seer.cancer.gov/statfacts/html/ lungb.html (8 August 2015, date last accessed).",Non-OADS,/arxiv_data1/oa_pdf/cd/e3/rrw023.PMC4915546.pdf
http://www.nccn.org/professionals/physician_gls/f_guidelines.,Non-OADS,/arxiv_data1/oa_pdf/cd/e3/rrw023.PMC4915546.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the originalwork is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/dc/88/rrw025.PMC4915547.pdf
https://www.alpco.com/pdfs/ 01/01-EK-M6S.pdf:; 2011.,Non-OADS,/arxiv_data1/oa_pdf/ad/d5/CTS-9-114.PMC4915567.pdf
(http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1752-8062) Clinical and T ranslational Science,Non-OADS,/arxiv_data1/oa_pdf/ad/d5/CTS-9-114.PMC4915567.pdf
"Video abstract available for more insights from the authors (see Supplemental Digital Content 1, http://links.lww.com/JNPT/A131 ).",Non-OADS,/arxiv_data1/oa_pdf/91/22/jnpt-40-203.PMC4915727.pdf
"A treatment schedule, consisting of a clear description of the types of tech- niques, exercises/activities, and strategies for delivering a pro- gressive FST program, was produced along with a manualcontaining detailed operating procedures (see Supplemental Digital Content 2, http://links.lww.com/JNPT/A132 ).",Non-OADS,/arxiv_data1/oa_pdf/91/22/jnpt-40-203.PMC4915727.pdf
"Materials: Physical and Informational Materials Used in the Intervention, Including Those Provided to Participants or Used in InterventionDelivery or in Training of Intervention Providers A standardized treatment manual describing the detailed procedures involved is used by the FAST -INdICATE trial re- search therapists procedures (see Supplemental Digital Con-tent 2, http://links.lww.com/JNPT/A132 ).",Non-OADS,/arxiv_data1/oa_pdf/91/22/jnpt-40-203.PMC4915727.pdf
Available at: http://docs.house.gov/meetings/FA/FA16/20140807/102607/HHRG-113-FA16-Wstate-FriedenT -20140807.pdf.,Non-OADS,/arxiv_data1/oa_pdf/dd/cc/pts-12-57.PMC4915748.pdf
"Available at: https://www.gpo.gov/fdsys/pkg/CHRG-113hhrg94053/html/CHRG-113hhrg94053.htm.Accessed January 7, 2016.",Non-OADS,/arxiv_data1/oa_pdf/dd/cc/pts-12-57.PMC4915748.pdf
Available at: http://www.thelancet.com/pdfs/journals/lancet/PIIS0140-6736%2815%2960696-1.pdf.,Non-OADS,/arxiv_data1/oa_pdf/dd/cc/pts-12-57.PMC4915748.pdf
"ClinicalTrials.gov Identifier: NCT00980980.Available at: https://clinicaltrials.gov/ct2/show/NCT00980980.Accessed October 13, 2015.",OADS,/arxiv_data1/oa_pdf/dd/cc/pts-12-57.PMC4915748.pdf
Available at: http://www.statnews.com/2015/12/13/clinical-trials-investigation/.,OADS,/arxiv_data1/oa_pdf/dd/cc/pts-12-57.PMC4915748.pdf
Available at: https://www.gpo.,Non-OADS,/arxiv_data1/oa_pdf/dd/cc/pts-12-57.PMC4915748.pdf
Available at: https://clinicaltrials.gov/ct2/show/NCT00100386.,Non-OADS,/arxiv_data1/oa_pdf/dd/cc/pts-12-57.PMC4915748.pdf
"October 10, 2015 3:00 pm.Available at: https://idsa.confex.com/idsa/2015/webprogram/Paper51995.html.",Non-OADS,/arxiv_data1/oa_pdf/dd/cc/pts-12-57.PMC4915748.pdf
"October 10, 2015.Available at: https://idsa.confex.com/idsa/2015/webprogram/Paper52925.html.",Non-OADS,/arxiv_data1/oa_pdf/dd/cc/pts-12-57.PMC4915748.pdf
Available at: http://www.ncbi.nlm.nih.gov/pubmed/18334690.,Non-OADS,/arxiv_data1/oa_pdf/dd/cc/pts-12-57.PMC4915748.pdf
Available at: http://www.ama-assn.org/ amednews/2011/04/25/prsb0426.htm.,Non-OADS,/arxiv_data1/oa_pdf/dd/cc/pts-12-57.PMC4915748.pdf
Available at: http://www.shea-online.org/Assets/files/ position_papers/SHEA_MRSA_VRE.PDF 51.,Non-OADS,/arxiv_data1/oa_pdf/dd/cc/pts-12-57.PMC4915748.pdf
"Box 7751, Havre, MT  59501-7751, USA Tel: 1-406-265-3719, Fax: 1-406-265-4129 E-mail: peter.hart@msun.edu  This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/4.0) which permits unrestricted noncommercial use, dis-tribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b9/de/jlm-6-001.PMC4915761.pdf
"1, 1-6 http://dx.doi.org /10.15280/jlm.",Non-OADS,/arxiv_data1/oa_pdf/b9/de/jlm-6-001.PMC4915761.pdf
Available from: http://www.cdc.gov/hrqol/pdfs/mhd.pdf.,OADS,/arxiv_data1/oa_pdf/b9/de/jlm-6-001.PMC4915761.pdf
Available from: https://www.healthypeople.gov/.,Non-OADS,/arxiv_data1/oa_pdf/b9/de/jlm-6-001.PMC4915761.pdf
"Key Words:  Football, Concussion, Depression, CESD-R Received: January 28, 2016, Accepted: February 8, 2016 *Corresponding author: Mark DeBeliso Department of Physical Education and Human Performance, Southern  Utah University, 351 West University Blvd, Cedar City, UT 84720, US A Tel: 1-435-586-7812, Fax: 1-435-865-8057E-mail: markdebeliso@suu.edu  This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/4.0) which permits unrestricted noncommercial use, dis-tribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/dc/e1/jlm-6-007.PMC4915762.pdf
"1, 7-15 http://dx.doi.org /10.15280/jlm.",Non-OADS,/arxiv_data1/oa_pdf/dc/e1/jlm-6-007.PMC4915762.pdf
Available from:  http://nsuworks.nova.edu/cps_facpresentations/12/ 27.,Non-OADS,/arxiv_data1/oa_pdf/dc/e1/jlm-6-007.PMC4915762.pdf
Available from: http://www.detroitlions.com/ team/roster.html.,Non-OADS,/arxiv_data1/oa_pdf/dc/e1/jlm-6-007.PMC4915762.pdf
"Key Words:  Healthcare system, Health status, Health insurance, Lifestyle, Korea and Japan Received: January 8, 2016, Accepted: February 7, 2016 *Corresponding author: Eun Woo Nam Department of Health Administration, College of Health Science,  Yonsei University, 1 Yonseidae-g il, Wonju 26493, Republic of Korea Tel: 82-33-760-2413, Fax: 82-33-760-2519 E-mail: ewnam@yonsei.ac.kr  This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/4.0) which permits unrestricted noncommercial use, dis-tribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/3a/d8/jlm-6-016.PMC4915763.pdf
"1, 16-26 http://dx.doi.org /10.15280/jlm.",Non-OADS,/arxiv_data1/oa_pdf/3a/d8/jlm-6-016.PMC4915763.pdf
"Source: Global Health Expenditure Database 2015,http://who.int/health-accounts/en/.4) Number of medical facilities Medical facilities are another health system resource in- fluencing the quality of services.",Non-OADS,/arxiv_data1/oa_pdf/3a/d8/jlm-6-016.PMC4915763.pdf
Available from: http://www.mhlw.go.jp/english/wp/wp-hw8/index.html.,Non-OADS,/arxiv_data1/oa_pdf/3a/d8/jlm-6-016.PMC4915763.pdf
Available from: http://www.ospedalesicuro.eu/attachments/   article/337/CLASSIFICA%20BLOOMBERG%20rankings%202014%20su%20SSN.pdf.,Non-OADS,/arxiv_data1/oa_pdf/3a/d8/jlm-6-016.PMC4915763.pdf
Available from: http://kosis.kr/statHtml/statHtml.do?orgId=101&tblId=DT_1B8000F&language=en&conn_path=I3.,OADS,/arxiv_data1/oa_pdf/3a/d8/jlm-6-016.PMC4915763.pdf
Available from: http://data.worldbank.,OADS,/arxiv_data1/oa_pdf/3a/d8/jlm-6-016.PMC4915763.pdf
Available from: http://www.mhlw.go.jp/eng-lish/database/db-hw/populate/dl/02.pdf.,OADS,/arxiv_data1/oa_pdf/3a/d8/jlm-6-016.PMC4915763.pdf
c2014 [cited 2015 Jun] Available from: http://apps.who.int/gho/data/node .main.,OADS,/arxiv_data1/oa_pdf/3a/d8/jlm-6-016.PMC4915763.pdf
Available from: http://www.mhlw.go.jp/bunya/iryouhoken/iryouhoken01/dl/ 01_eng.pdf.,Non-OADS,/arxiv_data1/oa_pdf/3a/d8/jlm-6-016.PMC4915763.pdf
Available from: http://www.ipss.go.jp/s-info/e/ssj2014/index.asp.,OADS,/arxiv_data1/oa_pdf/3a/d8/jlm-6-016.PMC4915763.pdf
[updated 2013 Mar 7; cited 2015 Jun] Available from: http://www.mhlw.go.jp/english/policy/care-welfare/ care-welfare-elderly/dl/ri_130311-01.pdf.,Non-OADS,/arxiv_data1/oa_pdf/3a/d8/jlm-6-016.PMC4915763.pdf
Available from: http://apps.who.int/nha/database.,OADS,/arxiv_data1/oa_pdf/3a/d8/jlm-6-016.PMC4915763.pdf
Available from: http://apps.who.int/iris/bitstream/   10665/128038/1/9789241507509_eng.pdf.,OADS,/arxiv_data1/oa_pdf/3a/d8/jlm-6-016.PMC4915763.pdf
"Key Words:  Fighting, Violence, Bullying, Adolescents, Peru Received: December 7, 2015, Accepted: January 17, 2016 *Corresponding author: Eun Woo Nam Department of Health Administration, College of Health Science,  Yonsei University, 1 Yonseidae-gil, Wonju 26493, Republic of Korea Tel: 82-33-760-2413, Fax: 82-33-762-9562 E-mail: ewnam@yonsei.ac.kr  This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/4.0) which permits unrestricted noncommercial use, dis-tribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/8e/33/jlm-6-027.PMC4915764.pdf
"1, 27-35 http://dx.doi.org /10.15280/jlm.",Non-OADS,/arxiv_data1/oa_pdf/8e/33/jlm-6-027.PMC4915764.pdf
Available from: http://www.who.int/gho/publications/mdgs-sdgs/en/.,OADS,/arxiv_data1/oa_pdf/8e/33/jlm-6-027.PMC4915764.pdf
Available from: http://www.who.int/mediacentre/factsheets/fs150/en/.,Non-OADS,/arxiv_data1/oa_pdf/8e/33/jlm-6-027.PMC4915764.pdf
"Key Words:  Malaria, Pregnant women, Insecticide-treated nets, Democratic Republic of Congo, KOICA Received: December 7, 2015, Accepted: January 8, 2016 *Corresponding author: Eun Woo Nam Department of Health Administrati on, Collage of H ealth Sciences,  Yonsei University, 1 Yonseidae-g il, Wonju 26 493, Republic of Korea Tel: 82-33-760-2413, Fax: 82-33-760-2519 E-mail: ewnam@yonsei.ac.kr  This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/4.0) which permits unrestricted noncommercial use, dis-tribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/02/d9/jlm-6-036.PMC4915765.pdf
"1, 36-42 http://dx.doi.org /10.15280/jlm.",Non-OADS,/arxiv_data1/oa_pdf/02/d9/jlm-6-036.PMC4915765.pdf
"Key Words:  Myasthenia gravis, Rocuronium, Sugammadex Received: December 17, 2015, Accepted: February 1, 2016 *Corresponding author: Soon Yul Kim Department of Anesthesiology and Pain Medicine, Yonsei University  Wonju College of Medicine, 20 Ilsan-ro, Wonju 26426, Republic of Korea Tel: 82-33-741-0114, Fax: 82-33-742-8198 E-mail: soonyul@naver.com  This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/4.0) which permits unrestricted noncommercial use, dis-tribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d9/c5/jlm-6-043.PMC4915766.pdf
"1, 43-46 http://dx.doi.org /10.15280/jlm.",Non-OADS,/arxiv_data1/oa_pdf/d9/c5/jlm-6-043.PMC4915766.pdf
"Body Composition and Non-alcoholic Fatty Liver Disease Ludovico Abenavoli1,*, Laura Di Renzo2, Antonino De Lorenzo2 1Department of Health Sciences, University Magna Graecia, Viale Europa, 88100 Catanzaro, Italy, 2Division of Clinical Nutrition and  Nutrigenomics, Department of Biomedicine and Prevention, University of Rome Tor Vergata, Via Montpellier 1, I-00133, Rome, Ital y Received: January 22, 2016, Accepted: February 2, 2016 *Corresponding author: Ludovico Abenavoli Department of Health Sciences, University Magna Graecia, Viale  Europa, 88100 Catanzaro, Italy Tel: 39-0961-3694387, Fax: 39-0961-754220 E-mail: l.abenavoli@unicz.it  This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/4.0) which permits unrestricted noncommercial use, dis-tribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/5b/52/jlm-6-047.PMC4915767.pdf
"1, 47-48 http://dx.doi.org /10.15280/jlm.",Non-OADS,/arxiv_data1/oa_pdf/5b/52/jlm-6-047.PMC4915767.pdf
"RESULTS A diagram of study selection is presented in Supplemental Figure 1, http://links.lww.com/MD/A466.",Non-OADS,/arxiv_data1/oa_pdf/5c/a7/medi-94-e1674.PMC4915867.pdf
The Cochrane Collaboration;2011. http://www.cochrane-handbook.org.,OADS,/arxiv_data1/oa_pdf/5c/a7/medi-94-e1674.PMC4915867.pdf
Available at: http://www.sign.ac.uk/guidelines/fulltext/50/checklist3.,Non-OADS,/arxiv_data1/oa_pdf/98/83/medi-94-e1710.PMC4915869.pdf
"MATERIALS AND METHODS Study Population The ‘‘Nancy Biochemical Database’’ is an electronic database that included consecutive patients hospitalized in 67healthcare departments at the University Hospital of Nancy and underwent concomitant blood procalcitonin assays and blood cultures for suspected bloodstream infections between January1, 2006 and December 31, 2012 (Supplemental Digital Content:Figure 1, http://links.lww.com/MD/A504).",OADS,/arxiv_data1/oa_pdf/c5/e0/medi-94-e1774.PMC4915876.pdf
"The median age was 49 years (range 0–102; IQR 13–66) and the median procalcitonin value of the entire population was 0.34 ng/mL (IQR 0.15–1.31) (see Supplemental Digital Content: Table1, http://links.lww.com/MD/A504 for the exhaustive list of departments and corresponding median procalcitonin values according to the health care department).",OADS,/arxiv_data1/oa_pdf/c5/e0/medi-94-e1774.PMC4915876.pdf
"Together, these results represented more than 50% of the positive bloodcultures in this study (Table 1 and Supplemental DigitalContent: Table 2, http://links.lww.com/MD/A504).",OADS,/arxiv_data1/oa_pdf/c5/e0/medi-94-e1774.PMC4915876.pdf
"The highest procalcitonin concentration was observed in patients with blood cultures growing Gram-negative bacteria (median 2.2 ng/mL [IQR 0.6–12.2]), and the lowest procalcitonin con-centration was observed in patients with negative blood cultures(median 0.3 ng/mL [IQR 0.1–1.1]) (Table 1 and Supplemental Digital Content: Figure 2, http://links.lww.com/MD/A504).",Non-OADS,/arxiv_data1/oa_pdf/c5/e0/medi-94-e1774.PMC4915876.pdf
"Among the patients with Gram-negative bacteremia, the highestprocalcitonin concentrations were noted for anaerobic bacteria(Bacteroides ) (median 2.7 ng/mL [IQR 0.7–13.0]) and enter- obacteria ( Escherichia ,Enterobacter ,Klebsiella , and Citrobac- ter) (median 2.5 ng/mL [IQR 0.7–13.5]) in comparison with NFGNB ( Pseudomonas ,Acinetobacter ) (median 1.1 ng/mL [IQR 0.3–8.1]) ( P<0.0001 across subgroups; P<0.05 for pairwise comparisons: anaerobic bacteria vs NFGNB and enter-obacteria vs NFGNB) (Table 1 and Supplemental DigitalContent: Figure 2, http://links.lww.com/MD/A504).",Non-OADS,/arxiv_data1/oa_pdf/c5/e0/medi-94-e1774.PMC4915876.pdf
"The patients from the PCBCs group (n ¼1658, 4.7%) had blood cultures that were positive for viridans streptococci (n ¼86) and coagulase-negative staphylococci (n ¼1572) consisting mainly of the 3 following species: epidermidis ,hominis , and capitis (Supplemental Digital Content: Table 3, http://links.lww.com/ MD/A504).",Non-OADS,/arxiv_data1/oa_pdf/c5/e0/medi-94-e1774.PMC4915876.pdf
"internationally validated procalcitonin concentration strata:11 0.05 to 0.1 ng/mL, 0.1 to 0.25 ng/mL, 0.25 to 0.5 ng/mL, 0.5 to 1 ng/mL, 1 to 2 ng/mL, 2 to 10 ng/mL, and procalcitonin concentrations /C2110 ng/mL (Supplemental Digital Content: Table 4, http://links.lww.com/MD/A504).",OADS,/arxiv_data1/oa_pdf/c5/e0/medi-94-e1774.PMC4915876.pdf
"Only patients fromthe PCBCs group were significantly overrepresented among the patients with procalcitonin concentration between 0.5 and 1 ng/ mL (n ¼4380), with a small effect size (odds ratio 1.21; 95% CI, 1.05–1.39) (Figure 1 and Supplemental Digital Content: Table 5, http://links.lww.com/MD/A504).",Non-OADS,/arxiv_data1/oa_pdf/c5/e0/medi-94-e1774.PMC4915876.pdf
"The percentage of cases correctlyclassified in this regression model was 92.7% (SupplementalDigital Content: Tables 5 and 6, http://links.lww.com/MD/ A504).",OADS,/arxiv_data1/oa_pdf/c5/e0/medi-94-e1774.PMC4915876.pdf
"All organisms significantly associated with each pre- defined procalcitonin stratum are shown in SupplementalDigital Content: Table 7, http://links.lww.com/MD/A504 and Figure 3, http://links.lww.com/MD/A504.",OADS,/arxiv_data1/oa_pdf/c5/e0/medi-94-e1774.PMC4915876.pdf
"http://www.nhlbi.nih.gov/guidelines/obesity(accessed April 3, 2011).",Non-OADS,/arxiv_data1/oa_pdf/9f/ba/medi-94-e1910.PMC4915892.pdf
"The items also reflect cognitive dimensions of functional capacity in terms of execu- tive functioning: Initiative (13 items), planning and organization(10 items), and execution (17 items) (Annex 1, http://links.lww.com/MD/A487).",OADS,/arxiv_data1/oa_pdf/b9/92/medi-94-e1925.PMC4915895.pdf
"The analysis of the differences inTotal DAD scores showed similar results to those obtained with the total sample: the participants who obtained the highest scores on Total DAD were the healthy participants (N ¼17), followed by those with MCD (N ¼7), prodromal AD (N ¼3), and finally by patients suffering from Alzheimer type dementia (N¼2) (K-W ¼21.95; P<0.000) (Graph 1, http://links.lww.",Non-OADS,/arxiv_data1/oa_pdf/b9/92/medi-94-e1925.PMC4915895.pdf
"The PCA groups all the scores on the ADL subscales in a single component,explaining 61.7% of the variance (Graph 2, http://links.lww.",OADS,/arxiv_data1/oa_pdf/b9/92/medi-94-e1925.PMC4915895.pdf
Available at: http://svneurologia.org/paidem.htm.,Non-OADS,/arxiv_data1/oa_pdf/b9/92/medi-94-e1925.PMC4915895.pdf
Available at:http://www.metodo.uab.cat/macros.htm (accessed 5 March 2013).,Non-OADS,/arxiv_data1/oa_pdf/b9/92/medi-94-e1925.PMC4915895.pdf
"1, http://links.lww.com/MD/A496), and 16.04% ofpopulation was >65 years in Chiayi, Taiwan.",Non-OADS,/arxiv_data1/oa_pdf/00/3b/medi-94-e1962.PMC4915906.pdf
http://eprints.qut.edu.au.,Non-OADS,/arxiv_data1/oa_pdf/00/3b/medi-94-e1962.PMC4915906.pdf
http://www.usnews.com/ pubfiles/BH_2014_Methodology_Report_Final_Jul14.pdf.,Non-OADS,/arxiv_data1/oa_pdf/00/3b/medi-94-e1962.PMC4915906.pdf
NASA Ames Research Center.http://ntrs.nasa.gov/archive/nasa/casi.ntrs.nasa.gov/19800013796.pdf.,Non-OADS,/arxiv_data1/oa_pdf/00/3b/medi-94-e1962.PMC4915906.pdf
"http://www.moi.gov.tw/files/news_file/week10429.pdf Published January 17, 2015.",Non-OADS,/arxiv_data1/oa_pdf/00/3b/medi-94-e1962.PMC4915906.pdf
Available at: http://globocan.iarc.fr/Pages/fact_sheets_cancer.aspx.,Non-OADS,/arxiv_data1/oa_pdf/fe/4e/medi-94-e1964.PMC4915907.pdf
World Population Ageing 2013. http://www.un.org/ en/development/desa/population/publications/pdf/ageing/WorldPopu-lationAgeing2013.pdf.,Non-OADS,/arxiv_data1/oa_pdf/fe/4e/medi-94-e1964.PMC4915907.pdf
"Cancer registry annual report, 2012,Taiwan, http://www.hpa.gov.tw/BHPNet/Web/Stat/StatisticsSho-w.aspx?.",Non-OADS,/arxiv_data1/oa_pdf/fe/4e/medi-94-e1964.PMC4915907.pdf
"Nevertheless, there were no noticeable changes in the AORs among models 1, 2, and 3 (Supplements 1and 2; Table S3, http://links.lww.com/MD/A494), whichapplied different levels of confounders.",Non-OADS,/arxiv_data1/oa_pdf/38/d9/medi-94-e1965.PMC4915908.pdf
"14The long sleep group ( /C218 hours) showed the highest physical activity and the shortest study time (Supplement 3, http://links.lww.com/MD/A494).",Non-OADS,/arxiv_data1/oa_pdf/38/d9/medi-94-e1965.PMC4915908.pdf
Available at: http://www.cdc.gov/healthyweight/assessing/bmi/childrens_bmi/about_childrens_bmi.html.,Non-OADS,/arxiv_data1/oa_pdf/38/d9/medi-94-e1965.PMC4915908.pdf
"http://dx.doi.org/10.1016/j.jtcvs.2016.02.047 The Journal of Thoracic and Cardiovascular SurgerycVolume 152, Number 1 235 PMPERIOPERATIVE MANAGEMENT: CARDIAC: KIDNEY INJURY",Non-OADS,/arxiv_data1/oa_pdf/67/57/main.PMC4915911.pdf
Website https://www.env.go.jp/press/15619   .html [accessed 18 May 2016] (in Japanese).,Non-OADS,/arxiv_data1/oa_pdf/08/4c/apps.1500143.PMC4915918.pdf
"The resulting raw Illumina paired-end sequencing reads were analyzed with  a Perl script, PAL_FINDER_v0.02.04 (available at http://sourceforge.net/projects/palfinder), which identifies microsatellite loci without the need for prior se-quence trimming and assembly (Castoe et al., 2012).",OADS,/arxiv_data1/oa_pdf/d0/41/apps.1600010.PMC4915920.pdf
"As DNA sequencing costs decrease, online resources such as the Sequence Read Archive (SRA), curated by the National Center for Biotechnology Information (NCBI; http://www.ncbi.nlm.nih.gov/sra), have grown substantially in the past decade.",OADS,/arxiv_data1/oa_pdf/0f/b3/apps.1600024.PMC4915922.pdf
"Developing microsatellites from transcriptomes—Our methods identified  5,739,271 microsatellite loci from 1334 transcriptomes (supplementary files are available from the Dryad Digital Repository at http://dx.doi.org/10.5061/dryad   .rb7h0; Hodel et al., 2016b).",OADS,/arxiv_data1/oa_pdf/0f/b3/apps.1600024.PMC4915922.pdf
"These annotated scripts are available on GitHub at: https://github.com/soltislab/transcriptome_microsats, and the data files are available from the Dryad Digital Repository (http://dx.doi.org/10.5061/dryad.rb7h0; Hodel et al., 2016b).",OADS,/arxiv_data1/oa_pdf/0f/b3/apps.1600024.PMC4915922.pdf
Turquoise boxes indicate software packages or scripts; custom scripts (available at https://github.com/ soltislab/transcriptome_microsats) designed by the authors are designated by asterisks.,Non-OADS,/arxiv_data1/oa_pdf/0f/b3/apps.1600024.PMC4915922.pdf
"http://dx.doi   .org/10.5061/dryad.rb7h0 Jennin Gs, t. n., b. J. Knaus , t. d. mullins , s. m. haiG, and R. c. cRonn.",Non-OADS,/arxiv_data1/oa_pdf/0f/b3/apps.1600024.PMC4915922.pdf
Mining existing data sets—  Another option for developing  microsatellite markers is using publicly available sequence data from online repositories such as the Sequence Read Archive (SRA; http://www.ncbi.nlm.nih.gov/sra).,OADS,/arxiv_data1/oa_pdf/4c/08/apps.1600025.PMC4915923.pdf
"Software Operating system Features URLCitations (Web of   Science/Google   Scholar) Reference Comments Geneious Linux, Mac OSX,   WindowsIntegrates multiple functions with plugins,   user-friendly interfacehttp://www.geneious.com/   features/microsatellite- analysis395/633 Kearse et al., 2012 Very user friendly, but requires a paid   license to run.",Non-OADS,/arxiv_data1/oa_pdf/4c/08/apps.1600025.PMC4915923.pdf
"The microsatellite   development plugin (Phobos,   http://www.ruhr-uni-bochum.de/ecoevo/cm/cm_phobos.htm) is freely available, very easy to use, and quick.",Non-OADS,/arxiv_data1/oa_pdf/4c/08/apps.1600025.PMC4915923.pdf
"GMATo Linux, Mac OSX,   WindowsBoth GUI and command line interface;   SSR mining and statistics at   genome levelhttp://sourceforge.net/   projects/gmato/files/   ?source=navbar0/8 Wang et al., 2013 Runs quickly and has clear output,  but it is hard for the user to change important parameter settings.",OADS,/arxiv_data1/oa_pdf/4c/08/apps.1600025.PMC4915923.pdf
"HighSSR Linux, Mac OSX,   WindowsA Java program is designed for NGS data   and capable of microsatellite detection,   elimination of redundancy and primer   development, and interacting with   PostgreSQL, MUSCLE, and Primer3.https://code.google.com/p/ highssr/7/12 Churbanov et al., 2012 Cannot open large files (>2 GB);  unsuitable for most NGS data.",OADS,/arxiv_data1/oa_pdf/4c/08/apps.1600025.PMC4915923.pdf
"MISA Linux, Mac OSX,   WindowsPreprocessing sequences, motif search,   and interacts with Primer3 for primer   designshttp://pgrc.ipk-gatersleben   .de/misa/669/1150 Thiel et al., 2003 Fast, easy to configure, generates  primers.",OADS,/arxiv_data1/oa_pdf/4c/08/apps.1600025.PMC4915923.pdf
"MSATCOMMANDER Linux, Mac OSX,   WindowsMotif search, interacts with Primer3 for   primer design, and primer auto-taghttp://code.google.com/p/ msatcommander/428/509 Faircloth, 2008 Output is difficult to view; requires lots   of filtering to find basic statistics.",OADS,/arxiv_data1/oa_pdf/4c/08/apps.1600025.PMC4915923.pdf
"PAL_FINDER Linux, Mac OSX,   WindowsIdentifies and characterizes microsatellite   repeat loci from shotgun genomic   sampling by 454 or Illumina   paired-end reads, and designs PCR   primers by interacting with Primer3http://sourceforge.net/   projects/palfinder/   or http://www   .snakegenomics.org/CastoeLab/Software.html87/115 Castoe et al., 2012 Slow, struggles with large files;   compatibility issues with many   FASTQ formats; would not complete   with the largest data set.",Non-OADS,/arxiv_data1/oa_pdf/4c/08/apps.1600025.PMC4915923.pdf
"QDD3 Windows and   LinuxA computer program to select   microsatellite markers from raw   sequence reads obtained from 454   or Illumina and design primers   from large sequences at genomic   level, dealing with the essential   bioinformatics and equipped   with both command line and a   user-friendly graphical interface on   the Galaxy server.http://net.imbe.fr/   ~emeglecz/qdd3/9 Meglécz et al., 2014 Relatively long running time; user   cannot easily change parameter   settings.",Non-OADS,/arxiv_data1/oa_pdf/4c/08/apps.1600025.PMC4915923.pdf
"SSR Locator Windows Integrates SSR searches, frequency of   occurrence of motifs and arrangements,   primer design, PCR simulation, global   alignments, and identity and homology   searches; eliminates overlaps between   adjacent sequences; interacts with   Primer3http://www.hindawi.com/ journals/ijpg/2008/412696/0/98 Da Maia et al., 2008 Requires tedious file reformatting; only   available for Windows.",OADS,/arxiv_data1/oa_pdf/4c/08/apps.1600025.PMC4915923.pdf
"SSR_pipeline Linux, Mac OSX,   WindowsIdentifies simple sequence repeats,   e.g., microsatellites from paired-end   high-throughput Illumina DNA   sequencing datahttp://pubs.usgs.gov/ds/   778/3/3 Miller et al., 2013 We could not get it to run after ~24 h   of effort.",Non-OADS,/arxiv_data1/oa_pdf/4c/08/apps.1600025.PMC4915923.pdf
"STAMP Linux, Mac OSX,   WindowsBased on STADEN package, with   comprehensive integration of a set of   extension modules to facilitate the   processing of microsatellite markers,   like Phobos, TROLL, Primer3,   SQLite module.http://www.awi.de/en/ research/scientific_computing/bioinformatics/software/11/15 Kraemer et al., 2009 Powerful, but not user friendly.",OADS,/arxiv_data1/oa_pdf/4c/08/apps.1600025.PMC4915923.pdf
Available at website  http://molecularecologist.com/next-gen-fieldguide-2014/ [accessed 15 February 2016].,Non-OADS,/arxiv_data1/oa_pdf/4c/08/apps.1600025.PMC4915923.pdf
Website http://www.rub.de/spezzoo/cm/cm_phobos.htm  [accessed 12 January 2016].,Non-OADS,/arxiv_data1/oa_pdf/4c/08/apps.1600025.PMC4915923.pdf
"Based on personal experience, the calculator provided by the Oregon State Center for Genome Research and Biocomputing (CGRB; http://hts2.cgrb.oregonstate.edu/calc/gbs/ [accessed 21 February 2016]), and a pricing quote from the University of Texas Genomic Sequencing and Analysis Facility (GSAF) website (https://wikis.utexas.edu/display/GSAF/Pricing [accessed 14 May 2016]), we estimate the cost of RAD/GBS with 96 samples to range from approximately $3400 to $5000.",Non-OADS,/arxiv_data1/oa_pdf/4c/08/apps.1600025.PMC4915923.pdf
This  is  an  open access article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/63/22/main.PMC4915948.pdf
Because  of  the  chronic inﬂammation  of  the  cyst  walls  and  their  consequent  adhesions http://dx.doi.org/10.1016/j.ijscr.2016.04.027 2210-2612/© 2016  The  Authors.,Non-OADS,/arxiv_data1/oa_pdf/63/22/main.PMC4915948.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Contents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/dibData in Brief http://dx.doi.org/10.1016/j.dib.2016.05.058 2352-3409/ &2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/43/3f/main.PMC4915949.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/43/3f/main.PMC4915949.pdf
Three different analysis methods were compared using a Venn diagram visualisation of peptides identi ﬁed using VENNY (http://bioinfogp.cnb.csic.es/tools/venny/ ).K.,OADS,/arxiv_data1/oa_pdf/43/3f/main.PMC4915949.pdf
Data availability D a t aa r ea v a i l a b l ef r o mP r o t e o m e X c h a n g eC o n s o r t i u m( http://proteomecentral.proteomexchange.org )[5] PRIDE: PXD003520 ;P r o j e c tN a m e :R a ts p l e e np r o t e o m i c sp r o ﬁling Project accession: PXD003520 ;P r o j e c t DOI: 10.6019/PXD003520 ; Reviewer account details: Username: re viewer67804@ebi.ac.uk; Password: tyP0Zh1t.,Non-OADS,/arxiv_data1/oa_pdf/43/3f/main.PMC4915949.pdf
Supplementary material Supplementary data associated with this article can be found in the online version at http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/43/3f/main.PMC4915949.pdf
6 (2015) 8664. http://dx.doi.org/10.1038/ncomms9664 .,Non-OADS,/arxiv_data1/oa_pdf/43/3f/main.PMC4915949.pdf
Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ) http://dx.doi.org/10.1016/j.nmni.2016.05.013,Non-OADS,/arxiv_data1/oa_pdf/5d/3e/main.PMC4915952.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases, NMNI ,13,1–2 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/5d/3e/main.PMC4915952.pdf
This  is  an  open access article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b8/77/main.PMC4915953.pdf
Care  was  taken  to  tightly  wrap  the  mesh  in  order  to  exert http://dx.doi.org/10.1016/j.ijscr.2016.05.031 2210-2612/© 2016  The  Authors.,Non-OADS,/arxiv_data1/oa_pdf/b8/77/main.PMC4915953.pdf
This  is  an  open access article under  the CC BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/aa/25/main.PMC4915954.pdf
"The  patient’s  postoperative  course  was  uneventful,  and she  was  discharged  on  the  postoperative  day  17. http://dx.doi.org/10.1016/j.ijscr.2016.05.053 2210-2612/© 2016  The  Author(s).",Non-OADS,/arxiv_data1/oa_pdf/aa/25/main.PMC4915954.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/68/21/main.PMC4915955.pdf
Contents lists available at ScienceDirect Annals of Medicine and Surgery journal homepage: www.annalsjournal.com http://dx.doi.org/10.1016/j.amsu.2016.05.017 2049-0801/ ©2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/68/21/main.PMC4915955.pdf
"16 (2001) 140 e144, http://dx.doi.org/10.1007/ s004670000522 .",Non-OADS,/arxiv_data1/oa_pdf/68/21/main.PMC4915955.pdf
"23 (2008) 1841 e1846, http://dx.doi.org/10.1007/s00467-008-0871-5 .",Non-OADS,/arxiv_data1/oa_pdf/68/21/main.PMC4915955.pdf
This  is  an  open access article under the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/62/4a/main.PMC4915956.pdf
"The small  bowel  was  placed  back  in  its  original  position  with  no  debulk- ing necessary,  but  unfortunately  the  right  testicle  was  found  to  be http://dx.doi.org/10.1016/j.ijscr.2016.05.039 2210-2612/© 2016  The  Authors.",Non-OADS,/arxiv_data1/oa_pdf/62/4a/main.PMC4915956.pdf
This  is  an  open access article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/c4/a9/main.PMC4915957.pdf
were  performed  to  obtain  more  infor- http://dx.doi.org/10.1016/j.ijscr.2016.05.049 2210-2612/© 2016  The  Authors.,OADS,/arxiv_data1/oa_pdf/c4/a9/main.PMC4915957.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/7b/37/main.PMC4915958.pdf
Contents lists available at ScienceDirect Respiratory Medicine Case Reports journal homepage: www.elsevier.c om/locate/rmcr http://dx.doi.org/10.1016/j.rmcr.2016.06.003 2213-0071/ ©2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/7b/37/main.PMC4915958.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Respiratory Medicine Case Reports 19 (2016) 12 e14,Non-OADS,/arxiv_data1/oa_pdf/7b/37/main.PMC4915958.pdf
"SUPPLEMENTARY MATERIAL is linked to the online version of the paper at http://www.nature.com/mi ACKNOWLEDGMENTS We thank Nelly Leung, Kate Banks, and Frank Guiliano for their technical support and helpful discussions throughout this study.",Non-OADS,/arxiv_data1/oa_pdf/19/d2/mi2015122a.PMC4915993.pdf
"This assay, the 21-gene recurrence score, is commer-cially available as the Oncotype DX  TM  Breast Cancer Assay  from Genomic Health (Redwood City, Calif., USA; http://www.oncotypedx.com).",Non-OADS,/arxiv_data1/oa_pdf/4a/11/mpp-0025-0073.PMC4916026.pdf
"This trial, the Trial Assessing Individualized Options for Treatment for breast cancer (TAILORx) has completed accrual (NCT00310180; https://clinicaltrials.gov).",Non-OADS,/arxiv_data1/oa_pdf/4a/11/mpp-0025-0073.PMC4916026.pdf
"Currently, a large ran-domized clinical trial of adjuvant chemotherapy in hor-mone receptor-positive, lymph node-positive early-stage  breast cancer patients is ongoing (NCT0127203; https://clinicaltrials.gov).",Non-OADS,/arxiv_data1/oa_pdf/4a/11/mpp-0025-0073.PMC4916026.pdf
A phase 3 trial in women with early-stage breast cancer (APHINITY) has completed accrual (NCT01358877; https://clinicaltrials.gov).,Non-OADS,/arxiv_data1/oa_pdf/4a/11/mpp-0025-0073.PMC4916026.pdf
"Lyon, International Agency for Re-search on Cancer, 2013. http://globocan.iarc.fr (accessed October 28, 2015).",Non-OADS,/arxiv_data1/oa_pdf/4a/11/mpp-0025-0073.PMC4916026.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/f2/58/main.PMC4916035.pdf
Contents lists available at ScienceDirect International Journal for Parasitology: Parasites and Wildlife journal homepage: www.elsevier.com /locate/ijppaw http://dx.doi.org/10.1016/j.ijppaw.2016.04.002 2213-2244/ ©2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/f2/58/main.PMC4916035.pdf
2015. http://dx.doi.org/10.1016/j.vetpar.2015.04.020 .,OADS,/arxiv_data1/oa_pdf/f2/58/main.PMC4916035.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/45/95/main.PMC4916047.pdf
Contents lists available at ScienceDirect Annals of Medicine and Surgery journal homepage: www.annalsjournal.com http://dx.doi.org/10.1016/j.amsu.2016.05.016 2049-0801/ ©2016 Published by Elsevier Ltd on behalf of IJS Publishing Group Ltd.,Non-OADS,/arxiv_data1/oa_pdf/45/95/main.PMC4916047.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/ licenses/by-nc-nd/4.0/ ).Annals of Medicine and Surgery 9 (2016) 15 e21,Non-OADS,/arxiv_data1/oa_pdf/45/95/main.PMC4916047.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Occipital seizuresNonketotic hyperglycemia Homonymous hemianopia Subcortical T2 hypointensity 1.,Non-OADS,/arxiv_data1/oa_pdf/b9/5d/main.PMC4916048.pdf
http://dx.doi.org/10.1016/j.ebcr.2016.04.008 2213-3232/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/b9/5d/main.PMC4916048.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b9/5d/main.PMC4916048.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d1/ab/main.PMC4916050.pdf
Contents lists available at ScienceDirect Annals of Medicine and Surgery journal homepage: www.annalsjournal.com http://dx.doi.org/10.1016/j.amsu.2016.05.013 2049-0801/ ©2016 The Author(s).,Non-OADS,/arxiv_data1/oa_pdf/d1/ab/main.PMC4916050.pdf
Supplementary video related to this article can be found at http://dx.doi.org/10.1016/j.amsu.2016.05.013 .,OADS,/arxiv_data1/oa_pdf/d1/ab/main.PMC4916050.pdf
This  is  an  open access article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/34/a9/main.PMC4916051.pdf
"At the  time  of  evaluation,  laboratory  tests  were  as  follow:  ele- vated  conjugated  bilirubin  =  290  /H9262mol/l  (normal  value  <5  /H9262mol/l) and  gammaglutamyl  transpeptidase  =  100  IU/l  (normal:  30  IU/l), http://dx.doi.org/10.1016/j.ijscr.2016.03.032 2210-2612/© 2016  The  Author(s).",Non-OADS,/arxiv_data1/oa_pdf/34/a9/main.PMC4916051.pdf
Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ) http://dx.doi.org/10.1016/j.nmni.2016.05.002,Non-OADS,/arxiv_data1/oa_pdf/ac/70/main.PMC4916054.pdf
"Then, 16S rRNA gene sequences were compared with those which are available in GenBank ( http://www.ncbi.nlm.nih.gov/ genbank/ ).",OADS,/arxiv_data1/oa_pdf/ac/70/main.PMC4916054.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases, NMNI ,13,3–12 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/ac/70/main.PMC4916054.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases, NMNI ,13,3–12 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/ac/70/main.PMC4916054.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases, NMNI ,13,3–12 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/ac/70/main.PMC4916054.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases, NMNI ,13,3–12 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/ac/70/main.PMC4916054.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases, NMNI ,13,3–12 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/ac/70/main.PMC4916054.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases, NMNI ,13,3–12 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/ac/70/main.PMC4916054.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases, NMNI ,13,3–12 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/ac/70/main.PMC4916054.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases, NMNI ,13,3–12 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/ac/70/main.PMC4916054.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases, NMNI ,13,3–12 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/ac/70/main.PMC4916054.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/8d/3b/main.PMC4916059.pdf
"Contents lists available at ScienceDirect Prostate International journal homepage: http://p-international.com http://dx.doi.org/10.1016/j.prnil.2016.02.002 p2287-8882 e2287-903X/Copyright ©2016 Asian Paci ﬁc Prostate Society, Published by Elsevier.",Non-OADS,/arxiv_data1/oa_pdf/8d/3b/main.PMC4916059.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/85/56/main.PMC4916060.pdf
"Contents lists available at ScienceDirect Prostate International journal homepage: http://p-international.com http://dx.doi.org/10.1016/j.prnil.2016.02.003 p2287-8882 e2287-903X/Copyright ©2016 Asian Paci ﬁc Prostate Society, Published by Elsevier.",Non-OADS,/arxiv_data1/oa_pdf/85/56/main.PMC4916060.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b3/e0/main.PMC4916061.pdf
"Contents lists available at ScienceDirect Prostate International journal homepage: http://p-international.com http://dx.doi.org/10.1016/j.prnil.2016.05.001 p2287-8882 e2287-903X/Copyright ©2016 Asian Paci ﬁc Prostate Society, Published by Elsevier.",Non-OADS,/arxiv_data1/oa_pdf/b3/e0/main.PMC4916061.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/91/8e/main.PMC4916062.pdf
"Contents lists available at ScienceDirect Prostate International journal homepage: http://p-international.com http://dx.doi.org/10.1016/j.prnil.2016.01.001 p2287-8882 e2287-903X/Copyright ©2016 Asian Paci ﬁc Prostate Society, Published by Elsevier.",Non-OADS,/arxiv_data1/oa_pdf/91/8e/main.PMC4916062.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/48/9c/main.PMC4916063.pdf
"Contents lists available at ScienceDirect Prostate International journal homepage: http://p-international.com http://dx.doi.org/10.1016/j.prnil.2016.02.001 p2287-8882 e2287-903X/Copyright ©2016 Asian Paci ﬁc Prostate Society, Published by Elsevier.",Non-OADS,/arxiv_data1/oa_pdf/48/9c/main.PMC4916063.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/43/8c/main.PMC4916064.pdf
"Contents lists available at ScienceDirect Prostate International journal homepage: http://p-international.com http://dx.doi.org/10.1016/j.prnil.2016.04.001 p2287-8882 e2287-903X/Copyright ©2016 Asian Paci ﬁc Prostate Society, Published by Elsevier.",Non-OADS,/arxiv_data1/oa_pdf/43/8c/main.PMC4916064.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Functional brain networkResting-state networkfMRIVolume shape descriptor Autism spectrum disorder Sparse representationConnectomics signature 1.,Non-OADS,/arxiv_data1/oa_pdf/e9/e4/main.PMC4916065.pdf
http://dx.doi.org/10.1016/j.nicl.2016.06.004 2213-1582/© 2016 Published by Elsevier Inc.,Non-OADS,/arxiv_data1/oa_pdf/e9/e4/main.PMC4916065.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/e9/e4/main.PMC4916065.pdf
"In response, we proposed an effective volumetric network descriptor, named connectivity map , to compactly and quantitatively de- scribe spatial pattern sof brain network maps and resort to the power of distributed system and implemented a fast, novel framework in the Apache Spark ( http://spark.apache.org /) environment that can identify group-wise consistent networks featured in ASD patients and controls.",OADS,/arxiv_data1/oa_pdf/e9/e4/main.PMC4916065.pdf
"To efﬁciently manage memory and to employ the power of parallel/ distributed computing, the whole computation was implemented on Apache Spark ( https://spark.apache.org ).",OADS,/arxiv_data1/oa_pdf/e9/e4/main.PMC4916065.pdf
199 initial clus-ters ( http://hafni.cs.uga.edu/autism/init ) were obtained after clustering.,OADS,/arxiv_data1/oa_pdf/e9/e4/main.PMC4916065.pdf
"For the convenience of further discussion and easy visualiza- tion, all of these ICNs were sorted by their reproducibility and each ICN is given an index ( http://hafni.cs.uga.edu/autism/templates/all.",OADS,/arxiv_data1/oa_pdf/e9/e4/main.PMC4916065.pdf
The method reproducibility webpage in our data portal ( http://hafni.cs.,Non-OADS,/arxiv_data1/oa_pdf/e9/e4/main.PMC4916065.pdf
"Thanks to the novel and powerful large-scale fMRI data mining framework proposed in this study and the availability of big rsfMRI dataset, it is surprising that the number of common ICNs in thehuman brain could be as large as 144 ( http://hafni.cs.uga.edu/autism/ templates/all.html ), which is signi ﬁcantly larger than the number of networks analyzed in the previous studies ( van den Heuvel and Hulshoff Pol, 2010; Rosazza and Minati, 2011 ).",Non-OADS,/arxiv_data1/oa_pdf/e9/e4/main.PMC4916065.pdf
"To enable explorations and investigations ofthe results generated from the framework, we built a data portal(http://hafni.cs.uga.edu/autism/ ) for the dataset and the obtained ICNs.",OADS,/arxiv_data1/oa_pdf/e9/e4/main.PMC4916065.pdf
"Improved optimization for the ro- bust and accurate linear registration and motion correction of brain images.NeuroImage 17, 825 –841 (http://www.ncbi.nlm.nih.gov/pubmed/12377157 ).",OADS,/arxiv_data1/oa_pdf/e9/e4/main.PMC4916065.pdf
8. http://dx.doi.org/10.3389/fnhum.2014.00349/ abstract .,Non-OADS,/arxiv_data1/oa_pdf/e9/e4/main.PMC4916065.pdf
"NeuroImage 52, 1059 –1069 ( http://www.ncbi.nlm.nih.gov/pubmed/ 19819337 ).",OADS,/arxiv_data1/oa_pdf/e9/e4/main.PMC4916065.pdf
"7, 802 ( http://www.ncbi.nlm.nih.gov/ pubmed/24319422 ).",Non-OADS,/arxiv_data1/oa_pdf/e9/e4/main.PMC4916065.pdf
"103, 297 –321 ( http://www.ncbi.nlm.nih.",Non-OADS,/arxiv_data1/oa_pdf/e9/e4/main.PMC4916065.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/4f/c0/main.PMC4916066.pdf
"Contents lists available at ScienceDirect Prostate International journal homepage: http://p-international.com http://dx.doi.org/10.1016/j.prnil.2016.03.002 p2287-8882 e2287-903X/Copyright ©2016 Asian Paci ﬁc Prostate Society, Published by Elsevier.",Non-OADS,/arxiv_data1/oa_pdf/4f/c0/main.PMC4916066.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: MRIGlioblastomaStatisticalAtlas Spatial 1.,Non-OADS,/arxiv_data1/oa_pdf/e7/10/main.PMC4916067.pdf
http://dx.doi.org/10.1016/j.nicl.2016.03.007 2213-1582/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/e7/10/main.PMC4916067.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/e7/10/main.PMC4916067.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 InternationalLicense (http://creativecommons.org/licenses/by-nc/4.0/), which per- mits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the originalauthor(s) and the source, provide a link to the Creative Commonslicense, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/b7/18/40262_2015_Article_360.PMC4916189.pdf
2015. https://aidsinfo.nih.gov/guidelines/html/ 1/adult-and-adolescent-treatment-guidelines/0 .,Non-OADS,/arxiv_data1/oa_pdf/b7/18/40262_2015_Article_360.PMC4916189.pdf
2012. http://apps.who.int/iris/handle/10665/70920 .,Non-OADS,/arxiv_data1/oa_pdf/b7/18/40262_2015_Article_360.PMC4916189.pdf
2015. https://clinicaltrials.gov/ct2/show/NCT02499874?,Non-OADS,/arxiv_data1/oa_pdf/b7/18/40262_2015_Article_360.PMC4916189.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which per-mits any noncommercial use, distribution, and reproduction in anymedium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.Prediction and conﬁrmation of ethnic sensitivity in PK 831",Non-OADS,/arxiv_data1/oa_pdf/48/22/40262_2015_Article_356.PMC4916198.pdf
1998. http://www.ich.org/ﬁleadmin/Public_Web_Site/ICH_Pro- ducts/Guidelines/Efﬁcacy/E5_R1/Step4/E5_R1__Guideline.pdf .,Non-OADS,/arxiv_data1/oa_pdf/48/22/40262_2015_Article_356.PMC4916198.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which per-mits any noncommercial use, distribution, and reproduction in anymedium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/b4/4b/40262_2015_Article_357.PMC4916199.pdf
"National Registry of Cancer Cases, http://onkologia.org.pl/ nowotwory-zlosliwe-jelita-grubego-c18-21/, 19.09.2014.",Non-OADS,/arxiv_data1/oa_pdf/af/f6/PG-11-25389.PMC4916231.pdf
"National Cancer Combatting Program, http://www2.mz.gov.pl/wwwmz/index?mr=q101&ms&ml=pl&mi&mx - =0&mt&my=0&ma=5232, 18.07.2014.",Non-OADS,/arxiv_data1/oa_pdf/af/f6/PG-11-25389.PMC4916231.pdf
"Society for colorectal cancer patients and promoting cancer  prevention, http://www.europacolon.pl/?rak-jelita-grubego,3,  19.09.2014.",Non-OADS,/arxiv_data1/oa_pdf/af/f6/PG-11-25389.PMC4916231.pdf
"14. International Association for the Study of Pain, IASP Taxon - omyhttp://www.iasp-pain.org/Education/Content.aspx?Item- Number=1698&navItemNumber=576#Pain (term: pain).",Non-OADS,/arxiv_data1/oa_pdf/af/f6/PG-11-25389.PMC4916231.pdf
"These guidelines, of course, do not exempt the specialist from tracking the new multicentre randomized trials  (http://apps.who.",Non-OADS,/arxiv_data1/oa_pdf/07/88/PG-11-27681.PMC4916242.pdf
Available on-line: [http://store.samhsa.gov/shin/content/SMA12-4686/SMA12-4686.pdf].,OADS,/arxiv_data1/oa_pdf/79/e2/PG-11-27682.PMC4916243.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), permitting all non-commercial use , distribution, and reproduction in any medium, provided the original work is properly cited.1 Citation: Infection Ecology and Epidemiology 2016, 6: 31514 - http://dx.doi.org/10.3402/iee.v6.31514 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/88/a6/IEE-6-31514.PMC4916256.pdf
"2 (page number not for citation purpose)Citation: Infection Ecology and Epidemiology 2016, 6: 31514 - http://dx.doi.org/10.3402/iee.v6.31514",Non-OADS,/arxiv_data1/oa_pdf/88/a6/IEE-6-31514.PMC4916256.pdf
"PCR products were separated by capillary electrophoresis in an ABI PRISM 3100 GeneticEvidence of household transfer of ESBL/pAmpC ... Citation: Infection Ecology and Epidemiology 2016, 6: 31514 - http://dx.doi.org/10.3402/iee.v6.31514 3 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/88/a6/IEE-6-31514.PMC4916256.pdf
"4 (page number not for citation purpose)Citation: Infection Ecology and Epidemiology 2016, 6: 31514 - http://dx.doi.org/10.3402/iee.v6.31514",Non-OADS,/arxiv_data1/oa_pdf/88/a6/IEE-6-31514.PMC4916256.pdf
"Tentatively, a lower sensiti- vity of the method used in samples from dogs could result in an underestimation of the extent of sharing of strains.Evidence of household transfer of ESBL/pAmpC ... Citation: Infection Ecology and Epidemiology 2016, 6: 31514 - http://dx.doi.org/10.3402/iee.v6.31514 5 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/88/a6/IEE-6-31514.PMC4916256.pdf
Available from: http://www.sva.se/en/antibiotics/svarm-reports [cited 14 January 2016].,Non-OADS,/arxiv_data1/oa_pdf/88/a6/IEE-6-31514.PMC4916256.pdf
Available from: http://www.sva.se/antibiotika/anmalningspliktig-resistens/esbl/antibiotikaresistens-i-livsmedel-och-var-omgivning [cited 14 January 2016].,OADS,/arxiv_data1/oa_pdf/88/a6/IEE-6-31514.PMC4916256.pdf
doi: http://dx.doi.,OADS,/arxiv_data1/oa_pdf/88/a6/IEE-6-31514.PMC4916256.pdf
Available from:http://www.sva.se/en/antibiotics/svarm-reports [cited 14 January 2016].,Non-OADS,/arxiv_data1/oa_pdf/88/a6/IEE-6-31514.PMC4916256.pdf
Available from:http://www.sva.se/en/antibiotics/svarm-reports [cited 14 January 2016].Oskar Ljungquist et al.,OADS,/arxiv_data1/oa_pdf/88/a6/IEE-6-31514.PMC4916256.pdf
"6 (page number not for citation purpose)Citation: Infection Ecology and Epidemiology 2016, 6: 31514 - http://dx.doi.org/10.3402/iee.v6.31514",Non-OADS,/arxiv_data1/oa_pdf/88/a6/IEE-6-31514.PMC4916256.pdf
"Infect Ecol Epidemiol 2015; 5: 25334,doi: http://dx.doi.org/10.3402/iee.v5.25334 32.",Non-OADS,/arxiv_data1/oa_pdf/88/a6/IEE-6-31514.PMC4916256.pdf
Available from: http://www.scb.se/sv_/Hitta-statistik/ Statistik-efter-amne/Befolkning/Befolkningens-sammansattning/Befolkningsstatistik/25788/25795/Helarsstatistik---Forsamling- landskap-och-stad/389798/# [cited 31 December 2014].,OADS,/arxiv_data1/oa_pdf/88/a6/IEE-6-31514.PMC4916256.pdf
"Infect Ecol Epidemiol 2015; 5: 28758, doi: http://dx.doi.org/10.3402/iee.v5.",Non-OADS,/arxiv_data1/oa_pdf/88/a6/IEE-6-31514.PMC4916256.pdf
"28758Evidence of household transfer of ESBL/pAmpC ... Citation: Infection Ecology and Epidemiology 2016, 6: 31514 - http://dx.doi.org/10.3402/iee.v6.31514 7 (page number not for citation purpose)",OADS,/arxiv_data1/oa_pdf/88/a6/IEE-6-31514.PMC4916256.pdf
"This is an open access article distributed under the terms of the Creative Commons Attribution Non-commercial IGO License (http://creativecommons.org/licenses/by/3.0/igo/legalcode), which permits distribution and reproduction in any medium, for non-commercial uses provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/cf/b1/GHA-9-31516.PMC4916258.pdf
"PAHO grants licenses for publishers using Creative Commons, but uses a different version that is specially designed for International Organizations called CC-BY-NC (non-commercial) IGO 3.0 version: http://creativecommons.org/licenses/b y-nc/3.0/igo/ legalcode.1 Citation: Glob Health Action 2016, 9: 31516 - http://dx.doi.org/10.3402/gha.v9.31516 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/cf/b1/GHA-9-31516.PMC4916258.pdf
"2 (page number not for citation purpose)Citation: Glob Health Action 2016, 9: 31516 - http://dx.doi.org/10.3402/gha.v9.31516",Non-OADS,/arxiv_data1/oa_pdf/cf/b1/GHA-9-31516.PMC4916258.pdf
"For the discussion of adolescence as a time ofvulnerability we drew from the previous review of riskfactors and from the programmatic literature aboutpromising responses to violence prevention.Intersections of violence against women and violence against children Citation: Glob Health Action 2016, 9: 31516 - http://dx.doi.org/10.3402/gha.v9.31516 3 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/cf/b1/GHA-9-31516.PMC4916258.pdf
"4 (page number not for citation purpose)Citation: Glob Health Action 2016, 9: 31516 - http://dx.doi.org/10.3402/gha.v9.31516",Non-OADS,/arxiv_data1/oa_pdf/cf/b1/GHA-9-31516.PMC4916258.pdf
"Shared risk factors for perpetration of violence against women and violence against children Individual (perpetration)/C147Witnessed or experienced violence as a child /C147Young age /C147Alcohol and drug use /C147Depression /C147Personality disorder/antisocial behaviour /C147Attitudes that condone violence and gender inequality Family/household /C147Marital conflict/family breakdown /C147Male dominance in the family /C147Economic stress /C147Poverty/destitution /C147Non-biological father figures Community /C147Institutions that tolerate/fail to respond to violence /C147Community tolerance of violence /C147Lack of services for women, children, families /C147Gender and social inequality in the community /C147Community norms about privacy in the family /C147High level of criminal violence or and armed conflict Societal /C147Weak legal sanctions /C147Social norms that support violence, including physical punishment of wives/children /C147Social, economic, legal, and political disempowerment of womenIntersections of violence against women and violence against children Citation: Glob Health Action 2016, 9: 31516 - http://dx.doi.org/10.3402/gha.v9.31516 5 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/cf/b1/GHA-9-31516.PMC4916258.pdf
"6 (page number not for citation purpose)Citation: Glob Health Action 2016, 9: 31516 - http://dx.doi.org/10.3402/gha.v9.31516",Non-OADS,/arxiv_data1/oa_pdf/cf/b1/GHA-9-31516.PMC4916258.pdf
"Percentage of caregivers who agreed corporal punishment is necessary for raising children, selected national surveys 2005 /C12013 (2).Intersections of violence against women and violence against children Citation: Glob Health Action 2016, 9: 31516 - http://dx.doi.org/10.3402/gha.v9.31516 7 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/cf/b1/GHA-9-31516.PMC4916258.pdf
"8 (page number not for citation purpose)Citation: Glob Health Action 2016, 9: 31516 - http://dx.doi.org/10.3402/gha.v9.31516",Non-OADS,/arxiv_data1/oa_pdf/cf/b1/GHA-9-31516.PMC4916258.pdf
"Child marriage (itself recognised as a harmful practice or form of violence against girls) and the partner violence that occurs inIntersections of violence against women and violence against children Citation: Glob Health Action 2016, 9: 31516 - http://dx.doi.org/10.3402/gha.v9.31516 9 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/cf/b1/GHA-9-31516.PMC4916258.pdf
"10 (page number not for citation purpose)Citation: Glob Health Action 2016, 9: 31516 - http://dx.doi.org/10.3402/gha.v9.31516",Non-OADS,/arxiv_data1/oa_pdf/cf/b1/GHA-9-31516.PMC4916258.pdf
"TraumaViolence Abuse 2013; 14: 133 /C1 67.Intersections of violence against women and violence against children Citation: Glob Health Action 2016, 9: 31516 - http://dx.doi.org/10.3402/gha.v9.31516 11 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/cf/b1/GHA-9-31516.PMC4916258.pdf
"12 (page number not for citation purpose)Citation: Glob Health Action 2016, 9: 31516 - http://dx.doi.org/10.3402/gha.v9.31516",Non-OADS,/arxiv_data1/oa_pdf/cf/b1/GHA-9-31516.PMC4916258.pdf
"Glob Health Action 2014; 7: 24774, doi: http://dx.doi.org/10.3402/gha.v7.24774 83.",Non-OADS,/arxiv_data1/oa_pdf/cf/b1/GHA-9-31516.PMC4916258.pdf
"Millett LS, Kohl PL, Jonson-Reid M, Drake B, Petra M. Child maltreatment victimization and subsequent perpetration ofIntersections of violence against women and violence against children Citation: Glob Health Action 2016, 9: 31516 - http://dx.doi.org/10.3402/gha.v9.31516 13 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/cf/b1/GHA-9-31516.PMC4916258.pdf
"Glob Health Action 2014; 7: 23591, doi: http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/cf/b1/GHA-9-31516.PMC4916258.pdf
"Eur J Psychotraumatol2014; 5: 24794, doi: http://dx.doi.org/10.3402/ejpt.v5.24794 112.",Non-OADS,/arxiv_data1/oa_pdf/cf/b1/GHA-9-31516.PMC4916258.pdf
Child Abuse Rev 2015. doi: http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/cf/b1/GHA-9-31516.PMC4916258.pdf
"14 (page number not for citation purpose)Citation: Glob Health Action 2016, 9: 31516 - http://dx.doi.org/10.3402/gha.v9.31516",Non-OADS,/arxiv_data1/oa_pdf/cf/b1/GHA-9-31516.PMC4916258.pdf
"Violence Against Women 2010; 16:348/C154.Intersections of violence against women and violence against children Citation: Glob Health Action 2016, 9: 31516 - http://dx.doi.org/10.3402/gha.v9.31516 15 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/cf/b1/GHA-9-31516.PMC4916258.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), permitting all non-commercial use , distribution, and reproduction in any medium, provided the original work is properly cited.1 Citation: Journal of Extracellular Vesicles 2016, 5: 31655 - http://dx.doi.org/10.3402/jev.v5.31655 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/08/94/JEV-5-31655.PMC4916259.pdf
"2 (page number not for citation purpose)Citation: Journal of Extracellular Vesicles 2016, 5: 31655 - http://dx.doi.org/10.3402/jev.v5.31655",OADS,/arxiv_data1/oa_pdf/08/94/JEV-5-31655.PMC4916259.pdf
"We also analysed theEV isolation for miRNAs detection in serum Citation: Journal of Extracellular Vesicles 2016, 5: 31655 - http://dx.doi.org/10.3402/jev.v5.31655 3 (page number not for citation purpose)",OADS,/arxiv_data1/oa_pdf/08/94/JEV-5-31655.PMC4916259.pdf
"4 (page number not for citation purpose)Citation: Journal of Extracellular Vesicles 2016, 5: 31655 - http://dx.doi.org/10.3402/jev.v5.31655",OADS,/arxiv_data1/oa_pdf/08/94/JEV-5-31655.PMC4916259.pdf
"Negative control corresponds to EV-loaded beads stained only with secondary antimouse antibody.EV isolation for miRNAs detection in serum Citation: Journal of Extracellular Vesicles 2016, 5: 31655 - http://dx.doi.org/10.3402/jev.v5.31655 5 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/08/94/JEV-5-31655.PMC4916259.pdf
"6 (page number not for citation purpose)Citation: Journal of Extracellular Vesicles 2016, 5: 31655 - http://dx.doi.org/10.3402/jev.v5.31655",OADS,/arxiv_data1/oa_pdf/08/94/JEV-5-31655.PMC4916259.pdf
"Lines indicate means.EV isolation for miRNAs detection in serum Citation: Journal of Extracellular Vesicles 2016, 5: 31655 - http://dx.doi.org/10.3402/jev.v5.31655 7 (page number not for citation purpose)",OADS,/arxiv_data1/oa_pdf/08/94/JEV-5-31655.PMC4916259.pdf
"8 (page number not for citation purpose)Citation: Journal of Extracellular Vesicles 2016, 5: 31655 - http://dx.doi.org/10.3402/jev.v5.31655",OADS,/arxiv_data1/oa_pdf/08/94/JEV-5-31655.PMC4916259.pdf
"In all cases, mean9SD is indicated.EV isolation for miRNAs detection in serum Citation: Journal of Extracellular Vesicles 2016, 5: 31655 - http://dx.doi.org/10.3402/jev.v5.31655 9 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/08/94/JEV-5-31655.PMC4916259.pdf
"10 (page number not for citation purpose)Citation: Journal of Extracellular Vesicles 2016, 5: 31655 - http://dx.doi.org/10.3402/jev.v5.31655",OADS,/arxiv_data1/oa_pdf/08/94/JEV-5-31655.PMC4916259.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), permitting all non-commercial use , distribution, and reproduction in any medium, provided the original work is properly cited.1 Citation: Infection Ecology and Epidemiology 2016, 6: 31191 - http://dx.doi.org/10.3402/iee.v6.31191 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/29/75/IEE-6-31191.PMC4916260.pdf
"2 (page number not for citation purpose)Citation: Infection Ecology and Epidemiology 2016, 6: 31191 - http://dx.doi.org/10.3402/iee.v6.31191",Non-OADS,/arxiv_data1/oa_pdf/29/75/IEE-6-31191.PMC4916260.pdf
"The approach to an extent bal- anced the predispositions of the researcher and the re- spondent’s descriptions, whereas the continuous measureOne Health stakeholder Citation: Infection Ecology and Epidemiology 2016, 6: 31191 - http://dx.doi.org/10.3402/iee.v6.31191 3 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/29/75/IEE-6-31191.PMC4916260.pdf
"4 (page number not for citation purpose)Citation: Infection Ecology and Epidemiology 2016, 6: 31191 - http://dx.doi.org/10.3402/iee.v6.31191",Non-OADS,/arxiv_data1/oa_pdf/29/75/IEE-6-31191.PMC4916260.pdf
"ALRMP, Arid Lands Resource Management Programme; APHIA II, AIDS, Population and Health Integrated Assistance Program; AU-IBAR, African Union Inter Bureau of Animal Resources; CBAHW , Community-Based Animal Health Workers; CDC, Centre for Disease Control and Prevention; CHW , Community Health Workers; DAO & DLPO, District Agriculture Ofﬁcer & District Livestock Production Ofﬁcer; DMO-MS/ PHS, District Medical Ofﬁcers, Medical Services/Public Health and Sanitation; DVO, District Veterinary Ofﬁcer; DVS, Department of Veterinary Services; EAC, East African Community; FAO, Food and Agriculture Organisation of the United Nations; GF-TAD, Global Framework for Transboundary diseases; GLEWS, Global Early Warning System; IAWG, Interagency Working Group; ICIPE, International Centre for Insect Physiology and Ecology; ICPAC, IGAD Climate Predictions and Applications Centre; IGAD, Inter Governmental Authority on Development; ILRI, International Livestock Research Institute; IPR/NMK, Institute of Primate Research of the National Museums of Kenya; KALRO, Kenya Agricultural and Livestock Research Organisation; KEMRI, Kenya Medical Research Institute; KEVEV API, Kenya Veterinary Vaccines Production Institute; KLMC/DMLC, Kenya/District Livestock MarketingCouncil; KVB, Kenya Veterinary Board; MOH, Ministries in charge of Health; NGO, Non-Governmental Organisations; OHCEA, One Health Central and East Africa Network; OIE, World Organisation for Animal Health; PDMO-MS & PHS, Provincial Medical Ofﬁcer Medical Services and Public Health and Sanitation; PDVS, Provincial Director of Veterinary Services; PSAHS, Private Sector Animal Health Service; PSPHS, Private Sector Public Health Service; UNHCR, United Nations High Commission for Refugees; UNICEF, United Nations Children Education Fund; WHO, World Health Organization; ZDU, Zoonotic Disease Unit; ZTWG, Zoonotic Technical Working Group.One Health stakeholder Citation: Infection Ecology and Epidemiology 2016, 6: 31191 - http://dx.doi.org/10.3402/iee.v6.31191 5 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/29/75/IEE-6-31191.PMC4916260.pdf
"6 (page number not for citation purpose)Citation: Infection Ecology and Epidemiology 2016, 6: 31191 - http://dx.doi.org/10.3402/iee.v6.31191",Non-OADS,/arxiv_data1/oa_pdf/29/75/IEE-6-31191.PMC4916260.pdf
"Centrality statistics measures for Garissa County stakeholders Cluster coefficientDegree Farness Closeness Acronym Actor In Out In Out In Out Between nBetween UNHCR United Nations High Commissioner for Refugees0.92 (36) 9 8 147 120 20 24 1 0.1 DANIDA The Danish International Development Agency0.84 (45) 10 9 137 110 21 26 14 2 CDC Centre for Disease Control 0.80 (10) 5 3 151 132 20 22 0.2 0.03 PDMS Provincial Director of Medical Services0.78 (36) 9 9 147 121 20 24 5 1 PDPHS Provincial Director of Public Health and Sanitation0.78 (36) 9 9 147 119 20 24 6 1 HHNGO Human Health NGOs 0.76 (55) 8 11 138 108 21 27 19 2 APHIA AIDS, Population and Health Integrated Assistance Program0.75 (55) 10 11 144 108 20 27 12 1 UNICEF United Nations International Children’s Emergency Fund0.74 (55) 10 9 143 110 20 26 12 2 WHO World Health Organisation 0.74 (55) 11 11 136 108 21 27 35 4 Local government 0.65 (10) 4 2 143 121 20 24 4 0.5Councillors 0.57 (15) 3 3 146 126 20 23 3 0.4KLMC Kenya Livestock Marketing Council0.55 (10) 4 3 144 123 20 24 17 2 CBAHW Community-Based Animal Health Workers0.55 (10) 3 4 153 122 19 24 4 1 Livestock traders 0.50 (6) 4 2 158 142 18 20 2 0.2 CHW Community Health Workers 0.45 (28) 7 6 143 115 20 25 20 2DMOH- PHSDistrict Medical Officer of Health /C1Public Health and Sanitation0.43 (105) 12 15 132 102 22 28 74 9 DMOH-MS District Medical Officer of Health /C1Medical Services0.43 (105) 12 14 132 104 22 28 61 8 KDLDP Kenya Drylands Livestock Development Program0.43 (21) 6 5 140 117 21 25 31 4 Chief 0.41 (28) 7 6 140 110 21 26 34 4 DLPO District Livestock Production Officer0.37 (15) 4 4 146 122 20 24 26 3 CARE CARE International in Kenya 0.35 (10) 3 4 147 116 20 25 6 1 ALRMP Arid Lands Resource Management Project0.28 (105) 14 13 129 101 23 29 259 32 DVO District Veterinary Officer 0.24 (36 a) 7 8 139 113 21 26 84 10 Community 0.30 (78) 7 10 139 106 21 27 92 11Milk traders (0) 0 0 870 870 3 3 0 0 FAO Food and Agriculture Organisation(0) 0 0 870 870 3 3 0 0 KWS Kenya Wildlife Service (0) 1 1 154 127 19 22 0 0 Pharmacy/Agro Vets (0) 1 1 164 132 17 22 0 0 PDVS Provincial Director of Veterinary Services(1) 1 2 164 137 18 21 3 0.4 PDLP Provincial Director of Livestock Production(1) 2 0 139 870 21 3 0 0 Mean, n/C3030 6 (3.9) 6 (4.4) 193 (181) 193 (226) 19 (4.3) 23 (7) 27 (50) 3.4 (6.2) aNumber in brackets refer to the number of pairs.One Health stakeholder Citation: Infection Ecology and Epidemiology 2016, 6: 31191 - http://dx.doi.org/10.3402/iee.v6.31191 7 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/29/75/IEE-6-31191.PMC4916260.pdf
"8 (page number not for citation purpose)Citation: Infection Ecology and Epidemiology 2016, 6: 31191 - http://dx.doi.org/10.3402/iee.v6.31191",Non-OADS,/arxiv_data1/oa_pdf/29/75/IEE-6-31191.PMC4916260.pdf
"AHNGOs, Animal Health Non Governmental Organisations; AU-IBAR, African Union Inter Bureau of Animal Resources; CDC, Centre for Disease Control and Prevention; DVS, Department of Veterinary Services; FAO, Food and Agriculture Organisation of the United Nations; HHNGO, Human Health Non Governmental Organisations; ICIPE, International Centre for Insect Physiology and Ecology; ILRI, International Livestock Research Institute; IPAR, Institute of Primate Research; KARI, Kenya Agriculture Research Institute (renamed Kenya Agricultural and Livestock Research Organisation); KEMRI, Kenya Medical Research Institute; KMD, Kenya Meteorological Department; KWS, Kenya Wildlife Service; MOH, Ministries in charge of Health; NMK, National Museums of Kenya; OIE, World Organisation for Animal Health; UON-VS, University of Nairobi-Veterinary Services; UON-PHM, University of Nairobi /C1Public Health; WHO, World Health Organization.One Health stakeholder Citation: Infection Ecology and Epidemiology 2016, 6: 31191 - http://dx.doi.org/10.3402/iee.v6.31191 9 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/29/75/IEE-6-31191.PMC4916260.pdf
"10 (page number not for citation purpose)Citation: Infection Ecology and Epidemiology 2016, 6: 31191 - http://dx.doi.org/10.3402/iee.v6.31191",Non-OADS,/arxiv_data1/oa_pdf/29/75/IEE-6-31191.PMC4916260.pdf
"This study also recommends that FAO, OIE, and WHO exploit their OH tripartite arrangements to strengthenOne Health stakeholder Citation: Infection Ecology and Epidemiology 2016, 6: 31191 - http://dx.doi.org/10.3402/iee.v6.31191 11 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/29/75/IEE-6-31191.PMC4916260.pdf
doi: http://dx.doi.org/10.3201/eid1112.050997 5.,Non-OADS,/arxiv_data1/oa_pdf/29/75/IEE-6-31191.PMC4916260.pdf
Available from: http://www.cfsph.iastate.edu/Factsheets [cited27 February 2016].,OADS,/arxiv_data1/oa_pdf/29/75/IEE-6-31191.PMC4916260.pdf
Available from: http://www.who.,Non-OADS,/arxiv_data1/oa_pdf/29/75/IEE-6-31191.PMC4916260.pdf
Available from: http://www.who.int/mediacentre/factsheets/mers-cov/en/ [cited 27 February 2016].,OADS,/arxiv_data1/oa_pdf/29/75/IEE-6-31191.PMC4916260.pdf
CABI ; 2015. doi: http://dx.doi.org/10.1079/978178 0643410.0000 20.,Non-OADS,/arxiv_data1/oa_pdf/29/75/IEE-6-31191.PMC4916260.pdf
Available from: http://www.who.int/inﬂuenza/resources/documents/tripartite_concept_note_hanoi_042011_en.pdf [cited 4 May 2013].,Non-OADS,/arxiv_data1/oa_pdf/29/75/IEE-6-31191.PMC4916260.pdf
"12 (page number not for citation purpose)Citation: Infection Ecology and Epidemiology 2016, 6: 31191 - http://dx.doi.org/10.3402/iee.v6.31191",Non-OADS,/arxiv_data1/oa_pdf/29/75/IEE-6-31191.PMC4916260.pdf
"Washington, DC: World Bank.One Health stakeholder Citation: Infection Ecology and Epidemiology 2016, 6: 31191 - http://dx.doi.org/10.3402/iee.v6.31191 13 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/29/75/IEE-6-31191.PMC4916260.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/Letter to the Editor 3 Blood Cancer Journal",Non-OADS,/arxiv_data1/oa_pdf/4e/c9/bcj201625a.PMC4916294.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/06/10/czv126.PMC4916317.pdf
Available at: http://www.ibge.gov.br/home/estatistica/populacao/censo2010/default_sinopse.shtm.,Non-OADS,/arxiv_data1/oa_pdf/06/10/czv126.PMC4916317.pdf
Available at: http://www.sispro.gov.co/.,Non-OADS,/arxiv_data1/oa_pdf/06/10/czv126.PMC4916317.pdf
Available at: http://www.minsalud.gov.co/salud/ Paginas/CoberturasdelR%c3%a9gimenSubsidiado.aspx.,Non-OADS,/arxiv_data1/oa_pdf/06/10/czv126.PMC4916317.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/7f/4f/czv129.PMC4916319.pdf
"http://ccmcentral.com/ benchmarks-and-indicators/benchmarks-framework/, accessed 1 July 2015.",OADS,/arxiv_data1/oa_pdf/7f/4f/czv129.PMC4916319.pdf
"http://www.mchip.net/node/2179, accessed 15 December 2015.",Non-OADS,/arxiv_data1/oa_pdf/7f/4f/czv129.PMC4916319.pdf
"http://www.mchip.net/ node/2812, accessed 13 June 2015.",Non-OADS,/arxiv_data1/oa_pdf/7f/4f/czv129.PMC4916319.pdf
"Journal of Global Health 4: 020401. http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid ¼ 4267096&tool ¼pmcentrez&rendertype ¼abstract, accessed 24 August 2015.",Non-OADS,/arxiv_data1/oa_pdf/7f/4f/czv129.PMC4916319.pdf
"http://www.who.int/hrh/documents/roadmap4health_measurent_account/ en/, accessed 11 September 2015.766 Health Policy and Planning , 2016, Vol.",Non-OADS,/arxiv_data1/oa_pdf/7f/4f/czv129.PMC4916319.pdf
Retrieved from: http://mdgs.un.org/unsd/ mdg/ on 15th July 2014.,Non-OADS,/arxiv_data1/oa_pdf/0e/0f/czv130.PMC4916320.pdf
The replication ﬁles for this analysis (Stata do- ﬁles) are available at: https://dataverse.harvard.edu/dataverse/cgdev.,OADS,/arxiv_data1/oa_pdf/61/9c/czv132.PMC4916321.pdf
"http://www.knchr.org/Portals/0/Ecosoc Reports/Implementing%20Free%20Maternal%20Health%20Care%20 in%20Kenya.pdf, accessed 9 April 2015.",Non-OADS,/arxiv_data1/oa_pdf/61/9c/czv132.PMC4916321.pdf
"http://www.healthpolicyproject.com/pubs/ 400_KenyaUserFeesBaselineReportFINAL.pdf, accessed 9 April 2015.",Non-OADS,/arxiv_data1/oa_pdf/61/9c/czv132.PMC4916321.pdf
"Calverton, MD: KNBS and ICF Macro, 2010. https://www.dhsprogram.com/publications/publication- FR229-DHS-Final-Reports.cfm, accessed 9 April 2015.",OADS,/arxiv_data1/oa_pdf/61/9c/czv132.PMC4916321.pdf
"Nairobi, Kenya: Kenya National Bureau of Statistics; 2015. http://dhsprogram.com/pubs/pdf/PR55/PR55.pdf, accessed 9 April 2015.",Non-OADS,/arxiv_data1/oa_pdf/61/9c/czv132.PMC4916321.pdf
"Leadership Council of the Sustainable Development Solutions Network; 2015 Feb. http://unsdsn.org/wp-content/uploads/2015/01/150218-SDSN- Indicator-Report-FEB-FINAL.pdf, accessed 12 March 2015.",Non-OADS,/arxiv_data1/oa_pdf/61/9c/czv132.PMC4916321.pdf
136. http://papers.ssrn.com/sol3/papers.cfm?,Non-OADS,/arxiv_data1/oa_pdf/61/9c/czv132.PMC4916321.pdf
"http://ma4health.hsaccess.org/docs/support-documents/common-roadmap-draft2-consultation-2015_03_25- edited.pdf?sfvrsn ¼12, accessed 9 April 2015. WHO 2006.",Non-OADS,/arxiv_data1/oa_pdf/61/9c/czv132.PMC4916321.pdf
http://documents.worldbank.,Non-OADS,/arxiv_data1/oa_pdf/61/9c/czv132.PMC4916321.pdf
"MDL: Moldovan Lei (1 MDL ¼0.053 USD, Treasury Reporting Rates of Exchange as of 30 June 2015, http://www.fiscal.treasury.gov).",Non-OADS,/arxiv_data1/oa_pdf/28/8a/czv136.PMC4916322.pdf
"http://www.bestbets.org/bets/bet.php?id ¼2283, ac- cessed 20 September 2015.",Non-OADS,/arxiv_data1/oa_pdf/28/8a/czv136.PMC4916322.pdf
"http://www.isdscotland.org/ Health-Topics/Prescribing-and-Medicines/Community-Dispensing/ Prescription-Cost-Analysis/, accessed 17 September 2015.",Non-OADS,/arxiv_data1/oa_pdf/28/8a/czv136.PMC4916322.pdf
"http://www.statistica.md, accessed 9 March 2015.",OADS,/arxiv_data1/oa_pdf/28/8a/czv136.PMC4916322.pdf
"http://www.whocc.no/atc_ddd_index/, accessed May– June 2013. WHO Regional Ofﬁce for Europe.",OADS,/arxiv_data1/oa_pdf/28/8a/czv136.PMC4916322.pdf
"http://apps.who.int/nha/database/DataExplorerRegime.aspx, accessed 19September 2014.",OADS,/arxiv_data1/oa_pdf/28/8a/czv136.PMC4916322.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/7d/76/ircmj-18-04-33115.PMC4916323.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/47/08/afw074.PMC4916346.pdf
Environ Microbiol 5:641– 649. http://dx.doi.org/10.1046/j.1462-2920.2003.00454.x .,OADS,/arxiv_data1/oa_pdf/b2/45/mBio.02057-15.PMC4916391.pdf
ISME J 4:862– 871. http://dx.doi.org/10.1038/ ismej.2010.21 .,OADS,/arxiv_data1/oa_pdf/b2/45/mBio.02057-15.PMC4916391.pdf
http://dx.doi.org/10.1128/mBio.00036-12 .,Non-OADS,/arxiv_data1/oa_pdf/b2/45/mBio.02057-15.PMC4916391.pdf
http://dx.doi.org/10.1038/nrg2319 .,Non-OADS,/arxiv_data1/oa_pdf/b2/45/mBio.02057-15.PMC4916391.pdf
http://dx.doi.org/10.1038/246096a0 .,Non-OADS,/arxiv_data1/oa_pdf/b2/45/mBio.02057-15.PMC4916391.pdf
http://dx.doi.org/ 10.1073/pnas.93.7.2873 .,Non-OADS,/arxiv_data1/oa_pdf/b2/45/mBio.02057-15.PMC4916391.pdf
http://dx.doi.org/10.1038/ nrmicro2670 .,OADS,/arxiv_data1/oa_pdf/b2/45/mBio.02057-15.PMC4916391.pdf
http://dx.doi.org/10.1016/0027-5107(64)90047-8 .,OADS,/arxiv_data1/oa_pdf/b2/45/mBio.02057-15.PMC4916391.pdf
http://dx.doi.org/10.1111/1462 -2920.12121 .,Non-OADS,/arxiv_data1/oa_pdf/b2/45/mBio.02057-15.PMC4916391.pdf
http://dx.doi.org/10.1534/ g3.113.009845 .,Non-OADS,/arxiv_data1/oa_pdf/b2/45/mBio.02057-15.PMC4916391.pdf
http://dx.doi.org/10.1007/s10709-006-9007-7 .,Non-OADS,/arxiv_data1/oa_pdf/b2/45/mBio.02057-15.PMC4916391.pdf
http://dx.doi.org/ 10.1111/nph.13136 .,Non-OADS,/arxiv_data1/oa_pdf/b2/45/mBio.02057-15.PMC4916391.pdf
http://dx.doi.org/10.1038/ismej.2013.151 .,Non-OADS,/arxiv_data1/oa_pdf/b2/45/mBio.02057-15.PMC4916391.pdf
http://dx.doi.org/10.1111/mec.13250 .,Non-OADS,/arxiv_data1/oa_pdf/b2/45/mBio.02057-15.PMC4916391.pdf
http://dx.doi.org/10.1126/ science.289.5486.1920 .,Non-OADS,/arxiv_data1/oa_pdf/b2/45/mBio.02057-15.PMC4916391.pdf
http://dx.doi.org/10.1111/nph.12805 .,Non-OADS,/arxiv_data1/oa_pdf/b2/45/mBio.02057-15.PMC4916391.pdf
http://dx.doi.org/10.1073/ pnas.80.23.7085 .,Non-OADS,/arxiv_data1/oa_pdf/b2/45/mBio.02057-15.PMC4916391.pdf
http://dx.doi.org/10.1128/JB.187.10.3455-3464.2005 .,OADS,/arxiv_data1/oa_pdf/b2/45/mBio.02057-15.PMC4916391.pdf
Mol Biol Evol 33:863– 869 http://dx.doi.org/10.1093/molbev/msw054 .,Non-OADS,/arxiv_data1/oa_pdf/b2/45/mBio.02057-15.PMC4916391.pdf
http://dx.doi.org/10.1371/ journal.pgen.1002511 .,Non-OADS,/arxiv_data1/oa_pdf/b2/45/mBio.02057-15.PMC4916391.pdf
Mycologia 105: 589 – 602. http://dx.doi.org/10.3852/12-135 .,Non-OADS,/arxiv_data1/oa_pdf/b2/45/mBio.02057-15.PMC4916391.pdf
http://dx.doi.org/10.1126/ science.1119966 .,Non-OADS,/arxiv_data1/oa_pdf/b2/45/mBio.02057-15.PMC4916391.pdf
http://dx.doi.org/10.1093/gbe/evr002 .,Non-OADS,/arxiv_data1/oa_pdf/b2/45/mBio.02057-15.PMC4916391.pdf
http://dx.doi.org/ 10.1534/genetics.106.063305 .,Non-OADS,/arxiv_data1/oa_pdf/b2/45/mBio.02057-15.PMC4916391.pdf
http://dx.doi.org/10.1080/2159256X.2015.1136375 .,Non-OADS,/arxiv_data1/oa_pdf/b2/45/mBio.02057-15.PMC4916391.pdf
http://dx.doi.org/10.1093/molbev/msk023 .,Non-OADS,/arxiv_data1/oa_pdf/b2/45/mBio.02057-15.PMC4916391.pdf
http://dx.doi.org/10.1098/ rspb.1993.0098 .,Non-OADS,/arxiv_data1/oa_pdf/b2/45/mBio.02057-15.PMC4916391.pdf
http://dx.doi.org/10.1111/j.1558 -5646.2012.01611.x .,Non-OADS,/arxiv_data1/oa_pdf/b2/45/mBio.02057-15.PMC4916391.pdf
http://dx.doi.org/ 10.1046/j.1365-294X.2003.01780.x .,Non-OADS,/arxiv_data1/oa_pdf/b2/45/mBio.02057-15.PMC4916391.pdf
http://dx.doi.org/10.1093/gbe/evu133 .,Non-OADS,/arxiv_data1/oa_pdf/b2/45/mBio.02057-15.PMC4916391.pdf
http://dx.doi.org/10.1093/gbe/evt044 .,Non-OADS,/arxiv_data1/oa_pdf/b2/45/mBio.02057-15.PMC4916391.pdf
http://dx.doi.org/10.1016/j.cub.2011.06.051 .,OADS,/arxiv_data1/oa_pdf/b2/45/mBio.02057-15.PMC4916391.pdf
http://dx.doi.org/10.1093/molbev/msp093 .,Non-OADS,/arxiv_data1/oa_pdf/b2/45/mBio.02057-15.PMC4916391.pdf
http://dx.doi.org/10.1371/journal.pbio.0030121 .,Non-OADS,/arxiv_data1/oa_pdf/b2/45/mBio.02057-15.PMC4916391.pdf
http://dx.doi.org/10.1371/ journal.pgen.1003381 .,Non-OADS,/arxiv_data1/oa_pdf/b2/45/mBio.02057-15.PMC4916391.pdf
http://dx.doi.org/10.1371/ journal.pntd.0002728 .,Non-OADS,/arxiv_data1/oa_pdf/b2/45/mBio.02057-15.PMC4916391.pdf
http://dx.doi.org/10.1093/gbe/evr096 .,Non-OADS,/arxiv_data1/oa_pdf/b2/45/mBio.02057-15.PMC4916391.pdf
http://dx.doi.org/10.1128/mBio.01958-14 .,Non-OADS,/arxiv_data1/oa_pdf/b2/45/mBio.02057-15.PMC4916391.pdf
http://dx.doi.org/10.1038/ hdy.2010.24 .,OADS,/arxiv_data1/oa_pdf/b2/45/mBio.02057-15.PMC4916391.pdf
BMC Genomics 12:114. http://dx.doi.org/ 10.1186/1471-2164-12-114 .,OADS,/arxiv_data1/oa_pdf/b2/45/mBio.02057-15.PMC4916391.pdf
http://dx.doi.org/10.1128/IAI.01172-09 .,Non-OADS,/arxiv_data1/oa_pdf/b2/45/mBio.02057-15.PMC4916391.pdf
http://dx.doi.org/10.1016/j.vetmic.2015.04.013 .,OADS,/arxiv_data1/oa_pdf/b2/45/mBio.02057-15.PMC4916391.pdf
http://dx.doi.org/10.1371/journal.pgen.1000775 .,Non-OADS,/arxiv_data1/oa_pdf/b2/45/mBio.02057-15.PMC4916391.pdf
http://dx.doi.org/10.1128/ AEM.03723-14 .,Non-OADS,/arxiv_data1/oa_pdf/b2/45/mBio.02057-15.PMC4916391.pdf
http://dx.doi.org/10.1093/sysbio/ sys029 .,OADS,/arxiv_data1/oa_pdf/b2/45/mBio.02057-15.PMC4916391.pdf
"Cells 2016; 39(6): 439-446  http://dx.doi.org/10.14348/molcells.2016.0088                    Clearing and Labeling Techniques for Large-Scale  Biological Tissues     Jinyoung Seo1,5, Minjin Choe2,5, and Sung-Yon Kim1,2,3,4,*      Clearing and labeling techniques for large-scale biological  tissues enable simultaneous extraction of molecular and structural information with minimal disassembly of the  sample, facilitating the integration of molecular, cellular  and systems biology across different scales.",OADS,/arxiv_data1/oa_pdf/61/ad/molce-39-6-439.PMC4916395.pdf
"We classified the contemporary meth- ods into three categories according to their main mode of ac-  tion: (1) simple refractive index (RI)-matching, (2) delipidation   combined with dehydration (solvent-based) or hyperhydration  Molecules and Cells http://molcells.org   Established in 1990     eISSN: 0219-1032   The Korean Society for Molecular and Cellular Biology.",Non-OADS,/arxiv_data1/oa_pdf/61/ad/molce-39-6-439.PMC4916395.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/.",Non-OADS,/arxiv_data1/oa_pdf/61/ad/molce-39-6-439.PMC4916395.pdf
Cells http://molcells.org     Fig.,Non-OADS,/arxiv_data1/oa_pdf/61/ad/molce-39-6-439.PMC4916395.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/61/ad/molce-39-6-439.PMC4916395.pdf
"Cells http://molcells.org     hydroxyl groups in the medium (Mao et al., 2008).",OADS,/arxiv_data1/oa_pdf/61/ad/molce-39-6-439.PMC4916395.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/61/ad/molce-39-6-439.PMC4916395.pdf
Cells http://molcells.org     within one day.,Non-OADS,/arxiv_data1/oa_pdf/61/ad/molce-39-6-439.PMC4916395.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/61/ad/molce-39-6-439.PMC4916395.pdf
"Cells http://molcells.org     Ukai-Tadenuma, M., Ukai, H., and Ueda, H.R.",OADS,/arxiv_data1/oa_pdf/61/ad/molce-39-6-439.PMC4916395.pdf
"Cells 2016; 39(6): 447-459  http://dx.doi.org/10.14348/molcells.2016.0083                    A New Insight of Salt Stress Signaling in Plant     Hee Jin Park1, Woe-Yeon Kim1,2, and Dae-Jin Yun1,*      Many studies have been conducted to understand plant  stress responses to salinity because irrigation-dependent salt accumulation compromises crop productivity and also  to understand the mechanism through which some plants  thrive under saline conditions.",Non-OADS,/arxiv_data1/oa_pdf/9c/33/molce-39-6-447.PMC4916396.pdf
"In agriculture, water supply is increasingly  dependent on irrigation systems that currently cover approxi-                                              1Division of Applied Life Science (BK21 Plus Program), Plant Mo- lecular Biology and Biotechnology Research Center, 2Institute of  Agriculture & Life Sciences, Graduate School of Gyeongsang Na-tional University, Jinju 52828, Korea *Correspondence: djyun@gnu.ac.kr  Received 4 April, 2016; revised 6 May, 2016; accepted 16 May, 2016; published online 30 May, 2016  Keywords:  circadian clock, GIGANTEA, NaCl, salinity, salt overly sensi- tive pathway     mately 15% of agriculturally useful land, which produces more  than a third of all food (Ghassemi et al., 1995; see also: USDA Salinity Laboratory, http://www.ars.usda.gov/Aboutus/docs.htm?",Non-OADS,/arxiv_data1/oa_pdf/9c/33/molce-39-6-447.PMC4916396.pdf
"Water deficit, hyperosmotic  stress, nutritional imbalance, and hyperionic toxicity are physio- logical hallmarks that may eventually lead to death (Cheong  and Yun, 2007; Cramer and Jones, 1996; Sairam and Tyagi, Molecules and Cells http://molcells.org   Established in 1990     eISSN: 0219-1032   The Korean Society for Molecular and Cellular Biology.",Non-OADS,/arxiv_data1/oa_pdf/9c/33/molce-39-6-447.PMC4916396.pdf
"T o view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/.",Non-OADS,/arxiv_data1/oa_pdf/9c/33/molce-39-6-447.PMC4916396.pdf
Cells http://molcells.org     2004).,OADS,/arxiv_data1/oa_pdf/9c/33/molce-39-6-447.PMC4916396.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/9c/33/molce-39-6-447.PMC4916396.pdf
"Cells http://molcells.org     NaCl interferes with Ca2+ uptake and lowers cytosolic Ca2+,  which is essential for membrane  stability, maintaining osmotic  balance, and intracellular signaling (Rengel, 1992).",Non-OADS,/arxiv_data1/oa_pdf/9c/33/molce-39-6-447.PMC4916396.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/9c/33/molce-39-6-447.PMC4916396.pdf
"Cells http://molcells.org     transduction exhibit diurnal oscillations, indicating gating by the  clock (Legnaioli et al., 2009).",OADS,/arxiv_data1/oa_pdf/9c/33/molce-39-6-447.PMC4916396.pdf
"Genes, such as SOS1, RD29A, and DREB2A, that are  involved in salinity stress exhibit a 24-h period of expression (diurnal web; http://diurnal.mockler lab.org/), sugges ting that salt  tolerance may also be affected by the circadian clock.",Non-OADS,/arxiv_data1/oa_pdf/9c/33/molce-39-6-447.PMC4916396.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/9c/33/molce-39-6-447.PMC4916396.pdf
"Cells http://molcells.org     and feed be produced on degraded soils, including saline lands.",Non-OADS,/arxiv_data1/oa_pdf/9c/33/molce-39-6-447.PMC4916396.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/9c/33/molce-39-6-447.PMC4916396.pdf
"Cells http://molcells.org     Ghassemi, F., Jakeman, A.J., and Nix, H.A.",Non-OADS,/arxiv_data1/oa_pdf/9c/33/molce-39-6-447.PMC4916396.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/9c/33/molce-39-6-447.PMC4916396.pdf
Cells http://molcells.org     K. (2011).,OADS,/arxiv_data1/oa_pdf/9c/33/molce-39-6-447.PMC4916396.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/9c/33/molce-39-6-447.PMC4916396.pdf
"Cells 2016; 39(6): 460-467  http://dx.doi.org/10.14348/molcells.2016.2265                    Fine Mutational Analysis of 2B8 and 3H7 Tag  Epitopes with Corresponding Specific Monoclonal Antibodies     Tae-Lim Kim1,2, Man-Ho Cho1,2, Kanidta Sangsawang1, and Seong Hee Bhoo1,*      Bacteriophytochromes are phytochrome-like light-sensing   photoreceptors that use biliverdin as a chromophore.",OADS,/arxiv_data1/oa_pdf/be/48/molce-39-6-460.PMC4916397.pdf
"The FLAG M2 antibody   showed non-specific Western blot bands in Brassica juncea   Indian mustard plant, especially on shoot and leaf tissue,  Molecules and Cells http://molcells.org   Established in 1990     eISSN: 0219-1032   The Korean Society for Molecular and Cellular Biology.",OADS,/arxiv_data1/oa_pdf/be/48/molce-39-6-460.PMC4916397.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/.",Non-OADS,/arxiv_data1/oa_pdf/be/48/molce-39-6-460.PMC4916397.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/be/48/molce-39-6-460.PMC4916397.pdf
Cells http://molcells.org      Fig.,Non-OADS,/arxiv_data1/oa_pdf/be/48/molce-39-6-460.PMC4916397.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/be/48/molce-39-6-460.PMC4916397.pdf
Cells http://molcells.org      Fig.,Non-OADS,/arxiv_data1/oa_pdf/be/48/molce-39-6-460.PMC4916397.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/be/48/molce-39-6-460.PMC4916397.pdf
Cells http://molcells.org     ble epitope tags are usually highly charged.,Non-OADS,/arxiv_data1/oa_pdf/be/48/molce-39-6-460.PMC4916397.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/be/48/molce-39-6-460.PMC4916397.pdf
"Cells 2016; 39(6): 468-476  http://dx.doi.org/10.14348/molcells.2016.0004                        PLZF+ Innate T Cells Support the TGF --Dependent   Generation of Activated/Memory -Like Regulatory   T Cells     Byung Hyun Kang1, Hyo Jin Park2,4, Hi Jung Park1, Jae -Il Lee1,3, Seong Hoe Park1,3, and   Kyeong Cheon Jung1,2,3,5,*      PLZF -expressing invariant natural killer T cells and CD4 T  cells are unique subsets of innate T cells.",Non-OADS,/arxiv_data1/oa_pdf/87/65/molce-39-6-468.PMC4916398.pdf
"Unlike mouse thymocytes,  human fetal thymocytes express  Molecules   and  Cells   http://molcells.org     Established in 1990     eISSN: 0219 -1032  The Korean Society for Molecular and Cellular Biology.",Non-OADS,/arxiv_data1/oa_pdf/87/65/molce-39-6-468.PMC4916398.pdf
"To  view a copy of this  license, visit  http://creativecommons.org/licenses/by -nc-sa/3.0/ .",Non-OADS,/arxiv_data1/oa_pdf/87/65/molce-39-6-468.PMC4916398.pdf
"Cells  http://molcells.org      (Beckton Dicki nson, USA).",OADS,/arxiv_data1/oa_pdf/87/65/molce-39-6-468.PMC4916398.pdf
Cells  http://molcells.org       A                      B                       The generation of activated/memory -like regulatory T cells  depends on IL -4 produced by thymic PLZF+ innate T cells.,Non-OADS,/arxiv_data1/oa_pdf/87/65/molce-39-6-468.PMC4916398.pdf
Cells  http://molcells.org        Airway inflammation is efficiently suppressed  by Treg cells from the CIITATgPIV-/- mice.,Non-OADS,/arxiv_data1/oa_pdf/87/65/molce-39-6-468.PMC4916398.pdf
Cells  http://molcells.org      required for development of CD4+ T cells selected by homotypic  thymocyte interaction.,Non-OADS,/arxiv_data1/oa_pdf/87/65/molce-39-6-468.PMC4916398.pdf
"Cells 2016; 39(6): 477-483  http://dx.doi.org/10.14348/molcells.2016.0027                    Overexpression of Heat Shock Factor Gene HsfA3  Increases Galactinol Levels and Oxidative Stress Tolerance in Arabidopsis     Chieun Song1, Woo Sik Chung1,2, and Chae Oh Lim1,2,*      Heat shock factors (Hsfs) are central regulators of abiotic  stress responses, especially heat stress responses, in plants.",Non-OADS,/arxiv_data1/oa_pdf/0b/be/molce-39-6-477.PMC4916399.pdf
"Additionally, HsfA3 regulates the  expression of many heat-inducible genes in the transcriptional  cascade downstream of the K homology (KH) domain-containing nucleus-localized putative RNA-binding protein (RCF3) Molecules and Cells http://molcells.org   Established in 1990     eISSN: 0219-1032   The Korean Society for Molecular and Cellular Biology.",Non-OADS,/arxiv_data1/oa_pdf/0b/be/molce-39-6-477.PMC4916399.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/.",Non-OADS,/arxiv_data1/oa_pdf/0b/be/molce-39-6-477.PMC4916399.pdf
"Cells http://molcells.org      stress-regulatory system, an important upstream regulator of  the HSR in Arabidopsis (Guan et al., 2013).",OADS,/arxiv_data1/oa_pdf/0b/be/molce-39-6-477.PMC4916399.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/0b/be/molce-39-6-477.PMC4916399.pdf
"Cells http://molcells.org     RESULTS    HsfA3  transcription is induced by oxidative stress   treatment  To verify the effect of oxidative stress on HsfA3  expression,  we exposed 10-day-old WT plants to exogenous H 2O2 or to  the endogenous H 2O2 propagator  DBMIB (Ślesak et al., 2003)  under low light conditions.",Non-OADS,/arxiv_data1/oa_pdf/0b/be/molce-39-6-477.PMC4916399.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/0b/be/molce-39-6-477.PMC4916399.pdf
Cells http://molcells.org     Table 1.,OADS,/arxiv_data1/oa_pdf/0b/be/molce-39-6-477.PMC4916399.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/0b/be/molce-39-6-477.PMC4916399.pdf
"Cells 2016; 39(6): 484-494  http://dx.doi.org/10.14348/molcells.2016.0049                    RNA-Seq Analysis of the Arabidopsis  Transcriptome  in Pluripotent Calli     Kyounghee Lee1, Ok-Sun Park2, and Pil Joon Seo1,2,*      Plant cells have a re markable ability to induce pluripotent  cell masses and regenerate whole plant organs under the appropriate culture conditions.",OADS,/arxiv_data1/oa_pdf/0a/bb/molce-39-6-484.PMC4916400.pdf
Molecules and Cells http://molcells.org   Established in 1990     eISSN: 0219-1032   The Korean Society for Molecular and Cellular Biology.,OADS,/arxiv_data1/oa_pdf/0a/bb/molce-39-6-484.PMC4916400.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/.",Non-OADS,/arxiv_data1/oa_pdf/0a/bb/molce-39-6-484.PMC4916400.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/0a/bb/molce-39-6-484.PMC4916400.pdf
"Gene ontology (GO) term  enrichment analysis   Gene functional annotation analysis for DEG list was performed using the DAVID tool (http://david.abcc.ncifcrf.gov/) (Huang et  al., 2009) to understand the biological meanings behind a large  list of genes.",OADS,/arxiv_data1/oa_pdf/0a/bb/molce-39-6-484.PMC4916400.pdf
Cells http://molcells.org      A                    B                                      Fig.,Non-OADS,/arxiv_data1/oa_pdf/0a/bb/molce-39-6-484.PMC4916400.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/0a/bb/molce-39-6-484.PMC4916400.pdf
Cells http://molcells.org     Table 1.,OADS,/arxiv_data1/oa_pdf/0a/bb/molce-39-6-484.PMC4916400.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/0a/bb/molce-39-6-484.PMC4916400.pdf
Cells http://molcells.org      Fig.,Non-OADS,/arxiv_data1/oa_pdf/0a/bb/molce-39-6-484.PMC4916400.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/0a/bb/molce-39-6-484.PMC4916400.pdf
Cells http://molcells.org      A                      B                     Fig.,Non-OADS,/arxiv_data1/oa_pdf/0a/bb/molce-39-6-484.PMC4916400.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/0a/bb/molce-39-6-484.PMC4916400.pdf
"Cells http://molcells.org     Melton, D.A.",Non-OADS,/arxiv_data1/oa_pdf/0a/bb/molce-39-6-484.PMC4916400.pdf
"Cells 2016; 39(6): 495-500  http://dx.doi.org/10.14348/molcells.2016.0055                    Crystal Structure of Hypothetical Fructose-Specific  EIIB from Escherichia coli     Jimin Park1,5, Mi-Sun Kim1,5, Keehyung Joo2,5, Gil-Ja Jhon3, Edward A. Berry4, Jooyoung Lee2,*, and  Dong Hae Shin1,*     We have solved the crystal structure of a predicted fruc- tose-specific enzyme IIB fruc from Escherichia coli  (EcEIIBfruc)  involved in the phosphoenolpyruvate-carbohydrate phos-photransferase system transferring carbohydrates across  the cytoplasmic membrane.",OADS,/arxiv_data1/oa_pdf/37/76/molce-39-6-495.PMC4916401.pdf
A PSI-BLAST  search (http://www.ncbi.nlm.nih.gov) of this sequence revealed around six hundred proteins with sequence identity above 35%  (Fig.,OADS,/arxiv_data1/oa_pdf/37/76/molce-39-6-495.PMC4916401.pdf
Based on the crystal structure analy-   Molecules and Cells http://molcells.org   Established in 1990     eISSN: 0219-1032   The Korean Society for Molecular and Cellular Biology.,OADS,/arxiv_data1/oa_pdf/37/76/molce-39-6-495.PMC4916401.pdf
"T o view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/.",Non-OADS,/arxiv_data1/oa_pdf/37/76/molce-39-6-495.PMC4916401.pdf
Cells http://molcells.org                                                                           Fig.,Non-OADS,/arxiv_data1/oa_pdf/37/76/molce-39-6-495.PMC4916401.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/37/76/molce-39-6-495.PMC4916401.pdf
Cells http://molcells.org      Fig.,Non-OADS,/arxiv_data1/oa_pdf/37/76/molce-39-6-495.PMC4916401.pdf
"In fact, the predicted secondary structure of the C-terminus of EcEIIB fruc calculated with  PSIPRED (http://bioinf.cs.ucl.ac.uk/psipred/) (Buchan et al., 2013) is a loop.",Non-OADS,/arxiv_data1/oa_pdf/37/76/molce-39-6-495.PMC4916401.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/37/76/molce-39-6-495.PMC4916401.pdf
Cells http://molcells.org     tide binding subunit B of A(1)A(0)  ATP synthases.,Non-OADS,/arxiv_data1/oa_pdf/37/76/molce-39-6-495.PMC4916401.pdf
"Cells 2016; 39(6): 501-507  http://dx.doi.org/10.14348/molcells.2016.0058                    Depletion of Inositol Polyphosphate   4-Phosphatase II Suppresses Callosal Axon  Formation in the Developing Mice     Liting Ji1, Nam-Ho Kim1, Sung-Oh Huh1,2,*, and Hae Jin Rhee2,*      The corpus callosum is a bundle of nerve fibers that con- nects the two cerebral hemispheres and is essential for coordinated transmission of information between them.",Non-OADS,/arxiv_data1/oa_pdf/74/50/molce-39-6-501.PMC4916402.pdf
Molecules and Cells http://molcells.org   Established in 1990     eISSN: 0219-1032   The Korean Society for Molecular and Cellular Biology.,OADS,/arxiv_data1/oa_pdf/74/50/molce-39-6-501.PMC4916402.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/.",Non-OADS,/arxiv_data1/oa_pdf/74/50/molce-39-6-501.PMC4916402.pdf
Cells http://molcells.org     MATERIALS AND METHODS    Animals  Timed pregnant mice of C57BL/6N strain were purchased from  Orient Bio (South Korea).,Non-OADS,/arxiv_data1/oa_pdf/74/50/molce-39-6-501.PMC4916402.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/74/50/molce-39-6-501.PMC4916402.pdf
Cells http://molcells.org      Fig.,Non-OADS,/arxiv_data1/oa_pdf/74/50/molce-39-6-501.PMC4916402.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/74/50/molce-39-6-501.PMC4916402.pdf
"Cells http://molcells.org     this report, we showed that INPP4B plays a role in the regula- tion of callosal axon formation by controlling the Satb2-positive pyramidal neuron population and axon polarization.",OADS,/arxiv_data1/oa_pdf/74/50/molce-39-6-501.PMC4916402.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/74/50/molce-39-6-501.PMC4916402.pdf
"Cells 2016; 39(6): 508-513  http://dx.doi.org/10.14348/molcells.2016.2170                    Protective Effects of Green Tea Polyphenol Against  Renal Injury Through ROS-Mediated JNK-MAPK Pathway in Lead Exposed Rats    Haidong Wang1, Deyuan Li2, Zhongze Hu2, Siming Zhao3, Zhejun Zheng2, and Wei Li1,*      To investigate the potential th erapeutic effects of polyphe- nols in treating Pb induced re nal dysfunction and intoxica- tion and to explore the detailed underlying mechanisms.",Non-OADS,/arxiv_data1/oa_pdf/df/90/molce-39-6-508.PMC4916403.pdf
"To our knowledge, no report has been made on the   Molecules and Cells http://molcells.org   Established in 1990     eISSN: 0219-1032   The Korean Society for Molecular and Cellular Biology.",Non-OADS,/arxiv_data1/oa_pdf/df/90/molce-39-6-508.PMC4916403.pdf
"T o view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/.",Non-OADS,/arxiv_data1/oa_pdf/df/90/molce-39-6-508.PMC4916403.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/df/90/molce-39-6-508.PMC4916403.pdf
Cells http://molcells.org      Fig.,Non-OADS,/arxiv_data1/oa_pdf/df/90/molce-39-6-508.PMC4916403.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/df/90/molce-39-6-508.PMC4916403.pdf
Cells http://molcells.org      Fig.,Non-OADS,/arxiv_data1/oa_pdf/df/90/molce-39-6-508.PMC4916403.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/df/90/molce-39-6-508.PMC4916403.pdf
